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 ABSTRACT 
The Liverpool Lung Project (LLP) risk model predicts an individual’s five-year 
absolute lung cancer risk. Smoking cessation has been identified as the most effective 
strategy for reducing lung cancer incidence, whilst tailored communications have been 
considered to be one of the most promising approaches to smoking cessation. The 
primary aim of this PhD project was therefore to examine whether the LLP 
intervention was associated with smoking cessation success and lung cancer risk 
perceptions among Stop Smoking Service (SSS) users. The LLP intervention was 
developed using the LLP risk model and involves calculation and communication of 
projected lung cancer risk, based on both smoking and non-smoking behaviour. A 
number of secondary aims pertaining to risk perceptions and smoking cessation are 
also considered and described in the main body of the thesis. 
 
The project adopted a mixed methods approach, integrating both quantitative and 
qualitative research components. In relation to the quantitative component, two 
randomised controlled trials were employed to evaluate the LLP intervention effect on 
smoking cessation success and lung cancer risk perceptions; baseline current smokers 
(n = 302) and baseline recent former smokers (n = 219) were recruited from a SSS in 
Liverpool, UK. All participants completed a baseline questionnaire, which considered 
socio-demographics, smoking behaviour, and lung cancer risk perceptions. Two 
separate single-blinded randomised controlled designs were implemented for baseline 
current and recent former smokers, whereby participants allocated to the intervention 
arm received the LLP intervention (based upon the LLP risk model). Follow-up 
smoking status and lung cancer risk perceptions were established at six months. 
Bivariate and multivariate analyses were undertaken to explore the strength of any 
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associations. Qualitative interviews were additionally undertaken with a sub-set of 
participants derived from the quantitative research component (n = 30). These 
interviews intended to explore factors implicated in smoking cessation success and 
smoking-related risk perception, thus complementing the additional findings of the 
quantitative research component. Interviews were transcribed and analysed using 
thematic analysis techniques. 
 
The analysis of baseline current smokers revealed that the LLP intervention failed to 
predict follow-up smoking status or lung cancer risk perceptions; however, the LLP 
intervention was found to predict follow-up smoking status among baseline former 
smokers (OR 1.91, 95% CI 1.03-3.55), but not lung cancer risk perceptions. This 
suggests that those who received the intervention were more likely to be classified as 
former smokers at follow-up. The qualitative results also provided insight regarding 
smoking-related risk perception and communication; issues such as perceived lack of 
control, risk contextualisation, and poor health literacy, were identified to be relevant 
components to smoking-related risk perception and communication. 
 
The results suggest that the intervention may predict follow-up smoking status among 
recent former smokers, although the trials entailed insufficient statistical power and 
therefore, an extension of recruitment or implementation of a larger trial is now 
required to build upon the results. Nevertheless, the current results contribute towards 
tobacco control research, practice and policy in various ways. For example, the 
delivery of the LLP intervention among recent former smokers in SSS, and potentially 
other healthcare settings, could improve smoking cessation rates and would require 
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little time and financial resources. In turn, improved smoking cessation success rates 
would lead to reduced smoking-related disease and associated deaths. 
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Chapter 1: Lung cancer risk factors and modelling 
1.1 Introduction 
Cancer is characterised by a “continuing, purposeless, unwanted, uncontrolled and 
damaging growth of cells that differ structurally and functionally from the normal cells 
from which they develop” (Stephens & Aigner, 2009, p. 3). Cancer presents itself in 
many forms; however, lung cancer is the most commonly diagnosed cancer 
worldwide. It was estimated that in 2012, there were 1.82 million new cases of lung 
cancer worldwide and 1.6 million lung cancer deaths (Ferlay et al., 2015). Lung cancer 
is not considered to be a single disease and rather, is typically accepted as being 
composed of several diseases, which are pathologically divided into two categories: 
(1) small cell lung cancer (SCLC); (2) non-small cell lung cancer (NSCLC). NSCLC 
represents more than 85% of all lung cancers and includes adenocarcinoma, squamous 
cell carcinoma and large cell carcinoma (National Comprehensive Cancer Network, 
2015). 
 
For NSCLC, surgery, radiotherapy, and chemotherapy are the most common treatment 
modalities, although targeted biological agents are becoming increasingly important 
(Baldwin, 2016). Comparatively, SCLC is a particularly aggressive malignancy; 
guidance recommends that localised SCLC should be treated with chemotherapy and 
radiotherapy, whilst chemotherapy is often considered to be a first-line treatment 
option for extensive SCLC (Heist, 2015). Unfortunately, most localised lung cancers 
cause no symptoms, which subsequently results in diagnosis at an advanced stage and 
sadly, such advanced cases have usually developed beyond curative treatment 
(Diederich et al., 2002; UyBico et al., 2010). Treatment options continue to evolve 
(Méry et al., 2015; Scott, Howington, Feigenberg, Movsas, & Pisters, 2007; White & 
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Pavlakis, 2008) but age-standardised five year survival for patients diagnosed with 
lung cancer during 2010-2011 in England and Wales, remains substantially low, at 
only 9.5% (Cancer Research UK [CRUK], 2014c). 
 
The poor prognosis associated with lung cancer has stimulated considerable effort 
directed towards lung cancer prevention. The most thoroughly documented causal 
relationship in the history of biomedical research is the positive correlation between 
tobacco smoking and lung cancer development (Alberg & Samet, 2003). Within the 
UK, it has been estimated that 86% of lung cancer cases are attributed to tobacco 
smoking (Parkin, 2011b). In addition to lung cancer, smoking has also been identified 
as a substantial contributor to a large range of other diseases, including cardiovascular 
disease (Kenfield, Stampfer, Rosner, & Colditz, 2008; Preston, Glei, & Wilmoth, 
2010), chronic obstructive pulmonary disease (COPD) (Forey, Thornton, & Lee, 
2011), peptic ulcers (Zhang et al., 2012), and at least a dozen other cancers (Baan et 
al., 2009). Overall, smoking-related ill health costs the National Health Service (NHS) 
an estimated £5.2 billion per year; approximately 5.5% of the total NHS budget 
(Allender, Balakrishnan, Scarborough, Webster, & Rayner, 2009).  
 
Smoking rates among men peaked at 82% in 1948 and among women, 45% in the 
mid-1960s; however, the health implications of smoking became more widely 
acknowledged within the UK between the mid-1970s and mid-1990s, resulting in a 
rapid decline in smoking rates (Action on Smoking and Health [ASH], 2015). Trends 
in lung cancer incidence rates reflect the trends in smoking prevalence in recent 
decades (see Figure 1). Consequently, smoking cessation has been highlighted as the 
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single most effective strategy to reduce lung cancer risk among the 1.3 billion smokers 
worldwide (Thun, DeLancey, Center, Jemal, & Ward, 2010).  
 
Although smoking cessation has been identified as a key strategy in reducing lung 
cancer incidence, tobacco control remains a continuous challenge. Smoking cessation 
success rates stand at a mere 1-5% of smokers per year (F. Song et al., 2002). In 1998, 
the Government produced a white paper, namely “Smoking Kills” (Department of 
Health [DH], 1998) in an attempt to address the burden associated with tobacco in the 
UK. Local Stop Smoking Services (SSS) were proposed as part of this initiative, 
providing pharmacotherapy products and behavioural support for smokers attempting 
to quit smoking. Although SSS have proven to be highly effective in reducing smoking 
prevalence (Ferguson, Bauld, Chesterman, & Judge, 2005; Judge, Bauld, Chesterman, 
& Ferguson, 2005), innovative and effective interventions would be welcomed to 
further improve smoking cessation rates. 
 
Risk perception has been described as “the subjective judgement that people make 
about the characteristics and severity of risk” (Lavino & Neumann, 2010, p. ix). 
Popular behaviour change theories and models have hypothesised that components, 
such as perceived vulnerability or risk of illness, contribute towards the 
implementation or maintenance of health protective behaviours. For example, 
Weinstein (1983, 1984) proposed that individuals may continue to practise unhealthy 
behaviours due to inaccurate perceptions of risk and susceptibility, known as 
optimistic bias (or unrealistic optimism). Previous research has suggested that 
providing smokers with personalised biomarker feedback in relation to smoking-
related disease may help to undermine optimistic bias among smokers, which could 
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result in enhanced motivation to stop smoking (Young, Hopkins, Smith, & Hogarth, 
2010).  
 
 
Figure 1. Smoking prevalence and lung cancer incidence, by sex in Great Britain 
between 1950 and 2010 (Smoking data is weighted as of 1998) (Wald & Nicolades-
Bouman, 1991; Office for National Statistics [ONS], 2013a; 2013b) 
 
The LLP risk model was developed based on data from an ongoing molecular-
epidemiological case-control study of lung cancer in Liverpool (J. K. Field, Smith, 
Duffy, & Cassidy, 2005). The risk model incorporates several lung cancer risk factors 
to predict an individual’s absolute five-year lung cancer risk, including smoking, age, 
gender, asbestos exposure (i.e. occupational exposure), prior malignant disease (other 
than lung), prior history of pneumonia, and family history of lung cancer. The model 
has been successfully validated in three independent and external populations from 
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Europe and North America, demonstrating good discrimination and evidence of 
predicted benefits for stratifying patients for lung cancer computerised tomography 
(CT) screening (Raji et al., 2012). The model also provides a means of communicating 
personalised lung cancer risk to smokers. Despite personalised risk communications 
being described as one of the most promising approaches to smoking cessation 
interventions (Velicer, Prochaska, & Redding, 2006), prior research has failed to 
examine the development, application, and evaluation of lung cancer risk models in 
the context of smoking cessation.  
 
The current PhD project entailed development of the “LLP intervention”, which 
utilises the LLP risk model to enable calculation and communication of projected lung 
cancer risk, based on both smoking and non-smoking behaviour. The primary 
objective of the PhD project was to apply and evaluate the LLP intervention among a 
population of smokers, to explore the effect on smoking cessation success and lung 
cancer risk perceptions. In brief, participants were approached during a selection of 
community groups, overseen by Liverpool’s commissioned SSS, Roy Castle FagEnds 
(RCFE). Participant consent was acquired and baseline questionnaires were completed 
to establish smoking status, among other factors. Baseline current and recent former 
smokers were randomised and analysed as two separate datasets, however, the 
procedure for both trials remained the same. Participants were randomised into one of 
two groups: (1) the intervention group, in which participants would be provided with 
generic lung cancer risk information and additionally, the LLP intervention, which 
entailed delivering personalised lung cancer risk projections based upon the LLP risk 
model; (2) the control group, in which participants would be provided with generic 
lung cancer risk information only. The groups were subsequently followed-up at six 
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months to examine whether any differences in follow-up smoking status and lung 
cancer risk perceptions occurred between the intervention and control groups. 
Secondarily, the thesis aimed to explore other factors implicated in smoking-related 
risk perception and smoking cessation success. The project incorporated quantitative 
and qualitative research methods to achieve these objectives. 
 
1.2 Thesis organisation 
Although the author of the thesis has a background in heath psychology, it was 
necessary to adopt a multidisciplinary approach to the research project, as the thesis 
draws upon many research disciplines, including biomedicine, epidemiology, 
psychology, public health, and sociology. Undertaking a multidisciplinary PhD project 
enriches the quality of the thesis, as the research can be explored from numerous 
perspectives; however, an understanding of various methodologies and analytical 
approaches is required to navigate and interpret a multidisciplinary thesis successfully. 
The author has therefore endeavoured to ensure that the thesis is clear and 
comprehendible to individuals from various research disciplines. 
 
The thesis is divided into nine chapters in total. This initial chapter not only introduces 
the PhD project, but additionally provides an overview of the key known lung cancer 
risk factors and lung cancer risk prediction models. The aim of this chapter is to 
identify and provide an understanding of the major risk factors for lung cancer, to 
appraise the risk prediction models that have been developed to incorporate risk 
factors, and to explore the application of such models. An awareness of lung cancer 
risk factors and models is important in demonstrating how the LLP risk model was 
developed and why this particular model was most relevant to the current project. 
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Chapter two presents a review of the literature in relation to smoking and risk 
perception. This chapter provides a profile of smokers in the UK, explores the 
predictors and associated mechanisms of smoking initiation and cessation, considers 
tobacco control strategies and interventions, and delivers an overview and review of 
risk perception theory applicable to the current project. Reviewing the literature not 
only informs the reader of current knowledge pertaining to tobacco control and 
behaviour change theory, but it additionally informs the current project design and 
subsequent analyses. 
 
Chapter three describes the current project methodology. The chapter firstly 
introduces the study aims and directs the reader towards each of the corresponding 
results chapters. The project design and justification is subsequently presented, 
whereby the mixed methods design adopted is discussed. Both quantitative and 
qualitative research methods are described, including details of participants, materials, 
and procedures, among other aspects. The analysis plans for both the quantitative and 
qualitative study components are described in detail within this chapter. 
 
Chapters four, five, six, seven and eight present the project results. Chapter four details 
the results of the bivariate and multivariate analyses undertaken to investigate the 
effect of the LLP intervention on follow-up smoking status and lung cancer risk 
perceptions. This chapter not only has implications for knowledge pertaining to 
smoking and risk, but additionally, positive results would demonstrate the benefit of 
delivering the LLP intervention in healthcare settings. 
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Chapter five presents further quantitative, as well as qualitative results. This chapter 
focuses on factors implicated in smoking-related risk perception. Quantitative 
analyses were undertaken to explore the effect of several baseline participant 
characteristics on perceived personal lung cancer risk, whilst, the qualitative analysis 
focuses upon exploring factors implicated in smoking-related risk perception. The 
qualitative results for this chapter discuss two prominent themes associated with 
smoking-related risk perception: (1) Increased risk awareness; (2) Denying risk. The 
results are discussed collectively to demonstrate the benefit of mixed methods 
research. Exploring factors implicated in smoking-related risk perception will 
contribute towards improved risk communication design, as well as increased 
knowledge regarding smoking-related risk perception. 
 
Chapter six explores factors implicated in smoking cessation success and refers to the 
results of the quantitative research component. Predictors of smoking status were 
explored across three datasets. Firstly, a cross-sectional analysis of all participants 
recruited in the current project (N = 521) was undertaken. Secondly, an analysis of 
baseline current smokers was undertaken (n = 297) to explore all potential baseline 
participant characteristics implicated in follow-up smoking status. Lastly, an analysis 
of baseline recent former smokers was conducted (n = 216) to explore the predictors 
of follow-up smoking status. The results are considered collectively to provide a 
detailed interpretation of potential baseline participant characteristic predictors of 
smoking status; in doing so, a better understanding of smoking behaviour can be 
achieved, which in turn may contribute towards improved smoking cessation support. 
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Chapters seven and eight present the remaining qualitative findings; both chapters 
explore factors implicated in smoking cessation success. These chapters provide the 
reader with further insight into the various influential factors associated with smoking 
cessation and the degree to which smoking cessation is viewed as severely 
challenging. Chapter seven focuses on psychosocial aspects of smoking and smoking 
cessation. Participants described motivating factors for quitting and sustaining 
abstinence, including a range of perceived benefits. Furthermore, participants 
described the experience of mental conflict upon engaging in a quit attempt. This 
chapter considers two major themes: (1) Experiences of mental conflict; (2) Perceived 
benefits of quitting. Chapter eight focuses on issues primarily related to tobacco 
control practice and policy; the results demonstrate the key features of tobacco control 
that participants perceived to either encourage or inadvertently deter smoking 
cessation. This chapter considers two major themes: (1) Reshaping social norms; (2) 
Attitudes regarding local Stop Smoking Services.  
 
Chapter nine is the final chapter of the PhD thesis. This chapter will draw upon the 
project results overall and demonstrate how the results of the quantitative and 
qualitative aspects of the project combine to complement each other and provide a rich 
understanding of smoking behaviour and risk perception. Each of the study aims are 
referred to and reflected upon. The research contribution in terms of tobacco control 
knowledge, practice and policy is explored. Future research directions are considered, 
followed by a conclusion, in which a summary of the key results and an overview of 
the project implications are presented. 
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Having provided an overview of the thesis organisation, the current chapter will now 
proceed to explore lung cancer incidence and survival, lung cancer risk factors, and 
lung cancer risk models. Providing insight into these important aspects of research 
provides the reader with background and justifies the adoption and application of the 
LLP risk model in the current project. 
 
1.3 Lung cancer incidence and survival 
Throughout the 20th century, the importance of lung cancer as a cause of death has 
increased. In the early 1900s, lung cancer was very rare and caused the deaths of less 
than 10 men annually per 100,000 (CRUK, 2007). Lung cancer deaths rose six-fold in 
men and three-fold in women by the 1950s. This increase prompted the first 
epidemiological study in the UK, which resulted in a confirmed association between 
smoking and lung cancer (Doll & Hill, 1950). From the early 1970s, lung cancer rates 
began to decline in the developed world. 
 
In 2012, 35,903 new cases of lung cancer were diagnosed in England, making lung 
cancer the second most common cancer for both males and females in England; lung 
cancer accounted for 11.9% of cancer cases among females and 13.6% of cancer cases 
among males (ONS, 2014b). According to CRUK (2013), lifetime risk of developing 
lung cancer within the UK in 2008, has been estimated at 1 in 14 for males and 1 in 
18 for females. Lung cancer is the primary cause of death in the UK, as reports estimate 
that 30,437 deaths across England and Wales were attributed to lung cancer in 2013 
(ONS, 2014c). Despite some improvements in survival rates over past decades, five-
year survival rate in England for 2010-2012 was recently reported at 12.7% (Walters 
et al., 2015). 
11 
 
 
1.4 Lung cancer risk factors 
A variety of risk factors have been associated with lung cancer. This section will 
concentrate on the lung cancer risk factors incorporated in the LLP risk model, 
including age, gender, smoking, occupational exposure (e.g. asbestos), prior malignant 
disease, prior lung disease (e.g. pneumonia), and family history of lung cancer. Other 
known epidemiological risk factors not included in the LLP risk model, yet worthy of 
discussion, will lastly be described. It is important to establish lung cancer risk factors, 
as such knowledge may enable identification of particularly high-risk groups, 
prompting implementation of risk prevention strategies.  
 
1.4.1 Age 
Lung cancer is strongly associated with age, as older people are more likely to develop 
the disease. Age-specific incidence of lung cancer rises dramatically from age 40 
years, peaking at the 85-89 age range overall (CRUK, 2013). Furthermore, in the UK, 
approximately three quarters of lung cancer cases were diagnosed among individuals 
aged 65 years and above in the UK between 2010 and 2012, whilst 87% of cases were 
diagnosed among individuals aged 60 years and over (CRUK, 2013). The mechanisms 
for age-related increases in cancer incidence are considered complex; however, the 
multistep model of cancer, which proposes that several sequential mutations are 
necessary for a cell to become malignant, advocates that carcinogen exposure duration 
is a primary cancer risk factor (de Magalhães, 2013). 
 
Age is additionally associated with lung cancer mortality, as deaths are highest among 
older people. For example, whilst 30% of lung cancer deaths have been reported 
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among individuals aged 80 years and over, only 27% of lung cancer cases were 
reported among individuals of the same age range (CRUK, 2014a). Since many lung 
cancer patients are elderly, they often present with co-morbid difficulties, deeming 
them unsuitable for radical treatment (Gould & Pearce, 2006); this may therefore 
contribute towards the increase in age-specific lung cancer deaths among older people. 
 
1.4.2 Gender 
Males consistently display higher lung cancer incidence compared to females (Ferlay 
et al., 2010). Consequently, more males than females die in England and Wales each 
year due to lung cancer. In 2013, 13,619 female lung cancer deaths were registered, 
whereas, 16,818 male lung cancer deaths were registered (ONS, 2014c). This 
significant difference in incidence between genders is likely to be due to males 
exhibiting higher rates of smoking, among other lifestyle choices, compared with 
females (e.g. ASH, 2014b). 
 
Despite greater prevalence of smoking and lung cancer among males, it has been 
suggested that females may be as, if not more, susceptible to lung cancer than males. 
During the late 1980s and 1990s, a number of case-control studies, were published, 
providing support for this suggestion (Brownson, Chang, & Davis, 1992; Lubin & 
Blot, 1984; Osann, Anton-Culver, Kurosaki, & Taylor, 1993; Risch et al., 1993; 
Schoenberg et al., 1990; Zang & Wynder, 1996). Engeland, Haldorsen, Andersen, and 
Tretli (1996) published the first prospective cohort study, which examined lung cancer 
susceptibility between males and females. A large number of participants (N = 26,000) 
were recruited in 1965 and followed-up from 1966 to 1993. The results suggested that 
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female current smokers exhibited a relative risk (RR) that was 2.3 times higher, 
compared with male current smokers (95% CI 1.3-4.1). 
 
More recent cohort studies have contradicted much of the earlier research, as they have 
tended to report no significant difference in lung cancer risk between males and 
females (Bain et al., 2004; N. D. Freedman, Leitzmann, Hollenbeck, Schatzkin, & 
Abnet, 2008; Jemal, Travis, Tarone, Travis, & Devesa, 2003; Kreuzer et al., 2000; 
Prescott et al., 1998). Furthermore, Y. Yu et al. (2014) recently conducted a systematic 
review and meta-analysis including 47 articles, containing 404,874 participants. 
Compared to non-smokers, male to female ratio of RR was 1.61 (95% CI 1.37-1.89) 
among current smokers. The authors also highlight how this finding conflicts with the 
traditional perspective that females may be more susceptible to lung cancer that is 
attributed to smoking tobacco. 
 
Interpretation of such conflicting results has therefore proven challenging. Donington, 
Le, and Wakelee (2006) highlighted considerations that should be made towards 
biases in the data, which can substantially impact comparisons of lung cancer risk 
made in respect to gender, such as inaccurate reporting of smoking habits and the 
confounding effects of passive smoke.  
 
Regardless of gender differences, Patel (2005) suggested that lung cancer is 
biologically a different disease among females compared to males. Adenocarcinoma 
has been found to occur more commonly among females, whereas squamous cell 
carcinoma has been found to occur more often among males (Ringer, Smith, Engel, 
Hendy, & Lang, 2005; Thun et al., 1997). The reported lung cancer disparity in relation 
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to gender, could be attributed to various factors, including genetic and epigenetic 
differences, gender-specific lifestyle factors, behavioural components, and sex 
hormones (Paggi, Vona, Abbruzzese, & Malorni, 2010). Further research is necessary 
to understand the extent to which this disparity exists and the impact of factors that 
may potentially contribute towards such differences. 
 
1.4.3 Smoking 
Doll and Hill (1950) were among the earliest researchers to establish the causal link 
between smoking and lung cancer. Since this time, numerous epidemiological studies 
and reviews have consistently identified tobacco smoking as a key risk factor for lung 
cancer (e.g. Powell, Iyen-Omofoman, Hubbard, Baldwin, & Tata, 2013; Pavlovska et 
al., 2008; Thun et al., 1997). The causal role of smoking in lung cancer mortality has 
been irrefutably recognised in longitudinal studies, one of which has spanned 50 years 
(Stampfer, 2004). Smokers have a 20-fold risk of developing lung cancer, compared 
to non-smokers (Alberg & Samet, 2003) and it has been estimated that the cumulative 
risk of death from lung cancer by age 75 among current smokers is 16% (Peto et al., 
2000). 
 
Tobacco smoke has been found to contain approximately 4,000 chemical compounds, 
including at least 69 potent respiratory carcinogenic properties, which damage cells 
within the lungs and often contribute toward lung cancer (International Agency for 
Research on Cancer [IARC], 2004). Such carcinogens, including “nicotine-derived 
nitrosaminoketone” (NNK) and “polycyclic aromatic hydrocarbons” (PAHs) require 
metabolic activation to apply their carcinogenic effects. The process of metabolic 
activation leads to the formation of DNA adducts, which are critical in the 
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carcinogenic process (Hecht, 2003). DNA adducts can potentially be repaired by 
repair enzymes, whereby DNA can return to its normal undamaged state (Hecht, 
1999); however, if the adducts persist during DNA replication, miscoding can occur, 
which results in a permanent mutation in the DNA sequence (Shrivastav, Li, & 
Essigmann, 2010). Cells with DNA damage may be removed by apoptosis 
(programmed cell death) but if a permanent mutation occurs in a critical region of an 
oncogene (a gene with the potential to cause cancer) or a tumour suppressor gene (a 
gene that protects a cell from an element of the cancer process), this can lead to 
activation of an oncogene or deactivation of the tumour suppressor gene (Croce, 
2008). Multiple events of this type result in loss of normal cellular growth-control 
regulation and ultimately, cancer (Wogan, Hecht, Felton, Conney, & Loeb, 2004).  
 
Smoking is a risk factor for all histological types of lung cancer, although the relative 
risk has been reported as highest for squamous-cell carcinoma (SCC) and SCLC, 
compared with adenocarcinoma (Simonato et al., 2001). Despite this, there have been 
dramatic increases in adenocarcinoma incidence within recent decades. For example, 
in the United States, the ratio of SCC compared with adenocarcinoma was about 18:1 
in 1950, whereas it was estimated at 1.2-1.4:1 in 1995 (Wynder & Muscat, 1995). A 
recent international study demonstrated how adenocarcinoma rates have surpassed 
those among the previous most frequent sub-type, SCC (Lortet-Tieulent et al., 2014). 
Such trends have been attributed to changes in smoking behaviour, such as cigarette 
design and manufacturing technology throughout the late 20th century. For example, 
average cigarette nicotine and tar delivery decreased respectively from 2.7 and 38mg 
in 1955, to 0.9 and 12mg in 1997 (Hoffmann, Djordjevic, & Hoffmann, 1997). 
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Choice of tobacco product used has been found to contribute towards lung cancer risk 
(Peter N. Lee, 2001; P. N. Lee, Foley, & Coombs, 2012). For example, P. N. Lee et 
al. (2012) conducted a meta-analysis to investigate epidemiological evidence in the 
1900s associating smoking with lung cancer, whereby they identified 287 studies. 
They found that hand-rolled cigarettes were associated with higher lung cancer risk 
overall, compared with manufactured cigarettes (random-effects RR 1.29, 95% CI 
1.12-1.49). Lung cancer incidence was also lower with use of filtered cigarettes 
compared to non-filtered cigarettes (RR 0.69, 95% CI 0.61-0.78); however, research 
suggests that smokers who move from non-filtered cigarettes to filtered cigarettes 
compensate by increasing the number of cigarettes per day, thus compensation acts as 
a lung cancer risk factor in itself (Augustine, Harris, & Wynder, 1989). Although 
unfiltered (or plain) cigarettes have become almost unheard of in England presently, 
hand-rolled cigarettes have become more prevalent within the past decade (ONS, 
2013b). 
 
Cigar and pipe smokers additionally exhibit significantly greater lung cancer risk, 
compared with never smokers, yet the risk is substantially less than it is among 
cigarette smokers (Shaper, Wannamethee, & Walker, 2003). This lower risk is 
believed to be attributed to a lesser amount of tobacco smoked and inhaled among 
cigar and pipe smokers (Boffetta et al., 1999). It should be noted, however, that 
cigarettes have remained the most commonly used form of tobacco in the UK since 
the early 20th century (Wald & Nicolaides-Bouman, 1991) and the popularity of cigars 
and pipes has dramatically decreased in past decades. In Great Britain, a mere 2% of 
males have reported smoking at least one cigar a month and less than 0.5% of males 
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stated they smoked a pipe; cigar and pipe smoking among females is even rarer than 
it is among males (S. Robinson & Harris, 2011). 
 
In addition to tobacco product use, cigarette design, and manufacturing technology, 
other smoking variables have been found to contribute towards lung cancer incidence, 
particularly smoking duration and number of cigarettes smoked per day (S. A. Khuder, 
2001; P. N. Lee et al., 2012; S. Yu & Zhao, 1996). For example, S. A. Khuder (2001) 
conducted a meta-analysis to explore the effect of smoking on major histological types 
of lung cancer. Heavier smokers (≥ 30 cigarettes per day) exhibited increased risk of 
adenocarcinoma (odds ratio [OR] 4.10, 95% CI 3.16-5.31) and SCLC (OR 18.3, 95% 
CI 9.26-36.4), whilst smokers with greater smoking durations (≥ 40 years) additionally 
exhibited increased risk of adenocarcinoma (OR 3.80, 95% CI 2.35-6.16) and SCLC 
(OR 38.6, 95% CI 11.9-125). 
 
There is a large amount of research that has demonstrated that ex-smokers convey a 
lower risk of developing lung cancer, in comparison to current smokers (Ebbert et al., 
2003; Gellert, Schottker, & Brenner, 2012; Peto et al., 2000; Pirie, Peto, Reeves, 
Green, & Beral, 2013). Peto et al. (2000) identified the cumulative risk of lung cancer 
death up to age 75 years as 10%, 6%, 3% and 2% for men who quit smoking at ages 
60, 50, 40 and 30, respectively. Such research identifies that the reduction in risk 
decelerates as smoking duration and age at smoking cessation increases but 
additionally, the research suggests that smokers who quit well into late-middle age 
could avoid a great proportion of their subsequent lung cancer risk. Although many 
ex-smokers will never return to the risk level of a never smoker due to genetic damage 
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incurred (Peto et al., 2000), smoking cessation is evidently an effective strategy in 
significantly reducing lung cancer risk among smokers. 
 
1.4.4 Occupational exposure 
Occupational exposure refers to contact with carcinogenic properties in the workplace, 
such as asbestos. In 2010, it has been estimated that20.5% of lung cancers among men 
and 4.3% among women have been found to be attributed to occupational exposures 
in the UK (Parkin, 2011a). Better insight into the carcinogenicity of chemical and 
physical agents has been achieved through investigating occupational groups, 
consisting of individuals who have been heavily exposed to such agents within the 
workplace. Research has identified that individuals working in specific occupations 
are at increased lung cancer risk, such as painters (Guha et al., 2011), asbestos cement 
workers (Magnani et al., 2008), hairdressers (Takkouche, Regueira-Mendez, & 
Montes-Martinez, 2009), asphalt workers and roofers (Partanen & Boffetta, 1994), 
printers (Lynge et al., 1995), rubber industry workers (Kogevinas et al., 1998), 
aluminium smelter workers (Selden, Westberg, & Axelson, 1997), iron and steel 
workers (Grimsrud, Langseth, Engeland, & Andersen, 1998), and workers exposed to 
high levels of lead (Anttila et al., 1995). Rushton et al. (2010) found that the three 
greatest risk factors of occupation-attributable lung cancer registrations in 2005, 
included asbestos, silica, and diesel exhaust, accounting for 41%, 17%, and 13% of all 
occupation-attributable cancer registrations, respectively. 
 
Asbestos consists of naturally occurring silicate minerals, often used commercially 
due to their desirable physical properties. Exposure to asbestos is commonly cited as 
a risk factor among both non-smokers and smokers (Brown, Darnton, Fortunato, & 
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Rushton, 2012; Cogliano et al., 2011; P. N. Lee, 2001; Subramanian & Govindan, 
2007) and it has been suggested that within Great Britain, asbestos-related lung 
cancers may have accounted for 2-3% of all lung cancer deaths between 1980 and 
2000 (Darnton, McElvenny, & Hodgson, 2006). An interaction between smoking and 
asbestos has also been documented. For example, Frost (2011) found that among a 
cohort of asbestos workers who smoked, approximately 3% of lung cancer deaths were 
attributable to asbestos alone, 66% were due to smoking alone, and 28% were due to 
the interaction between asbestos and smoking. Asbestos-attributed lung cancer relative 
risk has, however, been found to be dependent on various factors, including asbestos 
fibre type (Loomis et al., 2012), asbestos dose (Gustavsson et al., 2002) and asbestos 
assessment method (Lenters et al., 2011). 
 
Silicosis is a form of occupational lung disease, which develops as a result of 
inhalation of the chemical compound, silica. Erren, Morfeld, Glende, Piekarski, and 
Cocco (2011) reported a fixed-effects relative lung cancer risk of 2.1 (95% CI 2.0-2.3) 
among individuals affected by silicosis, utilising 38 studies. A dose-response 
relationship has also been documented between silica exposure and lung cancer risk 
(Lacasse, Martin, Gagne, & Lakhal, 2009), although the existing literature is 
somewhat ambiguous as to whether silica exposure increases lung cancer risk without 
silicosis (Brown, 2009). Checkoway and Franzblau (2000) suggested that efforts to 
fully comprehend the role of silica as a lung cancer risk factor have been hampered 
due to incomplete or biased ascertainment of silicosis, inadequate exposure 
assessment, and the inherently strong correlation between silicosis and silica exposure. 
Furthermore, Kurihara and Wada (2004) undertook a meta-analysis which examined 
the relationships between silica, smoking and lung cancer. The findings revealed that 
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cigarette smoking significantly increased lung cancer risk among those previously 
exposed to silica (RR 4.47, 95% CI 3.17-6.30). 
 
Diesel exhaust was additionally recently classified as a lung cancer risk factor (IARC, 
2012). Olsson et al. (2011) pooled information on lifetime work histories and tobacco 
smoking from 11 case-control studies conducted in Europe and Canada. The findings 
demonstrated increased lung cancer risk among individuals from the highest quartile 
of workers who reported diesel exposure, compared to those with no reported exposure 
(OR 1.31, 95% CI 1.19-1.43). Various professions involving high exposure to diesel 
have been associated with lung cancer risk, including mining (Silverman et al., 2012), 
railroad work (Garshick et al., 2004), and truck driving (Jarvholm & Silverman, 2003); 
however, epidemiological evidence has been assessed as limited, due to few studies 
reporting on exposure-response relationships and the majority of studies failing to 
adequately control for potential confounders (Olsson et al., 2011). For example, 
Larkin et al. (2000) examined the extent to which smoking may confound the 
relationship between diesel exhaust and lung cancer risk. Workers exposed to diesel 
exhaust exhibited greater risk prior to smoking adjustment (RR 1.58, 95% CI 1.14-
2.20), whilst adjustment for smoking presented significantly lower relative risk 
estimates (RR 1.44, 95% CI 1.01-2.05). A synergic effect on lung cancer risk between 
diesel exhaust exposure and smoking has been suggested (e.g. Pintos, Parent, 
Richardson, & Siemiatycki, 2012) but presently, evidence is limited. 
 
1.4.5 Prior malignant disease 
Lung cancer risk is associated with various forms of prior malignant disease, such as 
breast cancer (Lorigan, Califano, Faivre-Finn, Howell, & Thatcher, 2010), head and 
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neck cancer (Youlden & Baade, 2011), Hodgkin’s lymphoma (Ibrahim et al., 2013; 
Lorigan, Radford, Howell, & Thatcher, 2005), non-Hodgkin’s lymphoma (Morton et 
al., 2010; Mudie et al., 2006), testicular cancer (Travis et al., 2005), and uterine 
sarcoma (Koivisto-Korander et al., 2012). For example, Ibrahim et al. (2013) 
conducted a meta-analysis to examine lung cancer risk among patients who had 
survived Hodgkin’s lymphoma, which incorporated 21 studies and a median follow-
up of 11.5 years. Patients who had suffered Hodgkin’s lymphoma were significantly 
more likely to develop lung cancer compared to those who had not developed the 
disease (RR 4.62, 95% CI 3.18-6.70); however, relative risk varied in association with 
previous malignancy type. 
 
The exhibited increase in lung cancer risk among individuals with a history of 
malignant disease, has been primarily attributed to previous cancer treatment, 
including radiotherapy (Ibrahim et al., 2013; Lorigan et al., 2010; Lorigan et al., 2005; 
Travis et al., 2005), chemotherapy (Ibrahim et al., 2013; Lorigan et al., 2005; Mudie 
et al., 2006; Travis et al., 2005), or both (Ibrahim et al., 2013; Travis et al., 2005). For 
example, Travis et al. (2005) modelled relative risk of lung cancer, by compiling a 
cohort consisting of 40,576 one-year survivors of testicular cancer. They found that 
secondary cancer risk increased substantially, as a consequence of radiotherapy alone 
(RR 2.0, 95% CI 1.9-2.2), chemotherapy alone (RR 1.8, 95% CI = 1.3-2.5), and both 
(RR 2.9, 95% CI 1.9-4.2). A more recent study (Lorigan et al., 2010) explored the 
effect of breast cancer treatment on lung cancer risk and argued that radiotherapy only 
predicted lung cancer among patients who had experienced older treatment 
techniques. These findings suggest that more modern radiotherapy techniques, may 
contribute towards little, if any, increase in lung cancer risk. 
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1.4.6 Prior lung disease 
In addition to previous cancer diagnosis, it has also been suggested that prior lung 
disease is associated with lung cancer risk. A number of recent meta-analyses have 
confirmed relationships between various prior lung diseases and lung cancer risk, 
including chronic obstructive pulmonary disease (COPD), chronic bronchitis, 
emphysema, tuberculosis, and pneumonia (Brenner et al., 2012; Brenner, McLaughlin, 
& Hung, 2011; Denholm et al., 2014). For example, lung cancer risk is often reported 
as elevated among individuals with a previous diagnosis of pneumonia. Brenner et al. 
(2012) conducted a meta-analysis that incorporated 17 studies, including 24,607 cases 
and 81,829 controls. The studies were primarily conducted across Europe and North 
America, between 1984 and 2011, to explore the effect of a range of prior lung diseases 
on lung cancer incidence. Based on 12 studies investigating pneumonia, they found 
that individuals with a previous history of pneumonia exhibited increased lung cancer 
risk (RR 1.57, 95% CI 1.22-2.01). Denholm et al. (2014) also conducted a pooled 
analysis on previous lung disease, utilising 12,739 cases and 14,945 controls from 
seven case-control studies. They observed a positive effect of pneumonia on lung 
cancer risk among men (OR 3.31, 95% CI 2.33-4.70), however, the significance of 
this effect diminished upon including patients with a diagnosis of pneumonia more 
than two years prior to developing lung cancer. 
 
Schabath et al. (2005) suggested that prior lung disease can create long term 
inflammation within the bronchi, accompanied by a continual cycle of injury and 
repair; such damage is believed to contribute towards lung carcinogenesis. More 
recently, various researchers have highlighted possible methodological limitations, 
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which may have contributed towards the documented relationship (Brenner et al., 
2012; Brenner et al., 2011; Denholm et al., 2014). Brenner et al. (2011) suggested that 
reverse causality (whereby infections may have been the result of a weakened immune 
system due to undiagnosed early lung cancer), misdiagnosis (whereby a patient may 
have exhibited symptoms of early lung cancer, which were misdiagnosed as other lung 
disease), and detection bias (whereby individuals with disease such as tuberculosis or 
pneumonia may be more likely to be diagnosed with lung cancer as a result of 
additional diagnostic tests often used in infections), may partly contribute towards the 
evident association. The identified methodological limitations corroborate with 
Denholm et al.’s (2014) aforementioned findings regarding the relationship between 
pneumonia and lung cancer risk. The true extent of prior lung disease on lung cancer 
risk and the associated mechanisms of the relationship have yet to be fully understood, 
highlighting the importance of ongoing research.  
 
1.4.7 Family history 
Research suggests that family history of lung cancer is an important predictor of lung 
cancer risk. A recent pooled analysis (Cote et al., 2012) utilised 24 case-control 
studies, totalling 24,380 cases and 23,305 controls. Having adjusted for smoking and 
other potential confounders, they found that individuals with a first-degree relative 
with lung cancer exhibited increased lung cancer risk (OR 1.51, 95% CI 1.39-1.63); 
this association was strongest among those with sibling family history of lung cancer 
(OR 1.82, 95% CI 1.62-2.05). 
 
Matakidou, Eisen, and Houlston (2005) previously conducted a systematic review of 
28 case-control, 17 cohort, and seven twin studies, exploring the relationship between 
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family history and lung cancer risk. The findings suggested that risk is greater among 
relatives of cases diagnosed at a younger age and among those with multiple affected 
relatives. Cassidy, Myles, Duffy, Liloglou, and Field (2006) explored the impact of 
age at diagnosis among a first-degree relative, using 579 cases and 1,157 controls. 
They found that individuals with a first-degree relative diagnosed with lung cancer 
below 60 years, exhibited increased risk of developing lung cancer, compared with 
those without family history (OR 2.08, 95% CI 1.20-3.59). Furthermore, individuals 
with a first-degree relative diagnosed with lung cancer below the age of 60 years, were 
substantially more likely to develop lung cancer below 60 years themselves, compared 
with participants who had no family history (OR 4.89, 95% CI 1.47-16.25).  
 
Matakidou et al. (2005) suggested that the association between family history and lung 
cancer risk is attributed to genetic susceptibility but additionally, to shared 
environmental exposures. Further research is required to distinguish the extent to 
which genetic and environmental factors contribute towards the association between 
family history of lung cancer and lung cancer risk. 
1.4.8 Other known risk factors 
The aforementioned lung cancer risk factors are all of relevance to the LLP risk model, 
which is the focus of the current project; however, several other epidemiological lung 
cancer risk factors have been acknowledged in the literature, which were not included 
in the LLP risk model, such as air pollution, involuntary smoking, and radon gas. To 
provide a fuller overview of all identified lung cancer risk factors, such factors are 
briefly discussed within this section. 
 
1.4.8.1 Air pollution 
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Outdoor air pollution, particularly carcinogenic airborne particulate matter, has been 
identified as a lung cancer risk factor (H. Chen, Goldberg, & Villeneuve, 2008; Hamra 
et al., 2014). According to CRUK (2014b), approximately 7.8% of lung cancer cases 
in the UK are attributed to PM2.5 particulate exposure per year. The strongest 
evidence suggests an increased risk among those exposed to nitrogen oxides (Masri et 
al., 2005; Vineis et al., 2006), which may be due to nitrogen oxide exposure being 
easier to measure than many other air pollutants, such as sulphur dioxide (Vineis et 
al., 2007). 
 
Traffic fumes have been identified as the main source of air pollution in urban areas 
and IARC (2012) states that diesel exhaust may increase lung cancer risk among the 
general public; however, the majority of evidence arguing the effect of diesel exhaust 
is derived from studies examining highly-exposed workers. Hamra et al. (2014) 
conducted meta-analyses including 18 studies, which explored the relationship 
between lung cancer and exposure to particulates, PM2.5 and PM10. They estimated 
increased lung cancer risk by 10 micrograms per cubic metre of air (μg/m3) increase 
in PM exposure and found that lung cancer risk increased with exposure to PM2.5 (RR 
1.09, 95% CI 1.04-1.14) and PM10 (RR 1.08, 95% CI 1.00-1.17). 
 
Indoor air pollution from solid fuel use for home cooking or heating (i.e. coal and 
biomass, such as wood) has additionally been associated with increased lung cancer 
risk (Galeone et al., 2008; Hosgood et al., 2011; Kurmi, Arya, Lam, Sorahan, & Ayres, 
2012; Lin, Murray, Cohen, Colijn, & Ezzati, 2008). For example, Kurmi et al. (2012) 
conducted a meta-analysis of 28 studies, in which they found that users of solid fuels 
were more likely to develop lung cancer, than non-users (RR 1.70, 95% CI 1.50-1.94); 
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however, indoor air pollution rarely involves UK samples, as solid fuel is used far less 
frequently in the UK compared to many other nationalities where excessive use may 
be problematic (Lissowska et al., 2005).  
 
1.4.8.2 Involuntary smoking 
Involuntary smoking (or passive smoking) has been defined as “the exposure of a non-
smoker to the smoke produced by active smoking” (Sasco, Secretan, & Straif, 2004, 
p. S8) and is often referred to as environmental tobacco smoke (ETS) or secondhand 
smoke (SHS). Oberg, Jaakkola, Woodward, Peruga, and Pruss-Ustun (2011) estimated 
that worldwide in 2004, 33%, 35% and 40% of male non-smokers, female non-
smokers, and children, were exposed to secondhand smoke, respectively. An estimated 
14.8% of never smoker lung cancer cases have been attributed to secondhand smoke 
in the UK (Parkin, 2011b). In January 1981, two studies were published documenting 
how never smoking women living with a spouse who smoked, exhibited increased risk 
of lung cancer (Hirayama, 1981; Trichopoulos, Kalandidi, Sparros, & MacMahon, 
1981). 
 
Since the early 1980s, a vast body of evidence has continued to demonstrate the 
carcinogenic effect of passive smoking. R. Taylor, Najafi, and Dobson (2007) 
conducted a meta-analysis of 55 studies, with the aim of investigating the effect of 
involuntary smoking on lung cancer risk. This meta-analysis unveiled that the overall 
relative risk of spousal exposure was 1.27 (95% CI 1.17-1.37) among females. 
Furthermore, Stayner et al. (2007) also conducted a meta-analysis, which focused on 
the effect of involuntary smoking on lung cancer, specific to the workplace. The 
analysis incorporated data from 22 studies and indicated that involuntary smoking in 
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the workplace was associated with increased lung cancer risk (RR 1.24, 95% CI 1.18-
1.29); workers classified as being highly exposed exhibited an even higher level of 
risk (RR 2.01, 95% CI 1.33-2.60). These findings support previous suggestions of a 
dose-response relationship between involuntary smoking and lung cancer, similarly to 
active smoking and lung cancer (A. K. Hackshaw, Law, & Wald, 1997; R. Taylor et 
al., 2007), demonstrating that there may be no threshold for tobacco carcinogenesis 
(Alberg & Samet, 2003). 
 
1.4.8.3 Radon gas 
Radon is a natural radioactive gas that comes from the minute amounts of uranium 
that occur naturally in rocks and soils (Health Protection Agency, 2012). The 
carcinogenicity of radon has been investigated in occupationally exposed populations, 
particularly among miners (Leuraud et al., 2011). Lung cancer risk has also been 
associated with residential exposure to radon, whereby radon has filtered into homes 
from the ground; increasingly so in granite rich areas. Pavia, Bianco, Pileggi, and 
Angelillo (2003) conducted a meta-analysis of residential exposure to radon gas and 
lung cancer and reported a pooled OR estimate of 1.24 (95% CI 1.11-1.38) lung cancer 
risk based on residential exposure at 150 becquerel (a derived unit of radioactivity) 
per cubic metre (Bq/m3). It should be noted that the majority of homes in the UK have 
reasonably low radon levels, with an average of approximately 20 Bq/m3 (Bowie & 
Bowie, 1991; Scivyer, 2001). 
 
Estimates are unclear, but residential radon exposure in the home is likely to be 
responsible for 0.5% of lung cancer cases in the UK (Parkin, 2011b). Radon exposure 
is associated with lung cancer risk among both smokers and non-smokers but the 
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relationship between smoking and radon has been identified as synergistic, in 
consideration of their effect on lung cancer risk (Lubin & Steindorf, 1995); 3% of lung 
cancer cases are attributed to the synergic effect of radon and smoking combined 
(Parkin, 2011b). Darby and Hill (2003) detailed that based on an indoor concentration 
of 400 Bq/m3, absolute lung cancer risk by the age of 85 was estimated at 2.2% for 
non-smokers and 49.3% for smokers. The aforementioned research further highlights 
the damaging effect of tobacco smoking in combination with additional factors. 
 
1.5 Risk modelling 
Within recent years, there has been growing interest in the development of methods to 
predict individual lung cancer risk. Cancer risk prediction models provide an 
important approach to risk assessment through identifying high-risk individuals, 
facilitating the design and planning of clinical trials, assisting with the development 
of benefit-risk indices, improving clinical decision making, and enabling the 
estimation of cancer burden and cost among a population (A. N. Freedman et al., 
2005); this highlights how the utilisation of risk prediction models can contribute 
towards controlling cancer-related morbidities and deaths. 
 
The number of risk prediction models developed in the field of health has steadily 
increased since the first risk prediction model for coronary heart disease was published 
in 1976 (Kannel, McGee, & Gordon, 1976). Gail et al. (1989) developed the first 
model to predict the likelihood of developing a specific form of cancer (breast) within 
a given period of time. More recent cancer risk prediction models have been developed 
to enable the identification of individuals at high-risk of developing various forms of 
cancer, including bladder, breast, cervical, colorectal, oesophageal, liver, melanoma, 
29 
 
ovarian, pancreatic, prostate, testicular, and lung cancer (National Cancer Institute, 
2014). 
 
The accuracy of a cancer risk prediction model relies on a number of factors, including 
the identification of risk factors, the accuracy of risk factor measurement, the 
appropriateness of the population, and the statistical techniques used for modelling 
(Cassidy, Duffy, Myles, Liloglou, & Field, 2007). In comparison to risk models 
developed in relation to breast cancer and other forms of cancer, few lung cancer risk 
prediction models had been developed up until the last decade (J. K. Field, 2008); 
however, lung cancer risk prediction models have advanced substantially within this 
limited time period, with more recent models incorporating biological and genetic 
data, in addition to clinical and epidemiological factors (Raji, Agbaje, Duffy, Cassidy, 
& Field, 2010). 
 
1.5.1 Key lung cancer risk prediction models 
Within the past decade, several lung cancer risk prediction models have been 
developed, incorporating a number of risk factors. Colditz et al. (2000) used grouped 
consensus data to develop an early lung cancer risk index. Lung cancer risk factors 
identified included tobacco smoking characteristics, family history, passive smoking, 
and air pollution, among other components. This index provides a simple estimation 
of personal cancer risk. The index may help individuals understand applicable risk 
factors and consider specific lifestyle changes that will reduce risk, but it does not 
provide precise, individualised information on risk.  
 
30 
 
Peto et al. (2000) investigated the impact of prolonged smoking and smoking cessation 
on lung cancer risk. Using case-control data, they estimated the cumulative risk of 
death from lung cancer by age 75 years among all current smokers and current smokers 
of at least 25 cigarettes per day to be 16% and 24%, respectively. They further 
provided the same cumulative lung cancer risk estimates for males who quit smoking 
at various ages. For example, a male who quits smoking at age 60 years is exposed to 
a 10% cumulative risk of lung cancer death by age 75, whereas, a male who quits at 
age 40 years is exposed to only a 3% cumulative risk. Again, this study provides a 
general guide regarding the relationship between smoking behaviours and lung cancer 
risk, although it fails to consider other key lung cancer risk factors. 
 
Bach et al. (2003) published the first study to utilise modern statistical modelling in 
the development of a lung cancer risk model. They used prospective data on 18,172 
current and former smokers to determine the extent to which lung cancer risk 
differentiates predictably among smokers. This risk prediction model calculates 10-
year lung cancer risk and the model considers age, sex, asbestos exposure and smoking 
history. A concordance index of 0.72 was reported, which was internally validated, 
suggesting moderate discrimination. Furthermore, model calibration was 
demonstrated as good. Cronin et al. (2006) assessed the validity of Bach et al.’s (2003) 
model among smokers (N = 6,239) in the placebo arm of the Alpha-Tocopherol, Beta-
Carotene Cancer Prevention Study (ATBC). They found that the risk model 
underestimated lung cancer risk, as expected cases were lower than observed cases 
(lung cancer cases expected/observed = 0.89, 95% CI 0.80-0.99). Although the model 
has contributed substantially to the domain of lung cancer risk prediction, it does yield 
several limitations. The population used to develop the model was derived from 
31 
 
participants involved in the Carotene and Retinol Efficacy Trial (CARET), a 
chemopreventive trial involving high-risk populations (see Omenn et al., 1994); 
therefore, the model cannot be applied to individuals within a general population and 
is only predictive for smokers aged 50-75 years of age, consuming 10-60 cigarettes 
per day, for 25-55 years.  
 
Spitz et al. (2007) developed three risk prediction models, calculating absolute one-
year lung cancer risk by using case-control data, consisting of 1,851 cases and 2,001 
controls. Subject data were randomly divided into either training (75%) or validation 
(25%) groups for never, former, and current smokers, with multivariate models being 
constructed from the training sets. They aimed to expand the risk factors included 
within Bach et al.’s (2003) model and therefore, Spitz et al.’s (2007) models 
incorporate environmental tobacco smoke, family history of cancer, dust exposure, 
prior respiratory disease and smoking history. The researchers assessed the 
discriminatory ability of the three models in the validation sets by examining the area 
under the receiver operating characteristic curve (AUC), which was identified for 
never, former, and, current smokers, as 0.57, 0.63, and 0.58, respectively, indicating 
limited discrimination. Hosmer-Lemeshow goodness-of-fit yielded a non-significant 
result, which is typically associated with good calibration; however, it has been argued 
that the statistics do not provide convincing evidence of good calibration 
(Tammemagi, 2015). 
 
The lung cancer risk prediction model most relevant to the current project, is the LLP 
risk model. Cassidy et al. (2008) developed a lung cancer risk prediction model for 
five-year lung cancer risk, based on 579 lung cancer cases and 1,157 age and sex 
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matched population-based controls. Various risk factors were entered into the model, 
including age, sex, history of pneumonia, asbestos exposure, previous cancer, family 
history of lung cancer, and smoking duration. The model was applied to the case-
control population, whereby the AUC was 0.71, suggesting good discrimination 
between cases and controls. Tammemagi (2015) argued that although the Hosmer-
Lemeshow goodness-of-fit was non-significant, the statistics did not provide 
substantial evidence of good calibration and furthermore, the model’s ability to predict 
risk among never smokers had not been demonstrated. However, the LLP risk model 
has been externally validated substantial in comparison to the majority of lung cancer 
risk prediction models. Raji et al. (2012) validated the LLP risk model within three 
independent populations (UK, Europe and North America). The findings suggested 
that the model demonstrated good discrimination and support for the utility of the LLP 
risk model in stratifying individuals for low-dose computerised-tomography (LDCT). 
More recently, the model has been applied to stratify high-risk individuals for 
participation in the UK Lung Cancer Screening Trial (UKLS) (see McRonald et al., 
2014), demonstrating its suitability for application in such contexts. 
 
D'Amelio et al. (2010) compared the aforementioned three models (Bach et al., 2003; 
Cassidy et al., 2008; Spitz et al., 2007) in an independent population, using data for 
3,197 lung cancer cases and 1,703 controls. The five-year lung cancer risk for each 
model was ascertained and the discriminatory power, accuracy and clinical utility of 
each were compared. The Spitz et al. model and the LLP risk model similarly 
outperformed the Bach et al. model in terms of discrimination between former and 
current smoking cases and controls, potentially due to the Spitz et al. and LLP models 
incorporating population-based incidence rates. In terms of accuracy, Spitz et al.’s 
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model displayed the highest positive predictive values (PPV; The probability of 
accurately categorising an affected participant), whereas the LLP model demonstrated 
the highest negative predictive values (NPV; The probability of accurately 
categorising an unaffected participant). With regard to clinical utility, the LLP risk 
model was superior in identifying a greater number of lung cancer cases than the other 
models. These findings are potentially attributed to the importance of tobacco smoking 
in the LLP risk model, whereas smoking status is a matching variable in Spitz et al.’s 
model, as opposed to a risk factor. Although, the LLP risk model was superior in 
identifying a greater number of lung cancer patients, it additionally, incorrectly 
recognised a large number of controls as lung cancer patients. 
 
When the current project design was originally conceived in 2012, the LLP risk model 
was selected as the most appropriate lung cancer risk prediction model to base the LLP 
intervention on for several reasons: the model demonstrates good specificity and 
accuracy in predicting lung cancer; it has been externally validated among a number 
of populations; it can be applied among individuals who are asymptomatic; it is not 
costly in terms of generating output (unlike some other models, which incorporate 
clinical or biological components); it can be administered simply by non-clinicians. 
 
Several lung cancer risk prediction models have been developed following the LLP 
risk model and therefore, these will also be discussed to provide a rounded overview 
of lung cancer risk models. Tammemagi et al. (2011) developed the Prostate, Lung, 
Colorectal and Ovarian Cancer (PLCO) lung cancer risk models, using data derived 
from the PLCO screening trial (Gohagan, Prorok, Hayes, & Kramer, 2000). Model 1 
consisted of all PLCO controls (N = 70,964), whereas Model 2 was developed among 
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smokers from the PLCO control group (N = 38,254). Both models incorporated several 
risk factors including age, socioeconomic status (based on education), family history 
of lung cancer, COPD, recent chest x-ray, smoking status, pack-years smoked, and 
smoking duration. The models demonstrate good calibration and discrimination; the 
AUCs were 0.84 and 0.78, for Model 1 and 2, respectively. The models were, however, 
limited in that the sample included individuals only between the ages of 55-74 years, 
who generally had a higher socio-economic status and additionally, data on asbestos 
exposure and other variables was not available to the researchers. Furthermore, the 
sample used to externally validate the models was derived from the same population 
used to develop the model development sample (i.e. the sample consisted of those 
within the PLCO intervention arm); therefore, the models may be less applicable 
among more general populations. A subsequent version of the PLCO model has since 
been developed into the PLCOm2012 (Tammemagi et al., 2013). This version includes 
a further two risk predictors (previous history of malignant disease and race/ethnicity) 
and omission of a previous predictor (recent chest x-ray). The revised model 
demonstrated improved discrimination, with an AUC of 0.80 and good calibration. 
Further external validation of the model would be of benefit. 
 
Hoggart et al. (2012) built separate lung cancer risk prediction models by utilising data 
acquired from ever smokers (N = 169,035) recruited from the European Prospective 
Investigation into Cancer and Nutrition (EPIC) (see Riboli et al., 2002). Separate 
models were developed for current, former and never smokers and the dataset was 
divided into independent training and test sets. Several risk factors were originally 
considered during the development of the model but the resulting model incorporated 
only age and smoking history. The ever smoker model demonstrated good predictive 
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accuracy, with an AUC reported to be 0.84 (95% CI 0.81-0.88) and also, good 
calibration. Although a model was considered for never smokers, preliminary analyses 
displayed substantially poor predictive accuracy, potentially due to missing data and 
inaccurate recording of some risk factors; therefore, Hoggart et al. (2012) failed to 
report results for never smokers. Furthermore, external validation of the model is 
warranted. 
 
A number of lung cancer risk prediction models have recently focused on attempting 
to identify patients at risk of lung cancer within primary care settings, by incorporating 
epidemiological and clinical predictors. Hippisley-Cox and Coupland (2011) derived 
and validated an algorithm, which attempted to identify individuals with suspected 
lung cancer in primary care, by incorporating various epidemiological and clinical risk 
factors, including a variety of symptoms (e.g. coughing). The algorithm was 
developed using 3,785 lung cancer cases, arising from 4,289,282 person-years in the 
cohort. The algorithms were found to explain 72% of variation and the AUC statistic 
was 0.92 for both males and females but little is mentioned in terms of calibration. 
Furthermore, Iyen-Omofoman, Tata, Baldwin, Smith, and Hubbard (2013) developed 
a lung cancer risk prediction model by incorporating 12,074 lung cancer cases and 
120,731 controls, derived from a large general practice database. Socio-demographic 
and clinical features were ascertained up to two years prior to diagnosis. Upon 
validation, the model demonstrated good discrimination, with an AUC of 0.88, 
although information on calibration was not provided Utilising general practice data 
is clearly useful in developing models of risk, although such models might fail to 
consider variation in primary care presentation among patients (e.g. Galda, Cheater, 
& Marshall, 2005). 
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The Liverpool Lung Project recently developed and internally validated the LLP risk 
prediction model for lung cancer incidence (or LLPi) (M. W. Marcus, Chen, Raji, 
Duffy, & Field, 2015). The LLP cohort (N = 8,760) was followed-up between a ten-
year period, using hospital episode statistics. Cox proportional hazards models were 
utilised to identify lung cancer risk predictors. The model incorporates several 
significant predictors, including age, gender, smoking duration, prior history of 
COPD, prior diagnosis of malignancy, and family history of early onset of lung cancer 
(< 60 years). The LLPi model demonstrated a C-statistic of 0.85 (95% CI 0.83-0.87), 
which was similar to the bias-corrected bootstrap resampling statistic (0.85, 95% CI 
0.83-0.87), indicating excellent discrimination (Hosmer, Lemeshow, & Sturdivant, 
2013). A non-significant Hosmer-Lemeshow goodness-of-fit test indicated good 
calibration, although the LLPi model requires further validation. 
 
1.5.2 Clinical and biological risk model expansion 
Lung cancer diagnosis has been found to be predicted, in part, by prior lung disease 
(e.g. Brenner et al., 2012) and several clinical symptoms (e.g. Iyen-Omofoman et al., 
2013). Clinical and biological risk factors have been increasingly incorporated into 
lung cancer risk prediction models, as such measures can provide an objective, 
immediate measure of one’s current status, whilst avoiding the disadvantages of self-
reports, such as recall bias and social desirability. For example, several respiratory 
diseases can be objectively measured using spirometry (FEV1; forced expiratory 
volume in one second) and FEV1 has been independently associated with lung cancer 
risk (Fry, Hamling, & Lee, 2012), suggesting that the incorporation of spirometry 
outputs in risk prediction modelling may improve prediction specificity. 
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Key lung cancer risk prediction models reflect the strong causal relationship between 
epidemiological factors, such as smoking and lung cancer risk; however, 
epidemiological factors cannot account for all variations in lung cancer risk, 
particularly among never smokers and individuals exhibiting early lung cancer onset 
(D'Amelio et al., 2010). In such cases, it is likely that the occurrence of lung cancer is 
attributed to a genetic predisposition and therefore, lung cancer risk prediction models 
may benefit from considering genetic risk factors where possible. Validated 
biomarkers identified using biological specimens, such as serum/plasma and bronchial 
lavage/induced sputum, can also be utilised to ascertain those individuals exhibiting 
the highest levels of risk (J. K. Field, 2008). Incorporation of biomarkers into lung 
cancer risk prediction may enhance current methods, although this may also be 
challenging with regard to cost and feasibility. 
 
Prindiville et al. (2003) found that individuals with cytological atypia (abnormal cells) 
in sputum are at increased risk of lung cancer, independent of continued smoking. The 
study demonstrated cumulative lung cancer incidence rates among individuals with 
moderate or worse cytological atypia in sputum reaches 10% and 20%, at three and 
six years, respectively. The sample used consisted of heavy smokers only, suggesting 
that the results cannot be generalised among never and light to moderate smokers. 
Clinical measures, such as sputum cytology cannot replace the key lung cancer risk 
prediction models, but introducing such measures may complement them. 
 
Spitz et al. (2008) aimed to enhance their previous models (i.e. Spitz et al., 2007) by 
incorporating two markers of DNA repair capacity into them. This resulted in a more 
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precise, albeit limited, discriminatory performance increase when compared to the 
original model. For example, AUCs for former smokers were 0.67 for the original and 
0.70 for the enhanced model. Furthermore, Raji et al. (2010) expanded the original 
LLP risk model (Cassidy et al., 2008) by incorporating a genetic susceptibility 
polymorphism (a single nucleotide polymorphism [SNP], in locus SEZ6L) into the 
model. Raji et al. (2010) reported a significant, yet modest increase in AUC from 0.72 
for the original model, to 0.75 for the enhanced model. 
 
In recent years, large genome-wide association studies have enabled the discovery of 
a number of SNPs linked to lung cancer risk across the entire human genome, urging 
the potential expansion of genetic-based lung cancer risk prediction. Spitz et al. (2008) 
and Raji et al. (2010) clearly demonstrate the modest impact of polymorphisms on an 
individual basis, however, consideration of the impact of SNPs on a collective basis 
may be considerably more influential (J. H. Park, Gail, Greene, & Chatterjee, 2012). 
For example, statistical modelling may enable examination of the interactive effects 
between several SNPs and various epidemiological factors, however, such approaches 
may also be substantially complex to implement (Janssens et al., 2006; Spitz et al., 
2007). 
 
As discussed, the incorporation of individual biomarkers into risk prediction models 
is currently limited with regard to discriminatory performance (Raji et al., 2010; Spitz 
et al., 2008). Furthermore, collection and analysis of biological specimens can also be 
costly both in terms of finance and time, compared with epidemiologically-based 
models. It should also be considered that for a biomarker to be appropriate for lung 
cancer risk prediction, it should be measured using non-invasive sampling, such as 
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using saliva, to enable ease of collection within primary care and similar general 
population settings. These limitations demonstrate how integrating biomarkers into 
general population risk prediction may often be inappropriate. 
 
1.5.3 Applications of lung cancer risk models 
The National Institute for Health and Care Excellence (NICE) (2011) highlighted the 
promotion of early detection as one of its key priorities for tackling lung cancer within 
the UK, suggesting that the public should be better informed of the symptoms of lung 
cancer through awareness campaigns. Some lung cancer risk prediction models enable 
the discrimination between individuals exhibiting differing levels of risk and 
identification of individuals who have not developed lung cancer but are at risk of 
developing the disease in the future. The utility of risk models may therefore allow 
more appropriate selection of individuals for chemopreventive interventions or 
computerised tomography (CT) screening, enabling earlier diagnosis of lung cancer, 
compared to other clinical practices (Humphrey, Teutsch, & Johnson, 2004).  
 
Currently, there are no studies to our knowledge that have utilised lung cancer risk 
prediction models to stratify high-risk individuals for chemopreventive interventions; 
however, in recent years a number of studies have begun to investigate the application 
of risk models in stratifying individuals for CT screening. Maisonneuve et al. (2011) 
developed a risk model, designed primarily to quantify individual lung cancer risk 
based on the individual risk factors used in Bach et al.’s (2003) model, in addition to 
the factors associated with baseline CT screenings (i.e. lung nodule characteristics and 
evidence of emphysema), to enable further stratification of high-risk individuals. The 
study demonstrated that annual CT screening among those identified using the 
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recalibrated Bach model, as high-risk (predicted annual risk of > 0.3%) and low-risk 
(predicted annual risk of < 0.3%), resulted in lung cancer detection rates of 90% and 
10%, respectively. This model has not, however, been validated using an external 
population and despite the model being based on age and smoking exposure, little 
comment is provided with regard to the sensitivity of such an approach (Young & 
Hopkins, 2012). 
 
More recently, Raji et al. (2012) examined the predictive accuracy of the LLP risk 
model (Cassidy et al., 2008) for stratifying patients for CT screening. A technique 
called decision utility analysis was utilised to consider the potential harms and benefits 
of using the LLP risk model for clinical decision making. This analysis indicated that 
the model performed better than smoking duration or family history alone in 
stratifying high-risk individuals for lung cancer CT screening. Furthermore, as 
previously described, the LLP risk model was utilised to stratify high-risk potential 
participants as part of UKLS (McRonald et al., 2014). Few studies have been 
published examining the benefits of stratifying patients for CT screening based on 
lung cancer risk prediction modelling. Large-scale projects, such as UKLS, may 
provide future evidence in support of the utilisation of risk models in this context and 
additionally, may support the establishment of a standardised risk threshold at which 
to suggest population-based CT screening for lung cancer. 
 
Besides the clinical application, lung cancer risk prediction models could also be 
useful from a risk communication perspective. Some risk prediction models may be 
applicable for use within primary care or general population settings, in order to 
communicate lung cancer risk to the public, thus educating individuals regarding 
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avoidable risk factors (e.g. smoking) and methods of risk avoidance (e.g. smoking 
cessation). Hippisley-Cox and Coupland (2011) described how their lung cancer risk 
algorithm (The QCancer® Lung Algorithm) (previously described), was publically 
available as a simple web calculator. Furthermore, the feasibility of implementing the 
algorithm in primary care settings was also explored, although this was aimed at 
improving diagnostic assessment, rather than communicating risk to patients (Chiang, 
Glance, Walker, Walter, & Emery, 2015). Y. Chen, Marcus, Niaz, Field, and Duffy 
(2014) also described the development of a web-based self-assessment tool (“My 
Lung Risk”), which provided feedback on five-year lung cancer risk based on the 
original algorithm of the LLP risk model (Cassidy et al., 2008). The web-based self-
assessment tool, was designed to provide the public with accessible lung cancer risk 
information; however, the paper fails to evaluate the efficacy of delivering such risk 
communication in relation to promoting lifestyle changes to reduce risk. Further 
research is clearly needed to evaluate the application of lung cancer risk prediction 
models in health education settings. 
 
1.6 Conclusion 
This chapter introduced the PhD project and demonstrated how lung cancer is a 
dominant and challenging disease to treat, resulting in over 30,000 deaths per year in 
England and Wales (ONS, 2014c). An extensive number of lung cancer risk factors 
have been identified and acknowledged within this chapter, with primary focus on 
those incorporated in the LLP risk model (Cassidy et al., 2008), including age, gender, 
smoking, occupational exposure, prior malignant disease, prior lung disease, and 
family history of lung cancer. Among the identified risk factors, smoking is most often 
attributed to lung cancer development and the synergic effect between smoking and 
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several other risk factors is also particularly prominent. The extent to which smoking 
contributes towards the development of lung cancer surpasses that of any other known 
risk factor and consequently, smoking cessation has been identified as the most 
effective strategy in addressing the burden of lung cancer. 
 
Various lung cancer risk prediction models were explored within the current chapter. 
A number of key lung cancer risk prediction models have been developed within the 
past decade or so, with new and innovative risk models continuing to emerge. Such 
models traditionally entail the inclusion of epidemiological data, however, more 
recently, risk models have attempted to integrate clinical and biological data 
additionally. Although integration of clinical and biological characteristics appears to 
improve the predictive capabilities of such models, these improvements currently 
appear limited and can be costly to implement.  
 
Despite several studies acknowledging the application of lung cancer risk models for 
use in stratifying potential participants or patients for CT screening, a paucity of 
research was revealed with regards to the application of lung cancer risk prediction 
models in other health-related domains, such as health education; only one study, to 
the researcher’s knowledge, has acknowledged the potential for the application of lung 
cancer risk prediction models in health education settings (Y. Chen et al., 2014). The 
current chapter demonstrated that the LLP risk model (Cassidy et al., 2008) is a 
particularly appropriate risk model for application within health education settings, 
especially due to ease of delivery and low implementation costs. The PhD project 
explores whether the LLP risk model can be applied to promote smoking cessation, 
however, further understanding of smoking behaviour and risk perception is required 
43 
 
to inform the current project design and to truly appreciate the complexity of the 
relationship between smoking and risk. 
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Chapter 2: Smoking and risk 
2.1 Introduction 
Tobacco is cultivated from two species of tobacco plant named Nicotinana Tabacum 
and Nicotiana Rustica. The cultivation of tobacco is believed to have originated as 
early as 5000-3000 BC and it has been suggested that tobacco consumption occurred 
throughout America by 1492 AD, when Christopher Columbus arrived (Gately, 2001). 
Presently, tobacco can be consumed in various forms, however, smoked tobacco (i.e. 
cigarettes) remains the most common form of consumption in the UK since 1919 
(Wald & Nicolaides-Bouman, 1991), despite its use declining substantially in recent 
decades (ONS, 2013b). For example, it was reported that in 1974 most UK males 
smoked tobacco (51%), whereas in 2011, only 21% reported smoking (ONS, 2013b). 
It was not until the early 20th century that a growing body of research began to emerge 
reporting the association between smoked tobacco and smoking-related disease, such 
as lung cancer (Proctor, 2012). 
 
In recent years, the UK has made commendable efforts in relation to tobacco control 
policy (Joossens & Raw, 2007) but despite this, smoking-related disease and deaths 
remain common in the UK to the present day. For example, in 2013, 17% of all deaths 
among adults aged 35 and over in England were estimated to be associated with 
smoking (Health and Social Care Information Centre, 2014b). The current chapter 
explores the literature in relation to smoking and risk; doing so will inform the 
development of new and innovative tobacco control interventions, which could reduce 
smoking rates and consequently, smoking-related disease. 
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This current chapter will firstly explore addiction theory, the prevalence of smoking, 
smoking aetiology, and smoking-related disease. Factors that influence smoking 
initiation and common predictors of smoking cessation will also be explored. 
Exploring smoking behaviour in detail will inform the reader regarding the challenge 
of reducing smoking rates. This chapter additionally largely focuses on the role of risk 
perception throughout the smoking lifespan, leading one to consider the contribution 
of risk perception on smoking initiation and cessation. Tobacco control and policy are 
discussed and smoking cessation treatments and services are reviewed, which is 
particularly relevant to the current project, as a sample of Stop Smoking Service (SSS) 
users were recruited. This chapter will also explore current knowledge pertaining to 
assessments of risk and harm, especially with regard to lung cancer and lastly, 
effective risk communication strategies are considered; these aspects are important to 
incorporate in developing the format by which the Liverpool Lung Project (LLP) risk 
model (Cassidy et al., 2008) output will be delivered. 
 
2.2 Addiction theory  
Addiction is an abstract concept and debate exists as to whether addiction has any 
general objective structure (Ross & Kincaid, 2010). West and Brown (2013) explain 
that addiction has been defined in various ways throughout history and many partly 
overlapping definitions currently remain in the literature. They define addiction as “a 
chronic condition involving a repeated powerful motivation to engage in a rewarding 
behaviour, acquired as a result of engaging in that behaviour, that has significant 
potential for unintended harm. Someone is addicted to something to the extent that 
they experience this repeated powerful motivation” (p. 15). 
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The key psychoactive ingredient in smoked tobacco is the stimulant, nicotine, which 
is typically absorbed through the lungs, bloodstream, and activated in the brain within 
15 seconds of inhalation (Attwood et al., 2013); this speed of activation demonstrates 
why tobacco smoking is a particularly popular choice of tobacco consumption among 
consumers. Nicotine is the most addictive substance in smoked tobacco and the 
addictive potential of nicotine is considered high; in line with that of heroin and 
methadone (West & Brown, 2013). 
 
Nicotine addiction alters behaviour in a complex manner, involving numerous 
neuronal pathways and neurotransmitters; nicotine inhibits the nicotinic acetylcholine 
receptors in the central nervous system but also, mesolimbic dopamine, which is a 
potential neurotransmitter that mediates the reward effect implicated in nicotine use 
(Jamal, Ameno, Tanaka, Kumihashi, & Kinoshita, 2012). Heishman, Kleykamp, and 
Singleton (2010) conducted a meta-analysis, which identified that nicotine or smoking 
contributed towards enhanced motor abilities, attention, and memory. In addition to 
the conditioning effect of smoking tobacco, Benowitz (2010) described how nicotine 
addiction occurs as a result of a combination of positive reinforcements, including 
mood enhancement and withdrawal symptom avoidance. There are a multitude of 
physical and psychological tobacco withdrawal symptoms, some of which include: 
tobacco cravings, irritability, anxiety, concentration difficulties, and increased 
restlessness (Hughes & Hatsukami, 1986); however, the physiological effect of 
nicotine addiction cannot solely account for the difficulties that many smokers 
encounter in quitting smoking.  
 
47 
 
Since the 20th century, numerous new addiction models have emerged as a result of 
increased knowledge regarding learning, pharmacology, neurophysiology, and 
neuroanatomy (Westermeyer, 2013). Ross and Kincaid (2010) argue that there is little 
consensus on the extent to which any one contributing factor can effectively explain 
aspects of addiction alone and addiction is a multifactorial concept, involving genetics, 
molecular neurobiological (i.e. biochemical changes at the neuron level), systems 
neurobiological (e.g. brain regions), picoeconomic dynamics (i.e. sub-personal goal-
seeking systems, which compete in a manner that explains the individual’s whole 
behaviour), psychological and cognitive processes, and social and cultural influences. 
They conclude that not one specific model can account for all aspects of the addiction 
experience. One review, which explored nursing research on smoking cessation 
published between 1989 and 2008, established that almost half of the studies found 
were based on explicit formal psychosocial theories or health behaviour models and 
of these, the Transtheoretical Model of Change (TTM) (J. O. Prochaska & 
DiClemente, 1983) and the Self Efficacy Theory (Bandura, 1997) were the most 
frequently used (K. A. O'Connell, 2009). Furthermore, Sutton (2005) suggests that the 
TTM is one of the most dominant models of behaviour change, which has been applied 
extensively to smoking behaviour (Atak, 2007; Cahill, Lancaster, & Green, 2010; L. 
M. Robinson & Vail, 2012). 
 
The TTM proposes and systematically incorporates a number of concepts considered 
influential to behaviour change, primarily including the stages and processes of change 
(J. O. Prochaska & DiClemente, 1983; J.O. Prochaska & DiClemente, 1986) (see 
Figure 2). The TTM stipulates that behaviour change is a dynamic process, which 
involves progression through five qualitatively distinct stages and the model postulates 
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that behaviour change is a cyclical, rather than linear process, as individuals may 
recycle through the stages of change several times before cessation of an addictive 
behaviour (J. O. Prochaska, DiClemente, & Norcross, 1992). J. O. Prochaska and 
DiClemente (1984) proposed the five stages, as follows: 
1. Pre-contemplation, whereby an individual is not currently considering 
quitting. 
2. Contemplation, whereby an individual is considering quitting. 
3. Preparation, whereby an individual is seriously considering quitting within the 
next 30 days and will prepare to take action to achieve their goal. 
4. Action, whereby an individual is actively modifying the problematic 
behaviour. 
5. Maintenance, whereby an individual strives to prevent relapse and has 
sustained the action employed to change the behaviour for at least six months. 
 
The TTM postulates that progression through these stages of change is associated with 
engagement in ten processes of change (J. O. Prochaska & DiClemente, 1983; J.O. 
Prochaska & DiClemente, 1986). J. O. Prochaska, Velicer, DiClemente, and Fava 
(1988) stipulate that these processes of change can be either cognitive or behavioural 
processes. The cognitive processes include consciousness raising, dramatic relief, 
social liberation, self-re-evaluation, and environmental re-evaluation, whilst the 
behavioural processes include helping relationships, stimulus control, 
counterconditioning, reinforcement management, and self-liberation. These processes 
are defined in greater detail in Appendix A. 
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Figure 2. The stages and processes of change stipulated by the Transtheoretical 
Model of Change (TTM) (J. O. Prochaska & DiClemente, 1983; J.O. Prochaska & 
DiClemente, 1986) 
 
Despite the common application of the model with regard to smoking (e.g. Atak, 2007; 
L. M. Robinson & Vail, 2012), researchers have argued that the model is logically 
flawed in that it uses staging algorithms that are based on arbitrary time periods, it 
oversimplifies the complexities of behaviour change, and it assumes that individuals 
generally make coherent and stable plans (Littell & Girvin, 2002; Sutton, 2001; West, 
2005). Therefore, the model will not be solely relied upon in regard to informing the 
current project, although the model provides the reader with an overview of some of 
the behaviour change mechanisms and the associated strategies potentially employed 
by smokers. The multifactorial contributors of addiction highlight the complexity and 
challenge of smoking cessation for so many smokers. 
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2.3 Epidemiology of smoking 
Cigarette smoking varies extensively globally. The World Health Organisation 
(WHO) (2013) provided data on age-standardised prevalence estimates for cigarette 
smoking among adults globally in 2011. For males, smoking prevalence ranged from 
7% to 67%, whilst for females rates were substantially lower, ranging from 0 to 50%. 
In the United Kingdom, smoking prevalence was reported at 22% overall. ASH 
(2014a) provided smoking prevalence statistics in Great Britain by country and stated 
that among adults in 2012, rates were 20%, 23%, 23% and 24%, in England, Scotland, 
Wales and Northern Ireland, respectively. As the current study will recruit participants 
in Liverpool (England) specifically, it was of interest to ascertain smoking prevalence 
in Liverpool. Smoking prevalence in Liverpool is 24.5%; substantially higher than the 
average in England (Public Health England, 2014).  
 
Smoking prevalence declined rapidly between the 1970s and 1990s among adults (16 
years and over) and continued to fall since the mid-1990s but at a decelerated rate of 
approximately 0.4% per year (see Table 1) (ONS, 2013b). In addition to smoking 
prevalence, cigarette consumption per individual has also declined over recent decades 
in Great Britain. In 1974, average cigarettes smoked per day were estimated to be 18 
for males and 14 for females, whereas in 2013, the average number for males was 13 
and 11 for females (ONS, 2014a). Furthermore, the number of individuals defined as 
heavy smokers (those smoking over 20 cigarettes per day) has declined dramatically; 
26% of males and 13% of females were defined as heavy smokers in 1974, compared 
respectively to 5% and 3%, in 2012 (ASH, 2014b). 
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Table 1. Percentage of adults (16 years and over) who smoke from 1974 to 2012 in 
Great Britain (Office for National Statistics, 2013b) 
Year Percentage of adults who smoke 
  
16-19 
years 
20-24 
years 
25-34 
years 
35-49 
years 
50-59 
years 
60 years and 
over 
Total 
adults 
1974 40 48 51 52 51 34 45 
1978 34 44 45 45 45 30 40 
1982 30 40 38 39 41 27 35 
1990 30 39 36 36 35 25 33 
1994 30 38 35 34 29 21 27 
1998 27 39 32 30 27 17 27 
1998 31 40 35 30 27 16 28 
2002 31 40 35 31 28 16 26 
2006 25 38 34 28 26 15 22 
2010 20 31 30 25 22 12 20 
2012 19 27 26 24 20 13 20 
N.B. Data has been weighted since 1998. Weighted and unweighted data is included for 1988 
to display the effect of weighting. 
 
The relationship between smoking and various demographic characteristics will now 
be explored, with particular focus on sex, age, marital status, ethnicity, and education. 
ASH (2014b) suggested that there are approximately 10 million smokers in Great 
Britain. Sex differences have consistently been observed in relation to smoking. For 
example, the proportion of male adult smokers in Great Britain in 2013, was estimated 
at 22%, whilst the proportion of females was reported to be 17% (ONS, 2014a). 
 
Smoking prevalence also differentiates by age (see Table 1). Although prevalence is 
consistently lowest among adults aged 60 and above, individuals within this age group 
are more likely to be ever-smokers and more likely to have quit smoking (ASH, 
2014b). Table 1 suggests that smoking is highest among young people aged 20-24, 
however, a substantial decline in smoking among young people between 16-19 years 
52 
 
old is also evident from the figures; reflecting the drastic reduction in smoking 
initiation in recent years. 
 
Differences in smoking status have been identified by marital status (Office for 
National Statistics, 2014a). In England, the most common marital status overall is 
Married (46.6%), seconded by Single (34.6%); this is a stark contrast to Liverpool, in 
which Single is the most common marital status (49.7%), followed by Married 
(32.3%) (Office for National Statistics, 2014d). Married people are least likely to be 
current smokers (14%) but more likely to be former smokers (24%), compared with 
those who are cohabiting (33%) or single (9%). Single people were, however, 
substantially more likely to be never-smokers (54%), compared with all other groups. 
These statistics suggest that smoking cessation may be more common among 
individuals in married relationships and that being single may be a protective factor in 
relation to smoking initiation. 
 
In terms of ethnicity, the 2011 census revealed that the majority of the general 
population in England and Wales, classified themselves as White British (80.5%) 
(ONS, 2012b). White Other was the next largest ethnic group (4.4%), followed thirdly, 
by Indian (2.5%) and fourthly, Pakistani (2.0%). In contrast, 84.8% of people in 
Liverpool described themselves as White British, followed by White Other (2.6%), 
Black African (1.8%) and Chinese (1.7%); cumulatively, 2.5% of residents classified 
themselves as Mixed (ONS, 2012a). ONS (2011) reported that individuals who 
described their race as Mixed were most likely to be current smokers (27%), followed 
by those who were White (21.5%); however,  prevalence of former smoker status was 
highest among White ethnicities (34.3%), followed by Mixed (28.6%). Never smoker 
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status was highest among Asian or Asian British (75.0%) and secondly, Chinese 
(71.6%). This information provides insight into the ethnic groups most likely to smoke 
and suggests that some ethnic minorities may also be at increased risk of smoking. 
 
Smoking is also a health inequalities concern, as smoking rates are higher among 
lower socio-economic groups in most developed countries (Barnett, Pearce, & Moon, 
2009; Cavelaars et al., 2000; A. C. Marcus, Shopland, Crane, & Lynn, 1989). In 2011, 
in Great Britain, smoking prevalence among those with Managerial and Professional, 
Intermediate, and Routine/Manual statuses was 13%, 20%, and 28%, respectively 
ONS (2013b). These findings are particularly relevant in the present project as 
Liverpool remains the most deprived local authority in England (Liverpool City 
Council, 2011), which may have contributed towards the aforementioned increased 
prevalence of smoking in Liverpool, compared to the average in England (Public 
Health England, 2014). 
 
2.4 Smoking-related disease 
Smoking was associated with 17% of all deaths (79,700) in England alone in 2013 and 
the financial burden of smoking on the NHS has been estimated in England to be £2.7 
billion in 2006 (Callum, Boyle, & Sandford, 2011). In Liverpool, smoking related 
deaths are among the highest rates in England; Liverpool’s directly age standardised 
rate is 456 per 100,000 population, aged 35 years and above, 2010-2012, whereas 
England’s worst level is 480 and average in England is 292 (Public Health England, 
2014). 
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In 2013, it was estimated that smoking was linked with 28% of all cancers (Health and 
Social Care Information Centre, 2014b). The widely documented relationship between 
smoked tobacco and lung cancer is discussed elsewhere (see Section 1.3.3). Baan et 
al. (2009) conducted a review, in which it established a variety of cancers associated 
with tobacco smoking in addition to lung cancer, including nose and sinus, mouth and 
upper throat, larynx, oesophagus, liver, pancreas, stomach, kidney, bowel, ovary, 
bladder, leukaemia, and cervical cancer. 
 
Smoking was also responsible for approximately 35% of all respiratory disease deaths 
in 2013 (Health and Social Care Information Centre, 2014b). For example, based on 
random-effects meta-analyses of most-adjusted relative risks (RR) or odds ratio (OR), 
Forey et al. (2011) found that the effect estimates for ever smokers compared to never 
smokers were 2.89 (95% CI 2.63-3.17) for chronic obstructive pulmonary disease 
(COPD) using 129 studies, 2.69 (95% CI 2.50-2.90) using 114 studies for chronic 
bronchitis, and 4.51 (95% CI 3.38-6.02) for emphysema using 28 studies. 
 
Lastly, in 2013, smoking was attributed to 13% of cardiovascular disease (CVD) 
deaths (Health and Social Care Information Centre, 2014b). According to Lakier 
(1992), smoking is the most preventable cause of cardiovascular morbidity and 
mortality. There is a large body of research from epidemiological studies 
demonstrating the relationship between smoking and CVD (Kenfield et al., 2008; 
Preston et al., 2010). A recent study examined the impact of smoking on CVD among 
males (Ehteshami-Afshar, Momenan, Hajshekholeslami, Azizi, & Hadaegh, 2014). 
The study recruited 3,059 men (without CVD at baseline) and participants were 
followed-up for a median of 9.3 years. Former smokers were at increased risk of CVD 
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events (Hazard Ratio [HR] 2.42, 95% CI 1.28–0.56), although the results suggested 
that smoking had no effect on coronary heart disease (CHD) events and total/CVD 
mortality. Current smokers of over 10 cigarettes per day and 20 cigarettes per day were 
at cumulatively increased risk of CVD/CHD events and total/CVD mortality, although 
smoking fewer than 10 cigarettes per day was only related to lower levels of increased 
CVD risk (HR 2.12, 95% CI 1.14–3.95) and its mortality (HR 4.57, 95% CI 1.32–
15.79). 
 
Smoking has additionally been associated with other diseases, such as diabetes. The 
Health Professionals' Follow-up Study displayed that diabetes risk among males was 
increased among smokers of 25 cigarettes per day or more (RR 1.94, 95% CI 1.25-
3.03), in comparison to non-smokers (Rimm, Chan, Stampfer, Colditz, & Willett, 
1995). Additionally, one Japanese prospective study followed-up 6,250 non-diabetic 
males between the ages of 30 and 60 years old for 60,904 person-years and for those 
who smoked over 30 cigarette per day, they reported an increased risk (RR 1.73, 95% 
CI 1.20-2.48) (Uchimoto et al., 1999). Another study followed 21,068 US male 
physicians aged 40-84 for 255,830 person-years and the study reported an increased 
relative risk for current smokers of 20 cigarettes per day or more (RR 1.7, 95% CI 1.3-
2.3), as well as for current smokers of less than 20 cigarettes per day (RR 1.5 (95% CI 
1.0-2.2), after multivariate adjustment for body mass index, physical activity, and 
other risk factors (Manson, Ajani, Liu, Nathan, & Hennekens, 2000). Lastly, Ko, 
Chan, Tsang, Critchley, and Cockram (2001) examined the relationship between 
smoking and diabetes in 3,718 Chinese participants. They found that smoking was 
associated with diabetes in males (OR 1.71, 95% CI 1.11-2.63) but not females. 
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Despite these findings, research has typically reported an association between 
smoking and diabetes among females (Rimm et al., 1995; Sairenchi et al., 2004).  
 
The aforementioned studies demonstrate the role of smoking in the aetiology of a 
variety of diseases. The following section will explore contributing factors of smoking 
initiation and cessation, in order to identify particularly vulnerable groups and to 
understand the complexity of smoking behaviour; doing so, could potentially inform 
health interventions and subsequently, reduce the excessive number of smoking-
related morbidities and deaths previously described.  
 
2.5 Smoking initiation and cessation 
Having explored addiction, epidemiology and smoking-related disease, this section 
will explore risk factors for initiation and common predictors of smoking cessation. 
Section 2.5.1 will consider patterns in smoking initiation and various factors, which 
could lead to some individuals being more vulnerable to smoking initiation. Section 
2.5.2 will consider the common predictors of smoking cessation and cessation 
maintenance; doing so will enable identification of various groups for whom smoking 
cessation may be more or less challenging. Consideration of such factors will also 
inform the development of a statistical analysis plan for the current project. 
 
2.5.1 Risk factors for initiation 
It has been estimated that approximately 207,000 children aged 11-15 years old start 
smoking each year in the UK (Hopkinson, Lester-George, Ormiston-Smith, Cox, & 
Arnott, 2014). The legal age of sale of cigarettes in Britain rose from 16 years old to 
18 years old in 2007. Despite the enforcement of such legislation, in 2011 it was 
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revealed that the majority of British adult current or former smokers reported starting 
smoking before they were 18 years old (66%), whilst 40% started before the age of 16 
(ONS, 2013b). The proportion of children regularly smoking in England has, however, 
dropped dramatically in recent decades; this has been particularly evident within the 
past decade, whereby the percentage of regular smokers between the ages of 11-15 
years has decreased from 9% in 2003, to 3% in 2013 (Health and Social Care 
Information Centre, 2014a). Exploration of the predictors of smoking initiation may 
highlight particular groups more likely to smoke, enabling smoking initiation and 
consequently, smoking cessation interventions to be tailored towards such groups. 
 
Over recent decades, research has documented a variety of risk factors for smoking 
initiation: genetic factors; personality; socio-economic status and relationships; media; 
advertising. In the past decade or so, a number of reviews have documented the 
association between genetic factors and smoking initiation and maintenance, whilst 
acknowledging the interaction with environmental factors (Al Koudsi & Tyndale, 
2005; Baler & Volkow, 2011; Chatkin, 2006; Davies & Soundy, 2009; M. Munafo, 
Clark, Johnstone, Murphy, & Walton, 2004; M. R. Munafo & Johnstone, 2008; Russo 
et al., 2011; Schnoll, Johnson, & Lerman, 2007; Turner, Mermelstein, & Flay, 2004). 
Genetic variants can impact dopamine receptor functioning and liver enzymes that 
metabolise nicotine, which in turn may contribute towards increased risk of nicotine 
addiction (Moolchan, Ernst, & Henningfield, 2000) and it has been estimated that 56% 
of variance in smoking initiation is accounted for by genetic effects (Sullivan & 
Kendler, 1999).  
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Components of personality have also previously been associated with smoking 
initiation. There are two broad models of personality that are frequently implemented 
in health research: (1) The Five-Factor Model (FFM) (Costa, Fagan, Piedmont, 
Ponticas, & Wise, 1992); (2) Eysenck & Eysenck’s (1975) Three-Factor Model. The 
FFM suggests that personality traits are stable behaviours over time and postulates that 
personality is defined by five specific dimensions, including openness to experience, 
conscientiousness, extraversion, agreeableness, and neuroticism. Eysenck & 
Eysenck’s (1975) three-factor model was informed by genetics and physiology and 
suggests that personality differences can be attributed to brain function, stipulating 
three specific dimensions, including extraversion, neuroticism, and psychoticism 
(which also entails aggression). 
 
One of the most commonly reported relationships pertaining to smoking initiation and 
personality relates to the association between sensation-seeking, often incorporated in 
measures of extraversion and neuroticism. Numerous studies have identified that 
smokers are more likely to score highly on scales of extraversion, neuroticism, and 
psychoticism (Ajdacic-Gross et al., 2009; Arai, Hosokawa, Fukao, Izumi, & 
Hisamichi, 1997; Brook et al., 2008; Cherry & Kiernan, 1976; Forgays, Bonaiuto, 
Wrzesniewski, & Forgays, 1993; Lipkus, Barefoot, Feaganes, Williams, & Siegler, 
1994; Spielberger & Jacobs, 1982; van Loon, Tijhuis, Surtees, & Ormel, 2005). A 
recent review also concluded that sensation-seeking or risk-taking traits predict 
smoking but that the evidence for such a relationship is far stronger in self-reports, 
compared to real-life studies (Bloom, Matsko, & Cimino, 2014). Research also 
suggests that personality works as a mediator between genetic factors (e.g. increased 
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extracellular levels of dopamine in the ventral striatum i.e. reward centre) and 
personality (e.g. the trait of novelty seeking) (Boileau et al., 2003; Leyton et al., 2002). 
 
As described, smoking rates are higher among lower socio-economic groups (ONS, 
2013b), which highlights how socio-economic status is often associated with smoking 
initiation; however, there are a number of factors often associated with socio-
economic status that have also been found to independently relate to smoking 
initiation. Firstly, educational attainment is one aspect commonly associated with 
smoking initiation. One review summarised that smoking initiation has consistently 
been associated with school performance and additional evidence suggests that 
smoking is related to educational aspirations and commitment to school (Tyas & 
Pederson, 1998). A more recent study (Gilman et al., 2008) sought to examine whether 
the relationship between educational attainment and smoking initiation is causal. They 
explored smoking behaviours among a birth cohort, which began recruitment in 1959 
(N = 1311). They found that the number of pack years was higher among people with 
lower than high school education (RR 1.58, 95% CI 1.31-1.91); however, a repeat 
analysis, which incorporated having siblings reduced the relative risk considerably 
(RR 1.23, 95% CI 0.80 -1.93). They subsequently suggested that a large proportion of 
the education discrepancy in smoking initiation is attributable to aspects shared by 
siblings. 
 
There is a great deal of literature exploring not only the relationship between having 
siblings who smoke and smoking initiation, but also the relationship between having 
parents who smoke and smoking initiation. For example, Leonardi-Bee, Jere, and 
Britton (2011) undertook a systematic review and meta-analysis to assess the extent 
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of the effects of having other smokers in the family on smoking initiation.  In total, 58 
studies were included in the meta-analyses and ORs for smoking initiation in 
childhood were significantly increased if the child had at least one parent who smoked 
(OR 1.72, 95% CI 1.59-1.86); however, having a sibling who smoked particularly 
increased the likeliness of smoking initiation (OR 2.30, 95% CI 1.85-2.86). A number 
of reviews have further explored the association between smoking among peers and 
smoking initiation (Bindah & Othman, 2011; Hoffman, Sussman, Unger, & Valente, 
2006; Seo & Huang, 2012; Simons-Morton & Farhat, 2010). Bindah and Othman 
(2011) surmised that there is good supportive evidence that peer smoking is attributed 
to adolescent smoking behaviour and that adolescents who hold more positive 
attitudes towards their peers smoking will more likely be influenced to smoke. It has 
also been suggested that having a teacher who smokes can influence smoking initiation 
(Wold, Torsheim, Currie, & Roberts, 2004); this is likely to be less problematic within 
England currently because smoke-free schools guidance has been introduced within 
England in the past decade, which has become increasingly prominent nationwide and 
is aimed at both students and staff (e.g. NICE, 2010) and therefore, students should be 
less likely to observe teachers smoking. 
 
Many studies have attempted to ascertain the impact of tobacco advertising on 
smoking initiation but the magnitude of the impact can be challenging to assess, due 
to problematic data and the inability to analyse substantial changes in advertising 
(Levy, Chaloupka, & Gitchell, 2004). Lovato, Linn, Stead, and Best (2003) undertook 
a Cochrane review which identified nine longitudinal studies that followed up a total 
of 12,000 adolescents aged 18 or below, who were not regular smokers at baseline. 
All studies included assessed smoking behaviour at baseline and follow-up, exposure 
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to advertising, and receptivity or attitudes to tobacco advertising, or brand awareness 
at baseline. The review concluded that in all studies, increased awareness of, or 
receptivity to, tobacco advertising was associated with cigarette experimentation and 
smoking initiation. This established association is now less of a concern currently in 
the UK, because although tobacco advertising expenditure in the UK exceeded £100 
million per year in the 1980s and 1990s (ASH, 2006), the Tobacco Advertising and 
Promotion Act was introduced in 2002, which made tobacco advertising illegal, 
exclusive of point of sale displays. Following this, the 2009 Health Act was 
introduced, which additionally prohibited tobacco products to be displayed at point of 
sale; tobacco display prohibition was implemented for large shops from April 2012 
and from April 2015 for all other retail outlets (DH, 2011). 
 
2.5.2 Cessation and maintenance of cessation 
Recent research suggests that the majority of British current smokers (63-67%) would 
like to quit smoking (Lader 2009; Robinson and Harris, 2011). Furthermore, 26% of 
all current smokers are estimated to make at least one serious quit attempt per year 
(Lader, 2009). Despite these statistics, successful smoking cessation rates are very 
low. West (2006) estimates that the historic cessation rate in England over the past 40 
years is 1.2% of smokers and the cessation rate in England for 2006 was between 2.4-
2.8%; however, West (2006) recommends interpreting the data with caution as 
estimates were based on a number of assumptions and a limited sample size. Smoking 
cessation is valuable throughout the lifespan; quitting at 60, 50, 40, or 30 years old 
gains an individual approximately 3, 6, 9, or 10 years of life expectancy, respectively 
(Doll, Peto, Boreham, & Sutherland, 2004). 
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Reviewing common smoking cessation predictors will enable exploration of possible 
predictors or confounding variables in regard to the current project. More generally, 
doing so could inform the development of effective interventions and strategies to 
enable the identification of “high-risk” groups that may need more intensive support. 
Common smoking cessation predictors will be discussed within the following three 
themes: socio-demographics; smoking behaviour; and psychological factors. 
 
Common socio-demographic variables associated with smoking cessation success, 
including age, sex and marital status, will now be explored. A number of studies have 
found that older people are more likely to achieve smoking cessation success at follow-
up (Fidler, Brown, Stapleton, West, & Ferguson, 2013; Hymowitz et al., 1997; C. Lee 
& Kahende, 2007; Monsó, Campbell, Tønnesen, Gustavsson, & Morera, 2001). 
Abdullah et al. (2006) suggests intention to quit among older smokers is attributed to 
factors such as having health problems in the past, smoking duration, and cigarettes 
per day. 
 
Although females typically smoke less than males (ONS, 2014a), females have been 
found to be less successful in quitting smoking than males. Scharf and Shiffman 
(2004) conducted a meta-analysis, which found that women are less successful at 
quitting, regardless of treatment, whilst, further meta-analyses have suggested that 
these sex differences are evident, particularly in relation to the use of nicotine 
replacement therapy (NRT) (Cepeda-Benito, Reynoso, & Erath, 2004; Perkins & 
Scott, 2008). More recently, Vangeli, Stapleton, Smit, Borland, and West (2011) 
reviewed the evidence and concluded that there was no consistent relationship 
between sex and quit attempts or quit attempt success. It has been suggested that such 
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inconsistencies may be due to differences in risk factors for failure between real-life 
settings and randomised controlled trials (RCTs) (Caponnetto & Polosa, 2008). 
Nevertheless, Torchalla, Okoli, Hemsing, and Greaves (2011) suggested several 
underlying mechanisms as to why these sex differences might exist, such as genetic 
variants, hormonal influences, increased responsiveness to non-pharmacological 
support among females, increased vulnerability to depression and negative mood 
among females, weight concerns among females, and receipt of less effective social 
support among females. 
 
There are also several social factors that have been implicated in smoking cessation 
success. The smoking status of family or friends can have implications for an 
individual’s quit attempt success. For example, being married to a non- or former 
smoker has been found to enhance the likelihood of cessation (Coppotelli & Orleans, 
1985; Hanson, Isacsson, Janzon, & Lindell, 1990; McBride et al., 1998). There are, 
however, mixed findings in regard to the relationship between marital status and 
smoking cessation success, with some studies implicating the positive effect of 
marriage on smoking cessation (Broms, Silventoinen, Lahelma, Kaprio, & 
Koskenvuo, 2004; Gourlay, Forbes, Marriner, Pethica, & McNeil, 1994), whilst others 
found no association (Hagimoto, Nakamura, Morita, Masui, & Oshima, 2010; 
Hellman, Cummings, Haughey, Zielezny, & O'Shea, 1991; West, McEwen, Bolling, 
& Owen, 2001; Zhou et al., 2009). Research also suggests that social support 
behaviour is of great importance to successful cessation. For example, supportive 
behaviour, including co-operative support or reinforcement of an individual’s efforts 
to stop smoking, has been found to enhance smoking cessation success (Coppotelli & 
Orleans, 1985; Mermelstein, Lichtenstein, & McIntyre, 1983). Conversely, negative 
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social behaviour, such as nagging, regulating, or complaining about behaviour may 
increase the likeliness of relapse (Cohen & Lichtenstein, 1990; Roski, Schmid, & 
Lando, 1996). 
 
Research also suggests that greater affluence is related to smoking cessation success. 
Kotz and West (2009) found that 20.4% of participants from a higher social grade 
remained abstinent after one year compared to 11.4% of those from the lowest social 
grade; several other studies using populations of British smokers have found a 
relationship between socio-economic predictors and smoking cessation success 
(Chandola, Head, & Bartley, 2004; Fidler & West, 2011; West et al., 2001). Hiscock, 
Bauld, Amos, Fidler, and Munafo (2012) suggest that less affluent groups are less 
likely to successfully quit smoking due to several factors, including inadequate social 
support, lower motivation, higher levels of addiction, increased exposure to stress or 
psychological differences, poorer adherence to cessation treatment, and increased 
vulnerability to tobacco company marketing exposure. 
 
Common smoking-related predictors of cessation success will now be considered, 
including age at smoking initiation, tobacco dependence, and quit attempts. A number 
of studies suggest that age at smoking initiation is predictive of smoking cessation 
success later in life (Breslau & Peterson, 1996; J. Chen & Millar, 1998; Ellickson, 
McGuigan, & Klein, 2001; Hymowitz et al., 1997; Sadik A. Khuder, Dayal, & Mutgi, 
1999; Tucker, Ellickson, & Klein, 2002). For example, Hymowitz et al. (1997) 
conducted a large cohort study (N = 13,415), whereby smokers between 25 and 34 
years old were recruited. The study found that individuals who were over 20 years old 
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when they started smoking, were more likely to have quit smoking at five-year follow-
up (RR 1.16, 95% CI 1.01-1.32). 
 
Smokers who start smoking at an earlier age are also more likely to exhibit increased 
nicotine dependence (Breslau & Peterson, 1996; Lando et al., 1999; Taioli & Wynder, 
1991). Nicotine dependence is typically measured using the Fagerström Test for 
Nicotine Dependence (FTND) (Heatherton, Kozlowski, Frecker, & Fagerstrom, 
1991); a reliable measure of nicotine dependence that has been applied extensively 
across various populations (e.g. Fagerström & Furberg, 2008; Meneses-Gaya, Zuardi, 
Loureiro, & Crippa, 2009). Research suggests that dependence severity predicts less 
successful smoking cessation attempts (Breslau & Peterson, 1996; Dale et al., 2001; 
Fagerström, Russ, Yu, Yunis, & Foulds, 2012; Fidler & West, 2011; Hagimoto et al., 
2010; Harris et al., 2004; Killen, Fortmann, Kraemer, Varady, & Newman, 1992; 
Richmond, Kehoe, & Webster, 1993; Rohde, Kahler, Lewinsohn, & Brown, 2004; 
Scherphof et al., 2013; Stapleton et al., 1995; West et al., 2001; Zhou et al., 2009).  
Cigarettes per day (CPD) (a component of FTND) has also been found to predict less 
successful quit attempts, as individuals who smoke a greater number of cigarettes per 
day tend to find it more difficult to quit (Haug, Schaub, & Schmid, 2014; Hellman et 
al., 1991; Hymowitz, Sexton, Ockene, & Grandits, 1991; Li et al., 2010; Li et al., 2011; 
West et al., 2001). 
 
It has also been suggested that quit attempt history is a predictor of smoking cessation 
success among adults and adolescents (Andrews, Yeh, Pao, & Horn, 2011; Farkas et 
al., 1996; Hymowitz et al., 1991; Li et al., 2010; Li et al., 2011; R. P. Murray et al., 
2000; Zhou et al., 2009; Zhu, Sun, Billings, Choi, & Malarcher, 1999), as several 
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studies propose that smokers with shorter previous quit attempts are less likely to quit 
smoking successfully (Borrelli et al., 2002; Garvey, Bliss, Hitchcock, Heinold, & 
Rosner, 1992; Hagimoto et al., 2010; Li et al., 2010; Li et al., 2011; Zhou et al., 2009). 
Furthermore, a number of recent studies have suggested that planning a quit date is a 
less successful strategy for smoking cessation than spontaneously quitting (Cooper et 
al., 2010; Hughes & Callas, 2011; Sendzik, McDonald, Brown, Hammond, & 
Ferrence, 2011); however, Vangeli et al. (2011) advises that quit attempt history is not 
a consistent predictor of smoking cessation and therefore, the extent to which quit 
attempt history is indicative of smoking cessation success is unclear. 
 
Various psychological factors, including mental health, alcoholism, and motivation, 
have also been associated with smoking cessation success. Successful smoking 
cessation has been found to be inhibited by the presence of mental health disorders, 
such as major depression and anxiety disorder. Hitsman et al. (2013) conducted a 
recent systematic review and meta-analysis of 42 trials, which assessed the effect of 
having past major depression on short and long term smoking cessation. They found 
that smokers with past major depression were less likely to remain abstinent at three 
months (OR 0.83, 95% CI 0.72–0.95) and six months (OR 0.81, 95% CI 0.67–0.97). 
Morrell and Cohen (2006) also conducted a systematic review, in which they 
concluded that anxiety can reduce smoking cessation success; however, the authors 
advise that there are few studies to support this hypothesis due to most studies of affect 
and smoking cessation focusing on depressive symptoms and negative affect, rather 
than anxiety. One factor which may mediate the effect is the experience of severe 
withdrawal symptoms among individuals with mental health disorders during the 
cessation process, such as induced mood disturbances and increased anxiety (Breslau, 
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Kilbey, & Andreski, 1992; Covey, Glassman, & Stetner, 1997), although the 
interaction between mental health disorders and smoking cessation is believed to be 
highly complex (Leventhal & Zvolensky, 2015).  
 
Alcohol misuse is also a factor linked with smoking cessation. Research suggests that 
although current and former alcohol dependent individuals exhibit greater nicotine 
dependence and are less likely to quit smoking in their lifetime, smokers with a past 
history of alcohol misuse are not disadvantaged with respect to quitting smoking on a 
given attempt (Hughes & Kalman, 2006; Leeman, Huffman, & O'Malley, 2007). 
Furthermore, greater length of alcohol abstinence has been shown to predict successful 
smoking cessation (Heffner, Barrett, & Anthenelli, 2007). More generally, the use of 
alcohol has been linked to increasing urges to smoke among abstinent smokers 
(Epstein, Sher, Young, & King, 2007; Kirchner & Sayette, 2007). One review suggests 
that sequential, rather than simultaneous alcohol and smoking treatment programmes 
are preferable to support behaviour change (Kodl, Fu, & Joseph, 2006). 
 
A number of studies suggest that intention to quit or motivation is a predictor of 
smoking cessation success (Li et al., 2010; Li et al., 2011). For example, Li et al. 
(2011) found that smokers who intended to quit smoking within the following month 
were more than twice as likely to remain abstinent at follow-up (OR 2.18, 95% CI 
1.46-3.27); however, results regarding motivation are inconsistent. One review 
highlighted that although motivation to quit is a strong predictor of quit attempt, 
evidence suggesting that motivation to quit is a predictor of smoking cessation is weak 
(Vangeli et al., 2011). Despite this, therapeutic approaches to smoking cessation such 
as motivational interviewing, an approach that assumes motivation to change is 
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elicited from the client (Rollnick & Miller, 1995), have been found to increase 
abstinence rates by 2.3%  (Hettema & Hendricks, 2010). 
 
Relapse has been described as a “breakdown or failure in a person's attempt to change 
or modify any target behaviour” (Marlatt & George, 1984) (p. 261). Polosa and 
Caponetto (2013) described smoking cessation as “not an event but a process, and 
relapse is an ordinary component of this process” (p. 118); an estimated 4 out of 5 
smokers who make a quit attempt relapse within a month of quitting, whilst it has been 
estimated that only 3-5% of smokers who have made a quit attempt remain abstinent 
at 6 months (Hughes, 2007). Traditionally, the literature focuses largely on the initial 
behaviour change of smoking cessation, as opposed to maintenance of the behaviour 
change. 
 
In addition to the previously described factors that have been found to be strongly 
associated with smoking cessation, some clinical factors have been found to influence 
relapse. For example, one study found that the pharmaceutical intervention, 
Varenicline has been found to improve cessation rates when examined as a long term 
maintenance intervention, whereas, other behavioural and pharmaceutical 
interventions have not been found to be effective in reducing the risk of relapse 
(Tonstad, Tonnesen, Hajek, Williams, Billing, & Reeves, 2006). A handful of health 
behaviour models have, however, highlighted the role of maintenance and relapse in 
the smoking cessation process. 
 
The health behaviour model, the TTM (J. O. Prochaska & DiClemente, 1983; J.O. 
Prochaska & DiClemente, 1986), was described earlier in this chapter. The TTM 
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highlights the application of alternate processes of change throughout differing stages 
of change. This might suggest that certain processes are of greater or lesser importance 
among individuals at differing stages of smoking cessation. For example, some 
processes may be of particular importance to individuals initially embarking on a quit 
attempt, compared to those continuing to maintain abstinence. The model constructs 
highlight the importance of longer term relapse prevention research, as well as 
research focusing on initial predictor smoking cessation. 
 
Marlatt & Gordon (1985) specifically developed a model for relapse prevention. The 
model was developed to teach individuals to effectively anticipate and cope with 
potential relapse situations, using behavioural skill-training procedures with cognitive 
intervention techniques. Figure 3 displays the key features of the model and 
demonstrates how various factors can influence the result of a high-risk situation. The 
model proposes that immediate determinants (e.g. high-risk situations, coping skills, 
outcome expectancies, and the abstinence violation effect), as well as covert 
antecedents (e.g. lifestyle factors and urges and cravings) can influence outcomes. 
Again, this model will not be solely relied upon in informing the current project, but 
alongside the aforementioned literature, it does provide insight into understanding 
smoking cessation and maintenance. 
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Figure 3. The Relapse Prevention Model (Marlatt & Gordon, 1985) 
 
2.6 Tobacco control in England 
Having explored specific groups who may exhibit increased risk of smoking initiation, 
and having considered potential predictors or inhibitors of smoking cessation, the 
current section explores governmental efforts to address the aforementioned 
inequalities and to reduce the financial and health burden of tobacco overall. Section 
2.6.1 explores tobacco control policy in England, with particular reference to the white 
paper, “Healthy Lives, Healthy People: A Tobacco Control Plan for England” (DH, 
2011); this section provides an overview of the approaches and strategies implemented 
by the Government, which aim to tackle smoking prevalence. Following this, Section 
2.6.2 explores one of the key tobacco control strategies, which has been widely 
implemented within the past decade or so, SSS. Section 2.6.2 will provide an overview 
of SSS and explore pharmacotherapy and behavioural interventions recommended for 
delivery within such services; exploring these aspects will introduce the setting for the 
current project, whilst informing the reader of current smoking cessation interventions 
offered to smokers across England and reported efficacy in relation to such 
approaches. 
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2.6.1 Tobacco control policy in England 
In 2011, DH (2011) published the white paper, “Healthy Lives, Healthy People: A 
Tobacco Control Plan for England”. The document describes how the Government has 
set three national ambitions to concentrate tobacco control work as a whole. These 
include: (1) reducing smoking prevalence among adults in England; (2) reducing 
smoking prevalence among young people in England; (3) reducing smoking during 
pregnancy in England. Through the proposed tobacco control plan, the Government 
pronounced their support for a comprehensive approach to tobacco control in England 
across six internationally recognised elements. 
 
Firstly, the Government proposed the intention to stop the promotion of tobacco, 
which entails various sub-components including proposing consultation around the 
options to reduce the promotional impact of tobacco product packaging (i.e. plain 
packaging). More recently, increasing steps have been made to introduce regulations 
for standardised tobacco product packaging (DH, 2014); a recent systematic review 
(M. Stead et al., 2013) found that although study results were somewhat mixed, 
standardised packaging reduces the appeal of cigarettes and smoking. 
 
Secondly, the Government announced its intention to make tobacco less affordable 
through strategies including continuation of the ongoing policy to use tax to sustain 
the high price of tobacco; one review concluded that there is sufficient evidence for 
the effectiveness of increased tobacco excise taxes and costs in reducing tobacco 
consumption and smoking prevalence (Chaloupka, Straif, & Leon, 2011). 
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Thirdly, the Government detailed intentions to effectively regulate tobacco products. 
For example, they state how they aim to co-ordinate scientific and market research on 
the use of nicotine-containing products, such as electronic cigarettes (or e-cigarettes), 
via the Medicines and Healthcare Products Regulatory Agency (MHRA). The recently 
approved European Tobacco Product Directive (TPD) subjects e-cigarettes that make 
medicinal claims regarding smoking cessation or harm reduction and/or products 
containing above 20mg/ml nicotine, to a medicinal regulatory regime (European 
Commission, 2014). Products classified as medicinal will be licenced by the 
Medicines and Healthcare products Regulatory Agency (MHRA) by 2016 (MHRA, 
2013). 
 
Fourthly, helping tobacco users to quit was cited by the Government as another 
priority. This component focuses particularly on the continued provision of Local SSS. 
The white paper, “Smoking Kills” (DH, 1998) proposed the initiation of Local SSS. 
SSS in the UK deliver evidence based behavioural and pharmaceutical interventions 
to support smokers in quitting and such services have proven to be highly effective in 
reducing smoking prevalence (Ferguson et al., 2005; Judge et al., 2005). 
 
Fifthly, the Government announced intentions to reduce exposure to secondhand 
smoke, such as encouraging smokers to alter their behaviour, to deter smokers from 
smoking in family homes or cars, primarily because secondhand smoke is attributed 
to 165,000 new cases of disease among children each year in the UK (Royal College 
of Physicians, 2010). Efforts were recently proposed for smoking in cars carrying 
children to become illegal, this policy was implemented in October 2015 in England 
(DH, 2014). 
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Effective communication for tobacco control is the sixth and final element of the 
recent tobacco control plan. This entails sub-components, such as providing clear and 
consistent information to support smokers to stop smoking and signposting smokers 
to resources which may support quitting, such as the NHS smoke-free website 
(http://www.nhs.uk/smokefree). 
 
This section has provided an overview of current Government tobacco control policy 
priorities and the comprehensive approach to tobacco control that is adopted. The 
following section will focus on the aforementioned fourth strand of the “Healthy 
Lives, Healthy People” tobacco control plan (DH, 2011), “helping tobacco users to 
quit”, of which SSS provision is an important component. 
 
2.6.2 Stop Smoking Services in England 
The provision of local SSS in England is a key feature of the current national tobacco 
control plan (DH, 2011) and a network of services has existed in England since 1999 
(DH, 1998). Services aim to support smokers within local communities to quit by 
providing a range of pharmacotherapy products and behavioural therapies (NICE, 
2008) and they have proven to be consistently effective, both nationally (Ferguson et 
al., 2005; Godfrey, Parrott, Coleman, & Pound, 2005; Judge et al., 2005; West, May, 
West, Croghan, & McEwen, 2013) and among particularly disadvantaged groups 
(Bauld, Judge, & Platt, 2007; Chesterman, Judge, Bauld, & Ferguson, 2005). Self-
reported four-week quit rates in 2013-14 were 51% overall in services (National 
Centre for Smoking Cessation and Training [NCSCT], 2014) and it has been estimated 
that 36,000 premature deaths were prevented due to provision of services in 2012-13 
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(Bauld, 2014 as cited in NCSCT, 2014). The Smoking Toolkit Study used no 
medication or support as a reference point to identify that SSS support and medication 
was a considerably more effective approach to smoking cessation (OR 3.53, 95% CI 
2.12-5.88), than medication on prescription (OR 1.73, 95% CI 1.39-2.15), and nicotine 
replacement therapy (NRT) over-the-counter (OR 0.97, 95% CI 0.81-1.16) (West & 
Fidler, 2011). 
 
NICE (2008) and the NCSCT (2014) are key sources of service provision guidance 
for NHS professionals and others who have either a direct or indirect position in SSS 
provision. Both organisations advise on the use and evidence base of pharmacotherapy 
products and behavioural support; research regarding these recommendations will 
now be explored to provide an overview of the SSS settings and treatment approaches 
adopted. 
 
NICE (2008) recommends the use of a number of pharmacotherapy products, 
including nicotine replacement therapy, varenicline (Champix, Pfizer), and bupropion 
(or Zyban). Various forms of NRT are widely available within SSS. A Cochrane 
review established that NRT overall has been found to be substantially more effective 
at six-month follow-up compared to non-NRT control groups (RR 1.60, 95% CI 1.53-
1.68) (Stead et al., 2012). Furthermore, the review explored whether specific forms of 
NRT were more or less effective than others. They found that nasal spray was 
particularly effective (RR 2.02, 95% CI 1.49-2.73), in comparison to tablets/lozenges 
(RR 1.95, 95% CI 1.61-2.36), inhalers (RR 1.90, 95% CI 1.36-2.67), patches (RR 1.64, 
95% CI 1.52-1.78), and gum (RR 1.49, 95% CI 1.40-1.60). Lastly, the review revealed 
that combination of a slow-release nicotine containing product (i.e. nicotine patch) 
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with a fast-delivery form of NRT (e.g. inhalers) was a substantially more effective 
treatment approach than use of a single NRT product (RR 1.34, 95% CI 1.18-1.51). 
 
Varenicline (or Champix) is a non-nicotine drug, which binds to high affinity and 
selectivity of the α4β2 neuronal nicotinic acetylcholine receptor, acting as a partial 
agonist; thus, craving and withdrawal symptoms are alleviated and reinforcing reward 
effects of smoking are reduced by preventing nicotine binding to the receptors (NICE, 
2007). A recent Cochrane review assessed the efficacy of varenicline, measuring six-
month abstinence (Cahill, Stead, & Lancaster, 2012). Based on 14 trials, the pooled 
relative risk for sustained abstinence at standard dose compared to placebo was 2.27 
(95% CI 2.02-2.55). Mills et al. (2012) also conducted a meta-analysis, which explored 
the efficacy of varenicline. They found that at three months, varenicline was more 
effective than placebo (RR 2.26, 95% CI 1.69-3.02) or standard dose NRT (RR 1.29, 
95% CI 1.11-1.49), yet at six months, varenicline remained more effective than 
placebo (RR 2.24, 95% CI 1.75-2.88) but it was not significantly more effective than 
standard NRT (RR 1.18, 95% CI 0.95-1.48). It has previously been theorised that 
varenicline may impact mood and suicidal ideation, as it interacts with the central 
nervous system and dopamine release (Hays & Ebbert, 2008; Hughes, 2008); however, 
a recent systematic review concluded that there is consistent evidence among the more 
valid study designs, that varenicline either does not contribute towards increased 
suicide rates or if it does, the effect is extremely minimal (Hughes, 2015). 
 
Bupropion (or Zyban) is an anti-depressant drug, which is believed to enhance 
smoking cessation by inhibiting dopamine re-uptake and reducing the effect of 
nicotine on nicotinic acetylcholine receptors (Wilkes, 2008). Bupropion has been 
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found to be significantly effective in enhancing smoking cessation success. One 
Cochrane review revealed how the pooled analysis of 44 trials suggested that 
bupropion used independently is significantly more effective than placebo for long 
term abstinence (RR 1.62, 95% CI 1.49-1.76), yet they concluded that there was 
insufficient evidence to support the use of bupropion alongside NRT (Hughes, Stead, 
Hartmann-Boyce, Cahill, & Lancaster, 2014). Another Cochrane review suggested 
that bupropion and NRT were equally effective (RR 1.01, 95% CI 0.87-1.18) but 
combination of bupropion and NRT achieved significantly better abstinence rates (RR 
1.24, 95% CI 1.06-1.45) (Stead et al., 2012); however, bupropion has been found to 
be overall less effective for smoking cessation than varenicline (Cahill et al., 2012; 
Hughes et al., 2014). 
 
The NCSCT (2014) suggests that the most effective treatment method involves 
combination of smoking cessation pharmacotherapy and behavioural support provided 
by SSS, such as individual behavioural counselling, group behaviour therapy, and 
telephone support. NICE (2008) provide recommendations regarding individual 
behavioural counselling and group behaviour therapy. They suggest that individual 
counselling should involve scheduled face-to-face appointments between smoking 
counsellor and smoker, which typically involves weekly sessions over a minimum of 
four weeks following the quit date. With regard to group behaviour therapy, they 
suggest that therapy should comprise of scheduled meetings in which smokers receive 
information, advice, support and some form of behavioural intervention, such as 
cognitive behavioural therapy. As recommended for individual support, NICE also 
suggest that group behavioural therapy should be offered for at least the first four 
weeks following a quit date. 
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A number of studies have assessed the efficacy of individual and group support for 
smoking cessation. Lancaster and Stead (2005) conducted an analysis which 
incorporated 22 trials of individual behavioural therapy. They found that individual 
counselling was more effective than control in enhancing smoking cessation at long-
term follow-up (RR 1.39, 95% CI 1.24-1.57); however, no difference in effect was 
displayed between intensive and brief individual counselling (RR 0.96, 95% CI 0.74-
1.25). A Cochrane review on group therapy was also undertaken, in which 13 trials 
were included in an analysis of group therapy compared with self-help (Stead & 
Lancaster, 2005). The authors revealed that group support was significantly more 
effective than self-help (RR 1.98, 95% CI 1.60-2.46), yet no significant difference in 
effectiveness was detected between group therapy and individual counselling; 
nevertheless, one large study (N = 126,890) found that group therapy was significantly 
more effective than individual support within SSS (OR 1.43, 1.16-1.76) (Brose et al., 
2011). 
 
NCSCT (2014) dichotomise group therapy into open (or rolling) and closed group 
programmes. Open (or rolling) group programmes enable smokers to join a 
programme spontaneously, resulting in a group of smokers at varying stages of their 
cessation attempt, whereas closed group programmes require smokers to start the 
programme simultaneously, encouraging service users to continue attending sessions 
for a specific number of weeks. NICE (2008) fail to provide guidance on the format 
of group therapy, although a recent study (N = 202,084) which used individual 
behaviour as a reference point found that open group programmes were most effective 
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at 4-week quit (OR 1.26, 95% CI 1.12-1.41), compared to closed group programmes 
(OR 1.11, 95% CI 0.98-1.26) (Hiscock et al., 2013). 
 
The NCSCT (2014) categorises telephone support into proactive telephone support, 
reactive telephone support and text-based support. Telephone support (or Quitlines) 
typically entail providing support and encouragement to smokers who intend to quit 
or are actively quitting. Proactive telephone counselling involves smoking counsellors 
contacting the client, whereas reactive telephone counselling involves the client 
contacting the service (NICE, 2008). A Cochrane review into telephone counselling 
for smoking cessation found that cessation success was higher among smokers who 
had received a number of sessions of proactive telephone counselling (RR 1.37, 95% 
CI 1.26-1.50) (Stead, Hartmann-Boyce, Perera, & Lancaster, 2013). The authors also 
suggest that there is evidence to support the efficacy of reactive telephone counselling 
but that it is limited in comparison, as fewer studies have been conducted in this area 
of research, presumably because reactive telephone counselling RCTs would entail a 
control group of callers, who would be refused telephone support.  
 
One strategy adopted by some SSS, although not currently recommended by NICE 
(2008), is the use of text-messaging to support service users. Y. F. Chen et al. (2012) 
suggested that the use of computer and other electronic aids can enhance prolonged 
abstinence rates, in comparison to no intervention or generic self-help materials (RR 
1.32, 95% CI 1.21-1.45). Kong, Ells, Camenga, and Krishnan-Sarin (2014) conducted 
a narrative review of the literature regarding text-message support for smoking 
cessation. Of the studies they included, all used motivational messages, which were 
grounded in either socio-cognitive behavioural theories, behaviour change techniques, 
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and/or individually tailored messages. One pooled analysis, which included 9,000 
participants concluded that mobile-phone based interventions are significantly 
associated with improved six-month outcomes, compared to control programmes (RR 
1.71, 95% CI 1.47-1.99) (Whittaker et al., 2012). 
 
2.7 Introducing risk perception 
Having considered the literature regarding smoking and tobacco control, the 
remaining focus of the current chapter is risk. Risk may be regarded as “uncertainties: 
possibilities, chances, or likelihoods of events, often as consequences of some activity 
or policy” (Taylor-Gooby & Zinn, 2006, p.1); however, risk is not solely considered 
in terms of statistical probabilities but, it is explored extensively in psychosocial 
research and practice. We have always been exposed to risks but previous to 
modernity, risks were typically viewed as a result of non-human factors, such as 
natural disasters such as famine or earthquakes. Modernity (characterised by 
technological advancement and the development of governing institutions) has 
consequentially resulted in exposure of other risks, such as nuclear/chemical warfare 
or newly discovered diseases, leading our “risk society” to become increasingly aware 
and fearful of risks (Beck, 1992). Indeed, the term risk is now used in every day and 
professional discourses to denote danger or hazard (Douglas, 1992). 
 
Douglas (1992) also emphasised the shift towards a blame culture, in line with 
modernity, whereby any occurrence of death, accidents or misfortune is attributed to 
someone or something. Furthermore, Lupton and Tulloch (2002) described how within 
Western societies risk avoidance is linked closely with the ideal of the “civilised” 
body, an increasing willingness to seize control over one’s life, rationalise and regulate 
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the self and body, and ultimately, avoid the vicissitudes of fate. The ideal of the 
civilised body links closely with cognitive theory regarding health risk behaviour. For 
example, the Health Belief Model (HBM) (Rosenstock, 1966) is one of the most 
dominant theories in health behaviour research (Carpenter, 2010) and stipulates that 
health beliefs (e.g. perceived susceptibility of disease) predict health behaviour 
engagement. It has been argued that such approaches represent human behaviour in a 
computational manner, whereby risk avoidance is considered rational and risk-taking 
is viewed as irrational (Bloor, 1995 as cited in Lupton, 1999). Douglas (1992) further 
argues that such approaches depict humans as “hedonic calculators calmly seeking to 
pursue private interested. We are said to be risk-aversive, but alas, so inefficient in 
handling information that we are unintentional risk-takers; basically we are fools.” (p. 
13). Similarly to addiction theory, not one specific theory or model can account for 
interpretation and responses to risk and therefore, the current thesis will explore risk 
by incorporating a range of perspectives, as discussed. 
 
Risk perception is the subjective, individualised assessment of risk. It is 
conceptualised as a multi-factorial construct, integrating perceived vulnerability, 
unrealistic optimism, and precaution effectiveness (Borrelli, Hayes, Dunsiger, & Fava, 
2010). Perceived vulnerability reflects the perceived likelihood that an individual will 
suffer health consequences as a result of engaging in the risk behaviour (Gerrard, 
Gibbons, Benthin, & Hessling, 1996; Gerrard, Gibbons, & Bushman, 1996; Weinstein, 
1999; Weinstein, Rothman, & Sutton, 1998). Unrealistic optimism refers to the 
inaccurate underestimation of the occurrence of a negative event, relative to other 
people in similar circumstances (Weinstein & Klein, 1996). Lastly, precaution 
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effectiveness denotes the perceived likelihood that engaging in a precautionary 
behaviour will result in benefit to health (Weinstein, 1988). 
 
Cognitive dissonance theory has received substantial attention in the literature and 
may provide some explanation as to why some smokers quit and many continue to 
smoke despite the risks. In the context of smoking, cognitive dissonance can occur 
when a smoker holds at least two opposing but related cognitions (or perceptions), 
which can result in mental conflict (Festinger, 1957, 1962). Consequentially, a smoker 
will act in various ways in an attempt to reduce dissonance and mental conflict. For 
example, a heavy smoker may become increasingly aware of lung cancer risk, creating 
dissonance between willingness to smoke and fear of disease. The smoker may attempt 
to reduce cognitive dissonance in a number of ways, such as stopping smoking or 
rationalising or justifying continued smoking (e.g. being critical of a risk 
communication source). A number of studies have suggested that smokers reduce 
cognitive dissonance by rationalising or justifying smoking, which in turn has been 
associated with continued smoking and relapse behaviour (Dijkstra, 2009; Fotuhi et 
al., 2013; Gibbons, Eggleston, & Benthin, 1997; Halpern, 1994; Jenks, 1992; Kleinjan, 
van den Eijnden, Dijkstra, Brug, & Engels, 2006; Kleinjan, van den Eijnden, & Engels, 
2009; McMaster & Lee, 1991; Peretti-Watel, Halfen, & Grémy, 2007; C. A. Robinson, 
Bottorff, Smith, & Sullivan, 2010). 
 
The following sections aim to explore what makes some risks more acceptable than 
others, whether risk perception predicts smoking initiation, and how influential risk 
perception is in smoking maintenance and cessation. Understanding these components 
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will enable us to inform the development of effective risk communications; thus, 
preventing smoking initiation and promoting smoking cessation. 
 
2.7.1 Factors implicated in risk perception 
Whether an individual perceives a risk as threatening or not ultimately affects how the 
individual reacts towards the risk and the degree to which an individual perceives a 
risk as threatening can rely upon several factors, including voluntariness, 
controllability, familiarity, sociocultural factors, and the media. A pioneering paper by 
Starr (1969) detailed the evaluation of risk acceptability, by comparing risk 
information with risk behaviour. Starr suggested that people are prepared to accept 
voluntary risks approximately 1,000 times greater than involuntary risks; therefore, if 
an individual perceives a risk as voluntary (e.g. smoking), the risk is likely to be more 
acceptable compared with an involuntary risk (e.g. chemical exposure). Voluntary 
risk-taking is also associated with risk exposure benefit. Voluntary risk-taking has 
been described as engagement in a behaviour that is perceived as risky, yet undertaken 
intentionally and by choice (Lupton & Tulloch, 2002). Lupton (1999) describes how 
risk-taking can also be reported more positively and that to some, voluntary risk-taking 
may enhance a sense of personal agency, opportunity to discover a communal spirit 
with other like-minded individuals, and can provide “temporary liberation from 
routine constraints” (p. 166). This highlights how risks may not only be perceived as 
something disastrous or threatening, but to some, a risk may also be viewed as 
potentially beneficial. 
 
The concept of voluntariness links closely with controllability of risk. Compared with 
other health beliefs, perceptions associated with control have often been found to 
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contribute largely to variance when tested across a number of health behaviour 
theories (e.g. Godin & Kok, 1996). People will often perceive a risk as more 
threatening if the risk is perceived as uncontrollable, whilst a risk that is perceived as 
controllable is likely to be perceived as less threatening (Slovic, 2000a). For example, 
individuals tend to view their risk as lower if they are the driver of a car (and perceive 
themselves to be in control), rather than the passenger in a car (potentially perceiving 
themselves to be out of control) (McKenna, 1993). Sjoberg (2000) also describes how 
perceived personal risk is typically lower compared to perceived risk of others’ risk. 
Since it is not possible for the majority of us to be below average risk, this would 
suggest that many of us are unrealistically optimistic about our personal risk. The 
concept of unrealistic optimism in relation to smoking cessation is described further 
in Section 2.7.3. 
 
Familiarity or habituation is also an important factor with regard to risk perception. 
Risks perceived as new or unknown are often perceived as more threatening (e.g. E. 
C. Smith, Burkle, & Archer, 2011). Being exposed to a risk over time can result in 
perceiving the risk to be less threatening, despite the objective level of risk remaining 
the same (Slovic, 2000a); this illustrates the role of habituation, which is particularly 
relevant to smoking, as smoking can become routine, mundane and ultimately 
habitual. Furthermore, Lupton (1999) suggests that risk responses may not occur on a 
conscious level, despite models of rationality emphasising the role of conscious 
behaviour. For example, a passenger may automatically fasten a seat-belt as a response 
to habituation, as opposed to a response of rational risk avoidance.  
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Sociocultural variables have also been found to have a profound impact on risk 
perception. Douglas and Wildavsky (1982) contend that risk perception is itself a 
social process and they critique cognitive approaches to risk, arguing that such 
approaches fail to acknowledge social influence. For example, research suggests that 
white males consistently perceive risks as lower compared to other demographic 
groups (Finucane, Slovic, Mertz, Flynn, & Satterfield, 2000); this finding has been 
attributed to socio-political factors rather than biological factors. Risk perception has 
also been found to differentiate across socio-economic status. Lupton (1999) 
highlights how white males from particularly affluent groups more often perceive risks 
generally as less threatening; in considering smoking, however, recent research 
suggests that those from the most deprived households tend to perceive smoking-
related health risks as less threatening (Peretti-Watel, Seror, et al., 2014). It has been 
argued that insecurity and risk is concentrated among the poorest in society and since 
access to material resources determines action, deprivation may ultimately implicate 
risk acceptance or avoidance (A. Jones, Abbott, & Quilgars, 2006). 
 
Mass media might also play a role in the formation and adaptation of risk perception. 
It is challenging to escape media in contemporary society; we consistently seek or are 
exposed to information from various media sources, including the Internet, 
newspapers, television, and radio. Wahlberg and Sjoberg (2000) reviewed the 
evidence for a relationship between media and risk perception. They summarised that 
media is not a strong causal influence of risk perception, particularly personal risk 
perception; however, they do suggest that increased media exposure may affect risk 
perception but that the effects are weakened by impersonal impact. The media has also 
been accused of misrepresenting health threats. Bomlitz and Brezis (2008) argue that 
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emerging health threats are over-reported in mass media, compared with common 
threats. For example, the very limited outbreak of Ebola in America received an 
arguably disproportionate amount of media coverage for a number of weeks following 
the first imported case (Towers et al., 2015), especially when compared with other 
common, ongoing threats, such as smoking. With regard to smoking specifically, a 
more recent review suggested that the media plays a significant role in forming 
perceptions towards smoking among youths (Wakefield, Flay, Nichter, & Giovino, 
2003) and the media has been suggested as one of the primary sources of cancer risk 
related knowledge among smokers (Dowding, 2006).  
This section has identified various factors, which may impact the extent to which a 
risk is perceived as harmful. The following two sections will explore the literature in 
relation to the impact of risk perception on smoking behaviour, specifically smoking 
initiation and smoking cessation. In exploring these concepts, the reader will be 
provided with a more in-depth understanding of the role of risk perception in smoking 
behaviour and potentially, considering such aspects will aid the development of the 
LLP intervention. 
 
2.7.2 Risk perception and smoking initiation 
As the vast majority of smokers start smoking prior to the age of 18 years old (ONS, 
2013b), much of the literature regarding risk perception and smoking initiation tends 
to focus on initiation among children and adolescents. Determining whether 
perceptions of risk are important in smoking initiation is important; if young people’s 
perceptions of risk do not relate to smoking initiation, health campaigns focused 
towards educating young people about the harms of smoking may be ineffective. 
Furthermore, individuals who are more dismissive regarding the risks of smoking at 
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the point of initiation, might potentially be less receptive to risk communication 
encouraging smoking cessation at a later stage. 
 
Earlier research argued that young people are aware of the risks. For example, Viscusi 
(1990) found that young people greatly overestimate the effect of smoking on lung 
cancer, indicating that young people are particularly informed of the risks associated 
with smoking. In response to these findings, Jamieson and Romer (2001b) suggested 
that despite such findings, a large proportion of smokers are dissatisfied with their 
decision to start smoking; thus, arguably invalidating claims that young people are 
fully informed of smoking-related risks. They highlight that the first Annenberg 
Tobacco Survey results revealed that although again, young people tend to 
overestimate lung cancer risk, far fewer overestimate smoking-related mortality. 
 
A number of surveys have also found that smoking youths or those susceptible to 
smoking tend to underestimate the effect of smoking on health, compared to non-
smoking youths or those less susceptible (Aryal, Petzold, & Krettek, 2013; Halpern-
Felsher, Biehl, Kropp, & Rubinstein, 2004; Nichter, Nichter, Vuckovic, Quintero, & 
Ritenbaugh, 1997; Romer & Jamieson, 2001; Slovic, 2000b; Virgili, Owen, & 
Sverson, 1991). For example, Romer and Jamieson (2001) found that young non-
smokers were more likely to perceive the risk of lung cancer as high (79.1%), 
compared to smokers (69.6%); however, Greening and Dollinger (1991) found no 
difference in perceived risk estimates regarding cancer, emphysema, and stroke 
between smokers and non-smokers.  
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The second Annenberg Tobacco Survey revealed that health risk perceptions predict 
smoking among 14-22 years old youths who believed that smoking cessation is more 
difficult to achieve and disease onset happens sooner, yet this was not apparent among 
young people who did not hold the aforementioned views (Gerking & Khaddaria, 
2012).  A. V. Song et al. (2009) conducted a longitudinal study in which risk 
perceptions would be considered as continuous variables. They found that individuals 
who held the lowest perceptions of long-term and short-term smoking-related risks 
were approximately 3.64 and 2.68 times more likely to start smoking at follow-up, 
respectively, compared to those who perceived the risks as highest. Another 
longitudinal study, which followed participants (N = 477) over three years, also found 
that perceptions towards health and safety predicted smoking initiation (Gerrard, 
Gibbons, Benthin, et al., 1996). 
 
Despite the aforementioned findings, the literature suggests that perceptions of 
addiction may be stronger predictors of smoking initiation. Young people tend to 
overestimate their ability to quit smoking and underestimate the magnitude of 
addiction. One study suggests that young people are more likely to believe that they 
can smoke for a few years and then quit (60%), compared to adults (48%) (Arnett, 
2000). O'Loughlin, Karp, Koulis, Paradis, and DiFranza (2009) recruited 877 
participants and found that non-daily smokers at baseline, were more likely to become 
daily smokers at follow-up if they exhibited inflated perceptions of personal mental 
and physical addiction. Notably, Okoli, Richardson, Ratner, and Johnson (2009) 
recruited youths (N = 5051) and found that those who perceived greater personal 
mental and physical addiction were identified as being more susceptible to smoking, 
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despite participants being non-smokers. This suggests that potentially non-smokers 
form predisposed ideas around addiction and self, even before they begin to smoke. 
 
Lastly, it should also be noted that the relationship between health risk perceptions 
and smoking initiation may also be mediated by other factors, such as tobacco product 
options. For example, Brennan, Gibson, Momjian, and Hornik (2015) found that 13% 
and 23% of young people viewed menthol cigarettes as less harmful and addictive, 
respectively, compared with regular cigarettes. Furthermore, lower perceptions of 
harm were associated with intention to use. 
 
2.7.3 Risk perception and smoking cessation 
Understanding the role of risk perception in smoking maintenance and cessation is 
important in the development of effective smoking-related risk communications. A 
review of the literature regarding motivating factors that contribute towards smoking 
cessation found that smoking cessation was primarily predicted by concerns for health 
(McCaul et al., 2006), suggesting that health risk perceptions may play an important 
role in the process of smoking cessation. A number of studies have detailed how health 
risk perceptions in regard to smoking may be associated with variables including age, 
sex, ethnicity, education, smoking behaviour (e.g. cigarettes per day), and family 
history of disease (Ayanian & Cleary, 1999; Borrelli et al., 2010; E. J. Hahn, Rayens, 
Hopenhayn, & Christian, 2006; Strecher, Kreuter, & Kobrin, 1995). 
 
In comparison to their non-smoking counterparts, current smokers have been found to 
typically acknowledge personal risk of smoking-related disease as higher (Chassin, 
Presson, Sherman, & Kim, 2002; Eisinger, 1971; A. Hahn & Renner, 1998; E. J. Hahn 
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et al., 2006; Honda & Neugut, 2004; Horwitz, Hindi-Alexander, & Wagner, 1985; C. 
Lee, 1989; McKenna, Warburton, & Winwood, 1993; Peretti-Watel et al., 2007; 
Reppucci, Revenson, Aber, & Dickon Reppucci, 1991; Rise, Strype, & Sutton, 2002; 
Rutten, Blake, Hesse, Augustson, & Evans, 2011; Strecher et al., 1995; Weinstein, 
Marcus, & Moser, 2005; Williams & Clarke, 1997; Zlatev, Pahl, & White, 2010). For 
example, Rutten et al. (2011) undertook a survey (N = 1765) and identified that 
personal perceived lung cancer risk was most often perceived as “very high” by current 
smokers (15.2%), followed by former (1.9%) and never smokers (1.6%). They also 
established, however, that current smokers more often reported feeling reluctant to get 
checked for lung cancer, in case they had it (23.4%), compared to former (13.3%) and 
never smokers (9.8%). Furthermore, 18.4% of current smokers described themselves 
as worrying about lung cancer all of the time, compared to 3.1% and 1.8% of former 
and never smokers, respectively. This research suggests that although current smokers 
acknowledge and worry about their increased risk, they may exhibit some denial 
behaviours e.g. avoidance of screening, due to concerns around disease acquisition.  
 
A review by Weinstein (1998) concluded that smokers consistently acknowledge that 
smoking is responsible for increased health risks, yet they tend to regard the level of 
risk as lower in comparison to non-smokers. The review also highlighted how smokers 
underestimate personal health risks when considered relative to other smokers, 
potentially demonstrating unrealistic optimism (Weinstein & Klein, 1996). In recent 
decades, the domain of unrealistic optimism has received a great deal of attention in 
relation to smoking. Smokers are also more likely to underestimate the role of smoking 
in the acquisition of disease (Arnett, 2000; Chapman, Wong, & Smith, 1993; C. Lee, 
1989; Peretti-Watel et al., 2007; Reppucci et al., 1991; Ruchlin, 1999) and also more 
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likely to emphasise the likelihood that disease occurs due to factors other than smoking 
behaviour, such as chance or genetic factors (Chapman et al., 1993; Horwitz et al., 
1985; Rutten et al., 2011; Santos, Tonstad, Montgomery, Paalani, & Faed, 2011; 
Weinstein et al., 2005).  
 
A number of studies have also demonstrated how smokers exhibit substantial 
differences between how they perceive personal risk and general risk (Dillard, 
McCaul, & Klein, 2006; A. Hahn & Renner, 1998; McKenna et al., 1993; Reppucci et 
al., 1991; Rise et al., 2002; Segerstrom, McArthy, Caskey, Gross, & Jarvik, 1993; 
Strecher et al., 1995; Weinstein et al., 2005; Williams & Clarke, 1997; Zlatev et al., 
2010). More specifically, Weinstein et al. (2005) conducted a survey (N = 6369) 
consisting of current, former and never smokers. They found that 37.9%, 43.2% and 
47.1% of current, former, and never smokers, respectively, correctly estimated lung 
cancer survival to be below a quarter, suggesting that current smokers are 
unrealistically optimistic in their perceptions around lung cancer survival. 
Furthermore, the results suggested that despite absolute lung cancer risk increasing 
substantially with cigarette consumption per day, perceptions of relative and absolute 
lung cancer risk were similar across variations in cigarette consumption. Again, this 
suggests that smokers are either unaware of the reported increase in lung cancer risk 
in line with cigarettes per day, or consumers of greater numbers of cigarettes per day 
may underestimate the strength of this relationship. 
 
Unrealistic optimism has independently been found to be associated with other myths 
and beliefs about personal smoking. Dillard et al. (2006) compared objective and 
personal perceived risk, to stratify unrealistic optimists from a sample of smokers (N 
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= 377). They found that individuals who were unrealistically optimistic regarding 
personal lung cancer risk were more likely to believe that a greater number of lung 
cancers are cured and less likely to identify smoking cessation as a means of reducing 
lung cancer risk or to have plans to quit smoking. It has been suggested that when 
forming relative risk perceptions, smokers often characterise the behaviour of an 
abstract individual, a “risk stereotype”, whereby estimates of smoking duration, 
cigarettes per day and cigarette nicotine content are considered and incorporated (A. 
Hahn & Renner, 1998). A. Hahn and Renner (1998) suggested that smokers use these 
risk stereotypes when evaluating their relative personal risk; this could provide some 
explanation as to why smokers consistently underestimate comparative risk, as they 
have created an extreme example for comparison to themselves. 
 
The majority of the aforementioned research focuses on exploring differences in risk 
perception by smoking status. More in-depth exploration of risk perception throughout 
the process of smoking cessation is required to further establish the causal role of risk 
perception. Chapman et al. (1993) found that a number of self-exempting risk 
perceptions (e.g. “Many smokers live until a ripe old age so it’s not that bad for you”) 
were significantly more prevalent among individuals pre-contemplating smoking 
cessation, compared to those in the action stage of behaviour change, as stipulated by 
the TTM (see Section 2.2). E. J. Hahn et al. (2006) found that lung cancer risk 
perceptions were positively related to stage of change, although recent former smokers 
classified in the highest stage of change (maintenance), perceived their risk as lower 
than that of current smokers. Furthermore, Borrelli et al. (2010) found that individuals 
in the preparation stage of change perceived vulnerability of disease as higher and 
exhibited lower unrealistic optimism compared to those in preceding stages of change. 
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Again, this suggests that those embarking on smoking cessation may be more realistic 
in their judgements of risk and the consequences of smoking, compared to pre-
contemplators. 
 
Generally, research suggests that perceived risk increases with intention to quit 
(Borland et al., 2009; Dillard et al., 2006; Magnan, Koblitz, Zielke, & McCaul, 2009; 
Norman, Conner, & Bell, 1999; Williams & Clarke, 1997), although much of these 
findings are based on cross-sectional surveys and a number of studies have failed to 
find a strong relationship (Segerstrom et al., 1993; Umeh & Barnes, 2011). Several 
studies have also suggested that risk perceptions predict quit attempts (Borland et al., 
2009; Jacobson, Catley, Lee, Harrar, & Harris, 2014; Jamieson & Romer, 2001a) but 
again, a number of studies failed to find an association (Norman et al., 1999; 
Segerstrom et al., 1993). 
 
Arguably, the strongest evidence for an association between risk perception and 
smoking cessation, may derive from longitudinal studies that include a measure of 
cessation. Borland et al. (2009) found that risk perceptions were associated with 
intention to quit and making a quit attempt, yet they found no consistent predictive 
effect on sustained smoking cessation. Despite this, a small number of recent studies 
have found an association between health risk perceptions and smoking cessation. 
Among medically ill smokers (N = 237), increases in future perceived vulnerability 
have been found to predict continuous abstinence at two-months follow-up (OR 3.39, 
95% CI 1.09-10.55), whilst unrealistic optimism was also found to relate to continued 
smoking (Borrelli et al., 2010). Hayes and Borrelli (2013) conducted a study in which 
they dichotomised Latino smokers into light and heavy smokers (N = 131). They found 
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that for heavier smokers, health beliefs significantly predicted abstinence at two and 
three month follow-ups, but only among heavier smokers. Most recently, Jacobson et 
al. (2014) explored risk perception among college students who smoked (N = 243) and 
found that higher perceived vulnerability to disease at baseline predicted smoking 
cessation at 3-month follow-up (OR 1.41, 95% CI 1.15-1.72). These longitudinal 
studies demonstrate some promising results, although there is clearly a limited number 
of well-designed longitudinal studies exploring the impact of risk perceptions on 
smoking cessation. 
 
In summary, research suggests that risk perceptions differ by smoking status and that 
smokers typically underestimate their personal risk, when comparing themselves to 
other smokers. The majority of the research also suggests that risk perceptions are 
associated with stages of change, intentions to quit, and quit attempts; however, there 
are few longitudinal studies to support the notion that risk perception influences 
smoking cessation specifically. Attempts to explore this concept may have been 
hampered by the fact that risk perceptions are challenging to measure; they entail the 
fluid assessment of risk and can be influenced by many factors, at any time. Despite 
this, the risk perception literature will have undoubtedly influenced the inception of 
many risk communication tools aimed at enhancing smoking cessation. In general, the 
literature suggests a relationship between risk perception and smoking cessation. The 
following section will explore the literature in relation to smoking-related risk 
communication, as the delivery of communications based on objective assessments of 
smoking-related risk and harm, could undermine unrealistic optimism and potentially, 
enhance smoking cessation success.  
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2.8 Risk communication 
This section will explore risk communication, processing of risk communication, 
recommendations around communicating smoking-related risk, and previously 
investigated assessments of risk and harm in relation to smoking. Consideration of 
such aspects is essential when informing the design and implementation of a new 
intervention.  
 
2.8.1 Processing risk communication 
Risk communication has been described as “any purposeful exchange of information 
about risks between interested parties” (World Health Organisation, 2001) (p. 317). It 
is an essential, instrumental and purposeful process, which is typically conceptualised 
by a one-way flow process consisting of a sender, a message, and a receiver, but it can 
also sometimes include additional components, such as total understanding by the 
receiver and feedback to the communicator (Corcoran, 2007). 
 
Although risk perception can provide some explanation as to why individuals may 
engage in behaviour change, risk perception cannot solely account for behaviour 
change influenced by risk communications. There are various theories and models that 
have been used to describe the influence of risk communication on health behaviour 
and therefore, this section will provide a brief overview of three key health behaviour 
theories and models: (1) The Health Belief Model; (2) The Protection Motivation 
Theory; (3) The Extended Parallel Processing Model. 
 
The Health Belief Model (HBM) was based on work by Rosenstock (1966) and 
developed by Becker (1974). The model emphasises the role of cognitions in 
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processing risk information and describes how such constructs can influence 
behaviour change. Risk perception holds a key role in the model, as perceived 
seriousness and susceptibility of disease are said to influence perceived threat of 
disease, which in turn contributes towards likeliness of engagement in behaviour 
change. This would suggest that informing a smoker of their increased lung cancer 
risk may influence how threatening they perceive smoking-related risk to be, which in 
turn, may influence smoking cessation. Although the HBM has been described as one 
of the most dominant theories in health behaviour research (Carpenter, 2010), its main 
components have been criticised for exhibiting weak effect sizes and its predictive 
capacity has been demonstrated to be limited in comparison to that of other heath 
behaviour models (Harrison, Mullen & Green, 1992; Zimmerman & Vernberg, 1994). 
 
The Protection Motivation Theory (PMT) was developed by Rogers (1975; 1983). The 
model aims to provide understanding regarding the mechanisms by which fear appeals 
are processed. Fear appeals have been described as “communications presenting the 
threat of impending danger to motivate compliance with a proposed recommendation” 
(p. 233) (Keller & Lehmann, 2008, as cited in Orazi & Pizzetti, 2015). The model 
proposes that intentions to engage in a behaviour change, as a result of exposure to a 
risk message, rely upon a number of factors: (1) perceived threat severity (e.g. lung 
cancer); (2) perceived probability of the occurrence (e.g. personal perceived risk of 
developing lung cancer); (3) perceived response efficacy (e.g. perceived extent to 
which a preventive behaviour, such as smoking cessation, might reduce lung cancer 
risk), and; (4) perceived self-efficacy (one’s own perceived confidence in undertaking 
the preventive behaviour). The HBM and the PMT differ primarily in the way the 
models are organised. More specifically, the PMT is organised into two processes: (1) 
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threat-appraisal processes, and; (2) coping-appraisal processes. The PMT has been 
applied extensively to smoking cessation (Farhangmehr, Jalali, & Silva, 2015; 
Pechmann, Zhao, Goldberg, & Reibling, 2003; Smerecnik, Quaak, van Schayck, van 
Schooten, & de Vries, 2011; Wright, French, Weiman, & Marteau, 2006; Yan et al., 
2014); however, unlike the HBM, the PMT does not account for additional 
environmental and cognitive factors (e.g. social norms). 
  
One model that has particular relevance in the context of the current project is the 
Extended Parallel Process Model (EPPM) (Witte, 1992; 1994). The EPPM integrates 
aspects of previous theoretical perspectives, such as The Protection Motivation Theory 
(Rogers, 1975) and danger control/fear control framework developed by Leventhal 
(1970). The EPPM suggests that cognitions contribute to fear appeal success (e.g. 
changes in attitudes and behaviour) via danger control processes, whilst the emotion 
fear contributes to fear appeal failure (e.g. defensive avoidance) via fear control 
processes. Within the model, perceived threat of the risk and perceived efficacy of risk 
communication response are both particularly important components in processing 
risk communication. A small number of studies have also successfully explored 
smoking-related risk communication within the framework of the EPPM (Emery, 
Szczypka, Abril, Kim, & Vera, 2014; Gharlipour et al., 2015; Gould, Watt, Cadet-
James, Clough, 2015; Greening, 1997; Ho, 1992; Wong & Cappella, 2009; Wright, 
French, Weiman, & Marteau, 2006). 
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Figure 4. The Extended Parallel Processes Model (Witte, 1992; 1994) 
 
2.8.2 Optimising smoking-related risk communication 
The manner in which risk communication is presented is crucial and can influence the 
extent to which perceptions of risk affect behaviour change (Ahmed, Naik, 
Willoughby, & Edwards, 2012). Various factors attributed to risk communication 
presentation can contribute towards risk communication salience, including numerical 
format, the use of absolute versus relative risk, the use of visual imagery, message 
framing, and individualising communications. As the current project intends to 
transform statistical output from the LLP risk model (Cassidy et al., 2008) into a 
format appropriate for a general population, guidance pertaining to effective delivery 
of risk communications should be considered. 
 
One of the challenges in delivering effective risk communication is the difficulty that 
a vast proportion of society has in comprehending numbers and statistics (Gigerenzer, 
Gaissmaier, Kurz-Milcke, Schwartz, & Woloshin, 2007). Poorer health literacy has 
been associated with higher nicotine levels, more positive attitudes towards smoking, 
less knowledge regarding smoking related risks, and lower risk perceptions 
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(independent of socio-economic status) (Stewart et al., 2013). Furthermore, Lipkus, 
Samsa, and Rimer (2001) demonstrated how even highly educated participants (N = 
463) are frequently unable to correctly answer fairly simplistic numeracy questions; 
for example, only 15-21% correctly recalled that 1 in 1000 was the equivalent of 0.1%. 
This raises concerns regarding how numerical risk information is communicated to 
the public. One review recommended that health risk communication should be 
consistent in the use of numerical formats, use the same numeric denominator, and 
present round numbers rather than decimals, if possible (Lipkus, 2007). Reyna and 
Brainerd (2008) also highlights the importance of ratio bias, a phenomenon whereby 
higher frequencies bias probability judgements, such as 1 in 10 being perceived as 
fewer than 10 in 100, despite the probabilities being equal. This should also be 
incorporated into the presentation of numerical risk estimates among smokers. 
 
Another influential factor regarding risk communication salience is the use of absolute 
versus relative risk estimates. An earlier review suggested that presenting relative risk 
reduction information is much more persuasive than providing absolute risk reduction 
information (Adrian Edwards, Elwyn, Covey, Matthews, & Pill, 2001). Subsequent 
research suggested that relative risks are easily misinterpreted and information should 
preferably be communicated using absolute probabilities (O'Doherty & Suthers, 
2007). More recently, a Cochrane review was undertaken, which evaluated the effect 
of statistical presentation of information for the same risks on risk understanding (Akl 
et al., 2011). The review concluded that there was no significant difference in risk 
understanding between absolute and relative risk reduction (Standardised Mean 
Difference [SMD] 0.02, 0.39-0.43), although relative risk was perceived to be larger 
(SMD 0.41, 0.03-0.79) and more persuasive (SMD 0.66, 0.51-0.81).  
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Another favourable attribute of risk communication is the incorporation of graphical 
information, such as charts, graphs, and illustrations. Lipkus and Hollands (1999) 
emphasised how graphical imagery can enhance the understanding of numerical risk 
and suggested that graphical imagery possesses at least three attributes for effective 
risk communication: (1) graphics can convey patterns in data which may have 
otherwise gone unnoticed; (2) specific types of graph could evoke specific 
mathematical operations; (3) graphs may attract and sustain attention, unlike statistics, 
potentially.  Hill et al. (2010) conducted three focus groups (N = 37) consisting of both 
health practitioners and consumers. They explored 16 formats of the same risk 
information and established that graphical formats, the use of colour to represent risk, 
and comparative risk information (e.g. smoking status), were preferable risk 
communication attributes. 
 
The manner in which a risk message is framed has also been found to be substantially 
important in the communication of risk. A recent review assessed the most appropriate 
methods of framing risk messages with regard to smoking cessation (Toll et al., 2014). 
The authors concluded that loss-framed messages (e.g. “Smoking will harm your 
health by causing problems like lung cancer”) are less effective than gain-framed 
messages (e.g. “Quitting smoking will benefit your health by preventing problems like 
lung cancer”) in promoting smoking cessation. This is supported by the results of a 
recent meta-analysis, which incorporated 198 effect sizes from 94 studies (Gallagher 
& Updegraff, 2012). The results of the correlation analysis suggested that gain-framed 
messages were more likely to encourage prevention behaviours than loss-framed 
messages (r = 0.083, p = 0.002). The analysis incorporated a range of behaviours, 
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however, sub-analysis including only smoking cessation studies also found the result 
to be particularly significant (r = 0.198, p < 0.001). If applicable, it has also been 
suggested that messages should be framed in a number of ways (e.g. the chance of 
developing cancer, the chance of not developing cancer) (O'Doherty & Suthers, 2007). 
 
Lastly, one of the most promising approaches to smoking cessation interventions for 
entire populations are tailored (or personalised) risk communications (Velicer et al., 
2006). Tailored risk communications can take many forms, such as providing 
personalised feedback concerning risk status or genetic vulnerability to disease, and 
assessing readiness to change behaviour (Gerrard, Gibbons, & Reis-Bergan, 1999). A 
recent Cochrane review, suggested that personalised risk information was associated 
with increased informed choice, increased knowledge, more accurate risk perceptions, 
and increased likelihood of screening uptake (A. Edwards et al., 2013). 
 
2.8.3 Assessments of smoking-related risk and harm 
Providing smokers with individualised information in relation to markers of harm may 
be helpful to undermine smokers’ unrealistic optimism, resulting in enhanced 
motivation to quit (Young et al., 2010). Assessments of risk or harm in relation to 
smoking and focusing on lung cancer risk, might include lung cancer screening, 
measurement of exhaled carbon monoxide (CO), lung function, or genetic 
susceptibility to lung cancer. This section will evaluate whether undertaking 
assessments of risk and harm can influence smoking cessation or risk perceptions. 
 
Screening for lung cancer using low-dose computed tomography (CT) has been 
suggested as a means of reducing lung cancer deaths through the early detection and 
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treatment of lung cancers (J. K. Field, Oudkerk, Pedersen, & Duffy, 2013); however, 
a number of studies have also explored the impact of screening on smoking behaviour. 
A number of studies have attempted to identify whether participation in a lung cancer 
screening programme is associated with increased motivation to quit smoking (Gomez 
& LoBiondo-Wood, 2013; Munshi & McMahon, 2013; Poghosyan, Kennedy Sheldon, 
& Cooley, 2012; Slatore, Baumann, Pappas, & Humphrey, 2014). The results of such 
studies suggest that it is unclear whether undergoing screening is associated with 
smoking cessation as findings are inconsistent, although smoking cessation has been 
associated most often with screening results per se (e.g. abnormal scans) and overall 
screening trial participation. A number of studies suggest that individuals who 
participate in lung cancer screening trials or express interest in them, typically have 
increased perceptions of lung cancer risk (E. J. Hahn et al., 2006; E. R. Park et al., 
2014), which could explain the increased rate of smoking cessation among trial 
participants. 
 
Various forms of biomedical risk assessment have also been examined in relation to 
smoking cessation. A Cochrane review was undertaken to establish the effect of 
biomedical risk assessment on smoking cessation, which included fifteen trials (Bize 
et al., 2012). The authors highlight the scarcity of high quality studies and suggest that 
there is no evidence to confirm that feedback in relation to exhaled CO measurement 
(RR 1.06, 95% CI 0.85-1.32) or spirometry (RR 1.18, 95% CI 0.77-1.81) in primary 
care, are effective aids in promoting smoking cessation; however, these pooled results 
were based on only two trials each. Of the 11 remaining trials, two were statistically 
significant; one study assessed the effect of lung age feedback (RR 2.12, 95% CI 1.24-
3.62), whilst the other evaluated the effect of feedback on smoking cessation in regard 
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to ultrasonography (i.e. an ultrasound-based diagnostic imaging technique) of specific 
arteries (RR 2.77, 1.04-1.74). 
 
Since Bize et al. (2012) undertook the aforementioned Cochrane review, a number of 
other studies have been undertaken, providing further insight into the role of 
biomedical risk assessment in promoting smoking cessation. In relation to expired CO 
feedback, few studies have subsequently been published. Ripoll et al. (2012) published 
a protocol for a clinical trial, which will examine the efficacy of exhaled CO feedback 
for smoking cessation but the results are not yet apparent. Furthermore, Grant, Ashton, 
and Phillips (2014) undertook qualitative interviews with SSS users (N = 23) and 
found that almost all participants who received expired CO feedback found the 
information motivational, although most participants in this study were former 
smokers. This suggests that feedback pertaining to exhaled CO may be motivational 
for recent former smokers continuing to abstain, as low readings may reinforce 
behaviour change, although it is unclear whether current smokers in receipt of higher 
readings may be motivated by such information; the literature currently would suggest 
little effect, if any. 
 
Recent findings in relation to the effect of providing smokers with spirometry or “lung 
age” information have also been limited. One small scale study explored the effect of 
providing “lung age” information on smoking cessation among a sample of injection 
drug users (N = 100) (Drummond et al., 2014). They found no significant difference 
in cessation between the intervention and control groups, although the sample size was 
substantially low. The protocol for a larger study (N = 444) has been published (Irizar-
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Aramburu et al., 2013), which aims to measure the effect of spirometry feedback on 
smoking cessation but results have yet to be published.  
 
The aforementioned Cochrane review (Bize et al., 2012) included only three trials that 
involved delivering smokers risk information pertaining to genetic susceptibility of 
lung cancer. A review undertaken at a similar time included seven studies and 
identified a short-term effect of genetic notification on short-term smoking cessation 
(RR 1.55, 95% CI 1.09-2.21) (de Viron et al., 2012). One recent study required 
smokers to watch an educational video regarding the tumour suppressor protein p16 
and subsequently provided participants with results of a test for methylated p16 
presence in sputum (an indicator of lung cancer risk) (Shofer et al., 2014). The test 
failed to predict changes in lung cancer risk perceptions or cessation at follow-up, 
although the sample was substantially low (N = 35). Kammin, Fenton, and Thirlaway 
(2014) conducted a survey among SSS users in the UK (N = 139) and identified that 
service users expressed an interest in learning about their personal genetic 
susceptibility of lung cancer and reported that a high-risk result would increase 
motivation to quit. Lastly, a large-scale study protocol has been published, which also 
aims to establish the effect on smoking cessation of providing a gene-based test 
(Nichols, Grob, de Lusignan, Kite, & Williams, 2014). Although again results have 
been inconsistent in relation to the provision of gene-based risk information for 
smokers, this is a developing area of research that has shown some promise. 
 
It should lastly be noted that previous literature in this area has focused upon the effect 
of communicating lung health risk on the initial act of smoking cessation, as opposed 
to smoking cessation maintenance; therefore, future research should endeavour to 
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explore the effect of such risk communication on smoking cessation maintenance also, 
as smokers in various stages of behaviour change may employ differing cognitive and 
experiential processes to facilitate change (e.g. J. O. Prochaska & DiClemente, 1983; 
J.O. Prochaska & DiClemente, 1986). Potentially, some risk communication methods 
maybe more appropriate for smoking cessation, compared with smoking cessation 
maintenance, and vice versa. 
 
2.9 Conclusion  
Within recent decades, tobacco control policy and practice in the UK has resulted in 
substantial advances in relation to smoking initiation and cessation rates. In particular, 
SSS provide an effective and accessible service, aimed at enhancing smoking 
cessation rates throughout England; despite this, smoking cessation rates in SSS have 
remained similar for the past three years, demonstrating the need for new and 
innovative interventions. 
 
The literature suggests that health risk perceptions may predict smoking initiation and 
cessation, although further research is needed, particularly longitudinal studies. 
Furthermore, research suggests that unrealistic optimism regarding smoking-related 
risk perception could be undermined by the delivery of personalised smoking-related 
risk communication; this could potentially lead to increased smoking cessation rates. 
 
This review of the literature regarding smoking and risk contextualises the current 
project and informs the reader of present findings regarding the domains relevant to 
the PhD project. Furthermore, this literature review aids aspects of the methodology 
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section, including the development of the LLP intervention and the statistical analyses 
plans, which consider common smoking cessation and risk perception predictors. 
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Chapter 3: Methodology 
3.1 Introduction 
This chapter details the project development and methodology of the PhD project. 
Firstly, the chapter will describe the study aims and objectives, as informed by the 
literature discussed in the preceding chapters. The chapter will subsequently specify 
the development of the PhD project intervention (or the Liverpool Lung Project [LLP] 
intervention). The LLP intervention was developed using the LLP risk model (Cassidy 
et al., 2008) and involves calculation and communication of projected lung cancer risk, 
based on both smoking and non-smoking behaviour. Subsequently, the research design 
and ethical considerations are described and justified. Participants, design, procedure, 
and analysis plans for both the quantitative and qualitative research components are 
subsequently discussed. Finally, data analysis preparations are considered prior to the 
results chapters. 
 
3.2 Aims and objectives 
The primary aim of the thesis is to examine whether the LLP intervention (based on 
the LLP risk model) can be used to promote smoking cessation rates among Stop 
Smoking Service (SSS) users. Secondary aims of the thesis include investigating 
whether application of the LLP intervention influencesfollow-up lung cancer risk 
perception, exploring other associations with smoking cessation, and improving 
understandings regarding smoking-related risk perception and communication. The 
objectives of the thesis are as follows: 
 
1. To investigate whether application of the LLP intervention is associated with 
smoking cessation success and lung cancer risk perceptions. 
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2. To explore factors implicated in smoking-related risk perceptions. 
3. To explore factors implicated in smoking cessation success. 
 
By conducting this study, it is anticipated that the results will build upon current 
knowledge pertaining to smoking cessation, risk perception, and risk communication 
but additionally, the results could have important implications for tobacco control. For 
example, if the LLP intervention is found to be associated with follow-up smoking 
cessation success, it could potentially be implemented within various SSS. 
Implementation of an effective smoking cessation intervention would reduce smoking 
rates and in turn, reduce the burden of smoking-related disease and deaths. 
 
3.3 LLP intervention development 
Advanced statistical techniques are required to calculate lung cancer risk using the 
LLP risk model (as detailed in Cassidy et al., 2008) and in its standard form the output 
from the model is not appropriate for delivery among the general population. As 
described in the previous chapter, presentation is crucial in developing effective 
methods of risk communication (e.g. Ahmed et al., 2012). 
 
The aim in developing the LLP intervention, was to produce a risk communication 
tool, which incorporated an individualised (A. Edwards et al., 2013), gain-framed 
message (Toll et al., 2014), which could be framed in a number of ways (O'Doherty 
& Suthers, 2007). Furthermore, it was preferable for the intervention to communicate 
risk, whilst avoiding decimals (Lipkus, 2007) and incorporating imagery, to enhance 
the understanding of numerical risk (Lipkus & Hollands, 1999). It was therefore 
necessary to develop the LLP risk model output via several phases. 
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The screenshots of the user interfaces included within this section reflect the details of 
an example participation cases. This example case considers a 43 year old male, with 
33 years smoking duration and a previous diagnosis of pneumonia, with no previous 
malignancies, family history of lung cancer, or previous asbestos exposure (it is 
noteworthy that although smoking initiation at 10 years old seems unusual, this 
example information was a based on the details of a real study participant in the PhD 
project. The current project required the calculation and provision of output from the 
LLP risk model, among hundreds of participants with varying histories, in a time-
limited setting and therefore, it was essential to develop a means of achieving this 
objective. A desktop database was developed by an IT technician based within the 
LLP, using the program, Microsoft Access. This database incorporated the risk 
calculation formulae associated with the model (for details, see Cassidy et al., 2008). 
The original user interface for the database presented five-year lung cancer risk by 
incorporating the LLP risk model formulae (see Figure 5). 
 
Despite the development of this database easing risk calculations, presentation of the 
output in this format was deemed unhelpful to participants, as it failed to demonstrate 
the benefit of quitting smoking. The user interface was therefore developed further to 
enable presentation of projected risk at age 70 years, by comparing two scenarios: (1) 
continued smoking; (2) continued abstinence. This second user interface again, 
incorporated the LLP risk model formulae but manipulated the output to enable 
presentation of five-year projected risk scores at age 70 (see Figure 6). 
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Figure 5. The original risk calculator user interface 
 
 
Figure 6. The second risk calculator user interface 
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Risk projections were projected at the age of 70 years among all participants for 
several reasons. Firstly, the researcher aimed to ensure that all participants received 
consistently presented results, therefore avoiding the undesirable effects of extraneous 
variables. Secondly, life expectancy in Liverpool is considerably low. In the UK, 
overall average life expectancy for males and females has been estimated at 79 and 83 
years, respectively (WHO, 2015); whereas, in Liverpool, average life expectancy for 
males and females has been estimated at 75 and 79 years, respectively (ONS, 2012c). 
The researcher aimed to select an age preceding life expectancy, yet requiring an age 
old enough to exhibit a substantial level of risk if the participant continued to smoke, 
as almost 90% of lung cancer cases occur in those above age 60 (ONS, 2013a). This 
also ensured that the project inclusion criteria regarding age, refrained from focusing 
simply on older participants, as all participants could be provided with risk projections 
based on their current circumstances. 
 
 
Figure 7. The finalised LLP intervention 
 
111 
 
The second user interface presented addressed the design issues associated with the 
original user interface, however, the format was not appropriate for delivery among a 
general population visually. Output acquired from the user interface was therefore 
presented to participants in a more simplistic and visually appealing manner. The 
finalised LLP intervention (see Figure 7) achieved the objectives of clarifying the 
numerical estimates by avoiding decimals (Lipkus, 2007) and incorporating imagery 
to enhance the understanding of numerical risk (Lipkus & Hollands, 1999). Lastly, the 
LLP intervention could be delivered by a researcher, who would also provide verbal 
risk communication, reiterating the results and answering participant questions. 
 
3.4 Research design and justification 
A mixed methods research design was adopted in order to achieve the project 
objectives, which involved incorporation of both quantitative and qualitative 
approaches. Johnson, Onwuegbuzie, and Turner (2007) suggested that mixed methods 
research has become increasingly identified as the third key research paradigm, 
alongside quantitative and qualitative research. Variation exists in relation to the 
definition of mixed methods research; however, Tashakkori & Creswell (2007b, as 
cited in Creswell & Plano Clark, 2011) described mixed methods research as “research 
in which the investigator collects and analyses data, integrates the findings, and draws 
inferences using both qualitative and quantitative approaches or methods in a single 
study or a program of inquiry” (p. 4). 
 
Pragmatism is often considered the primary epistemological approach with regard to 
mixed methods research and several authors have identified pragmatism to be the most 
appropriate justification for adoption of such a research design (Johnson et al., 2007). 
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For example, a pragmatic approach stipulates that the research question should take 
precedence over the research methodology and the underpinning research paradigm, 
meaning that the research question ultimately dictates the research methodology 
(Tashakkori & Teddlie, 2010). A pragmatic perspective was adopted by the researcher 
in the design of the current project. The primary research objective for the current 
project was defined prior to determining the appropriate research methodology and 
underpinning research paradigm; consequently, the research question has informed the 
mixed methods design, which primarily aims to address the primary research 
objective. 
 
Some researchers contend that it is inappropriate to mix methodologies due to 
fundamental differences between philosophical paradigms, yet it is widely argued that 
combining research methods is appropriate in various settings (Teddlie & Tashakkori, 
2010). In relation to tobacco control research, it has been suggested that mixed 
methods research can be highly beneficial and may capitalise upon the strengths of 
both quantitative and qualitative research methods (Mathie & Carnozzi, 2005). Mathie 
and Carnozzi (2005) identified several motives for undertaking mixed methods 
tobacco control research, including triangulation, complementarity, conceptual 
development, and expansion. Triangulation involves applying the same research 
question across differing methodologies, to verify findings or biases used. 
Complementarity refers to how the results of one method may be elaborated, 
illustrated or clarified by the results of an alternate method. Expansion involves the 
implementation of mixed methods to increase the scope and depth of the research. The 
mixed methods approach adopted in the current project incorporated a quantitative 
exploration of the predictors of smoking status and lung cancer risk perceptions 
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(including an investigation of the LLP intervention effect), alongside a complementary 
and expansive qualitative investigation, whereby factors implicated in smoking 
cessation success and smoking-related risk perception were explored. 
 
3.5 Quantitative research methods 
The quantitative component of the research was designed to address all current project 
objectives, although the primary objective dictated the quantitative research design. In 
order to address the primary objective (i.e. to investigate whether application of the 
LLP intervention is associated with smoking cessation success and lung cancer risk 
perceptions) a randomised controlled trial (RCT) design was adopted. The effect of 
the LLP intervention was tested by randomly allocating participants to one of two 
groups: a control group; or, an intervention group. Following collation of baseline 
measures, all participants were followed-up in an identical manner. RCTs are 
considered the gold standard for assessing intervention efficacy, as they can eliminate 
selection bias (Moher et al., 2010). Data was collected at baseline and six months, in 
line with recommendations on best practice (West, Hajek, Stead, & Stapleton, 2005). 
The subsequent sections will provide comprehensive detail regarding the appropriate 
power calculation, participants, materials, procedure, and piloting for the quantitative 
component of the research. 
 
3.5.1 Sample size calculation 
Prior to the project implementation, a sample size calculation was generated using the 
computer program, G * Power (Faul, Erdfelder, Buchner, & Lang, 2009; Faul, 
Erdfelder, Lang, & Buchner, 2007). This calculation incorporated the anticipated 
smoking cessation success rate in control arm; the six-month smoking cessation rate 
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of 26% was estimated and communicated by Roy Castle Fagends SSS (RCFE) 
(Appendix B). Furthermore, a 10% difference in smoking cessation rate between 
control and intervention groups was considered, as guided by the literature (Parkes, 
Greenhalgh, Griffin, & Dent, 2008). The resulting power calculation indicated that a 
sample size consisting of 673 current smokers was required to detect a 10% difference 
(using 2 test), considering 80% power for a 5% two-sided type 1 error. Lastly, it 
should be noted that this calculation incorporated 1:1 randomisation allocation. 
 
Quit rates are typically measured for SSS at 4-weeks and 12-months and these have 
been reported at 51% (NCSCT, 2014) and 15% (Ferguson et al., 2005); however, one 
study identified 12-month quit rates for RCFE, at 21% (Owen & Springett, 2004). 
Local correspondence with RCFE informed the power calculation but regional 
differences should be noted. Furthermore, smoking cessation trials of a similar design 
utilised more general populations than the current study, which may also influence the 
difference that the power calculation aimed to detect. Both aspects should be 
considered when interpreting the results. 
 
3.5.2 Participants 
Between May 2013 and December 2013, a total of 521 participants between the ages 
of 18-60 years were recruited via 55 RCFE community drop-in sessions. Host 
locations for the drop-in sessions varied but included: GP surgeries; libraries; 
SureStart children’s centres; churches; council services; hospitals; sports centres; and 
community centres. Appendix C displays a full list of the drop-in centres in Liverpool 
at the time recruitment commenced, as an example. The finalised inclusion criteria for 
115 
 
the project required participants to be between 18-60 years old, to have no previous 
diagnosis of lung cancer, and to be engaged with RCFE. 
 
It was originally intended for current smokers only to be recruited and followed up at 
six months; however, it became apparent at the beginning of the recruitment phase that 
it would not be possible to recruit the estimated 673 current smokers required to 
achieve appropriate statistical power (see Section 3.5.1). This challenge was primarily 
due to the lack of current smokers available in RCFE drop-in sessions, partly attributed 
to the delivery of a rolling programme, consisting of both current and recent former 
smokers. It was subsequently decided to recruit both current and recent former 
smokers as two separate RCTs and two respective datasets; however, all participants 
were followed up at six months. By adopting this design, the impact of the LLP 
intervention on follow-up smoking cessation success could be analysed among 
baseline current smokers, as well as baseline recent former smokers, albeit using 
limited sample sizes. 
 
The initial sample of baseline current smokers consisted of 302 participants, whereas, 
the initial sample of baseline recent former smokers consisted of 219 participants; 
throughout the thesis, separate datasets for baseline current and recent former smokers 
are therefore referred to. 
 
Recent former smokers were defined as individuals who reported abstinence for at 
least seven days but remained engaged with SSS. Figure 8 demonstrates the 
distribution of quit duration across the sample of recent former smokers recruited at 
baseline (N.B. Figures do not equate to 219 due to some missing data). The median 
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number of days abstinence among the sample was 39.0 days (IQR = 21.0-75.0), with 
a minimum and maximum reported number of seven and 600 days abstinence, 
respectively. Quit duration varied among the samplebut it was recorded wherever 
possible and controlled for throughout the quantitative analyses (e.g. regression 
modelling). 
 
 
Figure 8. Self-reported baseline quit duration among recent former smokers 
 
3.5.3 Materials 
The design of the project materials was carefully considered. Printed project materials, 
included the participant information sheet (PIS) (Appendix D), consent form 
(Appendix E), baseline questionnaire (Appendix F), control leaflet (Appendix G), LLP 
intervention (see Figure 7), follow-up questionnaire (Appendix H), and a follow-up 
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letter (Appendix I). The questionnaires entailed several measures, which will be 
detailed later in this chapter (see Section 3.5.3.1). 
 
In developing the project materials, the researcher considered published 
recommendations on questionnaire development (Kelley, Clark, Brown, & Sitzia, 
2003; Rattray & Jones, 2007); doing so, would encourage service user involvement in 
the research, ease of questionnaire completion, and enhanced questionnaire reliability 
and validity. Questionnaire content, layout, and the use of consistent graphical 
imagery (e.g. inclusion of the University of Liverpool logo), were all key 
considerations. Pens and stamped addressed envelopes were also required to enable 
participants to complete the study and return questionnaires, in cases where telephone 
follow-ups were not possible. 
 
With regard to technological equipment, a password-protected laptop was required 
during recruitment, to enable the timely calculation of lung cancer risk projections 
based on the LLP risk model. Furthermore, an encrypted USB drive was utilised 
throughout recruitment to store a secure record of participants recruited, avoiding 
participant recruitment duplication. A telephone was required for questionnaire 
follow-ups. 
 
Several computer software packages were required to complete the project. The LLP 
database, “SB” was used to store participants’ details and the RCFE database, “Quit 
with us” was used to access additional, relevant service user information, with 
participant consent. University of Liverpool survey software was utilised to ensure 
that the follow-up questionnaire was accessible online via the URL, 
http://survey.liv.ac.uk/smoking-study. Microsoft Access and Excel were installed on 
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the project laptop. Microsoft Access facilitated the development and use of a risk 
calculator, which incorporated formulae based on the LLP risk model. Microsoft Excel 
was used to develop and securely store a record of participants recruited. Lastly, the 
computer program IBM-SPSS statistical software version 21.0 (New York, NY) was 
utilised to support data analyses. 
 
3.5.3.1 Questionnaire measures 
The baseline questionnaire (Appendix F) and follow-up questionnaire (Appendix H) 
included a wide range of measures; however, this section will focus on the measures 
of interest to the current project (see Table 2) and these measures cover three broad 
areas: (1) socio-demographics; (2) smoking behaviour; (3) lung cancer risk 
perceptions. 
 
Measures of interest pertaining to socio-demographics, included age, gender, 
ethnicity, marital status, highest educational attainment, and socio-economic status 
(using postcode). All of these measures (except socio-economic status) were taken 
from the established LLP questionnaire and have been previously validated (Cassidy 
et al., 2008). Postcodes were collated to establish English Index of Multiple 
Deprivation (IMD) ranks, which represent socio-economic status. IMD is a robust 
index that uses 38 separate indicators, based on weighted data from seven domains: 
income deprivation (22.5%); employment deprivation (22.5%); health deprivation and 
disability (13.5%); education, skills and training deprivation (13.5%); barriers to 
housing and services (9.3%); crime (9.3%); and, living environment deprivation 
(9.3%) (Deas, Robson, Wong, & Bradford, 2003). IMD information was obtained 
using a website developed by Mimas at the University of Manchester (Mimas, 2014). 
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IMD data are typically reported as ranks within quintiles, based on national population 
data: quintile 1 (most deprived) = IMD ranks 1-6,496; quintile 2 (above average 
deprivation) = IMD ranks 6,497-12,993; quintile 3 (average) = IMD rank 12,994-
19,489; quintile 4 (below average deprivation) = 19,490-25,986; quintile 5 (least 
deprived) = IMD rank 25,987-32,482 (e.g. McRonald et al., 2014). These quintiles 
will therefore be referred to in relation to socio-economic status. 
 
Table 2. Questionnaire variables of interest in the current project 
Variable Data type 
Demographics  
 Age Continuous 
 Gender Categorical 
 Ethnicity Categorical 
 Marital status Categorical 
 Highest educational attainment Categorical 
 Socio-economic status (using postcode) Categorical 
Smoking characteristics  
 Smoking status (7-day point prevalence)† Categorical 
 Quit duration † Continuous 
 Age started smoking Continuous 
 Living with another smoker Categorical 
 Nicotine dependence Continuous 
 Cigarettes per day Continuous 
Lung cancer risk perceptions  
 Perceived personal lung cancer risk † Ordinal 
 Perceived average smoker lung cancer risk † Ordinal 
 Perceived relative risk of lung cancer † Ordinal 
 Lung cancer worry † Ordinal 
 Perceived lung cancer survival Ordinal 
†Repeated measure 
 
Measures of interest relating to smoking behaviour, included smoking status (i.e. 7-
day point prevalence [PP]), quit duration (applicable to former smokers only), age 
started smoking, living with another smoker, nicotine dependence, and cigarettes per 
day. Smoking status was measured using 7-day PP. Seven-day PP is commonly used 
in smoking cessation trials and has a number of advantages. Velicer and Prochaska 
(2004) suggested that 7-day PP can be advantageous, as measurement at six or 12 
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months can include smokers who delayed action and quit, capturing the dynamic, real-
life process of smoking cessation and additionally, the measure can be potentially 
validated by biochemical measures. 
 
Smoking duration was calculated by deducting age started smoking from cessation 
age (having considered any gaps in smoking duration with the participant). Nicotine 
dependence was also measured using the Fagerstrӧm Test for Nicotine Dependence 
(FTND) (Heatherton et al., 1991). For participants who identified themselves as 
former smokers, cigarettes per day and the FTND were adapted to reflect habits prior 
to quitting, as previously described (Sherratt, Marcus, Robinson, Newson, & Field, 
2015). Finally, whether or not the participant lived with another smoker was recorded. 
 
Measures of interest regarding lung cancer risk perception, included perceived 
personal lung cancer risk, perceived average smoker lung cancer risk, perceived 
relative risk of lung cancer, lung cancer worry, and perceived lung cancer survival. 
Three of the measures regarding lung cancer risk perceptions were adapted from a 
previous study (Weinstein et al., 2005) and explored perceived personal lung cancer 
risk, perceived lung cancer risk of the average smoker, and perceived relative risk of 
lung cancer. Perceived personal lung cancer risk was asked with the question, “Would 
you say your chances of getting lung cancer in the future are…” Participants were 
provided with five response options: Very low; Somewhat low; Moderate; Somewhat 
high; Very high. Perceived lung cancer risk of the average smoker was ascertained 
with the question, “Would you say the chances of the average smoker getting lung 
cancer in future are…” Participants were offered five response options:  Very low; 
Somewhat low; Moderate; Somewhat high; Very high. Perceived relative risk of a 
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smoker compared with a non-smoker was ascertained using the question, “Would you 
say the average smoker has...” Participants were provided with five response options: 
About the same lung cancer risk as a non-smoker; A little higher lung cancer risk than 
a non-smoker; Twice the lung cancer risk of a non-smoker; Five times the lung cancer 
risk of a non-smoker; Ten times the lung cancer risk of a non-smoker. 
 
The remaining two items regarding lung cancer risk perceptions were adapted from a 
previous study (Rutten et al., 2011); one of which measured lung cancer worry with 
the question, “How often do you worry about getting lung cancer?” Participants were 
offered four response options: Rarely or never; Sometimes; Often; All the time. The 
other measure examined perceived lung cancer survival with the question, “Overall, 
how many people who get lung cancer do you think will live at least five years?” 
Participant were provided with five response options: Less than a quarter; About a 
quarter; About half; About three quarters; Nearly all. 
 
3.5.4 Procedure 
As described earlier, the quantitative research component effectively entailed two 
separate RCTs; one RCT investigated whether application of the LLP intervention is 
associated with smoking cessation success and lung cancer risk perceptions among 
baseline current smokers, whilst the other RCT investigated whether application of the 
LLP intervention is associated with smoking cessation success and lung cancer risk 
perceptions among baseline recent former smokers. Figures 7 and 8 display the flow 
of participants through the RCTs, for baseline current smokers and baseline recent 
former smokers, respectively. Although the current project entailed two separate 
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RCTs, the procedure for both RCTs remained the same. The study flow will now be 
described in full. 
 
The researcher attended a wide range of RCFE drop-in sessions, across Liverpool. 
Upon arrival at an RCFE drop-in session, service users were provided with a PIS 
(Appendix D) and introduced to the researcher (via an RCFE advisor), who was 
available for questions. All service users were provided with time to consider 
participation and following advisor consultation, service users were offered the 
opportunity to participate. Those who chose to participate were asked to complete a 
consent form (Appendix E), requiring participants to provide their contact details and 
sign each consent box that they agreed with. Participants were asked to retain the PIS 
and photocopies of consent forms were forwarded to participants within one week of 
recruitment. Participants completed a baseline questionnaire (Appendix F). 
 
Participants for both trials were randomised to either an intervention or control group. 
Randomisation software was utilised to allocate participants to one of the two groups 
(via the URL, http://www.randomization.com/). Double-blinding was not possible to 
implement due to the funding restrictions of the project, as the researcher was 
responsible for recruitment, randomisation, and delivering the intervention; however, 
participants were blinded to group allocation, as the PIS did not explicitly describe the 
information participants would receive. Schulz and Grimes (2002) described several 
benefits for participant blinding in RCTs, such as participants being less likely to have 
biased psychological or physical responses to the intervention.  
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Participants in both arms were provided with the control leaflet (Appendix G), which 
provided some brief, generic lung cancer risk information, whilst participants in the 
intervention group were additionally provided with the LLP intervention (Figure 7). 
The researcher was able to immediately calculate risk projections for participants, by 
inputting participant questionnaire responses into the desktop database using 
Microsoft Access. Participants in the intervention arm were also provided with a 
verbal explanation of the LLP intervention. Following the completion of the baseline 
questionnaire, participants were contacted at six-month follow-up to complete a 
follow-up questionnaire (Appendix H).  
 
Participants were contacted at follow-up via telephone firstly. Options to enhance the 
response rate were explored. If participants were not contactable via telephone (the 
researcher would attempt to contact them morning, afternoon and evening), the 
follow-up questionnaire was posted to the participant with a stamped addressed 
envelope and a letter (Appendix I), which requested the participant to complete the 
follow-up questionnaire and return it to the researcher. The researcher also adapted 
the follow-up questionnaire for online completion, via the URL, 
http://survey.liv.ac.uk/smoking-study. The URL was included in the follow-up letter. 
All participants were fully debriefed regarding the project and control participants 
were offered the LLP intervention following debrief. 
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Completed paper consent forms and questionnaires were stored in a locked cabinet, at 
the University of Liverpool Cancer Research Centre. A unique study identification 
number (MPI) was assigned to participants and all project forms were labelled with 
the study identifier and barcoded to facilitate handling of the data. All questionnaire 
data and consent options were inputted into the LLP database, “SB” (accessible to 
nominated LLP staff, requiring two passwords) and consent forms were scanned for 
electronic storage on a secure drive located on the LLP computer network. The 
accuracy of data collection was checked at regular intervals. Participant names, 
corresponding drop-in session attended, and treatment group allocation were recorded 
to avoid recruitment duplication. Microsoft Excel was used to record this information 
and the document was saved as a password-protected document on an encrypted USB 
memory stick.  
 
3.5.5 Piloting the questionnaire 
The questionnaire was pre-piloted with several members of the Roy Castle Lung 
Cancer Research Programme. This allowed the researcher to gain feedback on the 
questionnaire prior to presenting it to advisors and service users at RCFE. Minimal 
feedback was, however, generated from this meeting with LLP employees. 
Subsequently, the researcher attended RCFE drop-in sessions for one week, to observe 
the format of the drop-in sessions, explore project feasibility, and discuss 
questionnaire development with advisors and some service users. Piloting the study 
was necessary as it provided valuable feedback from potential members of the study 
population, thus offering an opportunity to improve questionnaire format and 
measures (Creswell, 2014).  
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Most RCFE advisors and service users were satisfied with the content and layout of 
the questionnaire but some commented on the language used in the project materials. 
For example, one of the validated measures was phrased “Overall, how many people 
who get lung cancer do you think will survive at least five years?” One service user 
commented that she was unclear what was meant by “survive”. As a result of such 
feedback, some questions were amended to ensure that questionnaire language used 
was suitable for individuals of varying literacy levels. Furthermore, advisors reported 
low levels of literacy among many service users, highlighting the importance of using 
uncomplicated, plain English language in the questionnaires. This also guided the 
delivery of questionnaires, as the researcher subsequently ensured that participants 
were consistently supported to undertake the questionnaire.  
 
Time was also an important factor to consider, which was identified subsequently to 
the questionnaire piloting. Service users were encouraged to drop-in sporadically 
within a pre-advertised time. In observing the drop-in sessions, it became apparent that 
some service users would engage in longer support sessions, whilst others attended 
simply to acquire a prescription and leave immediately. Time-burden was therefore an 
important factor to consider. To utilise time effectively, it was decided that service 
users would receive a PIS upon arrival at the venue, providing potential participants 
with the opportunity to consider engagement in the project. Furthermore, it was 
necessary to review the length of the questionnaire and RCFE management requested 
for completion to take no more than approximately ten minutes; this was adhered to. 
 
Lastly, some of the drop-in session host locations had limited facilities (e.g. simply a 
desk and two chairs). The researcher was often required to book a separate room for 
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the research or arrive early to acquire a small area away from the advisor. This would 
enable service users who did not wish to take part in the research to maintain their 
confidential relationship with RCFE, whilst enhancing confidentiality for the current 
project, and avoiding contamination of participant blinding. The researcher remained 
conscious of participant confidentiality and sensitivity at all times. 
 
3.6 Qualitative research methods 
The qualitative component of the research complements the aforementioned RCTs and 
was intended to address project objectives two and three (i.e. to explore factors 
implicated in smoking-related risk perceptions and smoking cessation success). Risk 
is a complex phenomenon and previous research has failed to utilise a lung cancer risk 
prediction model as a smoking cessation intervention; therefore, a qualitative approach 
was deemed most appropriate to address the project objectives, as qualitative research 
is “especially useful when the research is concerned with either a novel domain or 
where the issues are complex or dilemmatic” (p. 132-133) (J. A. Smith, Michie, 
Stephenson, & Quarrell, 2002). 
 
The qualitative research component involved conducting semi-structured telephone 
interviews with a sub-sample derived from the larger quantitative research component. 
Semi-structured interviewing is a qualitative method, which combines pre-determined 
questions, usually using an interview schedule, with the opportunity for the 
interviewer to examine certain themes or responses in greater detail. Semi-structured 
interviews have previously been implemented to explore smoking experiences among 
current and former smokers (L. Hackshaw, Bauld, & McEwen, 2012; Rachael L. 
Murray, McNeill, Lewis, Britton, & Coleman, 2010; Schofield, Kerr, & Tolson, 2007; 
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Vangeli & West, 2012). Furthermore, semi-structured interviews are recommended 
when the researcher is aware of the questions they wish to ask but they are not aware 
of the responses they are likely to receive (Morse, 2012). For example, at the point of 
undertaking the qualitative interviews, it was unclear as to whether the LLP 
intervention would have an effect on smoking cessation rates; therefore, semi-
structured interviews seemed the most appropriate methodology to gauge responses 
and experiences regarding smoking and risk. Open-ended questions were posed and 
related to the LLP intervention, attitudes to risk, and experiences of smoking and 
smoking cessation. 
 
Telephone interviews have been criticised because they lack face-to-face contact, 
which can facilitate the development of rapport; however, telephone interviews can be 
beneficial in that they increase anonymity in regard to examining sensitive issues and 
they also reduce costs in relation to time and finances (Irvine, Drew, & Sainsbury, 
2013).  
 
3.6.1 Participants 
Qualitative interviews were conducted between May 2013 and January 2014. 
Participants (N = 30) were sought via the larger quantitative research component. The 
sample consisted of both current (40%) and recent former (60%) smokers between the 
ages of 18-60 years old, who had attended RCFE within the previous two months. The 
sub-sample primarily consisted of males, who were classified as White British, and 
the median age was 49.0 years (IQR 39.5-55.3), whilst ages ranged from 25-59 years 
(see Table 2). 
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Table 3. Participant characteristics among the qualitative sample 
Pseudonym Age Gender Ethnicity Smoking 
status 
Treatment group 
1. Michael 48 Male White British Former Control 
2. Robert 34 Male White British Current Control 
3. Jean 59 Female White British Former Intervention 
4. Jacob 59 Male Mixed Caribbean Former Control 
5. Alex 56 Male White British Current Control 
6. Stuart 45 Male White British Former Control 
7. Ronald 40 Male White British Former Control 
8. Patricia 50 Female White British Former Control 
9. David 37 Male White British Current Control 
10. Andrew 34 Male White British Current Control 
11. Emily 59 Female White British Former Control 
12. John 53 Male White British Former Control 
13. Julia 49 Female White British Former Intervention 
14. Oliver 54 Male White British Former Intervention 
15. Jack 49 Male White British Current Control 
16. Charlotte 26 Female White British Former Intervention 
17. Matilda 33 Female White British Former Intervention 
18. Paul 38 Male White British Former Intervention 
19. Sophie 55 Female White British Former Intervention 
20. Peter 50 Male White British Current Control 
21. Joel 44 Male White British Current Control 
22. Luke 54 Male White British Current Intervention 
23. Charles 40 Male White British Current Control 
24. Gavin 45 Male White British Former Control 
25. Shaun 48 Male White British Current Intervention 
26. Sarah 55 Female White British Former Intervention 
27. Patrick 56 Male White British Former Intervention 
28. Timothy 58 Male White British Former Intervention 
29. Gemma 57 Female White British Current Intervention 
30. Eric 25 Male White British Current Intervention 
 
The sampling method was effectively opportunistic, dependent upon whether 
participants were available for interview, although participants did need to be stratified 
based on treatment group as part of the quantitative research design. Efforts were 
therefore made to achieve even numbers of participants from both the control and 
intervention groups, among both the baseline current and recent former smoker 
samples, in order to eliminate the extraneous effect of undertaking qualitative 
interviews on the RCT analyses. Despite these documented efforts, it was not possible 
to achieve an equal number of qualitative participants from both treatment groups 
across both samples due to the availability of participants. The majority of baseline 
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current and recent former smokers recruited for the qualitative sub-study were 
allocated to the intervention group; n = 8 (66.7%) and n = 10 (55.6%), respectively. 
 
3.6.2 Materials 
Printed study materials relevant to the qualitative component of the research, included 
the PIS (Appendix D) and the consent form (Appendix E). In relation to technological 
equipment, an encrypted USB memory stick was utilised to stratify participants for 
interviews and record participants who had completed qualitative interviews. The 
researcher used a landline speakerphone to contact participants and a Dictaphone to 
record interviews. A remote office was available to ensure that calls could be made 
confidentially to participants. Transcripts were electronically stored on the secure 
University of Liverpool “M:/” drive within the PhD researcher’s account. Interviews 
were transcribed in Microsoft Word. Microsoft Excel was used to store the 
aforementioned record of participants recruited, and NVIVO 10.0 (QSR International) 
was used to aid the analysis. 
 
3.6.3 Procedure 
An interview schedule was developed (Appendix J), which aimed to achieve the 
project objectives and provoke open responses and fruitful dialogue between 
researcher and participant. As the qualitative research component utilised a sub-
sample of participants derived from the RCT, the procedure regarding recruitment has 
previously been described (see Section 3.5.4); however, all participants were provided 
with the opportunity to sign an optional consenting statement as part of the consent 
from (detailed on Appendix E), which would grant permission to be contacted 
regarding the qualitative research component. The consent form stated: “I give 
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permission for the researcher to contact me by telephone, to ask me my views about 
receiving risk information on lung cancer and quitting smoking. I understand that these 
telephone interviews will be recorded and that the audio recording will be destroyed, 
once it has been transcribed.” 
 
Using Microsoft Excel, individuals who provided consent to be contacted in relation 
to the qualitative interviews were identified and contacted chronologically and 
opportunistically by recruitment date. Interviews were undertaken by telephone within 
two months of recruitment. Upon contacting participants via telephone, the researcher 
reiterated the aims of the qualitative study and confirmed whether or not the participant 
continued to consent to undertake the interview and whether it was a convenient time 
to be interviewed. The researcher informed participants that the call would be 
recorded, transcribed and subsequently, anonymised. Telephone interviews were 
guided by the interview schedule (Appendix K) and typically lasted between 20 and 
25 minutes but ranged from 15 to 60 minutes. Following the interview, participants 
were thanked for their involvement and informed that they would be contacted again 
in future, as part of the quantitative follow-up. 
 
Following each interview, the interview recording was immediately uploaded to the 
University of Liverpool M:/ and transcribed by the researcher in Microsoft Word. The 
accuracy of transcription was checked at regular intervals. All transcripts were 
anonymised and pseudonyms were generated. A separate Microsoft Word file was 
created, in which study identifiers were listed alongside pseudonyms, age, gender, 
ethnicity, smoking status, and treatment group (sourced from the quantitative study 
questionnaire [Appendix F] or the interview itself). This file and the anonymised 
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transcripts were saved as password protected documents on the secure University of 
Liverpool M:/ drive on the researcher’s account. Participant audio recordings were 
subsequently deleted, further ensuring participant anonymity. 
 
3.7 Ethical considerations 
An ethics application was submitted to Liverpool Research Ethics Committee, which 
detailed the full protocol for the PhD project. Full ethical approval was obtained on 
12th February 2013 (Appendix K). The researcher also undertook a National Institute 
of Health Research (NIHR) Good Clinical Practice course, to enhance knowledge 
regarding ethical considerations (Appendix L). Some of the pertinent ethical 
considerations in relation to the current project are noted in the following sections, 
including informed consent, voluntary participation, anonymity, appropriate handling 
of participants, and debriefing. 
 
3.7.1 Informed consent 
All participants received a PIS (Appendix D) and were given the opportunity to ask 
questions. Following this, participants signed a consent form prior to completing the 
baseline questionnaire. The PIS also included project contact details. Participants who 
consented to undertake a qualitative interview were contacted by telephone and were 
interviewed at a mutually convenient time over the telephone. Participants who agreed 
to complete a telephone interview were informed that interviews would be recorded, 
but that recordings would be deleted following transcription and anonymisation. 
 
3.7.2 Voluntary participation 
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Upon completing the consent form, participants were informed verbally and in writing 
of their option to withdraw from the study. It was highlighted that withdrawal from 
either the quantitative or qualitative research components would not affect 
participants’ treatment or within RCFE or any other health service provider. To avoid 
service users feeling coerced to participate, service users were informed that the 
researcher worked independently to RCFE, both verbally and via the PIS. 
Furthermore, participants were informed that it was not mandatory for them to answer 
all questionnaire measures or qualitative interview questions, should they wish to 
exclude any information. 
 
3.7.3 Anonymity 
Although full anonymity was considered initially, it was not appropriate to ensure 
participant anonymity throughout the project. This was due to two reasons; firstly, 
participants were to be contacted at six-month follow-up and therefore, contact details 
were required, and secondly, participant data contributed towards the larger LLP 
dataset, which required personal details for further follow-up. These aspects were 
relayed to participants in the consent form; however, at the point of data inputting, 
participants were assigned a study identifier number (MPI), ensuring that personal 
details were referred to minimally. The file linking the study identifier with 
identifiable participant details was kept under strict security, with access by authorised 
personnel only. All data were handled in accordance with the Data Protection Act 
1998. All interview transcripts were anonymised by assigning pseudonyms and names 
of people and places were omitted from the transcripts to further enhance anonymity. 
Lastly, interview recordings were deleted upon transcription. 
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3.7.4 Appropriate handling of participants 
It was necessary to remain sensitive to participant needs throughout both the 
quantitative and qualitative research components, as the questionnaire and qualitative 
interviews addressed some sensitive and emotive issues, such as lung cancer, risk, and 
blame; therefore, participants were informed that some questions could be omitted 
within the questionnaire and additionally, it was deemed inappropriate for the 
researcher to fully probe participants for responses in circumstances whereby 
participants presented in an uncomfortable or distressed manner. Furthermore, 
participants were referred to RCFE advisors if they had any further concerns regarding 
smoking cessation. 
 
3.7.5 Debriefing 
Participants were blinded to randomisation; following completion of the project, all 
participants were debriefed regarding the aims of the project and blinding (with the 
exception of those who were lost to follow-up). The researcher offered to deliver the 
LLP intervention to all control participants, who would not have received it at baseline. 
Participants who had since relapsed at follow-up were also encouraged to seek the 
support of RCFE. 
 
3.8 Quantitative research analyses 
This section describes the data analyses undertaken in regard to the quantitative 
research component. A variety of statistical tests were performed as part of the 
quantitative investigation. Study data were transferred from the program used to store 
LLP data, “SB” to IBM-SPSS statistical software version 21.0 (New York, NY), 
which was a more manageable format suitable for statistical analysis. Prior to devising 
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a data analysis plan, data preparation was necessary; this involved adapting the 
datasets to allow for intention to treat analyses, as well as transforming some variables, 
to ensure the dataset was suitable for multivariate analyses. Following data 
preparation, the data analysis plan was developed, whereby various statistical tests 
were selected to explore the data; these are described. 
 
The datasets needed to be adapted to account for an intention to treat approach to the 
analysis. West et al. (2005) recommended common standards for smoking cessation 
trials (The Russell Standard). As part of these recommendations, West et al. (2005) 
proposed that smoking cessation trials should adopt an intention to treat strategy, 
which stipulates that data from all randomised participants should be included in 
follow-up analyses, unless participants have died or have relocated to an untraceable 
address. If these circumstances are not applicable but smoking status cannot be 
determined, the participant is regarded as a current smoker when analysing the data. 
Figures 7 and 8 display the flow of baseline current smokers and baseline recent 
former smokers and demonstrate how the intention to treat approach was integrated 
throughout the trials. 
 
A number of steps were taken to prepare the dataset for the main analyses. Firstly, data 
transformation was considered. Cell frequencies for variable levels among all 
variables were calculated initially to explore the distribution of the data and to prepare 
the data for additional analyses. A number of variables were subsequently transformed 
to avoid low cell frequencies and therefore, develop robust regression model, in line 
with recommendations (A. Field, 2013). Appendix M displays the original cell 
frequencies for all variables of interest, which were subsequently recoded and the 
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transformation for each of the identified variables is described. These reformed 
variables and associated levels are consequently incorporated throughout the 
quantitative results chapters. 
 
3.8.1 Data analysis plans 
Following data preparation, data analysis plans were developed. The current section 
identifies the key research objectives associated with the quantitative research 
component and considers the appropriate statistical tests to address each of the 
objectives. It should be noted that the distribution of all study variables was considered 
prior to the implementation of any given test. In checking the distribution of variables, 
histograms and Q-Q plots were generated, whilst the Shapiro-Wilk test was 
implemented to examine the P-value (p < 0.05 suggests non-normal distribution) (A. 
Field, 2013); however, all baseline project variables considered were not-normally 
distributed, which ultimately influenced the choice of statistical tests that were 
conducted. 
 
A listwise deletion method was adopted for multivariate analyses, whereby cases with 
missing data were excluded from analyses. Efforts were, however, made to avoid 
missing data. For example, participants were contacted by telephone in cases where 
random questionnaire responses were missing; however, in many cases missing data 
was unavoidable. A number of participants requested not to provide responses in 
relation to perceived personal lung cancer risk, as they felt uncomfortable predicting 
their own risk and some participants chose not to provide some demographic details, 
such as ethnicity, as they disapproved of being categorised.  
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3.8.1.1 Objective one analysis 
It was necessary to undertake various analyses to address the first project objective, 
“To investigate whether application of the LLP intervention is associated with 
smoking cessation success and lung cancer risk perceptions”. This objective 
incorporated the use of both bivariate and multivariate analyses and all tests were 
undertaken firstly, for the dataset consisting of baseline current smokers and secondly, 
for the dataset consisting of baseline recent former smokers. Treatment group was the 
key predictor variable of interest, whilst the outcome variables of interest, included 
follow-up smoking status, perceived personal lung cancer risk, perceived average 
smoker lung cancer risk, perceived relative risk of lung cancer, and lung cancer worry. 
 
Bivariate tests were undertaken between baseline participant characteristics and 
treatment groups, to explore differences among treatment groups, in order to explore 
any potential confounding effects. The choice of bivariate test was largely dependent 
on the type of data the variable entailed and the number of variable levels included 
within the variable, as none of the baseline participant characteristic variables were 
normally distributed. Associations between treatment group and baseline participant 
characteristic variables with two or more categorical levels, were measured using Chi-
squared tests (or Fisher’s Exact test when expected cell frequencies were less than 
five). Associations between treatment group and continuous baseline participant 
characteristic variables were examined using Mann Whitney U-tests.  
 
Baseline characteristics significantly associated with treatment group at the level of p 
< 0.25 were highlighted and considered for inclusion in the development of several 
multivariate models to explore the previously described outcome measures. It should 
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be noted that p < 0.25 was identified as the appropriate level of significance for 
covariate selection, in line with guidance from Hosmer et al. (2013), regarding 
purposeful selection of covariates in logistic regression; by following this guidance, 
potentially confounding variables would be controlled for. 
 
Forced entry binary logistic regression was subsequently deemed the most appropriate 
method to guide multivariate model development to explore any associations between 
treatment groups and the aforementioned outcome variables, whilst controlling for 
potentially confounding variables. Studenmund and Cassidy (as cited in A. Field, 
2013)  recommend forced entry over stepwise modelling for theory testing, as stepwise 
techniques can be influenced by random data variation and subsequently, stepwise 
modelling rarely produce replicable output if the model is retested.  
 
Binary logistic regression entails a number of assumptions and therefore, further tests 
were required to ensure that these assumptions were not violated. Logistic regression 
assumes that each case is independent, that the model should be fitted correctly, that 
there is no multicollinearity, and that there is linearity of predictor variables and log 
odds (A. Field, 2013). In cases where these assumptions are violated, this is detailed 
throughout the results chapters but these aspects will now be discussed. 
 
All observations for the current quantitative investigation were independent. With 
regard to the model fit, logistic regression assumes that the model should be fitted 
correctly. The Hosmer-Lemeshow goodness-of-fit statistic was used to assess how 
well the model fitted the data; a non-significant statistic (p > 0.05) suggests that the 
model fits the data well (Hosmer et al., 2013). The goodness-of-fit statistic is stated in 
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regard to all relevant logistic regression analyses within the results chapters. Residual 
statistics were also explored to examine the model fit.  
 
Binary logistic regression also assumes that predictor variables should not be highly 
correlated with each other (i.e. multicollinearity). Variables to be included in 
multivariate models were explored by implementing a Spearman’s Rho correlation 
matrix to identify closely related variables. Following this, VIF and tolerance statistics 
were ascertained. To ensure the assumption of multicollinearity was not violated, VIF 
values needed to be below 10 (Bowerman & O’Connell, 1990; Myers, 1990, as cited 
in A. Field, 2013), whilst tolerance values needed to be below 0.1 (Menard, 1995, as 
cited in A. Field, 2013); however, no cases of multicollinearity were evident in the 
current project. 
 
Logistic regression also assumes that there is linearity of continuous predictor 
variables and log of the data (or logit). In order to explore linear relationships, the 
interaction term between the predictor and its log transformation were investigated; a 
significant result (p < 0.05) suggests that the main effect has violated the linearity of 
the logit assumption (A. Field, 2013). These tests were undertaken for all regression 
models and in cases where the assumption is violated, this is detailed in the results 
chapters. 
 
Lastly, logistic regression requires substantial sample sizes. A. Field (2013) proposes 
that goodness-of-fit tests for logistic regression assume that no cells have an expected 
count below one and no more than 20% should be below five; therefore, several 
variables were transformed, as previously described (see Appendix M). 
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3.8.1.2 Objective two analysis 
A selection of bivariate and multivariate analyses were undertaken to address the 
second project objective, “To explore factors implicated in smoking-related risk 
perceptions”. For these analyses, a dataset was utilised, which consisted of all project 
participants recruited (regardless of smoking status) who responded to the baseline 
perceived personal lung cancer risk measure (N = 502); the aim in undertaking these 
analyses was to investigate cross-sectional differences overall by perceived personal 
lung cancer risk. The predictive capacity of all baseline participant characteristics was 
considered and baseline perceived personal lung cancer risk was the key outcome 
variable of interest.  
 
Bivariate tests were undertaken between baseline participant characteristics and 
baseline perceived personal lung cancer risk, to explore differences among perceived 
personal lung cancer risk levels, in order to identify potential predictors and to explore 
any potentially confounding effects. Again, the choice of bivariate tests implemented 
was largely dependent on the type of data the variable consisted of and the number of 
variable levels included within each variable because as detailed, all baseline 
participant characteristic variables were not normally distributed. Relationships 
between baseline perceived personal lung cancer risk and predictor variables with two 
categorical levels, were measured using Mann Whitney U-tests, to ascertain 
differences in means between the two levels. Kruskal Wallis H-test was implemented 
to identify associations between baseline perceived personal lung cancer risk and 
predictor variables with more than two categorical levels. Lastly, relationships 
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between baseline perceived personal lung cancer risk and variables consisting of 
continuous or ordinal data were tested using Spearman’s Rho correlation analysis. 
 
Again, guidance proposed by Hosmer et al. (2013) pertaining to purposeful selection 
of covariates for the development of multivariate models was considered; therefore, 
predictor variables deemed to be significant at the level of p < 0.25 were considered 
in the development of further multivariate analyses. Hosmer et al. (2013) additionally 
recommended refining initial multivariate models to develop a more parsimonious 
final model, which typically involves removing non-significant variables. A 
parsimonious model is preferable because developing a model with too many 
independent variables can lead to a mathematically unstable outcome, with reduced 
generalisability beyond the current project sample (Stoltzfus, 2011). 
 
As the outcome variable was ordinal, ordinal regression, more specifically, a 
proportional odds (PO) regression model, was developed to examine predictors in 
greater detail. PO modelling has a number of key assumptions, similar to binary 
logistic regression; however, PO modelling assumes that the outcome variable 
includes interval levels and that the odds ratio (OR) is equal across each interval 
threshold. The score test for the PO assumption (or test of parallel lines) can be 
conducted to examine whether the assumption of PO is violated for a PO model; p < 
0.05 suggests that the assumption of PO is violated (A. A. O'Connell, 2005). The 
results of tests of parallel lines are detailed in the results chapter where applicable. 
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3.8.1.3 Objective three analysis 
It was necessary to undertake various analyses to address the third project objective, 
“To explore factors implicated in smoking cessation success”. This objective 
employed the use of both bivariate and multivariate analyses and all analyses were 
undertaken across three datasets: (1) baseline current smokers; (2) baseline recent 
former smokers; (3) all project participants recruited at baseline. Predictors of follow-
up smoking status were explored among the first two datasets, whilst predictors of 
baseline smoking status were explored using the sample of participants overall. To 
successfully achieve the current project objective, it was necessary to build a 
multivariate model for each of the described datasets; however, the analysis plan for 
each of the datasets remained almost identical. 
 
Bivariate tests were undertaken between baseline participant characteristics and 
smoking status, to explore potential predictors of smoking status and to identify any 
potentially confounding effects. As described, the choice of bivariate test was 
dependent on the variable data type and the number of variable levels included within 
the variable; no baseline participant characteristic variables were normally distributed. 
Associations between smoking status and baseline participant characteristic variables 
with two or more categorical levels, were measured using Chi-squared tests (or 
Fisher’s Exact test when expected cell frequencies were less than 5). Associations 
between smoking status and continuous baseline participant characteristic variables, 
were examined using Mann Whitney U-tests. 
 
Again, Hosmer et al.’s (2013) recommendations regarding purposeful selection of 
covariates in logistic regression guided the development of the multivariate models. 
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Therefore, all baseline participant characteristics associated with smoking status at the 
level of p < 0.25 were considered for inclusion in the development of multivariate 
models and efforts were made to refine initial models to ensure that they were 
parsimonious. 
 
Again, forced entry binary logistic regression was subsequently deemed the most 
appropriate method to guide multivariate model development to explore any 
associations between baseline participant characteristics and smoking status, whilst 
controlling for any potentially confounding variables. In conducting binary logistic 
regression analyses, the assumptions associated with binary logistic regression were 
noted; each case should be independent, the model should be fitted correctly, there 
should be no multicollinearity, and there should be linearity of predictor variables and 
log odds (A. Field, 2013). These aspects of binary logistic regression were previously 
discussed (see Section 3.8.1.1) but again, in cases where these assumptions are 
violated, details are provided within the respective results chapter.  
 
3.9 Qualitative research analyses 
This section describes the qualitative data analyses undertaken with regard to 
qualitative research component. Thematic analysis (TA) was selected as the most 
appropriate approach to analysing the dataset. Braun and Clarke (2006) explained that 
TA provides a flexible, useful research tool, capable of providing detailed and 
complex accounts of data with theoretical freedom. Furthermore, adopting an 
inductive TA approach to the study would enable us to explore and recognise 
frequently recurrent themes, primarily at a semantic level (i.e. basing analysis on the 
surface meanings). A number of studies have also implemented TA to explore 
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qualitative datasets involving service users engaged with SSS (Henderson, Memon, 
Lawson, Jacobs, & Koutsogeorgou, 2011; S. E. Jones & Hamilton, 2013). 
 
A step-by-step guide to TA helped to inform the process of analysis (Braun & Clarke, 
2006) and as previously described, the computer program, Nvivo 10 (QSR 
International) was used to aid the analysis. Braun and Clarke (2006) described the 
process of TA through six phases: (1) Familiarising oneself with the data; (2) 
Generating initial codes; (3) Searching for themes; (4) Reviewing themes; (5) Naming 
and defining themes; (6) Producing the report. These phases will now be explored in 
greater detail with regard to the current project. 
 
Firstly, the researcher aimed to familiarise themselves with the data. The researcher 
collated the data and transcribed the recordings in Microsoft Word. As the researcher 
personally transcribed the data, this provided an opportunity for the researcher to 
familiarise themselves with the data, whilst ensuring that the written transcripts 
accurately reflected the verbal recordings. Following transcription, the researcher 
actively read the transcripts at least three times to further familiarise themselves with 
the data. Furthermore, the researcher began to note prominent findings at this stage. 
 
Secondly, initial codes were generated. This was done firstly by annotating the paper 
transcripts themselves; however, as time progressed, this method proved challenging 
to develop and maintain, so transcripts were exported to Nvivo 10 (QSR International), 
which eased data organisation. Initial codes were identified by examining the data on 
a line-by-line basis. Figure 11 provides an example of a data extract and how this was 
coded initially.  
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Data extract Coded for 
“It’s just the fact that it’s been going on 
so long now, do you know what I mean? 
It’s like starting to do me head in, in a 
way, it’s not like, it’s not a joke anymore 
now, you know what I mean, it’s starting 
to proper do me head in, you know what 
I mean?” 
1. Considers smoking duration as 
extensive. 
2. Starting to feel frustrated about 
continued smoking.  
 
Figure 11. Qualitative data extract with applied initial codes 
 
Thirdly, the researcher searched for broader themes. This involved the researcher 
analysing the codes to consider how these codes could contribute towards the 
development of overarching themes. In doing so, the researcher developed several 
mind maps. These mind maps included key major themes (i.e. overarching themes) 
and sub-themes (collections of codes that contribute towards an overarching theme). 
 
Fourthly, themes were reviewed by the researcher. This involved reading all collective 
data extracts for each potential theme and considering whether they fit appropriately. 
Furthermore, themes were reviewed in consideration of the dataset as a whole and 
whether the thematic map reflected the meanings derived from the data. The review 
process was extensive and iterative, as initially some sub-themes did not fit well with 
the major themes developed; therefore, themes were reviewed until a satisfactory 
thematic map was developed. One of the PhD project supervisors was also an 
experienced social anthropologist, with vast experience in qualitative research; 
validation of themes occurred through face-to-face and online discussions between the 
respective PhD supervisor and PhD researcher. 
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The fifth stage entailed the researcher defining the themes and further refining the 
themes that were presented. The researcher produced a detailed analysis for each 
theme. Six major themes were finalised: (1) Increased risk awareness; (2) 
Disregarding risk; (3) Experience of mental conflict; (4) Perceived benefits of quitting; 
(5) Reshaping social norms; (6) Attitudes regarding local Stop Smoking Services. 
 
Some of the themes or sub-themes were inter-related and such cases are acknowledged 
in the results chapters. Figure 12 displays an example finalised thematic map for 
Chapter 5, which explores the major themes, “Increased risk awareness” and 
“Disregarding risk”. Qualitative results are presented in Chapters 5, 7 and 8. 
 
Lastly, the researcher wrote up the results, which entailed concisely and coherently 
providing an account of the data; as part of this, sufficient evidence of the themes 
derived from the data (i.e. relevant quotes) were required to demonstrate the 
prevalence of the theme. 
 
 
Figure 12. A finalised thematic map for two major qualitative themes 
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3.10 Conclusion 
The current chapter documented the development of the LLP intervention and 
presented the methodology for the PhD project. The project utilised a mixed methods 
research design to primarily investigate whether application of the LLP intervention 
was associated with follow-up smoking cessation success and lung cancer risk 
perceptions. The application of a lung cancer risk prediction model in the context of 
smoking cessation has not previously been investigated and this chapter highlights 
how adopting a mixed methods approach could be particularly beneficial in achieving 
the project objectives. 
 
The quantitative research component not only entails examination of the LLP 
intervention effect but additionally, it explores factors implicated in smoking cessation 
success and lung cancer risk perceptions. If application of the LLP intervention is 
found to be associated with follow-up smoking cessation success, this finding would 
have important implications for tobacco control practice; if effective, the LLP 
intervention could be delivered within SSS, thus reducing smoking rates and 
associated smoking-related disease. This component will also contribute towards 
understanding of smoking-related risk perception and smoking cessation success, 
which in turn could inform the delivery of SSS and the development of future lung 
cancer risk communication tools. 
 
The qualitative research component complements the quantitative research in that it 
aims to explore factors implicated in smoking cessation success and smoking-related 
risk perceptions; as part of this, the perceived efficacy of the LLP intervention can also 
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be investigated, as well as the potential mechanisms for the LLP intervention effect, 
if applicable. Again, the results of the qualitative investigation will inform both SSS 
and risk communication development, as well as contributing towards improved 
knowledge regarding how smokers perceive smoking-related risk and the extent to 
which this influences smoking behaviour. The discussion chapter of the thesis will 
draw upon the mixed methods approach in particular and detail all project results 
collectively. The results of the research are presented in the following chapters. 
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Chapter 4: Evaluating the LLP intervention 
4.1 Introduction 
This chapter aims to explore whether application of the LLP intervention is associated 
with smoking cessation success and lung cancer risk perceptions. The results discussed 
in this chapter will help to determine the extent to which application of the LLP 
intervention is associated with smoking cessation success and lung cancer risk 
perceptions. If the LLP intervention is found to be associated with smoking cessation, 
this has important implications for tobacco control practice. Furthermore, exploration 
of the relationships between the LLP intervention and lung cancer risk perceptions 
may enhance understandings regarding risk perception and the mechanisms by which 
the intervention may or may not be associated with smoking cessation success. The 
current chapter addresses one key thesis objective: 
 
 To investigate whether application of the LLP intervention is associated with 
smoking cessation success and lung cancer risk perceptions. 
 
In order to achieve the above objective, statistical analyses were conducted. Firstly, a 
list of baseline participant characteristics was compiled, which was informed by the 
literature (see Section 2.5.2). Analyses were undertaken to ascertain significant 
differences between the intervention and control groups; by undertaking these 
analyses potential confounding variables could be recognised and incorporated into 
further analyses. Multivariate analyses were undertaken to explore the extent to which 
application of the LLP intervention is associated with each of the follow-up outcome 
variables: (1) 7-day point prevalence (i.e. smoking status); (2) perceived personal lung 
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cancer risk; (3) perceived average smoker lung cancer risk; (4) perceived relative risk 
of lung cancer, and; (5) lung cancer worry. 
 
The current project originally aimed to recruit only baseline current smokers (i.e. those 
who had smoked in the previous seven days at baseline); however, both baseline 
current smokers and recent former smokers (i.e. those who had quit for at least one 
week but remained engaged in SSS) were ultimately recruited, due to the limited 
availability of baseline current smokers. Bivariate and multivariate tests, which 
examined the LLP intervention effect are therefore explored across two separate 
datasets: (1) baseline current smokers only (n = 297); (2) baseline former smokers only 
(n = 216). It is necessary to analyse these two datasets separately as some statistical 
associations could remain hidden or may not be applicable if both samples were 
analysed collectively as one. 
 
4.2 Evaluating the intervention effect among baseline current smokers 
The current section will utilise a sample of baseline current smokers (n = 297) to 
investigate whether application of the LLP intervention is associated with follow-up 
7-day point prevalence, perceived personal lung cancer risk, perceived average smoker 
lung cancer risk, perceived relative risk of lung cancer, and lung cancer worry. The 
results of all bivariate and multivariate analyses are described. Several bivariate tests 
were undertaken to explore significant differences between the treatment groups. 
Table 4 displays the distribution of baseline participant characteristics between the 
two treatment groups, as well as indicating significant differences of note. Hosmer et 
al. (2013) suggest incorporating all potential confounders, significant at the level of 
25% in further multivariate analyses.  
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The bivariate tests revealed that the baseline variables age (p = 0.154), socio-economic 
status (p = 0.003), and perceived relative risk of lung cancer (p = 0.024) significantly 
differed by treatment group. No significant effects were observed between treatment 
groups and the remaining baseline variables, including gender, ethnicity, marital 
status, highest educational attainment, age started smoking, living with another 
smoker, FTND, cigarettes per day, perceived personal lung cancer risk, perceived 
average smoker lung cancer risk, lung cancer worry, and perceived lung cancer 
survival. It should be noted that the identified relationship between treatment group 
and socio-economic status and perceived relative risk were not anticipated. It is 
unclear as to why these relationships occurred; these differences could be due to 
chance or limited cell numbers but highlighting them as significant to the level of p < 
0.25 ensures that any extraneous variable effects can be controlled for.  
 
To compare 7-day point prevalence abstinence, perceived personal lung cancer risk, 
perceived average smoker lung cancer risk, perceived relative risk of lung cancer, and 
lung cancer worry, logistic regression analyses were conducted to adjust for baseline 
between-group differences (i.e. age, socio-economic status, and perceived relative risk 
of lung cancer). Table 5 displays that no significant effects were detected between 
treatment groups and  any of the outcome variables, including 7-day point prevalence 
(p = 0.658), perceived personal lung cancer risk (p = 0.785), perceived average smoker 
lung cancer risk (p = 0.950), perceived relative risk of lung cancer (p = 0.580), and 
lung cancer worry (p = 0.455), even after adjusting for the relevant baseline 
characteristics. 
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Table 4. Participant characteristics by treatment group among baseline current 
smokers 
Baseline variable Control 
(n = 146, 49.2%) 
Intervention 
(n = 151, 50.8%) 
P-value 
§ 
Age (Median, IQR) 42.5 (33.0-51.0) 41.0 (30.0-50.0) 0.154* 
Gender   0.343 
 Female 83 (56.8) 94 (62.3)  
 Male 63 (43.2) 57 (37.7)  
Ethnicity†   0.802 
 White 134 (91.8) 137 (92.6)  
 Other 12 (8.2) 11 (7.4)  
Marital status†   0.823 
 Other 21 (14.4) 23 (15.4)  
 Single 76 (52.1) 81 (54.4)  
 Married and living together 49 (33.6) 45 (30.2)  
Highest educational attainment†   0.803 
 Basic or no qualifications 66 (46.2) 70 (47.6)  
 Higher qualifications 77 (53.8) 77 (52.4)  
Socio-economic status†   0.003* 
 Most deprived 117 (80.1) 138 (92.0)  
 Least deprived 29 (19.9) 12 (8.0)  
Age started smoking  (Median, IQR) 15.0 (13.0-17.0) 15.0 (13.0-17.0) 0.600 
Living with another smoker†   0.423 
 No 51 (34.9) 58 (39.5)  
 Yes 95 (65.1) 89 (60.5)  
FTND  (Median, IQR) 6.0 (4.0-7.0) 6.0 (4.0-7.0) 0.854 
Cigarettes per day  (Median, IQR) 20.0 (11.3-25.0) 20.0 (14.5-20.0) 0.668 
Perceived personal lung cancer risk†   0.514 
 Low 23 (16.4) 28 (19.2)  
 Moderate 53 (37.9) 61 (41.8)  
 High 64 (45.7) 57 (39.0)  
Perceived average smoker lung cancer risk†  0.688 
 Very low to moderate 33 (23.2) 39 (26.9)  
 Somewhat high 54 (38.0) 49 (33.8)  
 Very high 55 (38.7) 57 (39.3)  
Perceived relative risk of lung cancer†   0.024* 
 About the same to a little higher risk  26 (18.8) 31 (21.4)  
 Twice as high risk 17 (12.3) 29 (20.0)  
 Five times higher risk 37 (26.8) 48 (33.1)  
 Ten times higher risk 58 (42.0) 37 (25.5)  
Lung cancer worry†   0.986 
 Rarely or never 43 (30.1) 44 (29.7)  
 Sometimes 53 (37.1) 54 (36.5)  
 Often or all the time 47 (32.9) 50 (33.8)  
Perceived lung cancer survival†   0.869 
 Less than a quarter 51 (36.4) 54 (37.8)  
 About a quarter 44 (31.4) 39 (27.3)  
 About half 32 (22.9) 37 (25.9)  
 About three quarters to nearly all 13 (9.3) 13 (9.1)  
† Figures do not equate to 297 due to some missing data, FTND = Fagerström Test of Nicotine 
Dependence, § Categorical variables were analysed using 2 test and continuous variables 
with Mann Whitney U-test, * p < 0.25 
154 
 
 
T
a
b
le 5
. O
u
tco
m
e v
ariab
les at six
-m
o
n
th
 fo
llo
w
-u
p
 am
o
n
g
 cu
rren
t sm
o
k
ers 
155 
 
4.3 Evaluating the intervention effect among baseline recent former smokers 
The present section utilises a sample of baseline recent former smokers (n = 216) to 
investigate whether application of the LLP intervention is associated with the outcome 
variables, follow-up 7-day point prevalence, perceived personal lung cancer risk, 
perceived average smoker lung cancer risk, perceived relative risk of lung cancer, and 
lung cancer worry.  
 
Numerous bivariate tests were conducted to investigate significant differences 
between the intervention and control groups. Table 6 shows the distribution of baseline 
participant characteristics between the two treatment groups. Again, Hosmer et al. 
(2013) suggest incorporating all potential confounders, significant at the level of 25%, 
in further multivariate analyses; therefore, all variables of relevance to further 
multivariate analyses are indicated. 
 
A number of significant differences were revealed between the intervention and 
control groups (Table 6). Age (p = 0.122), gender (p = 0.243), ethnicity (p = 0.241), 
marital status (p = 0.178), highest educational attainment (p = 0.001), and quit duration 
(p = 0.156) significantly differed by treatment group. No significant effects were 
revealed between treatment groups and the baseline variables, socio-economic status, 
age started smoking, living with another smoker, FTND, cigarettes per day, perceived 
personal lung cancer risk, perceived average smoker lung cancer risk, perceived 
relative risk of lung cancer, lung cancer worry, and perceived lung cancer survival. 
 
 
Table 6. Participant characteristics by treatment group among recent former smokers 
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Baseline variable Control 
(n = 103, 47.7%) 
Intervention 
(n = 113, 52.3%) 
P-value 
§ 
Age (Median, IQR) 43.0 (36.0-52.0) 46.0 (38.5-53.0) 0.122* 
Gender   0.243* 
 Female 52 (50.5) 66 (58.4)  
 Male 51 (49.5) 47 (41.6)  
Ethnicity†   0.241* 
 White 92 (89.3) 105 (93.8)  
 Other 11 (10.7) 7 (6.3)  
Marital status†   0.178* 
 Other 16 (15.5) 22 (19.8)  
 Single 51 (49.5) 41 (36.9)  
 Married and living together 36 (35.0) 48 (43.2)  
Highest educational attainment†   0.001* 
 Basic or no qualifications 43 (41.7) 71 (63.4)  
 Higher qualifications 60 (58.3) 41 (36.6)  
Socio-economic status†   0.937 
 Most deprived 87 (84.5) 95 (84.1)  
 Least deprived 16 (15.5) 18 (15.9)  
Age started smoking  (Median, IQR) 15.0 (14.0-17.0) 15.0 (14.0-17.0) 0.812 
Living with another smoker†   0.567 
 No 80 (77.7) 84 (74.3)  
 Yes 23 (22.3) 29 (25.7)  
FTND  (Median, IQR) 6.0 (5.0-7.0) 6.0 (4.0-8.0) 0.943 
Cigarettes per day  (Median, IQR) 20.0 (20.0-30.0) 20.0 (15.0-30.0) 0.461 
Quit duration (days) (Median, IQR) 35.0 (21.0-70.0) 46.0 (26.0-76.0) 0.156* 
Perceived personal lung cancer risk†   0.987 
 Low 33 (33.0) 35 (32.1)  
 Moderate 43 (43.0) 47 (43.1)  
 High 24 (24.0) 27 (24.8)  
Perceived average smoker lung cancer risk†  0.277 
 Very low to moderate 19 (18.6) 22 (20.2)  
 Somewhat high 51 (50.0) 43 (39.4)  
 Very high 32 (31.4) 44 (40.4)  
Perceived relative risk of lung cancer†   0.447 
 About the same to a little higher risk  14 (13.9) 21 (19.3)  
 Twice as high risk 18 (17.8) 24 (22.0)  
 Five times higher risk 29 (28.7) 23 (21.1)  
 Ten times higher risk 40 (39.6) 41 (37.6)  
Lung cancer worry†   0.937 
 Rarely or never 36 (35.3) 37 (33.0)  
 Sometimes 41 (40.2) 46 (41.1)  
 Often or all the time 25 (24.5) 29 (25.9)  
Perceived lung cancer survival†   0.959 
 Less than a quarter 40 (40.4) 47 (43.1)  
 About a quarter 30 (30.3) 32 (29.4)  
 About half 21 (21.2) 23 (21.1)  
 About three quarters to nearly all 8 (8.1) 7 (6.4)  
† Figures do not equate to 216 due to some missing data, FTND = Fagerström Test of Nicotine 
Dependence, § Categorical variables were analysed using 2 test and continuous variables 
with Mann Whitney U-test, * p < 0.25
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To compare the outcome variables logistic regression analyses were undertaken, to 
ensure that identified between-group differences at baseline were adjusted for (i.e. age, 
gender, ethnicity, marital status, highest educational attainment, and quit duration).  
 
Table 7 demonstrates a significant relationship between treatment groups and 7-day 
point prevalence (p = 0.040), which indicates that individuals appointed to the 
intervention group were 1.91 (95% CI 1.03-3.55) times more likely to be classified as 
former smokers at follow-up compared to those in the control group. No significant 
effects were evident between treatment groups and lung cancer risk perceptions, 
including perceived personal lung cancer risk (p = 0.711), perceived average smoker 
lung cancer risk (p = 0.567), perceived relative risk of lung cancer (p = 0.874), and 
lung cancer worry (p = 0.274), despite adjusting for the aforementioned baseline 
characteristics. 
 
4.4 Discussion 
The current chapter primarily investigated whether application of the LLP intervention 
is associated with follow-up smoking cessation success. Furthermore, the effect of the 
LLP intervention on lung cancer risk perceptions was investigated. Exploring these 
concepts helps to establish the efficacy of the LLP intervention in promoting smoking 
cessation and additionally improves knowledge regarding the mechanisms by which 
risk communication often influences health behaviour change. This chapter intended 
to investigate whether application of the LLP intervention is associated with smoking 
cessation success and lung cancer risk perceptions; the results, potential strengths and 
limitations, as well as implications will now be discussed in greater detail. 
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4.4.1 Exploration of chapter findings 
Application of the LLP intervention was found to be associated with follow-up 7-day 
point prevalence (i.e. smoking status) among baseline recent former smokers, 
however, the intervention was not found to be associated with follow-up 7-day point 
prevalence among baseline current smokers. These differences in LLP intervention 
effect between the two datasets might indicate differences in psychological 
mechanisms implicated between current and recent former smokers in relation to the 
responses to the LLP intervention. 
 
Behaviour change theories, such as the Transtheoretical Model of Change (TTM) (J. 
O. Prochaska & DiClemente, 1983; J.O. Prochaska & DiClemente, 1986), suggest that 
some processes of change are more applicable than others to individuals at varying 
stages throughout a quit attempt; this might provide some explanation regarding the 
differences in intervention effect between current and recent former smokers that 
occurred in the present project. For example, the TTM (J. O. Prochaska & DiClemente, 
1983; J.O. Prochaska & DiClemente, 1986) stipulates that processes, such as 
“reinforcement management” are more applicable among individuals actively quitting 
(i.e. recent former smokers), whereas, the process “self-liberation” could be more 
applicable to current smokers progressing from the preparation to action stage of 
change (see Figure 2). 
 
No significant effects were identified regarding the relationships between LLP 
intervention and lung cancer risk perceptions but again, the theoretical underpinnings 
of behaviour change theories, such as the TTM (J. O. Prochaska & DiClemente, 1983; 
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J.O. Prochaska & DiClemente, 1986), may provide explanation as to why the LLP 
intervention failed to be associated with follow-up lung cancer risk perceptions. For 
example, the LLP intervention may be particularly suited to the process of change, 
“consciousness raising”, which is implicated among individuals progressing from pre-
contemplation to contemplation (see Figure 2). 
 
4.4.2 Potential strengths and weaknesses 
The current chapter describes the results of the two RCTs implemented to explore the 
effect of the LLP intervention on follow-up smoking status among baseline current 
and recent former smokers. A range of questionnaire variables were explored, 
allowing exploration of various predictors of smoking cessation, including several 
perceptions of lung cancer risk. Furthermore, efforts were made to ensure that 
participants were blinded as to which treatment group they had been allocated to and 
a six-month follow-up was implemented in order to provide greater confidence that 
abstinence will continue long-term and that a degree of health benefit can be achieved 
(West et al., 2005). There are, however, some potential study limitations, which should 
be noted. 
 
The original power calculation indicated that at least 673 current smokers were 
required to achieve appropriate statistical power (see Section 3.5.1) and it was 
therefore intended for only current smokers to be recruited. Recruitment was 
hampered by the lack of time and financial resources available to the PhD project; this 
led to an insufficient sample size to fully conclude the findings in relation to current 
smokers. In light of the lack of available current smokers, an exploratory study of 
recent former smokers was set-up to further explore differences in smoking behaviour 
and risk perception between the groups. Future research might benefit from inclusion 
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of a longer recruitment period, employment of more than one researcher, and, 
potentially expansion of the number or format of SSS recruitment sites included in the 
project. 
 
Seven-day point prevalence was used to measure smoking status at baseline and 
follow-up and the measure has been argued to be highly advantageous, as 
measurement at six months can include smokers who delayed action and quit, enabling 
the dynamic, real-life process of smoking cessation to be captured (Velicer & 
Prochaska, 2004); however, some researchers recommend the use of prolonged 
abstinence (i.e. self-reported continuous abstinence since quit attempt) in addition to 
7-day point prevalence to enhance reliability (Hughes, Carpenter, & Naud, 2010). If 
the trial was to be replicated, prolonged abstinence might be a favourable additional 
measure. 
 
The Russell Standard, a standard outcome criteria for smoking cessation trials, also 
promotes the use of biochemical verification of smoking status at follow-up (e.g. 
exhaled carbon monoxide [CO]) (West et al., 2005); however, it was not possible to 
collate such data in the current project, again due to the lack of PhD project resources. 
Although biochemical verification may have been preferable, the value of self-
reported smoking status should not be underestimated. Connor Gorber, Schofield-
Hurwitz, Hardt, Levasseur, and Tremblay (2009) undertook a review, in which the 
accuracy of self-reports was explored. They identified that whilst self-reported 
smoking status can occasionally be under reported, it may not always be feasible to 
ascertain biochemical verification of smoking status in some studies. Furthermore, one 
review, which explored 26 studies found that self-reports of smoking were accurate in 
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most studies. The review surmised that sensitivity means and specificity means of self-
report were both high when compared with biochemical indices; 87.5% and 89.2%, 
respectively (Patrick et al., 1994). Nevertheless, if the study was to be repeated, 
biochemical verification of follow-up smoking status should be considered, although 
this would require increased financial resources. 
 
Future research may also benefit from implementation of a clustered randomised 
controlled trial design, as participants were recruited within RCFE drop-in sessions 
and some service users may have therefore provided others with details of project 
participation, which could contaminate treatment blinding. Clustered randomised 
controlled trials do control for “contamination” across participants, although they 
involve a more complex design and analysis, and require a greater number of 
participants to achieve a similar level of statistical power, compared to individual 
randomised controlled trials (Campbell, Elbourne, & Altman, 2004). Efforts were 
made to avoid contamination in the current RCTs, as participants were blinded 
regarding randomisation and participants were seen by the researcher on a 1:1 basis, 
in a confidential setting. 
 
The current study established p < 0.25 as the appropriate variable entry level for 
multivariate analysis (Hosmer et al., 2013); p < 0.25 was deemed the most appropriate 
level, as traditional levels such as p < 0.05 can fail in identifying important variables 
(Bendel & Afifi, 1977; Mickey & Greenland, 1989). This criterion allowed for 
extraneous effects to be controlled for, however, future efforts could incorporate 
interaction terms in the analysis, to enable the identification of mediating and 
moderating variable effects, which may have been controlled for in the current study. 
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Lastly, the use of the LLP risk model in itself, as a risk communication tool, does yield 
some limitations. The risk model measures smoking duration, as opposed to age since 
quitting smoking (e.g. Peto et al., 2000). This may potentially influence the predictive 
accuracy of applying the model in this context, as although smoking duration and age 
since quit are likely to be highly associated, smoking duration alone cannot fully 
reflect quit behaviour. Furthermore, as risk was projected and some individuals were 
particularly young (i.e. 20-30 years), they may be exposed to further risk factors prior 
to reaching the age at which risk is projected for individuals (i.e. 70 years old). For 
these reasons, lung cancer risk may therefore be underestimated for some individuals.  
 
4.4.3 Implications for knowledge, practice and policy 
The current chapter findings have a number of important implications in relation to 
tobacco control knowledge, practice and policy. Despite the limitations of the study, 
the findings suggest that the LLP intervention promoted follow-up smoking cessation 
among recent former smokers, but not among current smokers. A recruitment 
extension or the implementation of a larger trial might address the current project 
limitations and provide further support for the use of the LLP intervention among 
certain populations. 
 
If further research was able to replicate the current project findings, a cost-benefit 
analysis may be beneficial to consider the implementation of the LLP intervention 
within SSS. Quit rates reported by SSS have remained fairly consistent in recent years 
(NCSCT, 2014) and therefore, a new cost-effective intervention that is deliverable 
within SSS would certainly be welcomed. Furthermore, the current intervention is 
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designed in a manner that enables non-clinicians to communicate risk and therefore, 
SSS advisors would be able to deliver the intervention to service users, with basic 
training. Alternatively, the present intervention could be developed to enable delivery 
via post or electronically via SSS, thus potentially reinforcing quit attempts. 
 
Future research could additionally explore the application of the LLP intervention 
among alternate populations, such as non-help seeking smokers. Considering the 
results alongside the literature, the LLP intervention might be successfully delivered 
among smokers who are pre-contemplating or contemplating behaviour change, rather 
than those already engaging in behaviour change. This is an area that certainly 
warrants further research, as interventions of this kind, may be more or less applicable 
to various audiences. 
 
4.4.4 Conclusion 
In summary, the current chapter presented the bivariate and multivariate analyses 
results, pertaining to the quantitative investigation. The chapter aimed to explore the 
utility of the LLP risk model in the context of smoking cessation and more specifically, 
the extent to which the LLP intervention is associated with follow-up smoking 
cessation success and lung cancer risk perceptions.  
 
The results suggest that the LLP intervention may be associated with follow-up 
smoking status among individuals who have recently quit smoking but not among 
current smokers; however, further research may be required to address some of the 
current project limitations. If future research can provide further support for the 
application of the LLP intervention, there are a number of implications for tobacco 
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control practice particularly. Furthermore, the results of the current chapter have 
important implications in terms of researcher understandings pertaining to smoking 
and risk perception, providing further insight into the mechanisms by which smokers 
perceive risk and the subsequent impact on smoking cessation success. The following 
chapter will expand upon the findings in the current chapter and will consider 
additional predictors of risk perception more broadly, thus providing further insight 
into the relationship between smoking behaviour and risk perception. 
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Chapter 5: An exploration of factors implicated in smoking-related risk 
perception 
5.1 Introduction 
Whilst the previous chapter demonstrated that the LLP intervention was not associated 
with follow-up lung cancer risk perceptions, the current chapter aims to explore 
predictors of lung cancer risk perception more broadly. Furthermore, participants’ 
attitudes and experiences regarding risk perception and communication are 
extensively investigated. By exploring the correlates and predictors of risk perception 
(including smoking behaviour), improved knowledge regarding risk perception and 
behaviour change can be achieved. In turn, a better understanding of the relationship 
between risk perception and smoking behaviour could inform the development of 
future risk communications. The present chapter addresses one key thesis objective: 
 
 To explore factors implicated in smoking-related risk perceptions. 
 
To achieve this objective, quantitative and qualitative analytic techniques were 
employed. Firstly, questionnaire data is referred to, as statistical analyses were 
conducted to explore associations by baseline perceived personal lung cancer risk. 
Bivariate and multivariate analyses were undertaken to establish associations. Several 
statistical models are described, which were developed to ascertain the extent to which 
baseline characteristics predict personal perceived lung cancer risk. Secondly, part of 
the results pertaining to the qualitative analysis are explored, with particular focus on 
service users’ experiences and perceptions regarding smoking-related risk. 
Considering the results of both the quantitative and qualitative methodologies 
collectively will provide an enriched insight into the extent to which smoking-related 
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risk perception can be predicted and will inform the development of future smoking-
related risk communications. 
 
5.2 Correlates and predictors of perceived personal lung cancer risk 
The current section will explore the predictors of baseline perceived personal lung 
cancer risk. The aim of conducting these analyses is to explores differences in baseline 
participant characteristics, such as smoking status, by perceived personal lung cancer 
risk; therefore, all participants recruited for the PhD project who responded to the 
baseline perceived personal lung cancer risk measure (N = 502) were included in the 
described analyses. Bivariate analyses were conducted to identify potential 
associations with perceived personal lung cancer risk and subsequently, multivariate 
tests were undertaken to develop a parsimonious model for the prediction of perceived 
personal lung cancer risk.  
 
Several bivariate analyses were undertaken firstly to ascertain which baseline 
participant characteristics may have differentiated across baseline perceived personal 
lung cancer risk levels. Table 8 provides an overview of baseline participant 
characteristics by baseline perceived personal lung cancer risk. All variables for which 
significance levels are below 25% are highlighted; these variables were deemed 
suitable to be entered in a multivariate model to predict baseline perceived personal 
lung cancer risk, as recommended (Hosmer et al., 2013). 
 
The bivariate tests unveiled several baseline participant characteristics that were 
significantly associated with baseline perceived personal lung cancer risk, at the 
described level of 25%, including age (p = 0.007), ethnicity (p = 0.026), smoking 
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status (p < 0.001), age started smoking (p = 0.147), nicotine dependence (p = 0.045), 
perceived average smoker lung cancer risk (p < 0.001), perceived relative risk of lung 
cancer (p < 0.001), and lung cancer worry (p = 0.005). These variables will therefore 
be included in the development of a multivariate model for the prediction of baseline 
perceived personal lung cancer risk. No significant relationships were observed 
between baseline perceived personal lung cancer risk and the remaining variables, 
including gender, marital status, highest educational attainment, socio-economic 
status, living with another smoker, cigarettes per day, and perceived lung cancer 
survival. 
 
Multivariate analyses were subsequently conducted to further examine the predictors 
of baseline perceived personal lung cancer risk. All aforementioned baseline variables 
at the level of p < 0.25 in Table 8, were included in an initial proportional odds (PO) 
regression model. The results regarding the initial PO regression model for predictors 
of baseline perceived personal lung cancer risk are displayed in Appendix N. The 
initial model was statistically significant, χ2(12) = 90.932, p < 0.001. The model 
explained 19.7% (Nagelkerke R2) of the variance in baseline perceived personal lung 
cancer risk; however, the model was refined in line with recommendations (Hosmer 
et al., 2013) in order to create a more parsimonious model, which typically involves 
removing non-significant variables. The final PO model for the prediction of baseline 
perceived lung cancer risk is presented (Table 9). The final model was statistically 
significant, χ2(7) = 88.113, p < 0.001. The model explained 18.8% (Nagelkerke R2) of 
the variance in baseline perceived personal lung cancer risk.  
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Table 8. Participant characteristics by baseline perceived personal lung cancer risk 
Baseline variable Baseline perceived personal lung cancer risk P-value § 
 Low 
(n = 123, 
24.5%) 
Moderate 
(n = 206, 
41.0%) 
High 
(n = 173, 
34.5%) 
 
Age (Median, IQR) 40.0 (30.0-51.0) 43.0 (35.0-50.3) 46.0 (35.0-53.0) 0.007* 
Gender    0.709 
 Female 72 (58.5) 115 (55.8) 97 (56.1)  
 Male 51 (41.5) 91 (44.2) 76 (43.9)  
Ethnicity†    0.026* 
 White 104 (84.6) 195 (96.1) 160 (93.0)  
 Other 19 (15.4) 8 (3.9) 12 (7.0)  
Marital status†    0.533 
 Other 18 (14.8) 27 (13.2) 33 (19.3)  
 Single 65 (53.3) 101 (49.3) 82 (48.0)  
 Married and living together 39 (32.0) 77 (37.6) 56 (32.7)  
Highest educational attainment†   0.963 
 Basic or no qualifications 60 (50.0) 103 (50.2) 86 (50.3)  
 Higher qualifications 60 (50.0) 102 (49.8) 85 (49.7)  
Socio-economic status†    0.433 
 Most deprived 106 (86.2) 177 (86.3) 144 (83.2)  
 Least deprived 17 (13.8) 28 (13.7) 29 (16.8)  
Smoking status    p<0.001* 
 Current 53 (43.1) 116 (56.3) 121 (69.9)  
 Former 70 (56.9) 90 (43.7) 52 (30.1)  
Age started smoking (Median, 
IQR) 
15.0 (14.0-18.0) 15.0 (13.0-17.0) 15.0 (13.0-17.0) 0.147* 
Living with another smoker†    0.710 
 No 91 (74.0) 134 (65.0) 120 (70.6)  
 Yes 32 (26.0) 72 (35.0) 50 (29.4)  
FTND  (Median, IQR) 6.0 (4.0-7.0) 6.0 (4.0-7.0) 6.0 (4.5-7.0) 0.045* 
Cigarettes per day (Median, IQR) 20.0 (15.0-30.0) 20.0 (15.0-25.0) 20.0 (15.0-23.8) 0.746 
Perceived average smoker lung cancer risk†   p<0.001* 
 Very low to moderate 43 (36.1) 54 (26.6) 14 (8.1)  
 Somewhat high 41 (34.5) 88 (43.3) 69 (40.1)  
 Very high 35 (29.4) 61 (30.0) 89 (51.7)  
Perceived relative risk of lung cancer†   p<0.001* 
 About the same to a little 
higher risk  
27 (22.7) 45 (22.6) 19 (11.0)  
 Twice as high risk 20 (16.8) 49 (24.6) 18 (10.4)  
 Five times higher risk 34 (28.6) 57 (28.6) 46 (26.6)  
 Ten times higher risk 38 (31.9) 48 (24.1) 90 (52.0)  
Lung cancer worry†    0.005* 
 Rarely or never 47 (38.5) 63 (30.7) 48 (27.7)  
 Sometimes 47 (38.5) 84 (41.0) 62 (35.8)  
 Often or all the time 28 (23.0) 58 (28.3) 63 (36.4)  
Perceived lung cancer survival†    0.289 
 Less than a quarter 44 (37.6) 72 (35.8) 73 (42.9)  
 About a quarter 37 (31.6) 58 (28.9) 48 (28.2)  
 About half 23 (19.7) 58 (28.9) 33 (19.4)  
 About three quarters to nearly 
all 
13 (11.1) 13 (6.5) 16 (9.4)  
† Figures do not equate to 502 (i.e. those who completed the baseline perceived personal lung cancer 
risk measure) due to some missing data, FTND = Fagerström Test of Nicotine Dependence, § 
Categorical variables were analysed using Kruskal Wallis H-test, however, binary categorical variables 
were analysed using Mann Whitney U-test, and continuous variables with Spearman’s Rho, * p < 0.25 
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Table 9. Final proportional odds model for the prediction of baseline perceived 
personal lung cancer risk 
Baseline variable Odds 
(95% CI) 
Lower 
(95% CI) 
Upper 
(95% CI) 
P-value 
Age 1.030 1.013 1.047 p<0.001* 
Smoking status    p<0.001* 
 Former 0.336 0.234 0.482  
 (Base = Current)     
Perceived average smoker lung cancer risk   
 Somewhat high 2.569 1.588 4.154 p<0.001* 
 Very high 3.210 1.937 5.320 p<0.001* 
 (Base = Very low to moderate)     
Perceived relative risk of lung cancer    
 Twice as high risk 1.103 0.621 1.961 0.738 
 Five times higher risk 1.314 0.772 2.236 0.314 
 Ten times higher risk 2.157 1.273 3.658 0.004* 
 (Base = About the same to a little 
higher risk) 
    
* p < 0.05 
  
The Wald criterion displayed that age (p < 0.001), smoking status (p < 0.001), and 
perceived average smoker lung cancer risk (p < 0.001) were significant predictors of 
baseline perceived lung cancer risk. Furthermore, participants who perceived the 
relative risk of lung cancer among smokers to be ten times higher than a non-smoker’s 
risk, were significantly more likely to perceive their personal lung cancer risk as higher 
(OR 2.16, 95% CI 1.27-3.66), compared to those who perceived a smoker’s relative 
risk of lung cancer to be about the same to a little higher than a non-smoker; however, 
no other levels were significant for the variable of perceived relative risk of lung 
cancer. 
 
Subsequently, goodness-of-fit and parallel lines tests were conducted to assess the 
model in greater detail. The Deviance goodness-of-fit test was not significant, χ2 (677) 
= 680.151, p = 0.459 and the Pearson goodness-of-fit test was not significant either, 
χ2(677) = 719.553, p = 0.125, indicating that the model fitted the data well; however, 
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the test of parallel lines was significant, χ2 (7) = 21.224, p = 0.003, suggesting that the 
assumption of proportional odds among the levels within the outcome variable, had 
been violated (A. A. O'Connell, 2005). 
 
The test of parallel lines has been described as being anti-conservative because it often 
results in rejection of the PO assumption, particularly when the number of explanatory 
variables is large (Brant, 1990) or there is a continuous explanatory variable in the 
model (Allison, 1999 as cited in A. A. O'Connell, 2005). It was therefore necessary to 
examine the data using several separate logistic regression analyses to explicitly 
investigate how the odds ratios (ORs) for the baseline predictor variables differentiate 
at varying thresholds. 
 
Baseline perceived personal lung cancer risk was dichotomised at two levels, namely 
“Moderate or above” (Vs. “Low”) and “High” (Vs. “Moderate or below”). Two 
separate binary logistic regression analyses were conducted to explore the ORs for the 
independent variables, across the separate levels in the data to assess the consistency 
(see Table 10). Furthermore, Table 10 demonstrates the results of individual tests of 
parallel lines that were conducted for each independent and dummy variable (where 
applicable), to further explore the PO assumption. 
 
The first logistic regression analysis compared “Moderate or above” with “Low” 
baseline perceived personal lung cancer risk (Table 10). The model was statistically 
significant, χ2(7) = 42.761, p < 0.001, explained 12.7% (Nagelkerke R2) of the 
variance, and the Hosmer-Lemeshow goodness-of-fit test indicated that the model 
fitted the data well, χ2(8) = 3.431, p = 0.904. Several variables were identified as 
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significant predictors, including age (p = 0.006), smoking status (p < 0.001), and both 
levels of perceived average smoker lung cancer risk (both p = 0.001); however, none 
of the levels attributed to perceived relative risk of lung cancer were significant. 
 
The second logistic regression analysis compared “High” with “Moderate or below” 
baseline perceived personal lung cancer risk (Table 10). The model was statistically 
significant, χ2(7) = 88.367, p < 0.001, explained 22.9% (Nagelkerke R2) of the 
variance, and the Hosmer-Lemeshow goodness-of-fit test indicated that the model 
fitted the data well, χ2(8) = 8.616, p = 0.376. The results of the second logistic 
regression analysis differed in some respects to the first. Age (p = 0.001) and smoking 
status (p < 0.001) were both found to be significant. In addition, for perceived average 
smoker lung cancer risk, both dummy variables, “Somewhat high” and “Very high” 
were significant (p = 0.002 and p < 0.001, respectively), whilst the perceived relative 
risk of lung cancer dummy variable, “Ten times higher” was highly significant (p < 
0.001) but other levels were non-significant. 
 
Separate tests of parallel lines were conducted to isolate variables which may have 
contributed towards the violation of the proportional odds assumption. Test of parallel 
lines were non-significant for age (p = 0.927) and smoking status (p = 0.998), 
indicating that the assumption of proportional odds was upheld for these variables. 
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With regard to perceived average smoker lung cancer risk, the PO assumption (p > 
0.05) was upheld for “Somewhat high” but not for “Very high” (p = 0.028). On 
inspection of the OR for the level “Somewhat high”, the assumption of PO is plausible; 
however, the OR for “Very high” is particularly high in comparison to the “Moderate 
or above” analysis. The results suggest that the cumulative OR for “Very high” (OR 
3.21) slightly underestimates the under-representation of “Very high” in the 
“Moderate to above” level (OR 2.72) and somewhat overestimates the under-
representation in the “High” level (OR 3.96); however, the directions of the 
coefficients are consistent across the data divides and the result is statistically 
significant across both models. This might suggest that the OR from the ordinal model 
may provide a fair representation of the overall pattern of individuals who perceive 
average smoker lung cancer risk as “Very High”. 
 
The PO assumption was also upheld for all levels of perceived relative lung cancer 
risk, except “Five times higher risk” (p = 0.002). “Five times higher risk” failed to 
display a significant value in neither the ordinal nor logistic regression models; 
however, the OR for “Five time higher risk” is particularly high in the binary logistic 
regression model for “High” perceived personal lung cancer risk (OR 1.80), compared 
with the model for “Moderate or above” (OR 1.04). This suggests that the cumulative 
OR for “Five times higher risk” (OR 1.31) somewhat underestimates the under-
representation of “Five times higher risk” in the “Moderate to above” level. Again, the 
variable level “Twice as high risk” failed to display a significant value in neither the 
ordinal nor logistic regression models; however, the test of parallel lines and the OR 
for “Twice as high risk” would suggest that the assumption of PO is plausible. 
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Perhaps most notably, the test of parallel lines was non-significant for “Ten times 
higher risk”, which was a significant predictor in the ordinal model (p = 0.004); 
however, the logistic regression analyses revealed that the dummy variable was non-
significant for the “Moderate or above” model (p = 0.754), yet highly significant for 
the “High” model (p < 0.001). Upon inspection of the ORs, these differences became 
increasingly apparent; the OR for “Ten times higher” were substantially lower in the 
“Moderate or above” model (OR 1.11), compared with the model for “High” (OR 
3.39). The cumulative OR, therefore, largely underestimates the under-representation 
of “Ten times higher” in the “Moderate or above” comparison.  
 
Consideration of the individualised ORs for a number of binary logistic regression 
models suggests that the PO model (Table 9) is a reasonable overview of the data 
patterns in regard to baseline perceived personal lung cancer risk; however, it should 
be noted that a small number of the variable levels may be under-represented in regard 
to high risk perception, including perceived average smoker lung cancer risk and 
perceived relative risk of lung cancer (particularly the level, “Ten times higher”) and 
therefore, this should be considered prior to generalising across all cumulative levels. 
 
5.3 A qualitative exploration of smoking-related risk perception 
The current section will explore the results of the qualitative investigation pertaining 
to smoking-related risk perception and communication. This section aims to better 
understand smoking-related risk perception among smokers, by considering 
participants’ experiences of risk perception more broadly in relation to smoking and 
by examining responses to the study intervention, with the intention of establishing 
facilitators and barriers to risk communication salience. Two major themes emerged 
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from the analysis: (1) Increased risk awareness; (2) Disregarding risk. Both themes 
will now be detailed. 
 
5.3.1 Increased risk awareness 
“Increased risk awareness” was one of the prominent themes identified throughout the 
investigation of smoking-related risk perception. The theme explores the factors that 
participants identified as influential in their experiences of smoking-related risk 
perception. This section also documents examples of how risk communication may 
have enhanced smoking-related risk awareness among participants. This major theme 
consisted of three prominent sub-themes, which included “Age and risk”, “Social 
comparison”, and “Influential risk communication”. These sub-themes will now be 
described and explored. 
 
5.3.1.1 Age and risk 
Nineteen participants described how they started smoking in their youth and how they 
were rarely concerned regarding smoking-related risk at the time of initiation; this was 
reflected across the full age range of participants. One participant said, “It never even 
passed me mind I don’t think. Well, what would happen to meself and others around 
me, I never took it into consideration, I just done it” (Robert, 34, Current). Another 
participant also described how even with an acknowledged increase in public risk 
awareness, this failed to deter smoking initiation. 
 
… not when I was younger, I never thought about it at all. Even when they 
started putting the warnings on the packets, I never thought about it. I should 
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have done I suppose, in hindsight but I didn’t. I was young, foolish. (Patrick, 
56, Former) 
 
Several participants described how they had previously considered smoking-related 
risk upon initiating smoking, but that these concerns had been minimal. The results 
suggested that these low perceptions of perceived risk were attributed to two primary 
concepts: (1) youthful smokers failing to experience the immediate negative effects of 
smoking; (2) optimistic bias during youth regarding personal perceived risk of 
smoking-related disease. The term optimistic bias was referred to in Chapter 2 but in 
brief, optimistic bias may occur when individuals continue to practice unhealthy 
behaviours due to inaccurate perceptions of risk and susceptibility (Weinstein, 1983, 
1984). 
 
Three participants believed that smoking was not associated with any negative health 
consequences in youth, and the results suggest that this belief had contributed towards 
smoking initiation or continued smoking in youth. One participant explained, “When 
you’re young, you’re fit and healthy, it doesn’t really affect you, you think, ‘I don’t 
know what they’re talking about, I smoke and I’m fine’ ” (Sarah, 55, Former). Another 
participant described, “I was young, erm, and the body is more resilient when you’re 
young and you just don’t worry about it” (Luke, 54, Current).  
 
Three participants demonstrated optimistic bias in youth regarding personal perceived 
risk of smoking-related disease. The results suggested that young people often fail to 
consider the development of smoking-related disease, or potentially they do consider 
it but they are not greatly concerned. Furthermore, observations of older smokers who 
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appear healthy provided reassurance for smokers during their youth regarding the 
development of disease.  One participant explained, “… ‘cause I wouldn’t even expect 
nothin’ like that, you know, when I first started … when I was younger, I wouldn’t 
even expect nothin’ like that to happen, do you know what I mean?” (David, 37, 
Current). Another participant described how he underestimated personal perceived 
smoking-related risk in youth, as he observed older smokers with seemingly no health 
concerns; this appeared to reinforce his sense of optimistic bias and encouraged him 
to continue smoking. 
 
In my opinion, young people who smoke, they just keep smoking. I don’t think 
health warnings are going to frighten them. ‘Cause they look around 
themselves and if they’re only twenty and they see people in their sixties and 
seventies smoking, they’re going to be thinking, oh, there’s nothing wrong 
with them and they just carry on smoking like. I used to think that meself. 
(Patrick, 56, Former) 
 
The majority of participants described how public awareness of smoking-related risk 
has substantially increased in recent decades. Two participants provided examples of 
how the landscape of tobacco control has changed over recent decades. One participant 
commented on the change in advertising regulations since he started smoking, 
highlighting how society’s attitude towards smoking-related risk has changed. 
 
I think then because I’m what, forty-five, so I think, when I was eleven, the 
adverts on the TV were for, erm, not just cigarettes but for pipes, smoking 
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pipes and cigars, adverts were on the billboards and in the papers. (Gavin, 45, 
Former) 
 
The lack of tobacco control legislation and risk communication appeared to enhance 
the normalisation of smoking in previous decades and therefore, promote uptake. 
Another participant also stated that when he started smoking, fewer people were aware 
of smoking-related risk. Furthermore, the participant suggested that smoking had been 
previously prescribed to alleviate symptoms associated with poor health. 
 
It wasn’t something that the general populous was aware of, never mind a 
seven year old, bearing in mind I’m forty years old now, so we’re talking 
thirty-odd years ago. The dangers of smoking were not as widely known 
among the scientific community, never mind the general populous … back in 
them days, that time, if you were asthmatic, this is more applicable to the adults 
than as a child, but if you were an asthmatic and had been admitted to hospital 
with an asthma attack, they would actually give you a fag in the morning. The 
whole point was being that it’d help cough up the mucus on your chest. 
(Charles, 40, Current) 
 
Several participants attributed limited risk awareness to smoking initiation, 
highlighting the lack of tobacco control and risk communication strategies in previous 
decades. Such comments were also irrespective of age, suggesting that smokers were 
viewing risk awareness comparatively to the present, rather than to a specific time 
point whereby certain legislation or guidance was introduced. For example, one older 
participant explained, “There was no like health scares or things like that back at that 
time, to what there is now. Compared to what they know now about smoking, there 
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wasn’t that much on it back in them days” (Alex, 56, Current), whilst, a younger 
participant commented, “It was early nineties, so no one really knew anything about 
it, well they knew but they were like, it’s just a myth and stuff like that, as I got older, 
I sort of realised it was an issue” (Matilda, 33, Former). These comments highlight the 
lack of risk awareness pertaining to smoking among service users upon initiating 
smoking. Although youth is commonly associated with risky behaviours, such as illicit 
drug usage, alcohol abuse, and smoking (see France, 2000), the present results suggest 
that poor risk awareness appeared to exacerbate smoking initiation in youth. 
 
The findings suggest that smoking-related risk perceptions are dynamic throughout 
the lifespan, as risk perception changes were observed among participants from youth 
to present day. Ten participants broadly described how with age, their personal 
perceived smoking-related risk had increased, making them more conscientious of 
smoking and risk. Although such comments were made by participants of varying 
ages, the majority of participants (n = 7) were over fifty years of age. One participant 
described, “I mean it does give you cancer, smoking, and erm, I mean, as you’re 
getting older and things, you tend to think about it more” (Michael, 48, Former). 
Another participant explained how they had experienced declining health with age, 
and that with increasing exposure to smoking-related health campaigns, they related 
their poor health to smoking. 
 
Erm, I think it’s when you get older and you start to feel the effects of smoking 
and when you see advertisements about how side effects of what smoking can 
do, then you can relate to them as you’re getting older. (Sarah, 55, Former) 
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More specifically, some age milestones or life events were additionally observed as 
being influential in the transformation of risk perception. Four participants described 
how “milestone” birthdays influenced the way in which they perceived smoking-
related risk, with many participants describing how ageing promoted intentions to quit.  
 
Well it was age. It was one of those things. I said I’m getting too old to smoke 
now. I decided about a year ago I wanted to quit but I never got round to it … 
well I’m fifty-five on me next birthday, which is a couple of weeks and I 
wanted to use that as a target to say I’ve quit smoking. (Luke, 54, Current) 
 
This comment demonstrates how milestone birthdays may facilitate intentions to quit, 
providing smokers with a target timeframe to work within. Another participant 
commented, “… also I think it is, I’m getting older now and I’ll be sixty next year and 
I think, oh god, I haven’t got long left now! (laughs) What’s going to kill me?! 
(laughs)” (Jean, 59, Former). This comment also demonstrates how the increased 
perception of risk associated with ageing, appears to be underpinned by fear of disease 
or mortality. This was apparent among a number of other participants. For example, 
one participant described how they intended to quit smoking with the aim of reducing 
risk of smoking-related disease and prolonging life. 
 
Well getting lung cancer and all that now. That’s what it is, I’m petrified to 
death, and that’s what goes through my head, I know it all comes to us one day 
but I am, I’m, I’m, trying all kinds of stuff so I can have a longer life … 
(Sophie, 55, Former) 
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Three participants additionally described how significant others were an important 
aspect of the reported fear of disease and mortality, which many participants attributed 
to motivation to quit. One participant described how she was responsible for the care 
of her daughter who had special needs, and expressed concerns that smoking could 
contribute towards deterioration of her health, which could ultimately impact her 
daughter’s care, “Well I’ve been trying to cut down for months and months and, erm, 
I was worrying because I’m getting older and I’ve got me daughter there to look after” 
(Gemma, 57, Current). Another participant described how she had young 
grandchildren and her concerns regarding smoking and mortality appeared to be 
partially attributed to her wishes to be present for her grandchildren’s upbringings. 
 
I look at them and I think, you know, “I wanna be here when you’re older” ... 
you know, to watch them growing up. Think the main thing is these three new 
babies ‘cause they’re so close together and they’re only babies and I’m 
thinking, that was what I said, I thought, I want to see these grow up. (Jean, 
59, Former) 
 
5.3.1.2 Social comparisons of risk 
The majority of participants (n = 17) provided examples of others whom they believed 
to have developed smoking-related disease and these experiences appeared to heighten 
perceived personal risk. Half of participants described significant others who had been 
affected by smoking-related disease. Participants typically described cases of 
smoking-related disease whereby significant others had developed cancer, particularly 
lung cancer. One participant described how lung cancer was common among members 
of his family, “Yeah well, I’ve known people in my own family that have died because 
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of smoking. Like me granddad, three of my uncles have died of lung cancer, they were 
all like smokers, they all died” (Michael, 48, Former). Another participant described 
how a family friend suffering with disease attributed to smoking, had advised them to 
stop smoking. 
 
My mate’s mum died of lung cancer and I still think of that and that was years 
ago, years and years ago and she always used to say to us, “all pack in 
smoking” and every now and again that goes through your head. (Sophie, 55, 
Former) 
 
Such comments demonstrate how the experiences of significant others, whether first 
degree relatives or more distant family or friends, can resonate and have a lasting 
impact on smokers’ perceptions of risk and worry. 
 
A small number of participants explicitly described how significant others’ 
experiences of smoking-related disease influenced their intention to quit smoking. One 
current smoker described how his cousin had been in hospital, with complications the 
participant described as attributed to smoking. The participant suggested that this 
event had influenced his intention to quit smoking. 
 
I only have to look at my cousin in hospital, look at her, she stopped smoking, 
she stopped smoking for 12 months and look at her, so “Hello!” If I don’t have 
the wake-up call now, I’ll never have the wake-up call, will I? You know? 
(Jack, 49, Current) 
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Another participant described how her parents had died from cancer, which she had 
attributed to smoking; she described how this incentivised her to quit smoking, “A big 
incentive for me to stop because both parents died of that, I don’t like mentioning the 
word, that thing that begins with C” (Timothy, 58, Former). This comment also 
demonstrates how some participants preferred not to speak about smoking-related 
diseases, such as cancer, presumably due to fear of disease. 
 
5.3.1.3 Influential risk communication 
As previously described within this chapter, participants described how public 
awareness of risk had increased in recent decades; in addition to this, participants 
observed a substantial increase in risk communication regarding smoking alongside 
the increased public awareness of risk. At least four participants felt that risk 
communication focusing on smoking had become increasingly prevalent, with some 
describing such communication as almost ubiquitous. These participants also 
suggested that increased risk communication exposure had promoted their motivation 
to quit smoking. One participant stated, “Yeah, I think what it is, everywhere you go, 
everywhere you turn around, there is some sort of information about smoking but it’s 
more in your face and it does make you think hard about it. You know?” (John, 53, 
Former). Another participant explained, “Hopefully, it’s all the publicity and all the 
stuff that’s written about it. You know? That’s basically what it is, isn’t it? … It’s 
changing people’s minds and the way they view it isn’t it?” (Shaun, 48, Current).  
 
Three key vehicles for risk communication were prominently discussed throughout 
the interviews: cigarette packaging; television; and, the LLP intervention. It should be 
noted that the interview schedule included questions pertaining to the LLP 
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intervention, whereas, cigarette packaging and television were not original 
components of the interview schedule. 
 
Eleven participants discussed their opinions regarding the use of cigarette packs in 
communicating risk to smokers. One participant referred to the messages conveyed on 
cigarettes packs, “It’s there on the (cigarette) packet, it’s telling you, you’re killing 
yourself or you’re doing serious damage to yourself, one of them, whichever way you 
want to put it” (Jack, 49, Current). All other participant comments referred to the 
images displayed on cigarette packaging. One participant explained, “They put scary 
things on cigarette boxes didn’t they? … Those things on where there’s lungs and what 
it could do to you, I thought that was a good idea” (Timothy, 58, Former). Another 
participant suggested that they found the images repelling and described efforts to 
ignore such images whilst smoking, “All those pictures on it … it’s just not nice. Even 
I’ve done, when I have a smoke, I tell them to turn the packet upside down but it stays 
in your mind what you’re doing to yourself” (Jacob, 59, Former).  
 
The majority of participants who discussed risk communication and cigarette 
packaging believed the images of smoking-related disease to be an effective method 
of promoting risk communication and discouraging smoking. One participant 
described how the images led him to question his personal perception of smoking-
related damage and encouraged him to stop smoking. 
 
I think some of the adverts actually hit home and make you want to stop, like 
when you see these pictures on the back of cigarette boxes, like people with 
half a throat missing and pictures of a black lung and stuff like that. That’s 
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when you, you start thinking, like what do my lungs look like? What’s it doing 
to me? (Robert, 34, Current) 
 
Another participant described the images as unpleasant and seemingly repelling, “I 
know when they started putting the lung things on … I used to look at that and go 
“Urgh! Oh my god!” You know? To meself” (Sophie, 55, Former). Other participants 
described efforts to ignore or deny risk messages on cigarette packs and this will be 
discussed in greater detail in the subsequent section (see Section 5.3.2.1). 
 
Television was also frequently described as a noted medium for smoking risk 
communication by several participants (n = 11). One participant was able to recall the 
details of a recent television campaign, suggesting that the imagery was memorable, 
“Well, that last one advert, you know with the cigarette, the pigment in the skin, that 
was a really, really horrible one, you know?” (John, 53, Former). One participant 
described an advertisement they had viewed, which depicted the association between 
cardiovascular disease and smoking, “Every time there’s an advert, there was an advert 
where they’d have a drag of a cigarette and it was the artery blocking up …” (Paul, 
38, Former). The participant continued to explain how such television campaigns had 
prompted him to consider his personal risk, “… and you know things like that make 
you think ‘Eeeh, why do I smoke?’ You know? There’s no need for it. So I do, I think 
those adverts definitely do work” (Paul, 38, Former). Another participant described 
how a similar campaign had influenced his friend’s children to question their mother’s 
smoking, which he described as thought provoking for the mother. 
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A friend of mine, her children had … seen the propaganda on TV and the mum 
was out having a cigarette in the backyard … and the children actually came 
out and were speaking to the mum and said, “Mum, do you want to die?” She 
was very puzzled and taken aback by that and she turned around and said 
“What do you mean?” and the children went “Well, you’re smoking and we 
all know cigarettes kill you, so do you want to die?” and I mean, I think things 
like that are more, certainly more motivators for families. (Charles, 40, 
Current) 
 
Although several participants commented on the prevalence and efficacy of television 
campaigns in promoting smoking cessation, all participants appeared to approve of 
them and no participants suggested the campaigns were ineffective. 
 
Lastly, the LLP intervention was discussed among participants who had received the 
intervention. The intention of the intervention was to improve smoking cessation 
success and increase risk awareness. The qualitative analysis suggested that for some 
participants, the LLP intervention had been memorable, as five participants were able 
to recall the projections they had been provided and some participants described how 
they still possessed the written piece of risk communication they were provided. One 
participant reiterated, “Yeah, I do (remember the LLP intervention); 10% if I carried 
on smoking and 5% if I quit” (Luke, 54, Current), whilst another participant stated, 
“I’ve still got it upstairs somewhere in me drawer. I think mine was 3% …” (Patrick, 
56, Former). 
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The majority of participants (n = 10) who received the LLP intervention in the 
qualitative sub-study, approved of the intervention, with comments suggesting that the 
LLP intervention might be beneficial as a motivational tool for smoking cessation. A 
small number of current smokers described how they felt the intervention may have 
contributed towards reinforcing their motivation to quit smoking, “It shed some light, 
as I say, I wasn’t too sure what figures I’d get back from you but as I say, it’s shed 
some light, it’s reinforced me target that I should quit smoking” (Luke, 54, Current). 
Another current smoker suggested that the intervention had an effect, albeit small, on 
his motivation to quit, “Erm, I suppose it affected it a little bit, you do think about 
those things, so obviously it affects it a bit” (Shaun, 48, Current). 
 
Some recent former smokers additionally provided similar accounts regarding the 
study intervention. One recent former smoker described how the study intervention 
reinforced her quit attempt, similarly to receiving feedback pertaining to exhaled CO 
when attending RCFE, “Oh yeah, that does (affect motivation) and the same as when 
I get the, erm, you know when I blow into the thing (the CO monitor)? Yeah, it just 
gave me a boost” (Gemma, 57, Current). Another recent former smoker additionally 
described how the risk projections he had received reinforced his quit attempt. 
Oh it’s a big difference, a massive difference if you’ve got that little bit of a 
scare in the back of your brain. That’s another incentive to pack it in … there’s 
no way I want to cop to that is there? (Timothy, 58, Former) 
 
As previously described, fear appeals have been described as “communications 
presenting the threat of impending danger to motivate compliance with a proposed 
recommendation” (p. 233) (Keller & Lehmann, 2008, as cited in Orazi & Pizzetti, 
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2015). The above comment also demonstrates how the LLP intervention incorporated 
aspects of fear appeals, as the aforementioned participant expressed fear or 
vulnerability to lung cancer and suggested that the LLP intervention would enhance 
his motivation to maintain abstinence for this reason. Several other participants 
commented on the notion of fear appeals. For example, one participant described how 
she found the risk communication to be provocative and frightening. 
 
Yeah, well when you look at it and you was like, if you carried on smoking 
and this, you know, what your percentages were like, it is frightening because 
I think anyone in their seventies now, that’s not old … You just don’t realise 
what cigarettes are doing to your body.” (Julia, 49, Former) 
 
Despite some positive remarks, several participants responded apathetically to the risk 
communication. Notably, no participants suggested that the risk communication 
discouraged their quit attempt; however, five participants suggested that the risk 
communication had little, if any, effect on their motivation and awareness of risk. 
Primarily, participants described how they were satisfied with their current quit 
attempt progress and therefore, felt that external factors had little impact. 
 
Erm, well, I sort of knew about most of it anyway … It didn’t really come as 
a surprise in anyway, you know, it was like a sort of update for me really, that 
was it really … I’m happy with the situation, like where I’m up to now, so I’m 
happy with the way things are going (laughs). (Oliver, 54, Former) 
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Another participant was asked whether they felt the risk communication influenced 
their motivation either positively or negatively, and they responded apathetically, “I 
don’t know really because I’ve never ever been for anything like that or heard anything 
like that, or tested anything like that. That’s the first time I’ve been tested for anything 
like that, lungs or anything like that” (Sophie, 55, Former). This comment also 
demonstrates how some participants highlighted that they were already substantially 
aware of smoking-related risk, which potentially reflects well on current tobacco 
control campaigns to improve risk awareness. 
 
It should be noted that participants additionally described limiting features of the LLP 
intervention and detailed barriers to risk communication more broadly; this is explored 
further throughout the following theme, “Disregarding risk”. 
 
5.3.2 Disregarding risk 
“Disregarding risk” is the other prominent key qualitative theme explored in the 
current chapter. Similarly to the previous theme, this theme explores risk perception 
and communication but it focuses on factors that may contribute towards reduced 
concerns regarding smoking-related risk, which could potentially promote continued 
smoking. The barriers to effective risk communication are considered within this 
section, with particular focus on the LLP intervention. This major theme consists of 
three key sub-themes, which include “Denying risk”, “Risk contextualisation”, and 
“Barriers to risk comprehension”. 
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5.3.2.1 Denying risk 
As described earlier in this chapter, participants acknowledged increased awareness 
of smoking-related risk and observed increases in smoking-related risk 
communication within society. Despite these observed increases, some participants 
described the experience of being aware of smoking-related risks, yet simply 
endeavouring not to focus on them. One participant described, “I’ve always known 
the risks to be honest but you don’t want to think about the risk while you’re smoking, 
do you?” (Robert, 34, Current). Another participant described how he experienced 
only fleeting thoughts whereby he considered smoking-related risk whilst smoking. 
 
I have always felt and thought about things like that but it never ever stopped 
me from smoking at the time. One minute it goes through your head and the 
next minute, in the blink of an eye, it’s forgotten. (Sophie, 55, Former) 
 
These comments demonstrate how smokers attempted to ignore the risks associated 
with smoking whilst smoking, potentially as a means of dealing with cognitive 
dissonance. Cognitive dissonance was described in greater detail in Chapter 2; in brief, 
cognitive dissonance might occur when a smoker holds at least two opposing but 
related cognitions, which can result in mental conflict (Festinger, 1957, 1962). For 
example, dissonance may develop when a heavy smoker continues to receive 
smoking-related risk communication; the smoker may ignore or deny further risk 
communications, in an effort to reduce mental conflict. 
 
Some participants explored the barriers to acknowledging risk further. Participants (n 
= 6) attributed the experience of addiction to the lack of risk acknowledgement whilst 
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smoking, as addiction was perceived as overpowering. One participant explained, “I 
think the nicotine has such a strong hold on you, that it puts, the danger of it doesn’t 
come across, do you know what I mean? Because you’re so addicted to it” (Stuart, 45, 
Former). Another participant suggested that smokers are aware of the risks of smoking 
and often want to quit but simultaneously, the strength of the addiction to cigarettes is 
overwhelming and creates challenges in quitting. 
 
You know it’s wrong and you know you shouldn’t be doing it but it’s not as 
easy as saying, you shouldn’t be buying it anymore … smoking is a disease, it 
is an illness, once  you get hooked, it is, takes a while to get it out the system, 
to like come off it, especially for some people. (Gavin, 45, Former) 
 
One current smoker actively demonstrated this conflict between risk awareness and 
addiction, as smoking-related disease was discussed, “Well now we’re talking about 
cigarettes, has made me feel I want one, isn’t that mad?” The interviewer responded, 
“It’s interesting because you’re telling me about all the health side of things…” and 
the participant responded, “And I want one.” The interviewer continued to ask, “And 
how do you explain that?” The participant attributed this response to the intense 
withdrawals and psychological mechanisms. 
 
It’s a craving … you know it’s doing you no good but you still want it, it 
doesn’t make sense. It’s withdrawals, you’re addicted to nicotine, so your body 
is just screaming out for it. I think a lot of it is mind over matter because until 
I’ve started talking to you, I wasn’t thinking of one. (Joel, 44, Current) 
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Finally, the analysis identified conflicting statements among two participants with 
regard to risk perception, suggesting that the participants were potentially minimising 
smoking-related risk. Both examples were among current smokers. One participant 
was initially asked what he felt had motivated him to stop smoking, the participant 
replied, “Since I got this COPD. Err, like, chest infection thing you know” (Alex, 56, 
Current); however, later in the interview, the participant explained, “If (cigarettes) 
were still round about £3 or £4, I’d still probably be a smoker but erm, erm, with them 
putting the prices up all the time, it’s forced my end” (Alex, 56, Current). This 
comment displays how initially the participant attributed his motivation to quit to ill 
health, yet later he acknowledges that he would have continued to smoke, if not for 
the increasing price of cigarettes. 
 
Another participant, who had suffered strokes, which his doctor had attributed to 
smoking, also demonstrated conflicting cognitions. The participant initially associated 
his smoking with the occurrence of strokes; however, the participant continued to 
suggest that he was not exhibiting any effects associated with smoking, “Yeah, me 
strokes are related to the smoking, yeah, … well, I still don’t think I’m suffering any 
effects from smoking at the moment but I know I will in the end” (Joel, 44, Current). 
These conflicting statements suggest that some current smokers minimise the damage 
attributed to smoking; minimising the associated mental conflict may aid continued 
smoking. 
 
5.3.2.2 Contextualising risk 
Perceptions of smoking-related risk were often contextualised among participants, 
alongside other external factors deemed significant by participants, such as 
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uncertainty, perceived lack of control, and other risks more widely. The analysis 
demonstrated how uncertainty could play an important role in the formation of 
smoking-related risk perceptions. This chapter previously discussed how the majority 
of participants described significant others whom they believed to have developed 
smoking-related disease; however, some participants questioned whether the disease 
described was smoking-related. 
 
I’ve found that I’m going to more funerals that what I’m going to Christenings 
and it’s people that when I was younger. They were all older than me and now 
they’re all dying and a lot of them were smoking-related. Well ok, you can’t 
say for definite it was smoking-related … (Ronald, 40, Former) 
 
One participant explained, “I’ve heard of people who’ve had breast cancer and you 
think, is this down to cigarettes? The smoking? You know?” (Julia, 49, Former). 
Despite strong associations between smoking and various diseases, it is often not 
possible to definitively attribute smoking to the development of a given disease; this 
uncertainty is communicated by participants but it is unclear as to the extent to which 
uncertainty influences perceptions of smoking-related disease in the current study. 
 
Perceived lack of control was another important component of risk perception 
discussed, which was underpinned by uncertainty. Five participants denoted a 
perceived lack of control in relation to the development of disease. Participants 
provided examples of seemingly healthy, non-smokers, who had developed diseases 
often associated with smoking, or alternatively, examples of older smokers who were 
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disease-free. For example, one participant referred to a non-smoking athlete who had 
developed lung cancer. 
 
People will get lung cancer regardless of whether they smoke or not, down to 
various environmental factors. One great athlete was someone called Lilian 
Boyd and she died of lung cancer but she didn’t smoke a day in her life. (Luke, 
54, Current) 
 
Another participant described how a number of her non-smoking, significant others 
had died at a relatively young age, “I’ve known loads of people, I mean, my Uncle 
was 44 and he’s died, and he’s never smoked in his life. Me Aunty, she was only 50 
and she’s never smoked in her life” (Charlotte, 26, Former). 
 
In addition to the aforementioned accounts, at least four participants explicitly 
described a perceived lack of control with regards to smoking-related disease. One 
participant explained how she reacted to individuals who were critical of her smoking, 
“If anyone said anything I’d say ‘Look, when your number’s up, your number’s up, 
no matter what you do” (Patricia, 50, Former), whilst, another participant described 
the inevitability of disease, “It was kind of one of these, you know, well if you’re 
gonna get it, you’re gonna get it.” (Charlotte, 26, Former). 
 
Specifically to lung cancer risk, the analysis also revealed how participants often failed 
to consider the importance of lung cancer risk, as the risk of lung cancer was 
contextualised among other risks that participants described exposure to. The results 
of the analysis also suggested that quit attempts did not take precedence when 
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considered in the context of additional stressors. One participant described how he had 
previously been homeless and alcohol dependent, deprioritising smoking cessation in 
favour of addressing other difficulties. 
 
I lost my home and everything through drink, do I want to go back to that? I 
don’t think so! So, I’ve had to go on the streets and everything to wake up and 
smell the coffee, building your life, and I did say when I was getting me life 
back and all that, the next thing that’s going is them stupid ciggies. (Jack, 49, 
Current) 
 
Another participant explained how he started to suffer with depression after a 
relationship breakdown. The participant emphasised how he concentrated his 
resources in addressing other lifestyle stressors, which were considered a priority, 
rather than focusing on smoking cessation. 
 
I think that I was, I was coming down with, err, at the time, I didn’t know I 
was starting to suffer with depression so, the likes of things like that (smoking 
cessation), you don’t really worry about things like that … I wasn’t sleeping 
and everything else … so for me it wasn’t about packing the cigarettes in, it 
was about changing me whole lifestyle. (Gavin, 45, Former) 
 
Two other participants also demonstrated how smoking and lung cancer risk were 
contextualised among other potential risks, demonstrating how resources can often be 
focused on broader areas of risk, as opposed to lung cancer alone, for example. One 
participant described over-saturation of information pertaining to risk factors, leading 
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her to dismiss communication regarding other risk factors, “It doesn’t really matter, I 
mean everyone says, ‘Oh don’t have that because that can give you cancer’ and ‘Don’t 
have that because, don’t go on the sunbeds because that can give you cancer’. Like, 
there’s always something” (Charlotte, 26, Former). One recent former smoker was 
asked how she felt about her lung cancer risk being reduced as a result of stopping 
smoking and she responded, “I’ve never give much thought about when you pack in 
smoking, about it all going down, I haven’t given it much thought, all I was concerned 
about was the amount of people that do die because they smoke” (Jean, 59, Former). 
The latter comment suggests that the participant was primarily concerned regarding 
overall disease and mortality in relation to smoking, as opposed to lung cancer 
specifically, which again demonstrates the range of potential risks smokers might 
consider. This concept also interlinks with the following section, “Barriers to risk 
comprehension”, as risk contextualisation may result in some sources of risk 
communication being neglected or being viewed as unimportant. 
 
5.3.2.3 Barriers to risk communication saliency 
The current section focuses on the barriers to risk communication saliency. The 
majority of this section refers to the LLP intervention, as participants who received 
the intervention were posed a number of questions regarding their response to the LLP 
intervention. Furthermore, some participants described additional barriers to risk 
interpretation and comprehension, which are discussed. 
 
A number of participants (n = 4) provided comments, which demonstrated a lack of 
understanding regarding the LLP intervention. One participant thought that the two 
risk projection scores (see Figure 7) compared a smoker and a non-smoker, rather than 
198 
 
the participant’s comparative scores between continued smoking and smoking 
cessation, “It was quite a shock, erm, especially when you see a person’s lungs who 
hadn’t smoked compared to a person who had smoked. The difference between them 
is quite alarming!” (Alex, 56, Current). Three of the four participants also 
demonstrated a level of misunderstanding, as they suggested that with smoking 
cessation, their risk could have been reduced further than the risk projections 
suggested. One participant explained, “Well, I’m hoping that I can get lower (laughs)” 
(Sophie, 55, Former). Another participant felt that her risk may have declined more so 
since being delivered the intervention, as she had since cut down the number of 
cigarettes consumed per day. 
 
Mine said if you continue smoking, at the age of 70-74 years old, your risk will 
be 12% and then, if you quit smoking from now on, your estimated risk of 
getting lung cancer will be 9%, so I’ve reduced them again since then, so 
hopefully it’ll go down. (Gemma, 57, Current) 
 
This suggests that some participants failed to understand that the LLP intervention 
provided a comparison of projected lung cancer risk, based on continued smoking or 
smoking cessation. This finding also fits well with the aforementioned results 
regarding uncertainty and risk, as often participants remained potentially unrealistic 
regarding risk, despite being provided with an arguably objective measure of risk. 
Furthermore, although the LLP risk model has demonstrated good discrimination 
between cases and controls (AUC 0.71) (Cassidy et al., 2008), it is not possible to 
account for all potential lung cancer risk factors (e.g. genetic factors), meaning that 
deviation may occur between projected and actual risk; this knowledge may have 
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further contributed towards the ideal adopted by some participants, that lung cancer 
should be substantially lower than projected with smoking cessation. 
 
One participant additionally demonstrated a lack of understanding in relation to the 
imagery displayed on the LLP intervention (see Figure 7), which was included to 
demonstrate the risk projections visually, “To tell you the truth, I didn’t understand it. 
I’m just looking for it now … I didn’t understand all the little square things … Yeah, 
I just didn’t understand what they were” (Gemma, 57, Current). This also suggests that 
the visual component of the LLP intervention may have been difficult to comprehend 
for some participants. 
 
One of the key issues that emerged in relation to the study intervention, was the 
perception that the levels of risk projected were very low. The median risk projection 
for participants overall who continued to smoke was 6.46% (IQR = 5.52-6.69), whilst 
the average risk projection for participants who continued to abstain from smoking 
was 1.66% (IQR = 1.11-3.40); several participants anticipated the percentages 
associated with continued smoking to be considerably higher. One participant 
commented, “Well higher, yeah … when I was smoking, I expected it to be higher, I 
think it was only 7, whatever it was, it was only really low, like I didn’t expect it to be 
so low” (Charlotte, 26, Former). Another participant additionally felt that her risk 
projection for continued smoking was particularly low, “I actually expected my lung 
cancer chances to be higher because everyone’s like, ‘Oh, you’re going to get lung 
cancer if you smoke’ and I think mine was 6% which I thought, well, that’s still quite 
low” (Matilda, 33, Former). The participant continued to provide her estimation of 
lung cancer risk, if she had continued smoking, “You know what I expected it to be 
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like up in the 20, maybe 30% range, that was like the figure I had imagined in my 
head. If I carry on smoking, there’s a very good chance I will die of lung cancer …” 
(Matilda, 33, Former). One participant suggested that the risk projections were so low 
that they could encourage some smokers to continue smoking. 
 
My sister’s a hardcore smoker and reason is, it would validate her to carry on 
smoking, “That’s a minimal percentage, oh, I’ll carry on”. So, ‘cause they’ll 
want an excuse anyway and you’re kind of, the University of Liverpool are 
saying I’ve got a 6% chance of getting lung cancer between 70 and 74. I’ve 
known people in their 70s die anyway and it’s all to do with the quality of life 
and people do think they are getting the quality of life they need through 
smoking and then not smoking and going through all the hassle and all that and 
I’m only going to get 6%; it’s a bit crap that! (Sarah, 55, Former) 
 
This comment also demonstrates how some smokers may perceive smoking to add to 
their quality of life and therefore, if such risk projections portray a minimal reduction 
in lung cancer risk from quitting, some smokers may not perceive quitting to be 
beneficial, as it could reduce quality of life. 
 
Some participants (n = 3) described feeling oversaturated with risk messages, which 
contributed to a desensitising effect in relation to further risk communication. This led 
participants to be dismissive towards further communication; this is also relevant to 
the previous section (see Section 5.3.2.2), which explored risk contextualisation, as 
the results suggested that participants consider smoking-related risk in the context of 
other risks. One participant explained, “If you listened to everything, you wouldn’t, 
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you wouldn’t move, you’d just be wrapped up in cotton wool (laughs)” (Charlotte, 26, 
Former). Another participant similarly commented how he had observed other 
smokers who seemingly appeared desensitised by the graphic images on cigarette 
packs, which depict smoking-related disease. 
 
Now, in work, there’s a few lads that do smoke, and when they started putting 
pictures on of the diseases and things like that, it didn’t really bother them, it 
become sort of blasé with them, like a swap shop, like what have you got on 
your packet? (Gavin, 45, Former) 
 
This quote not only demonstrates how ubiquitous risk communication could lead to 
desensitised attitudes towards smoking-related risk, but additionally, this was the only 
comment that conflicts with the aforementioned accounts in the previous section (see 
Section 5.3.1.3), which demonstrated how cigarette packs were considered an 
effective vehicle for risk communication messages. 
 
5.4 Discussion 
The current chapter explored smoking-related risk perception in greater detail by 
employing both quantitative and qualitative research methods. The quantitative 
research component allowed for the investigation of correlates and predictors of 
perceived personal lung cancer risk, whilst the qualitative research component 
explored smoking-related risk perception and communication in rich detail. This 
chapter aimed to address the thesis objective, to explore factors implicated in smoking-
related risk perception. By undertaking the aforementioned research and achieving this 
project objective, researcher knowledge regarding smoking-related risk perception 
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will be improved upon, potential groups that demonstrate inaccurate risk perceptions 
can be identified and potentially targeted for future health campaigns, and future risk 
communications can be better informed to improve efficacy. The current chapter 
findings also provide further explanation regarding the results of the previous chapter, 
in which the effect of the LLP intervention on follow-up smoking cessation and lung 
cancer risk perceptions was investigated. This section will explore the findings in 
relation to previous research, consider the strengths and potential limitations of the 
research methodology adopted in relation to this chapter, and lastly, discuss the 
implications of the chapter results. 
 
5.4.1 Exploration of chapter findings 
Several predictors of perceived personal lung cancer risk were identified in relation to 
the quantitative analysis, most notably, age, smoking status, perceived average smoker 
lung cancer risk, and perceived relative risk of lung cancer. The results of the 
quantitative research indicated that older participants were more likely to perceive 
their baseline perceived personal lung cancer risk as higher. Furthermore, the results 
of the qualitative analysis corroborated with the positive correlation between age and 
perceived personal lung cancer risk, identified as part of the quantitative analysis. The 
results suggested that throughout youth, concerns regarding the long-term effects of 
smoking were minimal, whilst with age, participants became increasingly fearful of 
disease and mortality, prompting them to consider smoking cessation in an effort to 
prolong life. 
 
Previous studies have suggested that with continued smoking and increased age, 
perceptions of risk increase (Arnett, 2000; C. Lee, 1989). Furthermore, research 
203 
 
suggests that younger people with lower perceptions of smoking-related risk are more 
likely to start smoking, whilst younger smokers are also more likely to perceive their 
ability to quit smoking as higher, compared with older smokers (A. V. Song et al., 
2009). 
 
Several participants in the current study described how, during their youth, they would 
employ self-exempting perceptions of risk (e.g. “There’s nothing wrong with them 
(older people) and they just carry on smoking”); this is consistent with previous 
research that has identified how young smokers tend to be optimistic and hold self-
exempting beliefs regarding smoking (Mantler, 2013). 
 
The current findings also suggest that baseline smoking status predicts baseline 
perceived personal lung cancer risk; the bivariate results suggest that current smokers 
more frequently perceived their personal perceived lung cancer risk as high. Previous 
research has also identified differences in perceived personal risk perception by 
smoking status, with current smokers being more likely to perceive their personal risk 
as very high, followed by former, and never smokers (Rutten et al., 2011). The current 
study is novel, in that it identified significant differences in perceived personal lung 
cancer risk between current and recent former smokers, despite all participants 
engaging with SSS. 
 
The result regarding the relationship between smoking status and personal perceived 
lung cancer risk also coincides with previous research. There is a common 
misconception among the general population that the lung cancer incidence rate 
declines among former smokers; on the contrary, upon smoking cessation, the 
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precipitous rise in risk does cease but generally risk remains constant (Peto, 2011). 
The current results might suggest that recent former smokers are less likely to suspect 
lung cancer in themselves if they were to develop symptoms and therefore, recent 
former smokers may benefit from further education in this respect, in order to increase 
symptom awareness. Ali et al. (2015) found that current smokers were less likely to 
engage in a lung cancer screening trial, compared to former smokers. However, E. J. 
Hahn et al. (2006) identified that former smokers were more likely to be interested in 
receiving screening information or being screened than current smokers not interested 
in quitting smoking, but less likely to be interested in screening information or being 
screened compared to current smokers who were thinking about or preparing to quit.  
Further research is required to better understand the relationship between smoking 
status and help-seeking and potentially implement better education, particularly across 
socio-economic status (as the current study results focused almost entirely on 
individuals from more deprived backgrounds). 
 
The quantitative results also revealed that perceived average smoker lung cancer risk 
and perceived relative risk of lung cancer were predictive of perceived personal lung 
cancer risk. This suggests that smokers who perceive the objective risk of lung cancer 
to be high, are more likely to perceive their personal risk of lung cancer to be high 
also. Previous research has additionally found perceptions of lung cancer to be 
correlated with other perceptions regarding lung cancer risk (e.g. Dillard et al., 2006). 
 
The results of the qualitative analysis provide further insight into certain factors 
implicated in smoking-related risk perceptions, which the quantitative survey 
neglected to investigate. For example, the qualitative component considered responses 
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to the LLP intervention and barriers to objectively perceiving personal smoking-
related risk. The qualitative investigation proved fruitful in identifying perceived 
efficacy of the LLP intervention in promoting smoking cessation, as several 
participants suggested that receiving the intervention promoted motivation to quit. The 
results suggest that the LLP intervention incorporated aspects of fear appeals, which 
have been described as “communications presenting the threat of impending danger to 
motivate compliance with a proposed recommendation” (p. 233) (Keller & Lehmann, 
2008, as cited in Orazi & Pizzetti, 2015). 
 
One meta-analysis described how fear appeals motivate adaptive behaviour change 
(e.g. message acceptance) but also, maladaptive behaviour (e.g. defensive avoidance) 
(Witte & Allen, 2000). Previous research has found that strong visual fear appeals (e.g. 
images of diseased lungs) influence smoking cessation intention and success 
(Gallopel-Morvan, Gabriel, Le Gall-Ely, Rieunier, & Urien, 2011; Hammond, Fong, 
McDonald, Brown, & Cameron, 2004). The results of the qualitative analysis provide 
evidence for both adaptive and maladaptive behaviours in relation to fear appeals. 
Witte’s (1992; 1994) Extended Parallel Process Model (EPPM) (see Figure 4) 
provides some explanation as to the mechanisms by which the LLP intervention may 
have been processed by some participants. The model highlights how cognitions can 
contribute to fear appeal success, whilst the emotion fear can contribute towards fear 
appeal failure. Potentially, participants who exhibited low self-efficacy or those 
deemed the impact of smoking cessation as minimal in reducing lung cancer risk, may 
have been less likely to adopt a protective behaviour (i.e. smoking cessation), yet many 
participants who continued to smoke appeared able to accept this message (as 
participant recall of the LLP intervention was high), as the EPPM suggests. 
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Fear appeals were also prominently discussed by participants with regards to other 
common platforms of smoking-related risk communication, such as those found on 
cigarette packs or televised tobacco control campaigns. Such methods were found to 
evoke fear and promote intention to quit smoking; however, at least one participant 
account supported the notion that fear appeals can evoke avoidance behaviours. 
 
The qualitative findings also corroborate with the quantitative findings that identified 
differing LLP intervention effects on follow-up smoking status, between baseline 
current and former smokers. The qualitative results revealed that current smokers 
described how receiving the LLP intervention provided additional risk information 
that was viewed as motivational in quitting smoking, whilst former smokers explained 
that receiving the information provided further reinforcement of their decision to quit. 
This finding fits with the notion that smokers at alternate stages of change may be 
more receptive to this kind of risk communication, as stipulated by the behavioural 
model, the Transtheoretical Model of Change (J. O. Prochaska & DiClemente, 1983; 
J.O. Prochaska & DiClemente, 1986). The model suggests that reinforcement 
management in itself is a process of change found to be implicated among recent 
former smokers, to help maintain long term cessation. In contrast with the quantitative 
results, the LLP intervention was described as having a motivational effect among 
baseline current smokers; potentially, some current smokers may have provided a 
socially desirable response, which could explain the discrepancy in results across 
methods or alternatively, too few participants were sampled in the trial of current 
smokers to detect a significant result. 
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Some participants failed to understand that the LLP intervention provided a 
comparison of projected lung cancer risk based on continued smoking and smoking 
cessation. Furthermore, a number of participants perceived the projected levels of risk 
provided as unexpectedly low; potentially this may have been due to limited 
understandings regarding the concept of five-year risk. Such limited understanding 
could be attributed to poor health literacy (Gigerenzer et al., 2007; Stewart et al., 2013) 
or the means by which the levels of risk were presented in the study intervention (Akl 
et al., 2011). Furthermore, one participant described how she failed to understand what 
the visual image on the written LLP intervention represented (see Figure 7). Previous 
research typically supports the use of visual imagery on written risk communication 
(Lipkus & Hollands, 1999), which suggests that potentially, the graphics included in 
the LLP intervention could benefit from further refinement. 
 
In addition to exploring participant responses regarding the LLP intervention, the 
results of the qualitative analysis in this chapter also revealed factors associated with 
risk perception, which could potentially undermine or enhance broader risk 
communication efforts. Factors, including uncertainty or perceived lack of control 
over disease, risk contextualisation, and experiences of addiction, were found to 
contribute towards participants’ responses to smoking-related risk communication. 
 
Uncertainty and perceived lack of control were key overlapping components 
considered by participants. Lindbladh and Lyttkens (2003) describe how genuine 
uncertainty could implicate risk preventative behaviours. They argue that an 
individual who has less confidence in probabilistic information, is less likely to engage 
in information gathering and behaviour change. Familiarity and habituation may also 
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contribute towards perceived lack of control, as being exposed to a risk over time can 
result in perceiving the risk to be less threatening, despite the objective level of risk 
remaining constant (Slovic, 2000a). Furthermore, a number of participants 
additionally revealed self-exempting risk perceptions associated with perceived lack 
of control. Self-exempting risk perceptions have been associated with stage of change 
(Chapman et al., 1993), however, the current findings suggest that these perceptions 
were independent of smoking status.  
 
Risk contextualisation was another important aspect considered by participants. 
Peretti-Watel, Seror, et al. (2014) suggested that those from the most deprived 
households tend to perceive smoking-related health risks as less threatening, whilst 
Lindbladh and Lyttkens (2003) described how individuals with fewer resources, fewer 
opportunities to mitigate poor outcomes, and greater exposure to social and material 
risk are less likely to be able to devote adequate resources to cope with health-related 
risk communication. This is relevant to the present thesis, as socio-economic 
disadvantage is closely associated to smoking and additionally, Liverpool is 
considered to be the most deprived local authority in England (Liverpool City Council, 
2011). Participants considered lung cancer risk alongside other risks in society, which 
appeared to overwhelm some participants, leading to prioritisation of risk preventative 
behaviours, dependent on the value attached to a specific risk. This was also true with 
regards to risk communication, as participants described over-saturation of risk 
messages, which led to sources of information being ignored; the quantitative results 
corroborate the qualitative findings in this instance, as lung cancer worry was 
considered to be substantially low, despite all participants demonstrating smoking 
history (see Section 5.2). 
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Lastly, participants often attributed failure to engage in smoking-related risk 
preventative behaviours to the experience of addiction. This notion fits well with the 
health behaviour theory, PRIME theory (West & Brown, 2013), which not only 
considers plans, intentions, and motives in addiction, but it also emphasises the 
importance of impulses; whereas, it has been argued that traditional models of 
behaviour change, such as the HBM (Rosenstock, 1966), represent human behaviour 
in a computational manner, whereby risk avoidance is considered rational and risk-
taking is viewed as irrational (Bloor, 1995 as cited in Lupton, 1999). A number of 
participants described an awareness of smoking-related risk but a simultaneous 
inability to quit smoking, due to the experience of addiction. 
 
5.4.2 Potential strengths and limitations 
The current chapter particularly draws on the mixed methods approach adopted 
throughout the PhD project and demonstrates how mixing methods can not only be 
complementary, but it can also increase the scope and depth of the research (Mathie 
& Carnozzi, 2005); this is a key strength, which is particularly relevant to the current 
chapter. 
 
The semi-structured design of the qualitative interviews combined pre-determined 
questions with the opportunity for the interviewer to examine various themes and 
responses in greater detail. This proved highly beneficial in relation to the current 
chapter results, as the researcher was unaware of the types of responses they were 
likely to receive (Morse, 2012), particularly as complex discussions regarding 
smoking-related risk perception ensued. Participation selection biases were 
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particularly relevant in relation to the qualitative component of this chapter, as some 
individuals are more likely to engage with cancer risk research compared to others 
(Loon, Tijhuis, Picavet, Surtees, & Ormel, 2003); presumably, individuals who tend 
to deny or ignore cancer risk were less likely to engage in the interviews. 
 
Another key strength in the current chapter is the use of both ordinal (or proportional 
odds [PO]) and logistic regression modelling in relation to the quantitative analysis. 
As the outcome variable of interest (baseline perceived personal lung cancer risk) was 
ordinal, PO regression was deemed most suitable for the analysis. In comparison to 
frequently used approaches for binary and nominal data, ordinal regression models 
benefit from making full use of ranked data, yet such approaches are often 
underutilised in biomedical and epidemiological studies (Thornicroft, Rose, Kassam, 
& Sartorius, 2007). The use of PO regression was, however, limited due to the 
assumption of PO often being violated. To further strengthen the analysis, binary 
regression models were additionally developed to complement the results and address 
any weaknesses in relation to the PO model; a multinomial regression model could 
have been considered, although this approach would have prevented the ordinal nature 
of the outcome variable from being detected. 
 
The correlational analysis in the current chapter included all participants recruited in 
the quantitative aspect of the PhD project, who responded to the baseline perceived 
personal lung cancer risk measure (N = 502); this allowed for a novel and in-depth 
analysis of risk perception among both current and recent former smokers engaged 
with RCFE. It should be noted that the quantitative findings in this chapter emanate 
from a correlational analysis and therefore, only causal inferences can be conveyed 
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(Bowen & Wiersema, 1999; Weinstein et al., 1998). Currently, it is unclear as to 
whether smoking status predicts perceived personal lung cancer risk, perceived 
personal lung cancer risk predicts smoking status, or potentially, the relationship is 
bidirectional; the following chapter will attempt to address this paucity in the research 
further. 
 
If a similar topic is to be researched in future, it would be beneficial to conduct the 
qualitative and quantitative methods sequentially. The qualitative research could 
therefore be conducted firstly to establish barriers and facilitators to communicating 
lung cancer risk, which could inform the design of the LLP intervention future and 
ultimately, improve LLP intervention efficacy. 
 
5.4.3 Implications for knowledge, practice and policy 
The current chapter findings have a number of implications for knowledge, practice 
and policy. The quantitative analysis revealed several results, which were often 
corroborated by the qualitative analysis. For example, age was consistently associated 
with risk perception. Some participants described how milestone birthdays prompted 
quit attempts. This has implications for tobacco control practice and policy, as 
potentially smoking cessation campaigns could target specific age groups. One recent 
review explored smoking cessation interventions aimed at smokers aged over 50 years 
old and concluded that only a small number of smoking cessation trials examined older 
smokers and that further research was required (D. Chen & Wu, 2015). Age-targeted 
smoking cessation interventions could easily be implemented in SSS, as service users 
provide their date of birth upon registration. 
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Associations were also identified between perceived personal lung cancer risk and 
smoking status, as well as objective perceptions of risk (e.g. perceived risk of the 
average smoker). These reported correlations suggest that potentially, smokers who 
are better educated or have more realistic perceptions regarding smoking-related risk 
of lung cancer, are more likely to perceive their personal lung cancer risk as higher. 
Health campaigns communicating the objective risk of lung cancer (particularly the 
relative risk) might therefore increase perceived personal lung cancer risk among 
smokers, which in turn, could promote smoking cessation. 
 
 Furthermore, future research might consider developing an intervention that 
incorporates lifetime risk (as opposed to five-year risk) and several smoking-related 
outcomes (as opposed to lung cancer alone); statistical presentation of risk information 
can greatly impact risk message persuasiveness (Akl et al., 2011). 
 
With regard to broader smoking-related risk perception, the current chapter results 
have several implications. Many participants described an overwhelming experience 
of exposure to several risks, whereby certain risk preventative behaviours (e.g. 
smoking cessation) were deprioritised in favour of other risk preventative behaviours. 
This emphasises the importance of the development of interventions aimed at 
improving the resources available to individuals from particularly deprived 
households, who may be exposed to a greater number of risks. 
 
Lastly, smokers who demonstrate high levels of risk awareness and acceptance, yet 
continue to smoke, would certainly be a potential sample to focus upon in future. For 
example, one study identified several barriers to smoking cessation success among 
smokers with COPD (Eklund, Hedman, Nilsson, & Lindberg, 2012). Further 
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investigation into smoking cessation barriers and facilitators among hard-to-reach 
smokers and individuals suffering with smoking-related disease might offer further 
knowledge regarding risk perception and smoking cessation theory. This could, in 
turn, lead to the development of more effective and targeted interventions. 
 
5.4.4 Conclusion 
In summary, the current chapter presented much of the results pertaining to both the 
quantitative and qualitative investigations. Key predictors of perceived personal lung 
cancer risk, such as age and smoking status, were discussed and potential implications 
regarding tobacco control research and practice were considered (e.g. age-specific 
smoking cessation interventions). Further factors implicated in risk perception were 
identified, which may inhibit the salience or efficacy of smoking-related risk 
communications; uncertainty of risk, risk contextualisation, and experiences of 
addiction were considerably notable aspects. This chapter also provides insight 
regarding participants’ responses regarding the LLP intervention more specifically; 
potential areas for improvement were highlighted and discussed. 
 
This chapter also demonstrates how implementation of a mixed methods design can 
strengthen a project, resulting in an in-depth exploration of risk perception among 
smokers; the quantitative results were able to qualify qualitative findings and vice 
versa, whilst the results of the qualitative analysis were able to provide meaning and 
explanation to associations established as part of the quantitative investigation. The 
following chapter will explore the predictors of smoking cessation through statistical 
analysis; in doing so, the relationship between lung cancer risk perceptions and 
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smoking status can be explored further using both cross-sectional and longitudinal 
methods. 
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Chapter 6: Predicting smoking status 
6.1 Introduction 
Whilst Chapter 4 intended to examine whether application of the LLP intervention 
was associated with follow-up smoking cessation success, this chapter aims to explore 
additional association with follow-up smoking cessation success. The results 
discussed in this chapter will help to determine a better understanding of the 
associations with follow-up smoking cessation among both baseline current and recent 
former smokers. By undertaking this research, groups struggle to quit or are more 
prone to relapse might be identified. Not only will these results inform the literature 
regarding smoking behaviour and risk perception but subsequently, new strategies 
might be developed and implemented to support identified vulnerable groups to 
successfully quit smoking. The current chapter addresses one key thesis objective: 
 
 To explore factors implicated in smoking cessation success. 
 
Statistical analyses were undertaken to achieve this objective. Both cross-sectional and 
longitudinal predictors of smoking status were examined. Firstly, differences in 
baseline participant characteristics by baseline smoking status were explored across 
all project participants recruited at baseline. Secondly, differences in baseline 
participant characteristics by follow-up smoking status were explored among baseline 
current smokers. Finally, differences in baseline participant characteristics by follow-
up smoking status were explored among recent former smokers. For all three 
investigations, bivariate analyses were conducted to inspect significant group 
differences and to select variables for inclusion in multivariate models. Logistic 
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regression models were subsequently developed to explore the extent to which 
variables predicted smoking behaviour.  
 
6.2 Differences between baseline current and recent former smokers 
The present section refers to analyses whereby the overall sample of participants 
recruited in the PhD project (N = 521) were utilised to investigate whether baseline 
participant characteristics predict baseline 7-day point prevalence. The results of all 
bivariate and multivariate analyses are described. 
 
A range of bivariate tests were undertaken to explore significant differences between 
baseline current and recent former smokers. Table 11 displays the distribution of 
baseline participant characteristics between the two smoking status groups; key 
differences of note are indicated. Hosmer et al. (2013) suggested incorporating all 
covariates significant at the level of 25%, in further multivariate analyses; therefore, 
this guidance was adhered to. 
 
The bivariate analyses revealed that the baseline variables age (p = 0.002), marital 
status (p = 0.052), highest educational attainment (p = 0.142), living with another 
smoker (p = 0.002), FTND (p = 0.007), cigarettes per day (p < 0.001), perceived 
personal lung cancer risk (p < 0.001), perceived average smoker lung cancer risk (p = 
0.109), perceived relative risk of lung cancer (p = 0.232), and lung cancer worry (p = 
0.232) significantly differed by baseline smoking status at the level of 25%. No 
significant effects were observed between baseline smoking status and the baseline 
participant characteristics, including gender, ethnicity, socio-economic status, age 
started smoking, and perceived lung cancer survival.  
217 
 
Table 11. Participant characteristics by baseline smoking status 
Baseline variable Baseline current 
smokers 
(n = 302, 58.0%) 
Baseline recent 
former smokers 
(n = 219, 42.0%) 
P-value § 
Age (Median, IQR) 41.5 (31.0-51.0) 44.0 (37.0-52.0) 0.002* 
Gender   0.308 
 Female 179 (59.3) 120 (54.8)  
 Male 123 (40.7) 99 (45.2)  
Ethnicity†   0.925 
 White 275 (92.0) 200 (91.7)  
 Other 24 (8.0) 18 (8.3)  
Marital status†   0.052* 
 Other 44 (14.7) 38 (17.5)  
 Single 161 (53.7) 93 (42.9)  
 Married or living together 95 (31.7) 86 (39.6)  
Highest educational attainment†   0.142* 
 Basic or no qualifications 139 (47.1) 117 (53.7)  
 Higher qualifications 156 (52.9) 101 (46.3)  
Socio-economic status†   0.616 
 Most deprived 259 (86.0) 185 (84.5)  
 Least deprived 42 (14.0) 34 (15.5)  
Age started smoking  (Median, IQR) 15.0 (13.0-17.0) 15.0 (14.0-17.0) 0.655 
Living with another smoker†   0.002* 
 No 189 (63.4) 167 (76.3)  
 Yes 109 (36.6) 52 (23.7)  
FTND  (Median, IQR) 6.0 (4.0-7.0) 6.0 (5.0-8.0) 0.007* 
Cigarettes per day  (Median, IQR) 20.0 (12.0-20.0) 20.0 (15.0-30.0) p<0.001* 
Perceived personal lung cancer risk†   p<0.001* 
 Low 53 (18.3) 70 (33.0)  
 Moderate 116 (40.0) 90 (42.5)  
 High 121 (41.7) 52 (24.5)  
Perceived average smoker lung cancer risk†  0.109* 
 Very low to moderate 73 (25.0) 42 (19.6)  
 Somewhat high 105 (36.0) 96 (44.9)  
 Very high 114 (39.0) 76 (35.5)  
Perceived relative risk of lung cancer†   0.232* 
 About the same to a little higher 
risk  
58 (20.2) 35 (16.4)  
 Twice as high risk 48 (16.7) 43 (20.2)  
 Five times higher risk 86 (30.0) 52 (24.4)  
 Ten times higher risk 95 (33.1) 83 (39.0)  
Lung cancer worry†   0.138* 
 Rarely or never 89 (30.1) 75 (34.6)  
 Sometimes 108 (36.5) 87 (40.1)  
 Often or all the time 99 (33.4) 55 (25.3)  
Perceived lung cancer survival†   0.524 
 Less than a quarter 105 (36.5) 88 (41.7)  
 About a quarter 84 (29.2) 63 (29.9)  
 About half 72 (25.0) 44 (20.9)  
 About three quarters to nearly all 27 (9.4) 16 (7.6)  
† Figures do not equate to 521 due to some missing data, FTND = Fagerström Test of Nicotine 
Dependence, § Categorical variables were analysed using 2 test and continuous variables 
with Mann Whitney U-test, * p < 0.25 
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Multivariate analyses were undertaken to explore the differences by baseline smoking 
status further. All aforementioned potential predictors of baseline smoking status at 
the level of p < 0.25 were included in the development of a binary logistic regression 
model. Appendix O provides the results pertaining to the first multivariate model for 
the prediction of baseline smoking status. The first model was statistically significant, 
χ2(16) = 71.458, p < 0.001. The model explained 19.1% (Nagelkerke R2) of the 
variance in baseline smoking status and correctly classified 63.9% of cases. 
Furthermore, the Hosmer-Lemeshow goodness-of-fit test indicated that the model 
fitted the data well, χ2(8) = 8.643, p = 0.373.  
 
As previously described, Hosmer et al. (2013) provide guidance for model building 
strategies and purposeful selection of covariates. They recommend refining the initial 
multivariate model to develop a more parsimonious final model, which typically 
involves removing non-significant variables. Furthermore, Hosmer-Lemeshow 
goodness-of-fit tests are conducted and compared throughout the development process 
to explore model fit. 
 
The finalised model was statistically significant, χ2(9) = 58.734, p < 0.001 (Table 12). 
The model explained 15.3% (Nagelkerke R2) of the variance in baseline smoking 
status and correctly classified 62.8% of cases. Furthermore, the Hosmer-Lemeshow 
goodness-of-fit test indicated that the model fitted the data well, χ2(8) = 6.638, p = 
0.576, demonstrating a considerable improvement in fit compared to the initial model.  
 
The Wald criterion displayed that age (p < 0.001), living with another smoker (p = 
0.022), and both “Moderate” (p = 0.026) and “High” (p < 0.001) levels of perceived 
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personal lung cancer risk were significant predictors. Furthermore, perceived relative 
risk of lung cancer level, “Ten times higher risk” (p = 0.003) and the lung cancer worry 
level, “Often or all the time” (p = 0.002) were both significant. 
 
Table 12. Final logistic regression model for the prediction of baseline former 
smoker status 
Baseline variable Odds 
(95% CI) 
Lower 
(95% CI) 
Upper 
(95% CI) 
P-value 
Age 1.040 1.021 1.060 p<0.001* 
Living with another smoker    0.022* 
 Yes 0.605 0.393 0.930  
 (Base = No)     
Perceived personal lung cancer risk     
 Moderate 0.576 0.354 0.936 0.026* 
 High 0.246 0.144 0.420 p<0.001* 
 (Base = Low)     
Perceived relative risk of lung cancer    
 Twice as high risk 1.648 0.872 3.115 0.124 
 Five times higher risk 1.468 0.809 2.664 0.206 
 Ten times higher risk 2.441 1.361 4.380 0.003* 
 (Base = About the same to a little 
higher risk) 
    
Lung cancer worry     
 Sometimes 0.846 0.536 1.334 0.471 
 Often or all the time 0.548 0.328 0.916 0.022* 
 (Base = Rarely or never)     
FTND = Fagerström Test of Nicotine Dependence, * p < 0.05 
 
6.3. Predicting follow-up smoking status among baseline current smokers 
The current section utilises baseline current smokers (n = 297) to examine whether 
baseline participant characteristics predict follow-up smoking status. Again, the 
results of all bivariate and multivariate analyses are described. 
 
Bivariate tests were undertaken to explore the association between baseline participant 
characteristics and follow-up smoking status, among baseline current smokers only (N 
= 297). Table 13 displays the distribution of baseline participant characteristics 
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between follow-up smoking status groups; key differences are indicated in the table. 
Again, guidance produced by Hosmer et al. (2013) suggested incorporation of all 
covariates significant at the level of 25% in further multivariate analyses. 
 
The bivariate analyses revealed that baseline variables, including ethnicity (p = 0.179), 
socio-economic status (p = 0.198), age started smoking (p = 0.159), living with another 
smoker (p = 0.247), FTND (p = 0.079), and perceived relative risk of lung cancer (p 
= 0.048) significantly differed by baseline smoking status at the level of 25%. No 
significant effects were observed between follow-up smoking status and the baseline 
participant characteristics, including age, gender, marital status, highest educational 
attainment, cigarettes per day, perceived personal lung cancer risk, perceived average 
smoker lung cancer risk, lung cancer worry, perceived lung cancer survival, and 
treatment group. 
 
Appendix P displays the results regarding the initial multivariate model for predictors 
of follow-up smoking status, among baseline current smokers. The original model was 
statistically significant, χ2(8) = 22.856, p = 0.004. The model explained 12.6% 
(Nagelkerke R2) of the variance in follow-up smoking status and correctly classified 
81.0% of cases. Furthermore, the Hosmer-Lemeshow goodness-of-fit test indicated 
that the model fitted the data adequately, χ2(8) = 9.661, p = 0.290. 
Table 13. Participant characteristics by follow-up smoking status among baseline 
current smokers 
Baseline variable Follow-up 
current smokers 
(n = 239, 80.5%) 
Follow-up 
former smokers 
(n = 58, 19.5%) 
P-value § 
Age (Median, IQR) 42.0 (31.0-50.0) 43.0 (30.8-52.0) 0.711 
Gender    
 Female 142 (59.4) 35 (60.3) 0.897 
 Male 97 (40.6) 23 (39.7)  
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Ethnicity†    
 White 220 (93.2) 51 (87.9) 0.179* 
 Other 16 (6.8) 7 (12.1)  
Marital status†   0.594 
 Other 35 (14.7) 9 (15.8)  
 Single 130 (54.6) 27 (47.4)  
 Married or living together 73 (30.7) 21 (36.8)  
Highest educational attainment†   0.950 
 Basic or no qualifications 110 (46.8) 26 (47.3)  
 Higher qualifications 125 (53.2) 29 (52.7)  
Socio-economic status†   0.198* 
 Most deprived 202 (84.9) 53 (91.4)  
 Least deprived 36 (15.1) 5 (8.6)  
Age started smoking  (Median, IQR) 15.0 (13.0-17.0) 15.0 (14.0-18.0) 0.159* 
Living with another smoker†    
 No 152 (64.4) 32 (56.1) 0.247* 
 Yes 84 (35.6) 25 (43.9)  
FTND (Median, IQR) 6.0 (4.0-7.0) 6.0 (4.0-7.0) 0.079* 
Cigarettes per day (Median, IQR) 20.0 (12.5-20.0) 20.0 (10.0-20.0) 0.300 
Perceived personal lung cancer risk†   0.581 
 Low 39 (16.8) 12 (22.2)  
 Moderate 95 (40.9) 19 (35.2)  
 High 98 (42.2) 23 (42.6)  
Perceived average smoker lung cancer risk†  0.909 
 Very low to moderate 58 (24.9) 14 (25.9)  
 Somewhat high 85 (36.5) 18 (33.3)  
 Very high 90 (38.6) 22 (40.7)  
Perceived relative risk of lung cancer†   0.048* 
 About the same to a little higher risk  51 (22.4) 6 (10.9)  
 Twice as high risk 40 (17.5) 6 (10.9)  
 Five times higher risk 68 (29.8) 17 (30.9)  
 Ten times higher risk 69 (30.3) 26 (47.3)  
Lung cancer worry†   0.427 
 Rarely or never 74 (31.6) 13 (22.8)  
 Sometimes 84 (35.9) 23 (40.4)  
 Often or all the time 76 (32.5) 21 (36.8)  
Perceived lung cancer survival†   0.663 
 Less than a quarter 89 (39.2) 16 (28.6)  
 About a quarter 61 (26.9) 22 (39.3)  
 About half 55 (24.2) 14 (25.0)  
 About three quarters to nearly all 22 (9.7) 4 (7.1)  
Treatment group   0.663 
 Control 116 (79.5) 123 (81.5)  
 Intervention 30 (20.5) 28 (18.5)  
† Figures do not equate to 297 due to some missing data, FTND = Fagerström Test of Nicotine 
Dependence, § Categorical variables were analysed using 2 test (except for those with expected cell 
frequencies < 5, which were analysed using Fisher’s Exact test) and continuous variables with Mann 
Whitney U-test, * p < 0.25 
 
Again, Hosmer et al.’s (2013) guidance pertaining to model building was followed in 
an effort to achieve a parsimonious model. Few variables remained of statistical or 
clinical relevance, resulting in the final model demonstrated in Table 14. 
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The finalised model was statistically significant, χ2(3) = 8.173, p = 0.043. The model 
explained 4.5% (Nagelkerke R2) of the variance in follow-up smoking status and 
correctly classified 80.6% of cases. The Hosmer-Lemeshow goodness-of-fit test was 
not applicable to the finalised model, as only one independent variable was included. 
The Wald criterion displayed that the perceived relative risk of lung cancer level, “Ten 
times higher risk” was significant (p = 0.017). 
 
Table 14. Finalised logistic regression model for the prediction of follow-up former 
smoker status among baseline current smokers 
Baseline variable Odds 
(95% CI) 
Lower 
(95% CI) 
Upper 
(95% CI) 
P-value 
Perceived relative risk of lung cancer    
 Twice as high risk 1.275 0.382 4.254 0.693 
 Five times higher risk 2.125 0.783 5.771 0.139 
 Ten times higher risk 3.203 1.228 8.354 0.017* 
 (Base = About the same to a little 
higher risk) 
    
* p < 0.05 
 
6.4 Predicting follow-up smoking status among baseline recent former smokers 
The present section utilises baseline recent former smokers (n = 216) to examine 
whether baseline participant characteristics predict follow-up smoking status. The 
results of all bivariate and multivariate analyses conducted are again described. 
 
Bivariate analyses were conducted to examine the associations between baseline 
participant characteristics and follow-up smoking status, among baseline recent 
former smokers. Section 3.5.2 provides further details regarding the definition of 
recent former smokers.  
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The distribution of baseline participant characteristics are displayed between follow-
up smoking status groups (Table 15). The key differences are indicated in the table. 
Again, Hosmer et al. (2013) suggested incorporation of all covariates significant at the 
level of 25% into an initial multivariate model. 
 
The bivariate results revealed that the baseline variables age (p = 0.029), marital status 
(p = 0.034), quit duration (p = 0.002), perceived lung cancer survival (p = 0.154), and 
treatment group (p = 0.032) significantly differed by baseline smoking status at the 
level of 25%. No significant effects were identified between follow-up smoking status 
and the baseline participant characteristics, including gender, ethnicity, highest 
educational attainment, socio-economic status, age started smoking, living with 
another smoker, FTND, cigarettes per day, perceived personal lung cancer risk, 
perceived average smoker lung cancer risk, perceived relative risk of lung cancer, and 
lung cancer worry. 
 
 Multivariate analyses were conducted to explore the predictors of follow-up smoking 
status among baseline recent former smokers. All aforementioned potential predictors 
of baseline smoking status at the level of p < 0.25 were included in the development 
of a binary logistic regression model. 
 
Table 15. Participant characteristics by follow-up smoking status among baseline 
recent former smokers 
Baseline variable Follow-up current 
smokers 
(n = 122, 56.5%) 
Follow-up former 
smokers 
(n = 94, 43.5%) 
P-value § 
Age (Median, IQR) 42.0 (36.0-52.0) 47.5 (39.0-53.0) 0.029* 
Gender   0.517 
 Female 69 (54.6) 49 (52.1)  
 Male 53 (43.4) 45 (47.9)  
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Ethnicity†   0.666 
 White 110 (90.9) 87 (92.6)  
 Other 11 (9.1) 7 (7.4)  
Marital status†   0.034* 
 Other 25 (20.8) 13 (13.8)  
 Single 57 (47.5) 35 (37.2)  
 Married or living together 38 (31.7) 46 (48.9)  
Highest educational attainment†   0.965 
 Basic or no qualifications 64 (52.9) 57 (47.1)  
 Higher qualifications 57 (47.1) 44 (46.8)  
Socio-economic status†   0.939 
 Most deprived 103 (84.4) 79 (84.0)  
 Least deprived 19 (15.6) 15 (16.0)  
Quit duration (Median, IQR) 35.0 (20.0-57.0) 50.0 (25.5-90.0) 0.002* 
Age started smoking (Median, IQR) 15.0 (14.0-17.0) 15.0 (13.0-17.0) 0.766 
Living with another smoker†   0.840 
 No 92 (75.4) 72 (76.6)  
 Yes 30 (24.6) 22 (23.4)  
FTND (Median, IQR) 6.0 (5.0-8.0) 6.0 (4.0-7.3) 0.305 
Cigarettes per day (Median, IQR) 20.0 (15.0-30.0) 20.0 (15.0-30.0) 0.797 
Perceived personal lung cancer risk†   0.590 
 Low 35 (29.9) 33 (35.9)  
 Moderate 51 (43.6) 39 (42.4)  
 High 31 (26.5) 20 (21.7)  
Perceived average smoker lung cancer risk†  0.324 
 Very low to moderate 26 (21.8) 15 (16.3)  
 Somewhat high 55 (46.2) 39 (42.4)  
 Very high 38 (31.9) 38 (41.3)  
Perceived relative risk of lung cancer†   0.383 
 About the same to a little higher risk  24 (20.2) 11 (12.1)  
 Twice as high risk 25 (21.0) 17 (18.7)  
 Five times higher risk 27 (22.7) 25 (27.5)  
 Ten times higher risk 43 (36.1) 38 (41.8)  
Lung cancer worry†   0.910 
 Rarely or never 42 (35.0) 31 (33.0)  
 Sometimes 49 (40.8) 38 (40.4)  
 Often or all the time 29 (24.2) 25 (26.6)  
Perceived lung cancer survival†   0.154* 
 Less than a quarter 50 (42.4) 37 (41.1)  
 About a quarter 40 (33.9) 22 (24.4)  
 About half 23 (19.5) 21 (23.3)  
 About three quarters to nearly all 5 (4.2) 10 (11.1)  
Treatment group   0.032* 
 Control 66 (64.1) 56 (49.6)  
 Intervention 37 (35.9) 57 (50.4)  
† Figures do not equate to 216 due to some missing data, FTND = Fagerström Test of Nicotine 
Dependence, § Categorical variables were analysed using 2 test and continuous variables with Mann 
Whitney U-test, * p < 0.25 
An initial model was developed but in line with recommendations (Hosmer et al., 
2013), model refinement was considered; the initial model developed was deemed 
most satisfactory following further exploration and was therefore, classified as the 
final model (Table 16). The final model was statistically significant, χ2(8) = 35.170, 
p < 0.001. The model explained 21.8% (Nagelkerke R2) of the variance in follow-up 
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smoking status and correctly classified 66.7% of cases. Furthermore, the Hosmer-
Lemeshow goodness-of-fit test indicated that the model fitted the data well, χ2(8) = 
7.427, p = 0.491.  
 
Table 16. Final logistic regression model for the prediction of follow-up former 
smoker status among baseline former smokers 
Baseline variables Odds 
95% CI 
Lower 
95% CI 
Upper 
95% CI 
P-value 
Age 1.042 1.005 1.080 0.026* 
Marital status     
 Single 1.917 0.712 5.164 0.198 
 Married and living together 3.242 1.275 8.247 0.014* 
 (Base = Other)     
Quit duration (days) 1.009 1.003 1.014 0.003* 
Perceived lung cancer survival     
 About a quarter 0.926 0.441 1.943 0.838 
 About half 1.467 0.646 3.330 0.360 
 About three quarters to nearly all 4.600 1.230 17.202 0.023* 
 (Base = Less than a quarter)     
Treatment group    0.046* 
 Intervention 1.888 1.013 3.521  
 (Base = Control)     
* p < 0.05 
 
The Wald criterion indicated that age (p = 0.026), quit duration (p = 0.003), and 
treatment group (p = 0.046) were significant predictors overall. Furthermore, the 
marital status level, “Married and living together” (p = 0.014) and the perceived lung 
cancer survival level, “About three quarters to nearly all” (p = 0.023) were both 
significant. 
6.5 Discussion 
The present chapter explored the predictors of smoking status. Analyses were 
undertaken to explore differences between current and recent former smokers at 
baseline and subsequently, analyses were conducted to investigate the predictors of 
follow-up smoking status among: (1) baseline current smokers; (2) baseline recent 
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former smokers. By investigating these concepts, a more in-depth understanding of 
the predictors of smoking cessation can be achieved. Furthermore, the findings will 
enable identification of potentially vulnerable groups, who may find smoking 
cessation more challenging. These groups could subsequently be targeted for 
additional support or intervention. The results, potential strengths and limitations in 
relation to this chapter, and implications will now be discussed sequentially. 
 
6.5.1 Exploration of chapter findings 
The current chapter results identified a number of predictors of baseline smoking 
status and follow-up smoking cessation. Predictors of baseline smoking status 
included age, marital status, living with another smoker, perceived personal lung 
cancer risk, perceived relative risk of lung cancer, and lung cancer worry. Predictors 
of follow-up smoking status among baseline current smokers included the perceived 
relative risk of lung cancer level, “Ten times higher”. Lastly, predictors of follow-up 
smoking status among baseline recent former smokers included age, marital status, 
quit duration, and perceived lung cancer survival. Some of the key predictors will now 
be discussed. 
 
The cross-sectional analysis demonstrated a positive relationship between age and 
former smoker status. This positive relationship remained at follow-up among baseline 
recent former smokers, but not among baseline current smokers; it is unclear why age 
failed to predict follow-up smoking status among baseline current smokers but 
potentially, the limited number of former smokers at follow-up within the analysis of 
baseline current smokers may have reduced power to detect a difference. A number of 
studies have found that older people are more likely to achieve smoking cessation 
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success, compared to younger smokers (Fidler et al., 2013; Hymowitz et al., 1997; C. 
Lee & Kahende, 2007; Monsó et al., 2001). 
 
Previous research has additionally found that marital status is associated with smoking 
cessation success, as smokers who are married are more likely to quit compared to 
those who are single (Broms et al., 2004; Gourlay et al., 1994). The current results 
suggest that individuals who were married or living together were more likely to be 
classified as a former smoker at follow-up, compared to those who were divorced, 
widowed, or other, in respect of the baseline former smokers analysis. Again, the 
analysis of baseline current smokers failed to detect a significant difference here. 
Furthermore, no difference in marital status was detected between smoking status 
groups in regards to the cross-sectional analysis; however, the cross-sectional analysis 
did reveal that participants who lived with a smoker were less likely to be categorised 
as a former smoker. This finding also corroborates with previous research that suggests 
that being married to a non- or former smoker enhances smoking cessation success 
(Coppotelli & Orleans, 1985; Hanson et al., 1990; McBride et al., 1998). 
 
The current study also identified that baseline quit duration was indicative of follow-
up smoking status among baseline recent former smokers. Previous research has also 
highlighted how baseline quit duration can be an important predictor of follow-up 
smoking cessation success. For example, Gilpin, Pierce, and Farkas (1997) explored 
follow-up abstinence rates among former smokers who had achieved varying quit 
durations at baseline. They estimated that 12%, 25%, and 52% of baseline former 
smokers who had quit for less than one month, 1-3 months, and 3-6 months, remained 
abstinent at follow-up, respectively. 
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Lastly, the analyses within this chapter revealed that several lung cancer risk 
perceptions were predictive of smoking status, although the specific lung cancer risk 
perceptions of relevance differed across each of the three datasets analysed. Previous 
research has provided cross-sectional support for the relationship between smoking 
status and lung cancer risk perceptions (e.g. Weinstein et al., 2005), whilst a number 
of recent studies have displayed a positive relationship between risk perceptions and 
follow-up smoking cessation success (Borrelli et al., 2010; Hayes & Borrelli, 2013; 
Jacobson et al., 2014). The identified differences between lung cancer risk perceptions 
and smoking status in the current project were most prevalent among variables tests 
across the cross-sectional results, compared to the longitudinal results. Furthermore, 
bivariate analyses demonstrated that overall, the majority of participants 
underestimated relative risk, compared to traditional values of relative risk (e.g. Pesch 
et al., 2012). 
 
6.5.2 Potential strengths and weaknesses 
The present chapter describes the results pertaining to the predictors of smoking status. 
Cross-sectional analyses were undertaken to explore differences between baseline 
smoking status groups, whilst longitudinal analyses were conducted to examine 
differences between follow-up smoking status groups: (1) baseline current smokers; 
(2) baseline recent former smokers. Not only does the chapter combine the results of 
cross-sectional and longitudinal analyses, to develop an improved understanding of 
smoking behaviour, but the extensive number of baseline characteristic variables 
allowed an in-depth analysis of the predictors of smoking behaviour. There are, 
however, some potential study limitations, which should be acknowledged. 
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The current project employed a self-report measure for smoking status, 7-day point 
prevalence. Although 7-day point prevalence can be highly advantageous (Velicer & 
Prochaska, 2004) and the sensitivity and specificity of self-reported smoking status 
has previously been identified as high when compared with biochemical indices 
(Patrick et al., 1994), inclusion of a measure of prolonged abstinence and biochemical 
verification of smoking status may have been preferable (West et al., 2005). This 
aspect was described in greater detail earlier in the thesis (see Section 4.4.2). 
 
Although the sample size was modest in relation to the cross-sectional analysis, the 
analysis of follow-up smoking status in relation to baseline current smokers was 
limited in particular, as 58 participants were classified as former smokers at follow-
up. This resulted in some data analysis challenges, such as the presence of low cell 
frequencies and the subsequent need for variable transformation (Appendix M). 
Furthermore, some associations highlighted in Table 11 were found to contradict the 
literature. For example, education was found to be significant at the level of p < 0.25 
and the data suggested that individuals with lower levels of education were more likely 
to be former smokers, yet the literature contradicts this. It should be noted that some 
associated relationships were identified at the level of p < 0.25, which is non-
traditional, for regression modelling. Furthermore, some variable levels were 
combined, which may mean that discreet differences among some variables were not 
possible to detect. A larger sample size could have addressed such issues and could 
have increased the number of significant results, as several variables were found to be 
non-significant that had previously been deemed significant in the literature. For 
example, one meta-analysis found that females are less successful in quitting smoking 
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than males (Scharf & Shiffman, 2004), whereas, the current project failed to establish 
this association.  
 
6.5.3 Implications for knowledge, practice and policy 
This section highlights a number of implications in relation to tobacco control 
knowledge, practice and policy. Several predictors of smoking status were identified 
within this chapter; however, key variables of interest differed across the three samples 
explored. Implications with regards to the key variables of interest, age, marital status, 
quit duration, and lung cancer risk perceptions, will be discussed. 
 
As described, a positive correlation was identified between age and smoking cessation. 
This might suggest that younger smokers find smoking cessation to be more 
challenging, compared to older smokers. This highlights the need to develop new and 
innovative interventions tailored towards younger people and potentially to explore 
the barriers to smoking cessation success among this population. 
 
The results also demonstrated how baseline recent former smokers who were single 
were less likely to be classified as a former smoker at follow-up, whilst the cross-
sectional results revealed that participants who reported living with a smoker were 
also less likely to be classified as a former smoker than a current smoker. As 
appropriate social support can enhance smoking cessation (Coppotelli & Orleans, 
1985; Mermelstein et al., 1983), future efforts should explore methods of improving 
social support and coping strategies, specifically among such groups to further 
improve smoking cessation rates.  
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The current project suggests that quit duration predicts follow-up smoking cessation 
success among baseline former smokers. NICE (2008) recommend that exploring the 
most effective and cost effective methods of preventing relapse among individuals 
who have already quit should be a research priority. The current findings further 
support this recommendation; potentially, extended provision of behavioural smoking 
cessation support could be a cost-effective method of improving long term smoking 
cessation attempts. Further research is required. 
 
The results also demonstrate how various lung cancer risk perceptions predict smoking 
behaviour, as the differences associated with perceived relative risk of lung cancer 
were of particular significance. Potentially, communicating risk in terms of relatives 
may be the most appropriate method of delivering information on cancer-related risk. 
Improving the methods by which risk is communicated could, in turn, improve 
smoking cessation rates. 
 
 
6.5.4 Conclusion 
The current chapter presented bivariate and multivariate results pertaining to the 
prediction of smoking status. The chapter aimed to utilise both cross-sectional and 
longitudinal datasets to explore the predictors of smoking behaviour in greater detail. 
Several key predictors were identified, including age, marital status, living with 
another smoker, quit duration (among baseline recent former smoker), and lung cancer 
risk perceptions; however, the results often differed across datasets, potentially due to 
sample size limitations  
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The results highlight a number of potential groups that may be particularly vulnerable 
to relapse. Further research should focus upon exploring such populations further and 
considering opportunities for delivering more intensive and potentially, tailored 
support to the identified groups. Furthermore, several lung cancer risk perceptions 
were found to predict smoking status; this finding indicates the need for further 
research and may be used to inform the development of future risk communications. 
The following two chapters will build upon the findings in the present chapter and will 
consider additional factors implicated in smoking cessation success, by implementing 
qualitative methods. 
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Chapter 7: Conquering smoking cessation: Accentuating the positives and 
eliminating the negatives 
7.1 Introduction 
The previous chapter involved a quantitative investigation of the predictors of 
smoking behaviour, whereas, the current and following chapter explore factors 
implicated in smoking cessation success using qualitative techniques. The current 
chapter results explore service users’ personal experiences of quitting smoking, with 
focus on various aspects that participants deemed helpful or unhelpful in quitting 
smoking. By undertaking this qualitative component, a better understanding of 
smoking and smoking cessation can be achieved, specific groups who experience 
difficulties quitting smoking can be identified, and the results could inform the 
development of tobacco control practice and policy. The present chapter addresses one 
key thesis objective: 
 
 To explore factors implicated in smoking cessation success. 
 
This chapter will firstly explore the experience of mental conflict, which many 
participants described upon attempting to quit smoking. The notion of mental conflict 
refers to the psychological struggle described among participants with respect to the 
choice between stopping smoking and continuing to smoke. Secondly, anticipated and 
experienced benefits of quitting smoking are discussed. Health, financial, and image 
or functionality benefits were all noted and participants would commonly refer to the 
benefits of quitting smoking, presumably to promote motivation and reinforce a quit 
attempt. The two major themes identified in this chapter include: (1) Experiences of 
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mental conflict; (2) Perceived benefits of quitting. These themes will be described and 
the respective sub-themes for each of these themes are discussed in turn. 
 
7.2 Experiences of mental conflict 
“Experiences of mental conflict” is the first major theme considered in this current 
chapter. Participants provided accounts of this experience, often referring to a 
psychological “battle” or “fight”. More specifically, participants described an 
experience of internal conflict, whereby they would psychologically battle conflicting 
intentions, motives, and impulses in relation to smoking cessation. This major theme 
consists of four prominent sub-themes, including “Motivation and self-efficacy”, 
“Regaining control”, “Self-doubt” and “Smoker identity”, which will subsequently be 
described. 
 
7.2.1 Motivation and self-efficacy 
“Motivation and self-efficacy” was the first prominent sub-theme associated with the 
major theme, “Experiences of mental conflict”. Participants consistently advocated 
that motivation is essential for any smoker embarking on a quit attempt, “…but I think 
it’s, it comes back to that old fashioned thing, you’ve got to want to do it, know what 
I mean?” (Paul, 38, Former) and “The thing is, you’ve got to want to do it, haven’t 
you? You’ve got to want to give up. If you don’t want to do it, it’s not going to work. 
You’ve got to in your mind though, that you want to do it.” (Shaun, 48, Current); 
however, such strong opinions regarding motivation were most common among recent 
former smokers. 
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Many participants additionally suggested that smoking cessation could only be 
sustained if the smoker demonstrated an autonomous willingness to quit smoking (i.e. 
quitting out of personal choice), as opposed to quitting to appease others, “Oh well, I 
think you’ve got to want to do it yourself like. It’s no good like other people telling 
you. It’s something you’ve got to do yourself” (Michael, 48, Former).  
 
Yeah, well, it’s got to be yourself, you’ve got to do it for yourself. There’s no 
use saying there’s FagEnds, you know, you can go to your doctor, chemist, 
Lloyds chemist do the no smoking. It’s ok saying that to people but they’ve 
got to do it for themselves. (Julia, 49, Former) 
 
Again, these comments were most prominent among recent former smokers, who 
provided insight into their quit. One current smoker attributed his quit attempt to a 
doctor’s recommendation, however, his subsequent comments portrayed him as less 
determined, “Well, I’ve thought it was time anyway but just the doctors telling me all 
the time anyway, you know, I thought I might as well stop (pause) or try to” (Joel, 44, 
Current). 
 
A central component of Bandura’s social learning theory (1977, 1982) is self-efficacy, 
which refers to an individual’s assessment of their effectiveness of competency to 
perform a behaviour successfully. Self-efficacy also appeared to be important to many 
participants. Many recent former smokers illustrated high levels of self-efficacy, with 
several expressing self-congratulatory, and often repetitive comments, presumably to 
demonstrate confidence in one’s ability to maintain change and to reinforce the 
behaviour change. For example, one recent former smoker commented, “I am 
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stopping, I am stopping, I have stopped and I have no intention now of coming this far 
and going back to how I did and I know that for a fact, that I’m not going back” (Jacob, 
59, Former), whilst another stated, “I went to watch Everton on Sunday and it never 
even bothered me, I didn’t even want a ciggy, it just didn’t bother me…” (Timothy, 
58, Former). 
 
A number of researchers have demonstrated that self-talk (i.e. inner speech), may 
assist cognitive and self-regulatory functions (Diaz & Berk, 1992; D. G. MacKay, 
1992). Participants described how they implemented positive self-talk, presumably to 
promote self-efficacy and reinforce change. Participants provided various examples of 
positive self-talk, seemingly to enhance self-efficacy and to combat temptation in 
situations whereby they might have felt vulnerable to smoking. 
 
I just thought come on (participant’s name) if you want to have any kind of 
quality of life much longer, you’re going to have to start looking after yourself 
a bit better, and that’s what I proposed to do, yeah, try to pack in smoking. 
(Peter, 50, Current) 
 
One recent former smoker described a situation whereby they experienced a craving 
but subsequently implemented self-talk to reinforce smoking cessation and reassure 
themselves of their ability to remain abstinent. 
 
I start getting really agitated and have to get up and walk out the room, ‘cause 
me body’s just had that little thing going “You want a ciggy!” and I’m like 
“No… bugger off! You’re not getting one!” (Matilda, 33, Former) 
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7.2.2 Regaining control 
The majority of participants (n = 21) described the experience of smoking as habitual. 
Fourteen participants detailed how smoking had effectively dictated their daily 
routine, which for some had contributed towards their motivation to quit. Several 
participants described an explicit sense of being controlled by cigarettes, as opposed 
to having control over cigarettes. Current smokers appeared particularly frustrated, 
presumably because they still felt enslaved by smoking, as the following comments 
suggest.  
 
I decided about a year ago I wanted to quit but I never got round to it. I finally 
got round to it and obviously, the next stage is to quit smoking and get on with 
the rest of me life but as I say, I really am a slave to cigarettes at the moment, 
and that’s got to stop. (Luke, 54, Current) 
 
It’s just the fact that it’s been going on so long now, do you know what I 
mean? It’s like starting to do me head in, in a way, it’s not like, it’s not a joke 
anymore now, you know what I mean? It’s starting to proper do me head in, 
you know what I mean? (Andrew, 34, Current) 
 
A number of recent former smokers also commented on the notion of regaining 
control. One participant was asked what he disliked about smoking and he responded, 
“Erm, being hooked on them really. Having something like a cigarette having so much 
control over me” (Sarah, 55, Former). Whilst, another recent former smoker stated, 
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“… being in control of meself and not having the ciggies controlling me. Feeling more 
in control” (Stuart, 45, Former). 
 
A number of participants from more deprived households described how dependence 
on cigarettes and concerns regarding cost, resulted in frequent consideration and 
planning in relation to acquiring cigarettes; this also seemed to contribute towards the 
perceived lack of control many participants experienced and appeared to contribute 
towards motivation to quit. One current smoker expressed hatred towards cigarettes 
and seemingly condemned his frequent pursuit of cigarettes. 
 
First thing I used to do as well, if I didn’t have a ciggy, if I did have money, 
I’d be at that shop at seven o’clock, when it opens, for a pack of ciggies. The 
last few ciggies that I have had, I don’t even enjoy them. I don’t even enjoy 
them anymore, horrible, nasty, I want yous gone, I want yous gone out me life. 
(Jack, 49, Current) 
 
One recent former smoker detailed how she felt the need to plan ahead for cigarettes 
and that this was a constant burden, which motivated her to quit smoking. 
 
Like, I was thinking, where am I going to get my ciggy, like these are going to 
do me until Friday, and then what do I do? And it was just, I thought, I don’t 
want to live like this … I just thought, I don’t want to plan my life around it 
anymore. I just didn’t want to, I just woke up and I thought, I just didn’t want 
to do it. I don’t want to smoke anymore. (Julia, 49, Former) 
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The financial relief attached to smoking cessation may contribute in part to the sense 
of liberation identified by many participants, especially among more deprived service 
users. 
 
Participants also frequently described examples whereby smoking contributed towards 
routine formation and how smoking restricted the choices and opportunities available 
to them often. One participant described how this aspect of smoking disrupted family 
life. 
 
Yeah well, you know, it dictates your life doesn’t it smoking? And you know, 
like when we were going out on days out with the kids, you would erm, the 
kids were all eager to go, you know they’re ready aren’t they before yous and 
they’re sat in the car and I’m standing out the door, going hang on just let me 
have a ciggy because can’t smoke ‘cause yous are in the car. They’re like “Dad, 
come on!” (Robert, 34, Current) 
 
Another recent former smoker who had previously smoked sixty cigarettes per day, 
described how smoking had interfered with participation in certain leisure activities. 
 
Last time I went to the pictures was, I think it was, ’89, 1989 because, I 
wouldn’t go, because, erm, it’s when they banned all the smoking in the 
cinemas and all that and, erm, but now I feel like I can go. I can do all the stuff 
that I couldn’t do before because of the ciggies. (Stuart, 45, Former) 
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Although many participants described the importance of habit and routine dictation in 
regard to regaining control, a substantial component was addiction. Addiction was 
viewed as a major barrier to smoking cessation success and an inhibitor of self-
efficacy. Seventeen participants described smoking as an addiction, although it should 
be noted that participants weren’t directly asked about addiction or habit, and rather 
they were asked why they felt they had continued to smoke since initiation. Although 
a small number of participants described the enjoyment of smoking, most explained 
that they no longer enjoyed smoking and that they continued to smoke due to the 
addiction. 
 
It’s like I said, it’s just the addiction really, you just want one. Like, you don’t 
smoke because you enjoy it, you smoke because you need the nicotine in it. If 
you could get injections where you could get that nicotine then that would just 
be the same wouldn’t it? ‘Cause when you’re smoking you just get that nicotine 
into your body and it’s nothing to do with anything else. (Shaun, 48, Current) 
 
Another current smoker described how their dependency had developed as they 
became accustomed to smoking, “It was just erm, it was like you’re addicted to them. 
That’s all it was, just smoking, smoking and smoking, that’s all it was, ‘cause you just 
got used to it” (David, 37, Current). Participants also often used the terms habit and 
addiction interchangeably, suggesting that some participants viewed the terms 
effectively as synonyms for dependency, “And I didn’t realise how hard it was to get 
out of that habit ‘cause it’s a drug, it’s a drug going through my body isn’t it? Going 
through my system?” (Julia, 49, Former). One current smoker described, “I suppose, 
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I suppose it was just like a habit, like you’re addicted to it then, so it wasn’t easy just 
to stop… ‘cause by that time you’re addicted to it aren’t you?” (Andrew, 34, Current). 
 
Two participants compared smoking to other addictions, seemingly to highlight how 
severe an addiction they perceived smoking to be and to demonstrate how challenging 
smoking behaviour is to regulate. One participant compared smoking to heroin use, 
“It’s like a heroin addict and when they inject, the risk of HIV and that, because they 
know all these things but it’s the addiction isn’t it?” (Sarah, 55, Former), whilst another 
participant compared smoking to alcohol dependency. 
 
Well I think it’s the same with anyone who’s an alcoholic, they could have 
liver failure or kidney failure or whatever and you could say to them look, your 
literally drowning yourself and your going to end up killing yourself in the 
next six months. (Gavin, 45, Former) 
 
The above participant continued to describe how he felt that some members of society 
were ignorant to the difficulties that smokers endure in attempting to quit smoking and 
how often non-smokers fail to empathise with how challenging smoking cessation can 
be. 
 
I think, you’ll probably find a lot of the ones that would say yeah, they feel 
sort of like interrogated, like the ones who you know, are mums, and when you 
see them pushing prams, because I’ve been out and I’ve seen people looking 
and the likes of having a baby in a pram and they’re smoking and you see them, 
giving them funny looks like, you know, “You shouldn’t be doing that”; you 
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know it’s wrong and you know you shouldn’t be doing it but it’s not as easy 
as saying, you shouldn’t be buying it anymore. (Gavin, 45, Former) 
 
Some participants discussed how withdrawal symptoms were viewed as a barrier to 
successfully quitting smoking, again demonstrating how some participants felt 
powerless in steering or controlling a quit attempt. One recent former smoker 
described how he suffered severe physical withdrawal symptoms, which he found 
difficult to endure. 
 
The withdrawals, I didn’t like them, I used to get pains in me gums, severe 
pains then but now I’m over all that and I never want to go back on them again. 
To come this far, and just to go back to them, honest to god, I’d never forgive 
meself. (Jacob, 59, Former) 
 
Another recent former smoker explained how his previous quit attempts had been 
limited due to the experience of severe withdrawals, “I’ve never packed in long 
enough ‘cause the longest I’d packed in for was 12 hours … Oh, it was horrible. It was 
the worst feeling ever” (Stuart, 45, Former). 
 
7.2.3 Self-doubt  
Participants expressed concerns regarding how challenging they often viewed quitting 
to be and how they feared they were incapable of quitting. The majority of participants 
admitted that quitting smoking had been challenging and often quit attempts were 
described as a struggle. This complements the sub-theme, “Motivation and self-
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efficacy” (see Section 7.2.1), as participants described how self-doubt effectively 
antagonised perceived self-efficacy. 
 
Although the majority of participants acknowledged the difficulties of quitting 
smoking (n = 24), current smokers were particularly more likely to portray quitting as 
a struggle and emphasise the difficulty of quitting, “I just wanted to quit, that’s all it 
is really, just erm, finding it hard all those years of smoking, I just wanna give it up 
now, I’m finding it a bit hard like” (David, 37, Current). Another current smoker 
commented, “Well that’s the aims of it (to quit) but erm, it is still a struggle trying to 
get off them... especially with people (are) smoking around you” (Alex, 56, Current). 
 
Recent former smokers who had quit for longer periods tended to acknowledge the 
difficulty of quitting, although their concerns often regarded the earlier stages of 
quitting and the previous difficulties they had experienced, “Well every time I’ve had 
the urge, I always think, I’m not going through another week like that… apparently, I 
was unapproachable that week!” (Ronald, 40, Former). One recent former smoker 
described how his present concerns regarded cessation of a pharmacotherapy product, 
rather than smoked cessation per se, “I’ve still got, I haven’t reached the stage where 
I’m comfortable coming off the lozenges yet, erm, but I think that’ll be the hardest 
part” (Stuart, 45, Former), thus highlighting the importance of nicotine cessation 
overall to some service users. 
 
Several participants also suggested that they had feared that they would be incapable 
of quitting smoking. This was most prevalent among recent former smokers who 
reflected on feelings prior to quitting. Recent former smokers described how they had 
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previously doubted their ability to quit, as they often expressed disbelief in the success 
of their quit attempt, “Yeah, I always assumed, I always thought I’d never, erm, have 
the courage to stop smoking” (Timothy, 58, Former). Another participant described 
the concept of smoking cessation as somewhat overwhelming prior to quitting.  
 
I went to the doctors and it was him who said you know, “Wouldn’t you think 
about it? Wouldn’t you consider it?” and I was like, “Well I have tried a few 
times and I went back on them.” and I said “I don’t think I could, I haven’t got 
the willpower.” (Patricia, 50, Former) 
 
This comment also demonstrates that previous failed quit attempts may contribute 
towards self-doubt, which appears to inhibit intentions to quit. Recent former smokers 
in the study willingly described the doubts they experience regarding smoking 
cessation prior to quitting smoking, yet current smokers failed to describe such 
experiences. This may have been due to social desirability bias, or potentially, self-
doubt may be more prominent among current smokers prior to service engagement. 
 
7.2.4 Smoker identity 
A behaviour-specific identity may be formed when a given behaviour is gradually 
internalised over time, as a defining aspect of a person (e.g. identity as a smoker); this 
is of importance, as there is a positive bi-directional relationship between behaviour-
specific identity and behaviour (Hertel & Mermelstein, 2012). The current results 
demonstrated that a sense of smoker identity was evident, as at least eight participants 
referred to the social-construction of smoker classification, how smoker identity 
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related to self-perception and quitting, or how smoker identity may have inhibited the 
reported sense of liberation from smoking that many participants portrayed. 
 
Although smoker identity was most commonly referred to by recent former smokers, 
two current smokers described how they perceived their identity as a smoker engaging 
with support services, in relation to other smokers. One current smoker often described 
themselves as a non-smoker throughout the interview, for example, “I’ll go outside 
and have a smoke but now I don’t have to do anything, them things anymore, ‘cause I 
don’t smoke” (Jack, 49, Current); however, the participant subsequently described a 
situation whereby an RCFE advisor challenged the participant’s perception of 
themselves as a non-smoker. 
 
I went on Monday to the Royal and Keith (RCFE advisor), Keith wasn’t 
there, Roy (RCFE advisor), the other guy, he said to me, ‘cause … I was 
having the odd few ciggies, and he said, “It doesn’t matter if I smoke 30 and 
you smoke 10; you’re still classed as a smoker, what you need to try and do if 
you can, he said, is … just make a date and when they’re going, they’re going 
altogether” … I’ll tell him about this ‘cause I’m still having the odd one you 
see Fran, so I’m still classed as a smoker, aren’t I? (Jack, 49, Current) 
 
Another current smoker, also refrained from describing himself as a smoker, 
suggesting that his alternate outlook positioned him separately to the way in which he 
viewed other smokers, “It’s something I’ve felt recently but the thing is we’re not all 
the same kind of people and my outlook on smoking is going to be different to 
somebody else’s and I’m at the point of giving cigarettes up and that to me is a 
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different outlook to a smoker.” (Luke, 54, Current). Such comments suggest that some 
current smokers adopt alternate or extended smoker identities, potentially to detach 
themselves from their traditional perception of a smoker and to promote successful 
smoking cessation. 
 
Smoker identity was referred to primarily by recent former smokers. One recent 
former smoker described how smoking was viewed as a part of her life, which she 
recognised as an initial barrier to quitting smoking. 
 
I always thought I’d never erm, have the courage to stop smoking, you know, 
because I’d smoked for that long and it was part of my life. That’s how I looked 
at it you know; I smoke, I’m a smoker.” (Julia, 49, Former). 
 
Another participant described a conversation with a friend who smoked, in which her 
friend proposed that she was not capable of quitting smoking, as it had been part of 
her life for such a long period. The participant viewed this as a challenge to stop 
smoking, and subsequently quit for several months. 
 
And I said, “Oh I’d like to quit”, just in passing conversation and she said “You 
can’t quit” and I said “Why can’t I quit?” and she said because you’ve been 
smoking for the past 20, 11 years …” and I said “I can quit … I’m quitting!” 
(Charlotte, 26, Former) 
 
This suggests that not only do participants view smoking as part of their own identity 
but additionally, some smokers view smoking as part of the identity of other smokers, 
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and this could potentially be viewed as a barrier or facilitator to quitting. In the above 
example, the participant appeared to challenge the constrictions of a smoker identity. 
 
Two participants also suggested that smoking would be a definitive aspect of identity 
among former smokers, throughout life. One participant described how former 
smokers should continue to be vigilant regarding cues to smoking, as a lack of 
vigilance could result in relapse. This also highlights how some service users viewed 
smoking to be part of their identity throughout the lifespan, regardless of quit duration. 
 
… there’s something about drinking alcohol that triggers something in your 
brain, even if you’ve given up smoking, all the ex-smokers, once they quit 
smoking, they’ll go out, have a couple of drinks, see someone else smoking, it 
takes that to go back for an ex-smoker. They pick up a cigarette again. Once 
you’re a smoker, you’re always a smoker. It’s like being an alcoholic, once an 
alcoholic, you’re always an alcoholic. A smoker has to avoid that one cigarette. 
(Sarah, 55, Former) 
 
Another recent former smoker described a conversation she had with a longer-term 
former smoker, in which she considered how smoking might remain part of her 
identity for life and this appeared to be initially disconcerting for the participant. 
 
… one of the women I worked with, she’s got breast cancer and that’s how 
she’s stopped and … she’s been stopped for years and she said “Oh god 
(participant’s name)! I’ve been stopped for years and every now and again I 
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want one and then it just goes.” and I thought, oh god, have I got that for the 
rest of me life? (Patricia, 50, Former) 
 
The participant continued to describe how she began to accept that smoking could 
remain an ongoing aspect of her life despite quitting. She continued to describe 
strategies that other long term former smokers had employed to avoid smoking. 
 
But they sort of talk me round ‘cause as quick as you’ve thought about them, 
you know, as quick as you think about them, you know it goes, that smell, I 
mean one of them kept a dirty ash tray and every times she felt like a ciggy, 
she’d have a smell of the ash tray, and that was enough to put you off, so you’re 
never bothered (laughs). You know little things like that? … You can still exist 
and do things that you normally do, just without smoking. (Patricia, 50, 
Former) 
 
It should be noted that both of the aforementioned participants were aged 50 years and 
over and therefore, it is unclear whether these perspectives are still relevant to younger 
recent former smokers throughout their lifespan. 
 
In summary, although participants described a sense of freedom from the mundane 
and restrictive routine and addiction that entailed smoking, many recent former 
smokers simultaneously realised that smoking could potentially be part of their lives 
long-term; a number of former smokers described how they might have to remain 
vigilant of cravings and cues to avoid smoking. Despite this, the final comment 
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suggests that former smokers are satisfied to accept this as a condition of remaining 
smoke-free. 
 
7.3 Perceived benefits of quitting 
“Perceived benefits of quitting” is the other key major theme considered in the current 
chapter. This theme explores current smokers’ perceptions and expectations regarding 
the benefits of quitting, whilst recent former smokers’ accounts focused on their 
experiences and future expectations regarding the benefits of quitting. Both current 
and former smokers focused on the positive aspects of quitting, such as the perceived 
benefits, presumably to promote motivation and to reinforce smoking cessation 
success. This major theme consists of three prominent sub-themes, including 
“Improved health”, “Improved finances”, and “Image and functionality”. 
 
7.3.1 Improved health 
Nearly all participants (n = 27) acknowledged an association between improved health 
and smoking cessation. The results demonstrate how most participants (n = 19) 
identified specific physical symptoms, which they typically attributed to smoking. 
Common symptoms identified to be associated with smoking, included coughing, 
breathlessness, and chest pain. Coughing was the most frequently cited symptom to 
be associated with smoking, “…it’s the same now. I’m getting up every morning, 
coughing, coughing” (Gemma, 57, Current). Another participant described, “…you 
tend to think about it more. Like your breathing and things like that, like your chest. 
I’ve had a lot of trouble you know, you know with me chest? Coughing all the time” 
(Michael, 48, Former). 
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Several participants (n = 14) directly attributed the experience of physical health 
symptoms to motivation to quit smoking, as participants’ comments tended to suggest 
that they sought relief from the physical symptoms associated with immediate health 
concerns through smoking cessation. 
 
Just getting puffed out, start getting, you know, a bit out of breathe, it’s just, 
it’s just, I could see it having an effect on me, using me inhaler more, erm, like 
I said, mobility issues, so I just thought sod it, kick it on the head while I can. 
(Matilda, 33, Former) 
 
Another participant explained how the occurrence of various symptoms had 
influenced them to consider smoking cessation, “It’s been everything, it’s been a 
health scare; I had high blood pressure, so I had to get that down” (Ronald, 40, 
Former). 
 
A number of recent former smokers (n = 4) also described how previous health 
diagnoses had influenced them to quit smoking. The nature of the diagnosis varied in 
regard to length of condition and severity. One participant described how recurrent 
coughs and chest infections had influenced his decision to quit smoking, “Erm, the 
health reasons ‘cause that’s what caused me to pack it in. ‘Cause I was forever having 
bronchitis, chesty coughs and things like that, so I had to pack it in” (Patrick, 56, 
Former), whilst another participant described how diagnosis of a cardiovascular 
condition had contributed towards her decision to quit, “Well I wanted to quit for ages 
but I couldn’t but then I was told I’ve got a blocked artery in me leg and I thought, this 
is it now. I’ve had me warning, I’ve got to do something” (Gemma, 57, Current). 
251 
 
 
Several current smokers (n = 5) described how they too had experienced ill health and 
that this had influenced their decision to quit. Sadly, at least three of these current 
smokers, described how they had suffered particularly ill health in recent years and 
none of the three participants reported previous quit attempts that had lasted beyond a 
few weeks. One participant explained how he had been diagnosed with a number of 
respiratory diseases and expressed frustration at himself for continuing to smoke. 
 
Then when I started with the asthma, I wasn’t diagnosed with asthma until I 
was about 30, if not younger, 29, 30, so, still smoked then and I couldn’t pack 
up even with me health … Now I’ve got the COPD as well, now, I’m like “ah 
hello!” (Jack, 49, Current) 
 
One participant who was slightly younger reported having suffered a number of 
strokes, “In the past, I’ve had two strokes and me doctors have told me smoking really 
doesn’t help” (Joel, 44, Current). These comments demonstrate how, many current 
smokers suffering with ill health do perceive the benefits of quitting and associate 
improved health with smoking cessation, yet they often fail to sustain a quit attempt. 
 
Improved health appeared to be a key anticipated benefit of quitting, however, the 
majority of participants also described health improvements subsequent to quitting. 
This was relevant to some current smokers, as well as former smokers, as some current 
smokers were able to recall experienced health improvements associated with previous 
quit attempts; this further enhanced anticipated perceived benefits of quitting among 
current smokers. 
252 
 
 
The most common health improvement associated with smoking cessation was an 
alleviation of respiratory symptoms, such as coughing or breathlessness. One recent 
former smoker described how their cough had improved since quitting. 
 
You tend to think about it more. Like your breathing and things like that, like 
your chest. I’ve had a lot of trouble you know, you know with me chest? 
Coughing all the time, but it has eased up a little but since I have quit. It has 
like, sort of eased off (Michael, 48, Former). 
 
One current smoker described improvements he had observed from cutting down, 
“Everything, you feel better in yourself, even when I’m walking, with me asthma and 
me COPD, I’m finding I can walk up the stairs better and everything” (Jack, 49, 
Current). 
 
Participants tended to focus on respiratory improvements they had observed, although 
one participant focused on anticipated improvements in cardiovascular health as a 
result of quitting, “With me heart, I’m on heart tablets and blood pressure tablets now. 
Well I was, I don’t know if I’ll still be on them now because it’s gone down an awful 
lot” (Sophie, 55, Former). 
 
Although most participants described improvements in health as a consequence of 
quitting, one participant described how she had not identified any health benefits as a 
result of quitting, although she was not suffering from any health concerns prior to 
quitting, “I’m not like one of these who’s feeling fit as a fiddle and all that like. I don’t 
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feel any different that way but I didn’t ever feel unwell or whatever” (Emily, 59, 
Former). The lack of health improvements did not appear to affect motivation, perhaps 
as her perceptions regarding the benefits of quitting whilst smoking were not of 
concern. 
 
7.3.2 Improved finances 
Comments regarding the cost of cigarettes featured heavily throughout the interviews. 
Several participants described being particularly conscientious regarding how much 
money they had spent on cigarettes, either currently or prior to quitting. Such 
participants were often able to recall and reflect on money spent on cigarettes, “If I 
was looking to smoke now though, it’d be costing me like £16.00 a day and I just 
couldn’t afford it anyway. ‘Cause they’re like £7.00 to £8.00 per pack aren’t they?” 
(Patrick, 56, Former). One participant had calculated the combined cost of his own 
and his spouse’s smoking per year, potentially as a strategy to further enhance 
motivation to quit. 
 
Yeah, because me and me wife smoked at the time and when we sat down and 
spoke about it, erm, I go to work in one direction and she goes to work in the 
other direction, and we were both taking £10.00 out of the machine, which was 
£140.00 a week, which £140.00 times 52, is £7280.00, just on cigarettes. Do 
you know what I mean? (Robert, 34, Current). 
 
The rising price of cigarettes was a particularly significant issue revealed in the 
analysis. Participants frequently commented regarding the increased cost of cigarettes, 
“‘Cause they’re getting more and more expensive aren’t they?” (Julia, 49, Former). 
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One recent former smoker stated, “I’d be a fool to go back to them now and with the 
money as well, I mean, they’re not going to make them cheaper,  they’re just going to 
keep going up and up and up, aren’t they?” (Patricia, 50, Former). Furthermore, 
participants did not seem to be opposed to the increasing cost of cigarettes, as most 
commented how increasing the cost of cigarettes would likely be the most effective 
way to encourage people to quit smoking. This also fits well with the next chapter, 
which explores influential aspects of tobacco control practice and policy. 
 
I mean I think like, the way the government goes about it, I mean because it is 
expensive, it does put people off, you know what I mean? You think like, you 
know it’s costing so much money and you’re not getting anything from it back, 
you’ve only got so much money to pay with so, it is to your benefit, so if you 
can pack in, pack it in. (Michael, 48, Former) 
 
Another participant commented, “I think it makes people think more about packing in 
and especially the prices now, that’s one of the issues of a lot of people now” (Sophie, 
55, Former). Indeed, one participant directly attributed quitting to the increased cost 
of cigarettes, suggesting that for some service users, money may be a particularly 
important motivating factor, “If they were still ‘round about £3.00 or £4.00, I’d still 
probably be a smoker …” (Alex, 56, Current). 
 
Although increasing the cost of cigarettes was typically viewed as an effective strategy 
to encourage smokers to quit, the analysis additionally revealed some aspects of this 
approach that could be problematic. The increasing cost of cigarettes appeared to put 
financial pressure on a number of participants, which is of particular relevance as most 
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participants were unemployed and in receipt of benefits. One recent former smoker 
explained how they had previously struggled to fund smoking, which was a source of 
stress, “Ok, you know, cigarettes, the price of them, and I was thinking, you know, 
where am I going to get my next pack of ciggies from?” (Julia, 49, Former), whilst 
another participant similarly described their concerns. 
  
‘Cause I know when I’m smoking and I have to say to meself, I can’t get that 
because I need to make sure I have enough money for ciggies or I can’t get that 
because I’d rather have 20 ciggies than that. (Charlotte, 26, Former) 
 
This is concerning, as although increasing the cost of tobacco can make smoking less 
affordable and therefore, reduce smoking rates, some participants from particularly 
deprived households may potentially prioritise cigarettes over essential items, which 
could jeopardise health and wellbeing. This aspect also inter-links with a previous 
section in this chapter, which explored regaining control (Section 7.2.2). Furthermore, 
some participants (n = 3) suggested how the increasing cost of cigarettes may lead 
some current smokers to consider other alternatives, including criminal activity or 
options that could potentially be worse for health. One participant suggested that 
increased cigarettes costs in the UK may influence smokers to obtain cheap cigarettes 
abroad, which could induce further damage to health. 
 
You can go to places like say Turkey and places like that where you can get 
cheap cigarettes… as soon as you have a cigarette, it burns the back of your 
throat and you know it’s a dodgy cigarette and that’s the other thing that people 
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are going to go down the line, they’re going to start just smoking anything. 
(Gavin, 45, Former) 
 
One current smoker suggested that increased cigarette prices could influence increases 
in crime, as smokers may feel that cigarettes are essential. 
 
The only way you can get a person to stop smoking is just to keep pricing it up 
and up and up, until they can’t afford it and the only option then is to give up… 
but then I don’t know, do people turn to crime then to go and get them? (Alex, 
56, Current) 
 
Participants were typically forthcoming in explaining how they had saved money since 
quitting or cutting down. As demonstrated in previous quotes, many participants 
reflected on the amount of money they would save over a given time period if they 
quit. A number of participants reported saving money since quitting or cutting down. 
One current smoker commented, “And the money, as well, I’m only on benefits as 
well, so I’m finding the extra money comes in handy, well handy” (Peter, 50, Current). 
One recent former smoker reflected on the money saved since quitting.  
 
At the moment now, I’m thinking of how much money I’m going to save and 
how much I’m going to have in me little tin that I’ve bought to put me money 
in (laughs). Oh, only it’s less than what you pay for your cigarettes but only 
like, up until now I think I’ve got £6.00 in there. It’s only like a pound or two 
pound, you know whatever I’ve got in me purse; I just put it in a little tin. (Jean, 
59, Former) 
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Participants also detailed how they intended to spend, or had spent, the money saved 
since quitting or cutting down. Although the nature of purchases or desired purchases 
varied, five participants described how they intended to go on holiday using the money 
saved. One recent former smoker commented, “Oh yeah, we’re going on holiday. Erm, 
for the first time in 10 years, we’re going abroad” (Charlotte, 26, Former). One current 
smoker described how the prospect of saving money and going on holiday with his 
family promoted his motivation to quit smoking. 
 
Yeah, so it was a no-brainer for me. I just wanted to quit and quit as soon as 
possible to give me children maybe that extra bit of money, to maybe go down 
the caravan more often or take them out a little bit more often.” (Robert, 34, 
Current) 
 
Four participants also described how they had spent, or intended to spend, money 
saved since quitting or cutting down on home improvements. One participant 
described how they felt they were no longer constrained financially since quitting, 
enabling them to feel less concerned about spending money on items other than 
cigarettes. 
 
And the money part of it as well. Say I used to go the shop, erm, any shop, say 
you went in B&M for instance, and seen like a bedding set or you know, 
something for the house and I’d go “Aww look at that!” and then I’d look at 
me money and think, aww that’d be ciggy money, so I wouldn’t buy it, 
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whereas, now I go in and if I see something, I’ll go “Look at that!” and I’ll just 
buy it, don’t even think about it. (Patricia, 50, Former) 
 
Another participant detailed how they were presently redecorating their home with the 
money saved over the three months since quitting. 
 
Well you know, the money I’ve saved, I’ve moved into me new flat, that’s 
what I’m doing right now, I’m painting it all, having a break, so, I’ve saved a 
hell of a lot of money. I’ve saved up and bought all new furniture and that’s 
just three months, so, you know, so, I’m made up with that, and deservedly 
am. (Paul, 38, Former) 
 
Overall, the cost of cigarettes was not only a motivating factor for quitting, but the 
money saved from quitting was perceived as a reward for the behaviour change, and 
this was acknowledged by several participants. 
 
It’s just the money now, because the money you spend on cigarettes, you know 
stopping and cutting down on it, I’ve been buying things around, you know the 
apartment where I am living and you know ... instead of just going out to buy 
ciggies, you can just put money to one side. I’m buying things now, I’ve got 
things to show for it. (David, 37, Current) 
 
Whilst, one recent former smoker stated, “Well, you know, if you can buy yourself 
something and then you know, think, well I bought that ‘cause I didn’t smoke, you 
know… I think it gives you a bit of a boost as well” (Patricia, 50, Former). 
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7.3.3 Image and functionality 
Participants were concerned with various components associated with self-image. 
Self-image may be described as the collection of subjective perceptions regarding 
oneself, one’s body, mental functioning, social attitudes, and adjustment in various 
aspects of life (Offer, Ostrov, Howard, & Dolan, 1989). With respect to self-image, 
participants in the present study commented most often regarding aspects of physical 
image, which they anticipated or experienced improvements in following smoking 
cessation. 
 
Seven participants acknowledged that weight gain was associated with smoking 
cessation. Two participants perceived weight gain as a benefit of quitting smoking, 
although both participants were male. One recent former smoker described how he 
had gained weight since quitting,  
 
It’s been four weeks that I’ve stopped and I’ve gone from 12 stone to 13 stone, 
which is like, ‘cause I’m 6 foot but I want to get my weight back up to like 13 
and a half, so I’ve got another half a stone to go and then I’m happy. That’s 
only within four weeks of not smoking.” (Jacob, 59, Former) 
 
One current smoker was also asked which benefits they associated smoking cessation 
with, to which they responded, “If I quit smoking, I’d probably put on more weight 
and things like that” (Eric, 25, Current). Contrary to these comments, five participants 
perceived weight gain as a disadvantage of quitting smoking, rather than a benefit; 
however, these participants made light of the degree to which weight gain was viewed 
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as disadvantageous, often with humour, as smoking cessation was viewed as a priority, 
“Instead of going for a ciggy, I go for a sandwich and I don’t care if I do go like a big 
roly pole (laughs)” (Jack, 49, Current). One recent former smoker described, “Yeah, 
although I have gained a little bit of weight, which I’m not happy about, but I’ll pedal 
that off in the nice warm sunshine (laughs)” (Charlotte, 26, Former). 
 
Several participants also commented on the effect smoking has on skin (n = 5), 
perceiving improvements in skin appearance as a key benefit of quitting. One younger 
female spoke extensively regarding the association between skin deterioration and 
smoking, suggesting that concerns regarding skin deterioration motivated her to quit 
smoking,  
 
I think last year … I’d seen me Aunty and she walks round with horrible 
wrinkles on her and it was all, that was the main reason and I think this time, 
even though I still don’t want wrinkles … I just think to meself, oh well you 
know, I’m only 26 and you know, these people are not ‘til, they’re like 50, 60 
when they find themselves getting wrinkles … but it still all adds up doesn’t 
it? (Charlotte, 26, Former) 
 
The remaining four participants of the five, were also recent former smokers, who 
described how they had observed an improvement in their skin condition since quitting 
smoking, with males and females commenting equally. One female stated, “I think me 
skin’s getting better as well … on me face; pity about me arms and me legs like! 
(laughs)” (Emily, 59, Former), whilst one male participant described how 
improvements in skin condition were considered a perceived benefit to quitting, 
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“Getting healthy again and seeing me skin, going back to, you know, the way it should 
be and stuff like that” (Jacob, 59, Former). 
 
A small number of participants expressed concerns regarding the associations between 
smoking and oral health issues, such as teeth discolouring and gum disease (n = 3). 
One participant also suggested that their teeth were whiter since quitting smoking, 
“…me teeth are a lot whiter” (Stuart, 45, Former), demonstrating that one perceived 
benefit of quitting was improvements in teeth colouring. Two of the participants who 
made the same association described teeth discolouring and gum disease as a deterrent 
for smoking, “(When you smoke) your teeth go yellow, like problems with your teeth 
and all that… all your gums start disease in. Do you know what I mean?” (Michael, 
48, Former). Another participant suggested that dental issues had previously motivated 
her last quit attempt. 
 
My reasons last year that I wanted to quit, me reasons last year were because I 
went the dentist and I’ve always had perfect white teeth and she said “Oh 
you’ve got a bit of build-up.” or something like that and I just went “Oh that is 
it! That is it! No more!” Because it was just horrible, I always said, I liked me 
teeth the way they are. (Charlotte, 26, Former) 
 
Although few comments focused on oral health, the above statements suggest that 
some service users may perceive improvements in oral health as a benefit of quitting, 
suggesting that such perceptions could promote motivation to quit smoking. 
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Lastly, but most significantly with regard to image, over two-thirds of participants 
commented on the odour associated with smoking (n = 21). This is relevant to self-
image in particular, as participants often described how they perceived themselves 
whilst smoking or how they felt others might have perceived them. Generally, 
participants disapproved of the smell of smoke, “You know when you go by someone 
who’s been smoking and I think ‘Oh my god, the smell is just vile!’ and I think I must 
have smelt like that meself, but you can’t smell it on yourself.” (Patricia, 50, Former). 
Another participant exclaimed, “Do you know what? When I go around to someone’s 
house and it stinks of it, and I cannot stand the smell, I cannot stand the smell!” (Jack, 
49, Current). All participants who commented on the smell disapproved of it, except 
one recent former smoker, who found the smell to be pleasurable and considered it a 
trigger. 
 
I do like the smell of people when they’re smoking when I walk past them, I 
do like that! (laughs) Bizarre! … when I’m walking past a shop … and I get a 
quick whiff of it, it’s like, “Ooh! That’s nice!” (laughs). (Ronald, 40, Former) 
 
Several recent former smokers explicitly perceived no longer smelling of smoke as a 
benefit of quitting smoking, “I smell a lot better, I don’t have to use as much aftershave 
(laughs)” (Stuart, 45, Former). Another recent former smoker noted, “Well, (when you 
smoke) you smell for a start. You’re conscious of your breath. I mean, you can brush 
your teeth ten times a day and you’ve sweaty breath because you’re smoking 
cigarettes” (Matilda, 33, Former).  
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Participants also commented on improved physical functionality in a number of areas. 
Firstly, eight participants described how they associated smoking with a loss of taste 
function. One participant described how smoking had affected their ability to taste, yet 
whilst they smoked, they had been unable to recognise this, “... the taste, you know 
when you have a cup of tea and then a ciggy, oh, your mouth just tastes horrible, 
because when I quit, I realised how bad that actually is” (Charlotte, 26, Former). 
Another recent former smoker described how their ability to taste had returned since 
quitting and how the extent of the improvement was unanticipated, “You don’t realise 
when you’re doing it, until you’ve stopped and all the, your taste buds and everything 
are back, how bloody idiotic it was …” (Timothy, 58, Former).  
 
Secondly, with regard to physical functionality, a number of participants also 
perceived an improved sense of smell as a benefit of quitting smoking, as smoking had 
dulled their sense of smell. One recent former smoker described, “Like you can smell 
things around you more, like flowers and all that, different types …” (Michael, 48, 
Former). Another participant was asked what they viewed as the best things about 
quitting, responded in part, “One, better smell, you can smell things better” (Shaun, 
48, Current). 
 
Thirdly in relation to improved functionality, and relevant to improved taste and 
weight gain, a number of participants (n = 5) also briefly described how they had 
observed an improved appetite since quitting smoking, “Yeah, I’m eating like a horse! 
I’ve just spent a week in Egypt all-inclusive and I’ve never eaten so much in me life!” 
(Ronald, 40, Former). Another recent former smoker stated, “Yeah, well it improves 
your health, improves your appetite” (Jacob, 59, Former). 
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The last component observed in regard to functionality, which was expressed among 
both current and recent former smokers, was an overall sense of improved vitality and 
quality of life (QOL). Seven participants identified this benefit, since they had quit or 
cut down. A number of participants described how they had exhibited improved 
energy levels. 
 
I had no energy. And since I have stopped smoking, I feel as though, erm, I’m 
not as tired. I think that when I was smoking, not all the time but I’d feel tired, 
I felt drained. But now I don’t, I feel like, because I keep saying to meself, I 
say, “God, where am I getting the energy from?” and I think, is this because I 
stopped smoking or is it just me? (Julia, 49, Former) 
 
Another participant also commented on feeling more energetic, “I feel, I was feeling 
healthy anyway because after feeling so big (the participant refers to previous weight 
loss) but I do feel a lot fitter. And me energy, I find me energy picked up as well” 
(Gavin, 45, Former). 
 
Several participants described a general sense of improved QOL, incorporating 
psychological and physical components of wellbeing, “Everything!  Everything! You 
feel better in yourself … just everything, everyday life, just a better quality of life as 
well” (Jack, 49, Current). Another recent former smoker stated, “I feel younger 
(laughs) … I’m not young like but I feel it ... I felt like, 90 before I packed in smoking 
… I’m 21 now!” (Sophie, 55, Former). 
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7.4 Discussion 
The current chapter explored factors implicated in smoking cessation success. 
Qualitative methods were employed to explore aspects relevant to service users’ 
personal experiences of quitting smoking. In particular, this chapter identified two key 
themes, including “Experiences of mental conflict” and “The benefits of quitting”. 
Participants appeared to draw upon psychological resources to focus upon the positive 
implications of quitting; this was apparent as they extensively described the key 
benefits of quitting smoking, as well as discussing efforts to combat negative 
cognitions regarding aspects such as self-doubt and temptation. The results of the 
current chapter, the potential strengths and limitations, and the implications are now 
discussed. 
 
 
7.4.1 Exploration of chapter findings 
The findings in relation to the theme, “Experiences of mental conflict” will be 
explored firstly. This particular major theme demonstrated the confliction of 
intentions, motives, and impulses that service users described encountering upon 
quitting smoking. The sub-themes associated with this major theme, included 
“Motivation and self-efficacy”, “Regaining control”, “Self-doubt” and “Smoker 
identity”. 
 
Motivation and self-efficacy were both identified by participants as important 
components for smoking cessation success. Motivation is a well-established predictor 
of smoking cessation success (Li et al., 2010; Li et al., 2011), whilst self-efficacy has 
also been found to predict smoking cessation success (Hendricks, Delucchi, & Hall, 
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2010; Schnoll et al., 2011). More specifically, several participants described how 
smoking cessation should be an autonomous decision, motivated by self, rather than 
others. This links closely with behaviour change theory, such as Self-determination 
Theory (SDT) (Deci & Ryan, 1985), which stipulates that smoking cessation (or 
behaviour change more broadly) is most likely when individuals feel that the choice 
is autonomous (i.e. the individual chooses to change behaviour), rather than the choice 
being forced upon them. 
 
In relation to motivation, self-efficacy and additionally, self-doubt, participants 
described implementation of positive self-talk. As described, self-talk (i.e. inner 
speech), has been found to assist cognitive and self-regulatory functions (Diaz & Berk, 
1992; D. G. MacKay, 1992). Furthermore, a number of studies have implicated the 
effect of self-talk in regulating smoking behaviour (Kelly, Zuroff, Foa, & Gilbert, 
2010; Merchant, Pulvers, Brooks, & Edwards, 2013; Naughton, McEwen, & Sutton, 
2013). The current findings provides further evidence for cognitive-specific strategies, 
as participants described how they would implicate self-talk to regulate smoking 
behaviour. 
 
Participants described an experience of regaining control over cigarettes and over their 
lives more broadly, upon quitting smoking. In some contexts, smoking has previously 
been adopted as an integral aspect of a liberated identity; for example, the cigarette 
was previously promoted as a symbol of emancipation among women, a “torch of 
freedom” (Amos & Haglund, 2000). The current results demonstrate how smokers, 
including women, no longer associate a sense of liberation with the opportunity to 
smoke, but rather a sense of liberation was associated with smoking cessation. Many 
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participants felt that their lives had been dictated by smoking and therefore, smoking 
cessation was associated with regaining control, as recent former smokers were able 
to live their lives without the constraints of smoking. One recent review (Goldenberg, 
Danovitch, & IsHak, 2014) concluded that there is a negative relationship between 
smoking and QOL; the current results support these findings and demonstrate the 
mechanisms by which smoking can impact QOL. 
 
The concept of a smoker identity was also frequently discussed among participants. A 
recent meta-ethnography (Tombor et al., 2015) suggested that identity plays a role in 
smoking cessation, as identity appears to influence intentions to quit. The current 
results provide further support for this notion and demonstrate how this relationship 
may be facilitated. A number of recent former smokers in the present project expressed 
concerns that smoking would always be part of their identity; one previous study found 
that identity progression to that of a “non-smoker” was not necessary in order to 
achieve long-term abstinence (Vangeli & West, 2012), whilst the current findings 
appear to corroborate this result.  
 
“Perceived benefits of quitting” was the other key theme identified in the current 
chapter, which consisted of the sub-themes “Improved health”, “Improved finances”, 
and “Image and functionality”. Anticipated and experienced perceived benefits of 
smoking cessation were consistently discussed across the interviews; participants 
appeared to focus largely on the perceived benefits of smoking cessation in order to 
promote motivation and to reinforce behaviour change.  
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Health concerns featured prominently throughout the interviews as one of the key 
incentives for quitting. Previous research has found health concerns to be a key 
implicating factor in smoking cessation motivation (McCaul et al., 2006), whilst health 
improvement is one of the key aspects that former smokers find helpful in remaining 
abstinent (Katz & Singh, 1986). The vast majority of participants described how the 
experience of physical symptoms and development of disease attributed to smoking 
prompted their decision to quit smoking. This finding also complements the results of 
the present quantitative analysis, which indicated differences in health risk perceptions 
between current and recent former smokers. 
 
Previous research suggests that many current smokers in poor health often fail to 
internalise or personalise the health effects of smoking (e.g. Bock et al., 2001); some 
current smokers in the present study described poor health and limited smoking 
cessation success previously, yet they often fully acknowledged the effects of smoking 
on their health. This example demonstrates how risk perception alone cannot fully 
explain smoking cessation behaviour, as addiction is a complex, multifaceted 
phenomenon (Ross & Kincaid, 2010). 
 
Participants also commonly noted how improved finances were perceived as a 
beneficial outcome of smoking cessation. The increasing cost of cigarettes appeared 
to motivate some participants to quit smoking, a notion which supports previous 
research. For example, Hsieh, Chen, Lee, and Yeh (2014) examined the effect of 
cigarette price levels on smoking prevalence; simulated results suggested that a 10% 
increase in cigarette price would result in a reduction in smoking prevalence of 1.42% 
in the UK. Simultaneously, the current findings also generated some concerns, as some 
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participants from more deprived backgrounds described how they had previously 
prioritised cigarettes over other general needs. This suggests that participants’ overall 
health and wellbeing could have been jeopardised, as cigarettes were viewed as 
essential. This demonstrates how some tobacco control strategies may result in 
inadvertent consequences, which could result in marginalisation of smokers in society. 
 
Improvements in self-image and functionality were also considered to be a beneficial 
outcome associated with smoking cessation, albeit, not to the extent improved health 
and finances were. In particular, physical appearance was of greatest concern. 
Improvements in image have previously been cited as one of the key components that 
former smokers found helpful in remaining abstinent (Katz & Singh, 1986). The 
majority of research that considers the relationship between physical appearance and 
smoking cessation, refers to young females (e.g. Grogan, Fry, Gough, & Conner, 
2009; Hysert, Mirand, Giovino, Cummings, & Kuo, 2003; Riedel, Robinson, Klesges, 
& McLain-Allen, 2002); however, the current project identified that perceived benefits 
of quitting regarding image were valued irrespective of age or sex, except in relation 
to weight-gain. 
 
A number of components of functionality were also acknowledged as a perceived 
benefit of smoking cessation. A recent meta-analysis identified that former smokers 
exhibited improvements in mental health, as they no longer experienced negative 
affect associated with acute nicotine withdrawal between cigarettes (G. Taylor et al., 
2014), whilst, further research found that recent former smokers often exhibit changes 
in energy expenditure (Allen, Brintnell, Hatsukami, & Reich, 2004; Perkins, Epstein, 
& Pastor, 1990; Vander Weg, Klesges, Eck Clemens, Meyers, & Pascale, 2001); such 
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factors could contribute towards the denoted perceived improvements in energy levels 
and overall QOL described among recent former smokers in the current project.  
 
It should be noted that participants would freely describe the perceived benefits of 
smoking cessation in great detail, with little focus on the perceived barriers to smoking 
cessation, regardless of smoking status. This might suggest that participants relayed 
such benefits in an effort to reinforce behaviour change, in line with behaviour change 
theories, such as the Transtheoretical Model of Change (TTM) (J. O. Prochaska & 
DiClemente, 1983; J.O. Prochaska & DiClemente, 1986); again, recent former 
smokers were most forthcoming with regards to listing perceived benefits, which fits 
well with the stages and processes of change stipulated in the model. 
 
7.4.2 Potential strengths and weaknesses 
As described earlier in the thesis, the semi-structured design of the qualitative 
interview schedule allowed for both the inclusion of pre-determined questions and the 
opportunity for the interviewer to explore varying themes and responses more in-
depth. This approach enabled the identification of several sub-themes and concepts in 
this chapter, such as smoker identity and positive self-talk, which might not have been 
identified if a semi-structured design had not been implemented. 
 
The current qualitative investigation does, however, prevent the inference of causal 
relationships between smoking behaviour and potentially motivating factors, such as 
perceived benefits of quitting; Some qualitative designs have integrated a number of 
waves to interviews, to explore the effects of various potential predictors of smoking 
cessation over time (Hargreaves et al., 2010; Ritchie, Amos, & Martin, 2010a, 2010b); 
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doing so, could have further enriched understandings of smoking behaviour. Recent 
former smokers were, however, able to retrospectively recall their experiences of 
quitting at various stages, which enriched the analysis and provided justification for 
some suggested causal relationships. 
 
7.4.3 Implications for tobacco control knowledge, practice and policy 
The current chapter findings have several implications for tobacco control knowledge, 
practice and policy. The analysis aided the development of the prominent theme, 
“Experiences of mental conflict”, which generated various sub-themes and concepts 
of interest. Areas for future development include positive self-talk, inadvertent effects 
of tobacco control campaigns, and smoker identity. 
 
There is a paucity of research in regards to the application of positive self-talk among 
smokers attempting to quit. The current project revealed that this method of self-
regulation was common among smokers, yet, previous research has failed to explore 
the development and evaluation of interventions to promote positive self-talk among 
smokers. Further research is warranted, as the results of the current qualitative analysis 
deem positive self-talk to be a helpful strategy in promoting smoking cessation 
success. 
 
The results of the current chapter also identified the concept of a smoker identity. 
Some recent former smokers expressed concerns that attributes associated with a 
smoker identity might remain following long-term smoking cessation and this 
appeared to be accepted as a condition of abstinence. There is currently a paucity of 
research in relation to the concept of smoker identity, especially in respect to 
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quantitative research. Further studies could explore this concept in greater detail and 
establish whether the existence of a smoker identity inhibits or promotes smoking 
cessation success. 
 
The current chapter also demonstrated how some tobacco control strategies (e.g. 
cigarette price increases) could inadvertently potentially marginalise and jeopardise 
the health and wellbeing of some smokers. This concept is considered further in the 
following chapter, which focuses upon influential aspects of tobacco control practice 
and policy; however, future efforts should remain sensitive to the impact of tobacco 
control policies on some current smokers. 
 
The present chapter results also demonstrate how many participants underestimated 
the improvement smoking cessation would have on functionality, such as QOL; 
further research should explore this concept further, as improved awareness of such 
benefits could encourage more smokers to quit. 
 
7.4.4 Conclusion 
In summary, the current chapter presented the results of part of the qualitative analysis, 
which aimed to examine factors implicated in smoking cessation success. The results 
of the current chapter demonstrated how participants would focus greatly upon the 
positive aspects of smoking cessation, such as the perceived benefits of quitting, and 
only briefly, were the perceived barriers considered. Furthermore, the experience of 
mental conflict was described consistently among participants, demonstrating the 
psychological battle which ensued upon attempting to quit smoking and sustain 
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abstinence; again, participants described efforts to promote positive coping strategies 
and counter negative cognitions in an attempt to remain smoke-free. 
 
This chapter demonstrates the benefits of implementing a semi-structured design, as 
much of the chapter implications emerged from sub-themes and concepts, which 
would not have been identified if the interviews had been designed in a strictly 
structured manner. Various opportunities for future research and development were 
also considered in relation to aspects, such as positive self-talk, inadvertent effects of 
tobacco control campaigns, and smoker identity. The following chapter will further 
explore factors implicated in smoking cessation success, focusing on influential 
aspects of tobacco control practice and policy.  
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Chapter 8: Influential aspects of tobacco control practice and policy 
8.1 Introduction 
Similarly to the last chapter, the current chapter investigates factors implicated in 
smoking cessation success. The present chapter results explore service users’ 
experiences of smoking and smoking cessation, with focus on components associated 
with tobacco control practice and policy. By conducting such research, it is possible 
to consider aspects related to policy and practice that service users might have found 
helpful or potentially unhelpful in promoting smoking cessation. The findings can be 
used to inform future service development and policy-making. The present chapter 
addresses one key thesis objective: 
 
 To explore factors implicated in smoking cessation success. 
 
The current chapter will firstly considers participants’ experiences regarding the 
transformation of smoking-related social norms in recent decades. Participants 
suggested that smokers had become increasingly marginalised within society, whilst 
several described feelings of judgement or stigma, which were primarily attributed to 
tobacco control policy. Secondly, attitudes regarding local SSS are explored. SSS were 
greatly valued by participants; key aspects of services are detailed and potential 
service improvements are also described. The two major themes identified in this 
chapter include: (1) Reshaping social norms; (2) Attitudes regarding local Stop 
Smoking Services. These two themes will be described in greater detail and the 
respective sub-themes for each will be discussed subsequently. 
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8.2 Reshaping social norms 
“Reshaping social norms” is the first major theme considered in this chapter. Lapinski 
and Rimal (2005) suggested that collectively, “Norms serve as prevailing codes of 
conduct that either prescribe or proscribe behaviours that members of a group can 
enact” (p. 129). The white paper, “Healthy Lives, Healthy People: A Tobacco Control 
Plan for England” (DH, 2011) described how tobacco control efforts aimed to 
encourage communities across England to reshape social norms, with the intention of 
making smoking less desirable, acceptable and accessible. This desired change in 
social norms was evident in the results of the current chapter, as participants reported 
transformation with regards to societal attitudes towards smoking and considered how 
such changes impact smoking behaviour. This major theme consisted of two 
prominent sub-themes, including “A sense of belonging” and “Judgement and 
stigma”, which will now be described. 
 
8.2.1 A sense of belonging  
“A sense of belonging” was the first prominent sub-theme associated with the major 
theme, “Reshaping social norms”. Participants were firstly asked what they felt 
triggered them to start smoking initially and primarily, participants described how 
smoking was a normal behaviour among family and friends throughout youth. Most 
participants (n = 23) described how many of their relatives smoked and a number of 
participants additionally attributed smoking initiation to the culture of smoking that 
was prevalent within their families. One older participant described how most of her 
first and second-degree relatives smoked at the time she started smoking, “My 
grandmother smoked, all my aunties smoked, my father smoked; it was one of the 
things that you did back in the day” (Sarah, 55, Former). It was anticipated that this 
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account would be most prevalent among older participants, as smoking prevalence has 
declined for a number of decades; however, this association appeared to be evident 
irrespective of age. One younger participant described how her mother and step-father 
both smoked, which she attributed to her own smoking initiation. 
 
Yeah, err, it was because of me mum, me mum had smoked for all me life and 
then she quit for like 4 years, and er, I walked in one day and caught her 
smoking after like four years … I think it was just like payback like oh I’ll try 
it ‘cause there must be something to it (laughs). I was only 14, so you don’t 
know much then do you? … I think ‘cause me stepdad was smoking as well, I 
used to pinch his ciggies, I think that was it (laughs). (Charlotte, 26, Former) 
 
At least nine participants suggested that smoking was typical within their friendship 
groups, at the time of smoking initiation. Several participants provided accounts of 
how they experimented with smoking among friends in school. 
 
Yeah, just friends. I always remember, we all started at the same age, which 
was about 12 and we were sitting behind a coach, having a ciggy each and then 
throwing up, and then having another ciggy, and then throwing up and having 
another ciggy! And then before we knew it, we got hooked on them. (Stuart, 
45, Former) 
 
Another participant commented, “Start smoking? It’s just that all my friends were 
smoking at the time. I was young … yeah, everyone smoked” (Gemma, 57, Current). 
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The analysis also identified the mechanisms by which social norms effect smoking 
initiation. Two participants suggested that smoking was learnt by observing significant 
others smoking. For example, one participant attributed his daughter’s non-smoking 
status to his own non-smoking status throughout the time she grew up. 
 
I think it’s changed now with the young ones ‘cause the likes of me daughter, 
she doesn’t, I put that down because of her growing up, I didn’t smoke and 
while she was growing up I never smoked. I put that down to she never saw us 
smoking, so she never wanted to try it or copy it. (Gavin, 45, Former) 
 
At least seven participants, however, suggested that smoking initiation was attributed 
to a willingness to feel a sense of acceptance or belonging within a particular social 
group, in which smoking was considered normal. One participant described how they 
had started smoking in an attempt to fit in with new friends, 
 
Erm, all me friends smoked when I was 13, so I just like joined in, everyone 
else was doing it … I joined a youth group and everyone else smoked, so it 
was just sort of like, to fit in with everyone else, ‘cause everyone else smoked. 
(Matilda, 33, Former) 
 
Another participant described how they conformed to smoking seemingly to seek 
group acceptance, “I was about twelve when I started. Everyone at school was doing 
it so you just get in with the gang, don’t you?” (Emily, 59, Former).  
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Social norms were not only important in contributing towards smoking initiation but 
they also appeared to greatly implicate smoking cessation and relapse. In the mid-
1970s, almost half of the British population smoked, whereas currently, smokers 
consist of only a fifth of the British population (ONS, 2013b). Six participants 
highlighted observed reductions in smoking prevalence within recent decades, which 
implicated social norms around smoking. Three of these participants explicitly 
attributed changes in social norms to motivation to quit. 
 
Erm, I was about twenty when I started, and I think it’s err, I think it’s the way 
the world’s going, everyone smoking not become sociable no more. Do you 
know what I mean? I think that’s why I gave up because everyone had stopped 
around me and I’m glad I did because I feel much better in meself. (John, 53, 
Former) 
 
One participant highlighted how being the remaining smoker in a social group not only 
motivated her to quit, but knowing of others who had successfully quit enhanced her 
perceived self-efficacy to quit. The participant also described how a smoking habit is 
easier to maintain when others smoke. 
 
I had friends that smoked and it was just so easy when they were smoking, you 
know, “have one”. You know but it’s different now ‘cause the girls I actually 
work with they’ve quit for 9 months and the caretaker at the school, where I 
work, he packed in smoking about two years ago, and we all used to go for a 
ciggy and me other friend who used to smoke as well, she’s left but she used 
to go and have a smoke, but then he packed in and she left so that’s just left 
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me and I thought, oh well, and I’d just said, aww, if they can pack in then I 
must be able to. (Patricia, 50, Former) 
 
Although several participants described how smoking became atypical within their 
social networks and this had motivated some to quit, conversely, many more 
participants described how smoking was normal among their present social networks 
(n = 17), which often antagonised attempts to quit smoking. One participant described 
how he found it difficult to refrain from smoking in the presence of his girlfriend 
smoking, “Yeah, me girlfriend does smoke. I do find it hard with her, I do have the 
odd cig but that’s about it … in my view, it’s when I’m sitting ‘round people” (David, 
37, Current), whilst, another participant described how smoking was normal within 
his family, which posed a barrier to quitting. 
 
Yeah, being around people smoking … it really is, especially around meal 
times, around meal times and that, you know your family and everyone else 
and you start lighting up … it is still a struggle trying to get off them ... 
especially with people smoking around you. (Alex, 56, Current) 
 
The results demonstrate how social norms can be viewed as either a facilitator or a 
barrier to quitting, dependent on the situation; if a smoker is part of a social group in 
which members are predominantly non-smokers, this could promote smoking 
cessation, whereas, if a smoker is part of a social group in which members are 
predominantly smokers, this could impede attempts to quit smoking. Furthermore, 
three participants described how they associated social smoking with a kind of 
280 
 
camaraderie and even a sense of belonging, which meant that becoming a non-smoker 
led to feelings of social isolation. 
 
Erm, probably feeling pushed out, because I’m in an atmosphere where 
everyone smokes, everyone who comes to my house smokes, and ‘cause I feel 
like I’m not involved in the atmosphere, I think that’s going to be, especially 
this time as well, I think that’s going to be the hardest ‘cause I’m the only one 
who doesn’t smoke, I’m the only one who goes in the living room because 
everyone else sits at the table and as soon as they put a cig out, they’ll be 
lighting another one … (I’m) just trying to get out of the way, but that’s not 
helping ‘cause I feel isolated, like I don’t belong at the minute but if I 
remember rightly, I went through this last time because I could go and sit in 
the kitchen and not want one. (Charlotte, 26, Former) 
 
Another recent former smoker described a similar experience, whereby she felt 
uncomfortable and out of place in the early stages of smoking cessation, but that this 
stage passed eventually. 
 
Most of my friends and family are smokers, so I found that I had a stigma 
because I wasn’t smoking … because I didn’t feel like I was part of the group. 
At the local pub, everyone goes outside for one so if you’re a non-smoker, 
you’re sat at the table, minding the drinks while they’re all outside having a 
ciggy, and when they come back in, you feel like you’ve missed out. At first I 
found it difficult and then, you know, I just went outside with them for a 
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cigarette but I didn’t smoke, just to be part of the conversation … (Matilda, 33, 
Former) 
 
These comments further highlight the impact of social norms on smoking behaviour 
and demonstrate how feelings of social isolation could potentially promote or impede 
quit attempts; group membership and acceptance is clearly a primary concern for many 
smokers. 
 
Despite many participants expressing concerns regarding social isolation in the early 
stages of quitting, two recent former smokers described how they had no concerns 
regarding significant others smoking in their presence, “Me dad’s seventy-seven and 
he smokes and all that, and he smokes in front of me, and it doesn’t bother me in the 
slightest” (Stuart, 45, Former). Another recent former smoker explained, “People still 
smoke around me now but you know, it doesn’t bother me” (Sophie, 55, Former). 
These comments, alongside the aforementioned accounts, suggest that the extent to 
which social smoking antagonises quitting potentially diminishes over time. 
 
8.2.2 Judgement and stigma 
“Judgement and stigma” was the second prominent sub-theme associated with the 
major theme, “Reshaping social norms”. Stigma occurs “when elements of labelling, 
stereotyping, separating, status loss, and discrimination co-occur in a power situation 
that allows these processes to unfold” (Link & Phelan, 2001, p.382). The majority of 
participants (n = 17) reported feeling judged and even stigmatised for smoking. One 
recent former smoker described, “They’re looked down upon now aren’t they by a lot 
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of people, people who smoke. You are really stigmatised if you’re a smoker in some 
places” (Patrick, 56, Former). 
 
Participants suggested that the reported stigma attached to smoking had become 
increasingly apparent within recent years, potentially due to increased implementation 
of tobacco control strategies, such as the smoking ban in England. Feeling 
uncomfortable or judged for smoking outside public places was common among 
participants. One participant described, “You know, you felt like, once the smoking 
ban came in, kind of a leper, that you had to go outside and all that” (Emily, 59, 
Former), whilst, another participant explained, “… there’s definitely a stigma now, 
it’s terrible … if you go to a restaurant or a bar or anything, you get looks off people 
and that” (Gemma, 57, Current). 
 
Several participants described how the introduction of policies such as the smoking 
ban and the increasing sense of marginalisation may have promoted motivation to quit, 
“I suppose in a way it’s good because it does make you think more, it actually does 
because it’s like with the weather, you used to stand out there, smoking, a couple of 
pints, you’re having a cigarette and people are looking at you and you think well, what 
am I doing?” (Michael, 48, Former). Another recent former smoker also described 
how he previously felt judged and subsequently, guilty for smoking outside public 
places despite it being legal, “…sort of like people staring at me and I was like oh, 
well I was outside but I felt guilty, you know what I mean? I can understand it, you 
know what I mean?” (John, 53, Former). The aforementioned comments suggest that 
increased feelings of guilt and discomfort associated with smoking outside public 
places may potentially promote motivation to quit. 
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In addition to participants reporting feeling judged or stigmatised for smoking, the 
analysis suggested that many participants (n = 9) made judgements regarding other 
smokers, which were typically disapproving. Furthermore, all of the participants who 
commented regarding other smokers were recent former smokers. One participant 
described how his daughter smoked; he describes how his daughter did not smoke in 
his presence, yet, he deemed his daughter to be antisocial and selfish, as she often 
smelt of smoke in his presence. 
 
… when one of our girls walks in, I can smell it a mile away and they’re 
sucking mints before they come in here and you can still get on it. It’s very, 
what’s the word I’m looking for, very unsociable and selfish is the word ...  
selfish yeah, I’m not saying every smoker’s selfish, well I am really aren’t I? 
(Timothy, 58, Former) 
 
Another recent former smoker reflected on how she felt observing others smoking 
since quitting. The participant appears to view the image of smoking as unpleasant 
and undesirable; such negative judgements could potentially further reinforce her 
smoking cessation success. 
 
I look at people with their ciggies and I’m thinking it might sound strange but, 
the other week I was just, I was sitting outside, the weather was lovely and 
there was just like two women, just gabbing a bit and I was looking at them, 
and they were smoking and I felt like saying to them, “Do you enjoy that?” 
‘Cause to me, looking at them, it didn’t look as if they were enjoying it. They 
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were more like talking and I thought, that used to be me with a ciggy in me 
hand; it doesn’t look nice to be honest with you. (Julia, 49, Former) 
 
Three recent former smokers additionally made judgements regarding current smokers 
who were attempting to quit but had yet to become abstinent; participants 
demonstrated little empathy for such smokers. One recent former smoker described 
how some of his neighbours who were gradually reducing their cigarette consumption 
continued to smoke whilst using nicotine patches. 
 
I’ve got people in the street and they were trying to pack in, they had erm, they 
were a couple like, they had patches but the ones you cut down gradually, and 
I thought well, I couldn’t see the point of that, you either smoke or you don’t 
and like using the patches as well, they were still smoking. (Patricia, 50, 
Former) 
 
Additionally, another recent former smoker appeared somewhat confounded 
considering other RCFE service users who had been engaged in services for a 
substantial time but continued to smoke. 
 
That’s why I went to FagEnds and erm, I’m here to stop, not to cut down. But 
there’s still people going down there, and they’re still smoking - they’ve been 
going since I’ve been going, I, I can’t get me head round it. (Timothy, 58, 
Former) 
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Several participants described encounters with other former smokers who expressed 
anti-smoking attitudes; participants condemned this characteristic apparent among 
some former smokers, yet many of the participants continued to express similar, 
conceited attitudes. One recent former smoker suggested that she wanted to remain 
non-judgemental regarding others smoking, yet she described how she often felt 
“superior” as a non-smoker. 
 
Yeah, but I don’t want to turn into one of these ex-smokers who goes “Ooo! 
(makes a noise to suggest condescending) Oh my god!” Do you know what I 
mean? Don’t make me sound like that! … Yeah, when you smell it on other 
people, it makes me feel a bit superior really (laughs). (Emily, 59, Former) 
 
One recent former smoker explained how during his previous quit he became strongly 
opposed to smoking, yet following a relapse, he continued to judge other current 
smokers negatively. The comment also suggests that the participant may have 
identified himself separately to other current smokers, having adopted conceited 
attitudes associated with his previous quit, 
 
To be honest, I’ve been on both sides … when I, I did smoke … I didn’t care 
less what people thought, but when I did pack in smoking, I became the biggest 
anti-smoker, I could ever think of and even when I started smoking again I still 
hated the smell of smoke. Even though I smoked, if someone was standing 
next to me smoking, and it was coming towards me, I’d be giving them dirty 
looks and I’d be moving away and then I’d start lighting a cigarette up. (Gavin, 
45, Former) 
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Although the majority of comments from recent former smokers were negative 
towards smoking and current smokers, one participant expressed empathy for current 
smokers. 
 
I know what it’s like to smoke, so I wouldn’t preach to anyone, for the simple 
reason that is, if they want to pack in smoking, they will do. You can only 
advise someone who wants to take it further, do you know what I mean? 
(Stuart, 45, Former) 
 
8.3 Attitudes regarding local Stop Smoking Services 
“Attitudes regarding local Stop Smoking Services” is the second key major theme 
considered in this current chapter. The development and implementation of Stop 
Smoking Services (SSS) were proposed in the white paper, “Smoking Kills” (DH, 
1998), as part of a wider initiative aimed at addressing the burden associated with 
tobacco in the UK. The value of SSS was evident among participants in the current 
project. Participants described their personal experience of engaging with RCFE, with 
focus on particularly valued components of the service and notable areas for service 
development. This major theme consists of four prominent sub-themes, including 
“Pharmacotherapy”, “Recording progress”, “Behavioural support”, and “Accessibility 
and awareness”. 
 
8.3.1 Pharmacotherapy 
“Pharmacotherapy” was the first prominent sub-theme associated with the major 
theme, “Attitudes regarding local Stop Smoking Services”. All participants were 
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advised and typically prescribed pharmacotherapy products via RCFE. Further, 
participants described how RCFE promoted a wide range of licenced pharmacotherapy 
products, including nicotine patches, Nicorette inhalators, varenicline (Champix), 
lozenges (often described as mints), oral spray, nasal spray, and chewing gum. 
Nicotine patches were the most popular choice of pharmacotherapy for the most recent 
quit attempt reported by participants (n = 15), although, it should be noted that a small 
number of participants did not disclose pharmacotherapy choice throughout the 
interviews (n = 5) and therefore, it cannot be assumed that half of all participants had 
used or intended on using nicotine patches for their most recent quit attempt. Most 
participants who reported using nicotine patches, also detailed the use of a fast-
delivery form of nicotine replacement therapy (NRT), most often Nicorette oral spray.  
 
Several participants identified barriers to use of certain pharmacotherapy products, 
which were most commonly identified in relation to nicotine patches and varenicline. 
With regard to nicotine patches, five participants reported reacting badly to nicotine 
patches, whereby use resulted in nausea or allergic reactions and participants described 
how this deterred use, “I can’t have the patches because the glue; I’m allergic to it” 
(Jack, 49, Current). One participant described a skin reaction to nicotine patches that 
discouraged use and the participant expressed concerns regarding possible medical 
contraindications associated with using nicotine patches. The participant describes 
how such concerns could deter smokers from quitting. 
 
I’ve had a really difficult time this week, cause I don’t know if it’s bein’ on 
pencillin, ‘cause I had a really bad infection and had to take 2 tablets 4 times a 
day but the patches, where they’ve been on me skin today, they’re all blistering 
288 
 
up, I don’t know if it’s a reaction to the penicillin or what I don’t know, so 
that’s put me off a bit. (Gemma, 57, Current) 
 
Two participants also described barriers to using varenicline. One participant 
explained how they were unable to use varenicline, as they were already using anti-
depressants, demonstrating additional concerns regarding contraindications, “I can’t 
have the tablets (varenicline) because I’m on anti-depressants and I might have a 
reaction to it...” (Jack, 49, Current). Another participant complained regarding the 
difficulty they encountered in accessing a prescription for varenicline. Unlike NRT, 
RCFE advisors were unable to prescribe varenicline, although advisors could issue 
services users with a letter recommending a prescription of varenicline, which service 
users were required to present to their GP. This particular comment suggests that some 
service users may perceive the process of obtaining a prescription for varenicline as 
inconvenient, which could potentially deter use. 
 
I’ve just gone through the rigmarole of trying to get onto Champix 
(varenicline). Now, I got given a letter from FagEnds to take to the doctor and 
I got told they’d give you a prescription in 48 hours but it turns out what I’ve 
got to do first is get an appointment because they won’t give out. They said … 
you need an appointment with the doctor for the first prescription. (Luke, 54, 
Current) 
 
Barriers to pharmacotherapy use was closely related to pharmacotherapy perceived 
efficacy. Participants who cited more barriers to use were less likely to perceive 
various products as effective and were more likely to be a current smoker. For 
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example, one current smoker explained, “Erm, I think they should have made stronger 
patches… they were ok at first, I went on the patches, they didn’t seem to work” (Eric, 
25, Current). Another current smoker commented, “… sometimes the patches just 
don’t give you the right amount of nicotine that your body usually takes and that makes 
you go back on to them, or, just things like that” (Shaun, 48, Current). Such comments 
suggest that perceived barriers and efficacy regarding pharmacotherapy may 
contribute towards use and potentially, smoking cessation success. 
 
As anticipated, recent former smokers were more likely to perceive the 
pharmacotherapy products they were using as effective, compared with current 
smokers. There was no prominent pattern among recent former smokers regarding 
product choice, although the perceived efficacy of the product was typically based on 
personal experience, “The patch helps as well, yeah. That’s sort of like, that’s sort of 
like, well you’re not putting it up to your mouth, so that must help you a lot, mustn’t 
it? The patch?” (Michael, 48, Former). Another participant favoured the lozenges 
(mints), “The gum worked for her but I couldn’t, the gum, the chewing gum. I had the 
little mints. They seemed to have worked for me” (Timothy, 58, Former). 
 
8.3.2 Recording progress 
“Recording progress” was the second prominent sub-theme associated with the major 
theme, “Attitudes regarding local Stop Smoking Services”. Quit duration was 
consistently recorded and recalled among recent former smokers, despite variations in 
duration length. The accounts suggest that keeping a record of quit duration was a 
means of recording progress. One participant described how she recorded quit duration 
on a daily basis; this method of recording progress enabled her to break down the quit 
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attempt and reinforced behaviour change, “Well, I’ve never told anyone this but I’ve 
got a calendar and every day I’ve packed in I cross off, so when you look at it you go 
‘Wow!’ ” (Patricia, 50, Former). Another participant also described how they recorded 
progress by mentally acknowledging each week they had quit, which also appeared to 
reinforce the quit attempt, “… like four to five weeks now isn’t it? So, you kind of go, 
‘another week!’ You know what I mean?” (Michael, 48, Former). 
 
Engagement with RCFE created additional opportunities to record progress, as service 
users were required to attend regular drop-in sessions. Participants described how they 
attended RCFE on a weekly or bi-weekly basis. Regular appointments appeared to add 
further structure to quit attempts, enhancing opportunities to record and consider 
progress, “With having FagEnds … they say … ‘There’s another week’, and then your 
week turns into a month” (Paul, 38, Former). Another participant similarly explained, 
“Well going to FagEnds helped me … you’ve gone another fortnight without 
smoking” (Patrick, 56, Former). 
 
As part of engagement with RCFE, service users were required to provide a breath 
sample to ascertain exhaled CO and following this, the RCFE advisor would provide 
feedback regarding the reading and record it on the service user’s record card. Four 
recent former smokers described receiving feedback regarding exhaled CO and felt 
that this method of recording progress was also beneficial. One participant 
commented, “I like the fact that when you go to FagEnds, you can see the results when 
you blow into the tube and stuff like that, you can see that nicotine’s not in your 
system” (Jacob, 59, Former). One participant demonstrated how the reading could 
have a direct impact on mood, 
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I’ll go down there and be like that “Give me a reading!” (laughs). You know, 
it’s funny, I went down there today and Keith (RCFE advisor) said “Do you 
want your reading?” and I said “It should be nought, ‘cause it’s been nought 
for ages.” and Keith said “It’s one.” and I said “Where’s the one come from?” 
and he could see me, I got a little bit of a cob on. He said “Unless you come in 
with a mask on, it’s a brilliant reading, we know you haven’t had a ciggy, it’s 
car fumes and things like that”, so it was one, normally it’s nought … 
(Timothy, 58, Former) 
 
These comments suggest that exhaled CO measurement feedback is beneficial for 
recent former smokers as it provides an objective measure of carbon monoxide, which 
indicates non-smoker status; however, current smokers failed to comment on this 
aspect, which might suggest that this method of recording progress is only beneficial 
to service users who have recent quit. 
 
8.3.3 Behavioural support 
“Behavioural support” was the third prominent sub-theme associated with the major 
theme, “Attitudes regarding local Stop Smoking Services”. Nine participants praised 
RCFE advisors for the behavioural support they had received and explained how the 
service had been beneficial, whilst no participants described negative experiences as 
a result of engaging in the service. 
 
A number of participants (n = 4) expressed favourable opinions regarding the advice 
and support they received from RCFE advisors. One participant described a previous 
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discussion with an RCFE advisor, whereby the advisor provided recommendations 
regarding gradual NRT reduction and this advice was deemed beneficial, 
 
I said to him, “I must have forgot to put a couple on (nicotine patches)”, ‘cause 
I still had them, and he said “Well, that’s ‘cause you’ve forgot about it and 
you’ve thought you had one on, ‘cause you’ve seen the patch you see” and he 
said, “Well, try and do it, you know you haven’t put one on, you know, so 
leave one off on purpose and say to yourself, you haven’t put one on”. So, I 
got another packet of seven days supply off him and they’re still in the 
cupboard. (Patricia, 50, Former) 
 
Another participant described how he had previously accessed a local chemist, which 
failed to offer more comprehensive behavioural support. The participant continued to 
describe how he valued RCFE and the behavioural support they offered, as he 
suggested that this component of support enhanced his quit attempt, 
 
I don’t think I would have done it without FagEnds, without going to that 
meeting because there was another thing I done, I went to a Lloyds chemist a 
while back, and it was just handing things out, just giving me these little 
lozenges. I was just going in having them and still having a ciggy but with 
FagEnds, there’s a meeting, they have a little talk to you, there’s more advice. 
(Timothy, 58, Former) 
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Advisor feedback was also an important component of behavioural support considered 
by five participants, as rewarding comments were deemed beneficial in reinforcing the 
behaviour change. One recent former smoker described, 
 
I think the whole thing with FagEnds has been really good, certainly for 
someone like me, I’m a bit like a dog getting a reward. On a Friday when I go 
there, I get me chewing gum and I get me “Well done, there’s a pat on the 
back” and you know, I think doing it on my own would have been more 
difficult … (Ronald, 40, Former) 
 
Another participant also described the benefit of receiving positive feedback from 
advisors whilst attending drop-ins, “It’s nice to go back and they say well done …” 
(Paul, 38, Former). 
 
Finally, RCFE additionally offers proactive telephone support, which was referred to 
by two participants; both participants felt that proactive telephone support was 
beneficial in that telephone advisors helped to reinforce smoking cessation and 
provided service users with reassurance that support was regularly available. 
 
Yeah and you see like the likes of these phone calls you get, really makes you 
feel proud that you’ve achieved something, do you understand what I’m ... I 
know people might find it a bit patronising but it’s nice for someone to say 
you’re doing good and you are doing good if you’ve packed it in and that. 
(Jacob, 59, Former) 
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Another participant explained, “… the help is there and it’s there for me, you know, 
even if they phone up, it helps you through the phone and talking, stuff like that. You 
know, there will always be somebody there to help you” (John, 53, Former).  
 
8.3.4 Accessibility and awareness 
“Accessibility and awareness” was the fourth prominent sub-theme associated with 
the major theme, “Attitudes regarding local Stop Smoking Services”. The accessibility 
of SSS was considered by several participants (n = 9). Participants commented on how 
support services had become increasingly prevalent and accessible within Liverpool 
more recently. One participant described how local support services were unheard of 
in the 1990s and how his current quit attempt had been aided by the increased 
availability of support services, 
 
‘cause when I first packed in, the patches had just come out and I was buying 
them meself but I didn’t have them, like support or anyone to talk to … I think 
it’s easier this time around because there’s more help and support and there’s 
more people doing it. (Gavin, 45, Former) 
 
Another participant also highlighted the changing landscape of SSS in Liverpool, 
within the past decade or so, “Yeah, there’s loads of changes now, there’s loads of 
help now as well. You wouldn’t even … five years ago, really, well really since 
FagEnds come on the scene” (Jack, 49, Current). 
 
With regard to accessibility, the frequency and locality of community drop-in sessions 
appeared to be of particular importance. One participant explained, “… and you’ve 
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got that now; they’re coming to your area. Do you know what I mean? So there’s no 
need for you to go travelling anyway, they come to you, so I think that’s a good thing” 
(John, 53, Former). Another participant expressed approval regarding the availability 
of support in Liverpool and described how RCFE drop-in sessions were available 
within workplaces in addition to community settings, which he was already accessing, 
“I just think there’s loads and loads of support out there for people … There’s lots of 
help, like I believe people (RCFE advisors) were coming to our work I was told...” 
(Paul, 38, Former). Such comments indicated that accessibility was an important 
attribute of SSS; this suggests that if there were fewer accessible community-based 
services, fewer smokers would be likely to engage with services. 
 
Awareness of services was another component of this sub-theme, which a small 
number of participants (n = 4) identified in relation to service engagement. Participants 
highlighted the importance of service publicity in engaging smokers with services. 
One participant suggested, “I think like, more awareness, like groups, like FagEnds, 
where other stop smoking things, I think if people knew, and they’re a bit like, sort of 
like determined, they would try and pack in” (Michael, 48, Former). Another 
participant advised increasing advertising expenditure for support services, to 
encourage smokers to engage and quit, “I suppose what would help people is, I 
suppose, with the advertising side of things, like more, FagEnds and stuff” (Andrew, 
34, Current). Despite such comments, two participants described how they had 
previously postponed engagement with RCFE, despite knowing of the service, as they 
felt that they could initially quit without the additional support. One participant 
explained how eventual engagement in services propelled her motivation to quit. 
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… you just keep saying, “Aww I’m giving up, so I’m not doing this”, “I’m 
going to give up after this packet”, so no, that went on for a while, so I don’t 
really know what made it, I think the fact that I actually went to FagEnds 
definitely helped. (Emily, 59, Former) 
 
Another participant described how they had avoided engagement with services and 
this coincided with repeated quit attempts; the participant continued to emphasise the 
significance of support in quitting. 
 
… I never went to FagEnds. I’d been on and off for a few years, and just gone 
for the odd two weeks and not gone back, but you can’t do the smoking on 
your own, you do need to get the help that’s available now for you, so use it. 
(Jack, 49, Current) 
 
8.4 Discussion 
The present chapter explored the factors implicated in smoking cessation success, 
using qualitative methods. Participants’ experiences of smoking and smoking 
cessation were explored in relation to aspects associated with tobacco control policy 
and practice. In particular, this chapter identified two key themes, including 
“Reshaping social norms” and “Attitudes regarding local Stop Smoking Services”. 
Participants observed a transformation in smoking-related social norms, in line with 
the introduction of tobacco control policy and these observed changes in societal 
norms were often attributed to motivation to quit. Furthermore, participants highly 
valued RCFE, the SSS. Various components of the service were discussed, whilst 
some participant proposed opportunities for service improvement. The results of the 
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current chapter, the potential strengths and limitations, and the implications will now 
be discussed. 
 
8.4.1 Exploration of chapter findings 
The results in relation to the theme, “Reshaping social norms” will be explored firstly. 
This particular major theme demonstrated the impact that changing smoking-related 
social norms has on smoking. More specifically, participants expressed a need to 
belong within society and the results indicated that this need could potentially inhibit 
or promote smoking cessation success. Feelings of judgement or stigma were also 
described and attributed to smoking. The sub-themes associated with this major theme 
included “A sense of belonging” and “Judgement and stigma”. 
 
The results provided evidence in support of a relationship between changing social 
norms and smoking cessation behaviour. The majority of participants described how 
smoking no longer remained a social norm within their closer social networks and 
also, society overall. A large number of studies have found that individuals are more 
likely to start or continue to smoke if smoking is normative within their local social 
networks (Bindah & Othman, 2011; Hoffman et al., 2006; Leonardi-Bee et al., 2011; 
Seo & Huang, 2012; Simons-Morton & Farhat, 2010), whilst, research also suggests 
that smokers are more likely to quit if their significant others are non- or former 
smokers  (Coppotelli & Orleans, 1985; Hanson et al., 1990; McBride et al., 1998). 
 
Contrary to the above finding, a small number of participants described how smoking 
had remained socially normal within their local social networks, which created some 
difficulties in attempting to quit smoking. Many participants, who were affiliated with 
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social groups of smokers, attached a sense of belonging to smoking and therefore, 
these participants felt socially isolated by quitting smoking; this could potentially 
impede smoking cessation success. 
 
Judgement and stigma were also important concerns, as many participants described 
feeling judged and even stigmatised by others in society. This finding is supported by 
previous research, which suggests that non-smokers do stigmatise smokers. For 
example, Peretti-Watel, Legleye, Guignard, and Beck (2014) conducted a survey of 
non-smokers (N = 3091). A cluster analysis revealed four contrasting profiles, one of 
which represented respondents whereby a strong sense of moral condemnation and 
social rejection of smokers was demonstrated. 
 
Feelings of judgement and stigma were particularly associated with the introduction 
of tobacco control policy (e.g. the smoking ban in England). A number of studies have 
found that the implementation of smoke-free legislation in public places is associated 
with feelings of stigmatisation among smokers (Betzner et al., 2012; Hargreaves et al., 
2010; Ritchie et al., 2010a, 2010b), whilst several studies have identified a relationship 
between the implementation of smoke-free legislation and increased quit attempts and 
smoking cessation success within the UK (Lock et al., 2010; D. F. Mackay, Haw, & 
Pell, 2011; Nagelhout et al., 2012). The current findings suggest that the 
implementation of smoke-free legislation contributes towards uncomfortable feelings 
of judgement and stigma, which in turn contributes towards motivation to quit. 
 
Participants not only described concerns regarding being judged and stigmatised by 
others, but many participants appeared to project similar attitudes towards other, 
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current smokers. Ritchie et al. (2010a) suggested that some smokers attempt to 
ameliorate smoking-related stigma by participating in the stigmatisation of other 
smokers; the current research supports this notion, as participants, albeit typically 
recent former smokers, often referred to other smokers in a conceited manner. 
Furthermore, Vangeli and West (2012) additionally described how some recent former 
smokers form negative, albeit unintentional, judgements towards current smokers. The 
current findings further support for this notion. 
 
The results in relation to the theme, “Attitudes regarding local Stop Smoking Services” 
will now be explored. This major theme explored the components of SSS, which were 
deemed particularly valuable to participants, whilst some recommendations were 
proposed regarding service improvements. The sub-themes associated with this major 
theme included “Pharmacotherapy”, “Recording progress”, “Behavioural support”, 
and “Accessibility and awareness”. 
 
The current study findings suggest that all participants favoured the use of SSS and 
deemed engagement as beneficial in aiding a smoking cessation attempt. Previous 
research suggests that SSS have been proven to provide effective stop smoking support 
to smokers intending on quitting (Ferguson et al., 2005; Godfrey et al., 2005; Judge et 
al., 2005; West et al., 2013), which supports the current findings. 
 
With regards to pharmacotherapy, nicotine patches were used most often to aid quit 
attempts among participants, whilst a combination of fast and slow release NRT was 
frequently favoured. A recent Cochrane review (Stead et al., 2012) found that 
combination NRT was substantially more effective compared to use of a single NRT 
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product and the current results suggest that this approach was promoted by RCFE 
advisors. 
 
Perceived barriers to pharmacotherapy use were also considered. Few studies have 
explored perceived barriers to NRT use, although one small qualitative study (Silla, 
Beard, & Shahab, 2014) interviewed 15 smokers and identified key concerns 
regarding NRT use, including addiction, long-term use, efficacy, health consequences, 
and delays with quitting process. The present results identified a number of barriers to 
use in relation to nicotine patches (including skin reactions and nausea) and 
varenicline (including accessibility and contraindication concerns); such barriers were 
found to deter some smokers from using various smoking cessation aids. 
 
Participants also noted the opportunities that SSS provided them with regards to 
recording smoking cessation progress, such as the provision of feedback pertaining to 
exhaled CO. A recent Cochrane review (Bize et al., 2012) suggested that there was no 
evidence to confirm that feedback in relation to exhaled CO enhanced smoking 
cessation; however, the review pooled only two studies in the analysis regarding 
providing exhaled CO, the studies pooled reported delivering feedback pertaining to 
exhaled CO measurement on only one occasion (SSS typically relay exhaled CO 
weekly or bi-weekly), and the authors additionally highlighted the scarcity of high 
quality studies. A previous, smaller qualitative study (Grant et al., 2014) found that 
almost all participants who received exhaled CO feedback found the information 
motivational. The current findings build upon this research and highlight how, for 
recent former smokers at least, the provision of exhaled CO feedback is deemed to be 
a method of reinforcing behaviour change. 
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Participants listed several potential aspects of behavioural support, which were 
considered beneficial in promoting motivation to quit or sustain abstinence. One 
particular aspect of note was the delivery of proactive telephone counselling. A recent 
Cochrane review supported the implementation of proactive telephone counselling, 
rather than reactive telephone counselling (L. F. Stead et al., 2013); however, the 
review also noted a paucity of evidence with regard to the efficacy of proactive 
telephone counselling. The current findings support the implementation of proactive 
telephone counselling in SSS, as a small number of participants described how 
receiving telephone calls was reassuring and reinforcing; further research is needed. 
 
Accessibility and awareness were also identified as important aspects of SSS delivery, 
as some participants suggested that increased knowledge and opportunities regarding 
accessing services would enhance engagement and potentially smoking cessation 
success. One recent review (R. L. Murray, Bauld, Hackshaw, & McNeill, 2009), 
explored methods of improving access to SSS among disadvantaged groups, such as 
proactive case finding; however, the evidence on effective strategies to increase access 
was found to be limited. The current findings suggest that increasing the breadth of 
SSS drop-in session locations would be preferable but further research is needed.  
 
 
8.4.2 Potential strengths and weaknesses 
In parallel to the previous chapter, the semi-structured design of the qualitative 
interview schedule allowed for pre-determined questions, as well as providing the 
opportunity for the interviewer to explore varying areas of interest. This was 
particularly apparent in the current chapter, as participants described important aspects 
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related to tobacco control policy and practice, which were deemed to be influential in 
promoting motivation to quit or smoking cessation success, such as the impact of the 
smoking ban in England or valued attributes of SSS. There are, however, some 
potential limitations of note, in relation to the current chapter results. 
 
Potential participation selection biases should be considered in relation to the current 
chapter results (e.g. Loon et al., 2003). Participants who favoured RCFE may have 
been more willing to participate in the qualitative investigation, compared to those 
who were dissatisfied with RCFE; this may have resulted in some biased perspectives 
and should be considered when interpreting the results. Nevertheless, the current 
chapter results present a number of implications relevant to SSS development. 
 
Barriers regarding the use of various pharmacotherapy products were identified and 
attributed to current smokers, more often than recent former smokers. Similarly to the 
previous chapter, this chapter demonstrates how qualitative research can be used to 
identify potential associations, although the design prevents the inference of causal 
relationships. For example, a qualitative design incorporating a number of waves 
could have enabled a more extensive exploration of the relationships between barriers 
to pharmacotherapy use and smoking cessation success; however, the exploration of 
both current and recent former smokers’ experiences adopted in the current project 
provides in-depth insight into the experiences of service users overall. 
 
 
8.4.3 Implications for tobacco control knowledge, practice and policy  
The current chapter presented several key implications for tobacco control knowledge, 
practice and policy. The qualitative analysis resulted in the development of the 
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prominent theme, “Reshaping social norms”, which generated various sub-themes and 
concepts of interest. Potential areas for future development include exploration of 
topics, including social isolation, stigma, and former smokers’ judgements. 
 
In relation to social isolation, a small number of participants associated with a social 
group of smokers described feeling isolated and alone throughout quitting, which was 
often deemed to be challenging. The finding highlighted the need for future research 
among such individuals who feel socially isolated, which in turn could inform the 
development of further interventions to support such individuals. 
 
The current findings also indicate an association between smoke-free legislation and 
smoking cessation, with stigma seeming to mediate this relationship. This potentially 
provides support for the implementation of smoke-free legislation; however, the 
findings regarding stigma also fit well with the previous chapter findings, which 
demonstrated how some tobacco control strategies (e.g. increasing cigarette costs) 
may inadvertently impact aspects of smoker QOL. Future tobacco control policies 
could potentially marginalise smokers further and therefore, means of avoiding such 
effects should be considered prior to policy dissemination. 
 
A final implication of interest in relation to reshaping social norms relates to the 
finding that many participants described arguably negative attitudes regarding other 
current smokers. It is presently unclear whether adopting such judgements towards 
other smokers promotes smoking cessation success, however, further research would 
certainly be of interest and might contribute towards understandings of behaviours 
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associated with sustained abstinence. Potentially, the adoption of such attitudes could 
reinforce smoking cessation success. 
 
The qualitative analysis also resulted in the development of the prominent theme, 
“Attitudes regarding local Stop Smoking Services”, which generated various sub-
themes and highlighted several aspects for research and practice development. Some 
of the key areas for future development, include exploration of barriers to varenicline, 
the benefits of providing exhaled CO feedback, and the efficacy of proactive telephone 
counselling.  
 
In relation to the barriers to using varenicline, the current results highlighted several 
reasons as to why some participants refrained from using varenicline. Whilst barriers 
proposed may certainly have been valid among some participants, the findings 
highlight the need for further research. To the researcher’s knowledge, previous 
research has failed to explore this concept. Potentially, misconceptions and 
misinterpretations regarding varenicline may deter some smokers from using the 
product; further research could contribute towards improved knowledge regarding 
barriers to use of varying pharmacotherapy products and subsequently, work towards 
addressing any concerns that may be prevalent among smokers. 
 
As mentioned, many participants described the benefit of receiving exhaled CO 
feedback during SSS drop-in sessions. There is a currently limited evidence regarding 
the efficacy of providing exhaled CO feedback as a tool for promoting smoking 
cessation, however, this is primarily due to the lack of relevant and quality research. 
A well-designed randomised controlled trial could examine the effect of receiving 
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regular exhaled CO feedback on smoking cessation success and would enable 
researchers to better understand the extent to which this approach might be effective. 
 
The last key implication in relation to SSS delivery regards the efficacy of delivering 
proactive telephone counselling. Whilst the current study demonstrated a number of 
participants’ accounts in favour of proactive telephone counselling, there is presently 
limited evidence to support its efficacy due to a lack of quality research. The 
implementation of a qualitative study focusing on telephone support specifically may 
provide further guidance on the implementation of telephone support services, whilst 
avoiding the limitations of implementing an RCT (see L. F. Stead et al., 2013). 
 
8.4.4 Conclusion 
In summary, the present chapter discussed the results of part of the qualitative 
investigation, which aimed to examine factors implicated in smoking cessation 
success. The current chapter discussed several concepts relevant to tobacco control 
policy and practice, which participants deemed helpful and sometimes unhelpful in 
promoting smoking cessation. In particular, the relationship between smoking-related 
social norms and smoking behaviour was explored and the results indicated that a 
sense of belonging and experiences of stigma were potential inhibitors of smoking 
cessation success. Furthermore, participants discussed aspects of SSS, which they 
deemed to be beneficial and opinions regarding areas for service development were 
offered. 
 
Again, this chapter demonstrates the benefits of conducting semi-structured qualitative 
research, as aspects relating to tobacco control practice and policy were not originally 
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intended as part of the interview schedule, yet the majority of participants discussed 
issues regarding social norms and support services, thus demonstrating the importance 
of these issues to participants. Several opportunities for future research and 
development were discussed, such as exploring strategies for supporting smokers who 
feel isolated as a result of quitting and considering potential barriers and facilitating 
factors associated with use of varying pharmacotherapy products. The next and final 
chapter will consider the PhD project results as a whole by reflecting upon the thesis 
objectives, considering the overall research contribution of the PhD thesis, and finally 
exploring future directions. 
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Chapter 9: Discussion 
9.1 Introduction 
This PhD thesis describes a mixed methods project, combining quantitative and 
qualitative research methodologies, which primarily aimed to investigate whether 
application of the Liverpool Lung Project (LLP) intervention (based on the LLP risk 
model) was associated with follow-up smoking cessation success and lung cancer risk 
perceptions. Factors implicated in smoking-related risk perception and smoking 
cessation success were additionally explored. The project findings will: contribute 
towards improved knowledge regarding smoking behaviour and risk perception; 
identify potential improvements regarding the delivery of Stop Smoking Services 
(SSS); and, inform the development of future smoking-related risk communications. 
All of the aforementioned implications could contribute towards improved smoking 
cessation rates and subsequently, reduced smoking-related disease and deaths. 
 
The present chapter is organised into several sections. Firstly, the key research 
findings are presented for each of the thesis objectives. Secondly, the project research 
contribution overall in relation to tobacco control research, practice and policy is 
explored. Thirdly, potential future directions for research are considered. Lastly, 
conclusions are drawn regarding the overall project. 
 
9.2 Key findings 
Three project objectives were determined, which were achieved using a combination 
of quantitative and qualitative research methods. This section will denote each project 
objective and describe the corresponding key findings pertaining to each of the given 
objectives. 
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9.2.1 Objective one 
The first objective investigated whether application of the LLP intervention (based on 
the LLP risk model) was associated with follow-up smoking cessation success and 
lung cancer risk perceptions. Statistical analyses were undertaken to evaluate the effect 
of the LLP intervention on six-month follow-up smoking status and several lung 
cancer risk perceptions. 
 
Baseline current smokers and recent former smokers were recruited as two separate 
samples. The results suggested that application of the LLP intervention was not 
associated with follow-up smoking status among baseline current smokers but was 
significantly associated with follow-up smoking status among baseline former 
smokers only. Baseline former smokers who received the intervention were almost 
twice as likely to be classified as a former smoker at follow-up compared to those in 
the control group (OR 1.91, 95% CI 1.03-3.55). 
 
Statistical analyses were undertaken to assess the effect of the LLP intervention on 
lung cancer risk perceptions at six months. The results of the analysis suggested that 
application of the LLP intervention was associated with follow-up perceived personal 
lung cancer risk, perceived average smoker lung cancer risk, perceived relative risk of 
lung cancer, and lung cancer worry, among baseline current smokers. The analyses of 
baseline recent former smokers also failed to find an association with the 
aforementioned four lung cancer risk perceptions at six months.  
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These results were of interest as the LLP intervention was associated with follow-up 
smoking status among baseline recent former smokers, but not baseline current 
smokers, and additionally, the LLP intervention was not associated with any of the 
four follow-up lung cancer risk perceptions across both of the datasets. Potentially, 
this suggests that other psychosocial mechanisms may have been responsible for the 
LLP intervention effect on follow-up smoking status, independent to lung cancer risk 
perceptions. 
 
To the researcher’s knowledge, this is the first time such an analysis has been 
undertaken and it is of particular note that a relationship was established between the 
LLP intervention and follow-up smoking status among baseline former smokers; 
however, it is necessary to be cognisant of the fact that this project was not fully 
statistically powered as a result of sample size limitations, primarily due to recruitment 
being undertaken solely by the PhD researcher.  
 
9.2.2 Objective two 
The second objective entailed exploring factors implicated in smoking-related risk 
perceptions. This objective was addressed using both quantitative and qualitative 
research methods. Figure 13 summarises the key factors implicated in personal 
perceived smoking-related risk, as identified in the current project. The results of the 
quantitative investigation identified age, baseline smoking status, perceived average 
smoker lung cancer risk, and the perceived relative risk of lung cancer level “Ten times 
higher risk”, as predictors of baseline perceived personal lung cancer risk. Cross 
tabulation results suggested that objective risk perceptions were closely related to 
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personal risk perceptions, whilst older participants, classified as current smokers were 
more likely to perceive their risk as higher. 
 
 
Figure 13. Key identified factors implicated in smoking-related risk perceptions 
 
The qualitative analysis further explored factors implicated in smoking-related risk 
perceptions. As discussed, the quantitative results identified age as a predictor of 
baseline perceived personal lung cancer; the qualitative results provided further 
support for this finding, as many individuals who participated in the qualitative 
research component described how their personal perception of smoking-related risk 
had increased with age. Several other key factors implicated in smoking-related risk 
perception were identified in relation to the qualitative research component; the 
qualitative results greatly emphasised the importance of an individual’s personal 
experiences on personal perceptions of risk. Important factors, which appeared to be 
implicated in smoking-related risk perception, included having significant others who 
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had experienced smoking-related disease, public risk awareness campaigns and 
interventions, addiction, risk contextualisation, perceived lack of control, and health 
literacy. 
 
9.2.3 Objective three 
The third objective entailed exploring factors implicated in smoking cessation success. 
This objective was also addressed using a combination of quantitative and qualitative 
research methods. The quantitative research component utilised three separate datasets 
to achieve this objective: (1) a sample of baseline current smokers, to explore 
predictors of follow-up smoking status among those who had not yet quit; (2) a sample 
of baseline recent former smokers, to explore predictors of follow-up smoking status 
among those who had already quit; (3) a combined sample of both baseline current 
and recent former smokers, to explore cross-sectional associations with smoking status 
at baseline. Figure 14 summarises the identified predictors of smoking status across 
the three datasets. 
 
The predictors of baseline current smokers were limited (potentially, due to the low 
number of participants classified as recent former smokers at follow-up within this 
dataset); the perceived relative risk of lung cancer level, “Ten times higher risk” was 
the only significant result following model refinement. A greater number of baseline 
participant characteristics were found to predict follow-up smoking status with regards 
to the dataset consisting of baseline recent former smokers; significant variables 
included LLP intervention (as discussed), age, marital status, quit duration, the 
perceived lung cancer survival level, “About three quarters to nearly all”. Furthermore, 
the cross-sectional analysis of baseline smoking status, which combined all current 
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smokers and recent former smokers recruited during the project, identified several 
predictors, including age, living with another smoker, perceived personal lung cancer 
risk, the perceived relative risk of lung cancer level, “Ten times higher risk”, and the 
lung cancer worry level, “Often or all the time”. 
 
 
 
Figure 14. Predictors of smoking status at baseline and follow-up, across the three 
quantitative datasets 
 
Some of the aforementioned quantitative results were corroborated by the results of 
the qualitative analysis. For example, the quantitative results displayed how age was 
positively correlated with smoking cessation success (among some of the datasets), 
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whilst the qualitative results described how participants had little desire to quit 
smoking throughout their youth and that with age, they had become more determined 
to quit smoking. The qualitative analysis enabled the identification of a wide range of 
variables, which appeared to be implicated in smoking cessation success. Some of the 
relevant psychosocial factors included motivation, self-efficacy and self-doubt, self-
regulatory behaviour (e.g. self-talk), smoker identity, and perceived benefits of 
quitting smoking, whilst factors associated with tobacco control practice and policy 
implicated in smoking cessation success, included social norms, stigma, and various 
components of local SSS. 
 
9.3 Research contribution 
The overall findings of the current project contribute towards three key areas of 
tobacco control, including knowledge, practice and policy. The results pertaining to 
each of these three aspects will now be discussed. 
 
9.3.1 Contribution to tobacco control knowledge 
The PhD project findings contribute towards tobacco control knowledge in numerous 
ways; key contributions will now be explored. Previously, lung cancer risk prediction 
models have been considered or utilised to stratify high-risk patients for CT screening 
(Maisonneuve et al., 2011; McRonald et al., 2014; Raji et al., 2012) and adapted to 
deliver web-based self-assessment tools (Y. Chen et al., 2014). This project is 
innovative, as to the researcher’s knowledge, it is the first project, to explore the 
adaptation, delivery, and evaluation of a lung cancer risk prediction model in the 
context of smoking cessation. Application of the LLP intervention was found to be 
associated with follow-up smoking status among baseline former smokers but not 
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among baseline current smokers, which provides insight into the mechanisms by 
which the LLP intervention was effective; the findings provide support for the 
behavioural model, the Transtheoretical Model of Change (TTM) (J. O. Prochaska & 
DiClemente, 1983), which stipulates that behavioural processes of change 
differentiate by stage of change. Furthermore, the LLP intervention was found to have 
no significant effect on lung cancer risk perceptions at follow-up; this finding 
corroborates with the notion that the significant relationship between the LLP 
intervention and follow-up smoking status among baseline former smokers, might 
have been due to the LLP intervention being viewed as a reinforcing message. 
 
The qualitative findings in relation to the LLP intervention effect also 
contribute towards risk communication literature more widely. Gigerenzer et al. 
(2007) described how the vast proportion of society have difficulty in comprehending 
numbers and statistics, which can have implications for effective risk communication 
delivery. Research has also explored the effect of communicating risk in absolute or 
relative terms; findings suggest relative risk has been found to be perceived as larger 
and more persuasive (Akl et al., 2011). The present project contributes towards further 
knowledge, as the results demonstrated that five-year lung cancer risk was perceived 
as low, even among those who were deemed particularly high-risk. Furthermore, the 
results suggested that many participants failed to understand the concept of five-year 
risk, with some participants often suggesting that the figures pertained to life-time risk. 
This highlights the benefit of producing multiple risk scores that would provide a range 
of risks with continued smoking and smoking cessation; a more rounded figure could 
potentially be better communicated to patients and the precision of the LLP risk model 
alone could potentially be misinterpreted, as evidence by the qualitative results. 
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Another potential research opportunity might be to develop a lung cancer risk model, 
which specifically aims to communicate lung cancer risk attributed to smoking; 
current lung cancer risk models are typically developed with the aim of identifying 
high-risk individuals (A. N. Freedman et al., 2005), often to stratify individuals for 
screening. A model that integrates various smoking-related predictors of lung cancer 
would certainly be of value and would be far more applicable for application in this 
context compared risk models already available. 
Previous research has suggested that perceived personal lung cancer risk differentiates 
based on smoking status (Rutten et al., 2011), a finding which was corroborated in the 
current project. Despite this, there are only a handful of studies in support of a 
relationship between risk perception and smoking cessation success, at varying long-
term follow-up periods (Borrelli et al., 2010; Hayes & Borrelli, 2013; Jacobson et al., 
2014). The current project addresses this paucity of research, in that the results 
demonstrate a relationship between some aspects of lung cancer risk perceptions and 
follow-up smoking status. 
 
Baseline current smokers who perceived a smoker to exhibit “Ten times higher risk” 
of developing lung cancer than a non-smoker, were more likely to be classified as 
recent former smokers at follow-up, compared to those who perceived a smoker to 
exhibit “About the same to a little higher” lung cancer risk as a non-smoker; however, 
other lung cancer risk perceptions failed to predict follow-up smoking cessation 
among baseline current smokers. This finding provides some support for the 
relationship between baseline lung cancer risk perceptions and follow-up smoking 
status. 
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Another key finding, which contributes towards the literature, was the documented 
association between age, risk perception, and smoking cessation. Previous research 
has suggested that older smokers are more likely to achieve smoking cessation at 
follow-up compared to younger smokers (Fidler et al., 2013; Hymowitz et al., 1997; 
C. Lee & Kahende, 2007; Monsó et al., 2001). In the current project, age was not found 
to predict follow-up smoking cessation among baseline current smokers, but it did 
predict follow-up smoking cessation among baseline former smokers, which suggests 
that older smokers may be more capable of maintaining abstinence in comparison to 
their younger counterparts. The qualitative results also contributed towards improved 
knowledge of the relationship between age, risk perception, and smoking cessation. 
The qualitative results suggested that, with age, participants appeared to become 
increasingly concerned regarding the development of disease and mortality; older 
participants would often perceive smoking cessation as an opportunity to prolong life. 
These findings demonstrate how the qualitative results shed light on the quantitative 
relationship between age, risk perception and smoking cessation. 
 
It has been suggested that medically unwell current smokers often fail to internalise or 
personalise the effects of smoking (Bock et al., 2001). The results of the current project 
highlight the multifaceted manner of addiction (Ross & Kincaid, 2010), as many 
current smokers in the present project were fully aware of the risks of smoking and 
attributed smoking to their own poor health, yet they continued to smoke; the present 
project explores participants’ responses to this experience and highlights the 
challenges that service users experience in overcoming smoking-related impulses, as 
stipulated in the health behaviour theory, PRIME theory (see West & Brown, 2013). 
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A recent review (Goldenberg et al., 2014) described a negative relationship between 
smoking and quality of life (QOL). The current findings contribute towards improved 
understandings of the mechanisms by which this relationship occurs. For example, in 
addition to the documented impact of smoking on health, the introduction of smoke-
free legislation, such as the smoking ban in public places, led some smokers to feel 
marginalised. Furthermore, participants described how increased cigarette prices often 
failed to deter smoking and, alternatively, increased deprivation. These findings also 
demonstrate how smoking cessation was subsequently associated with a sense of 
liberation. 
 
 
Previous research has also found that self-efficacy has been found to predict smoking 
cessation (Hendricks et al., 2010; Schnoll et al., 2011). Regarding self-efficacy, the 
current project was able to contribute towards knowledge regarding behaviour change 
techniques associated with increased self-efficacy. Self-talk (i.e. inner speech) may 
assist cognitive and self-regulatory functions (Diaz & Berk, 1992; D. G. MacKay, 
1992) and a small number of studies have implicated the effect of self-talk in 
regulating smoking behaviour (Kelly et al., 2010; Merchant et al., 2013; Naughton et 
al., 2013). Despite this, previous research has failed to explore the application of self-
talk in the context of SSS. The current findings suggest that positive self-talk can 
combat temptation to smoke, and ultimately, improve self-efficacy and smoking 
cessation success. 
 
The present findings also increased research knowledge with regards to the association 
between smoke-free legislation and smoking cessation. Previous research has found 
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that smoke-free legislation has been found to increase quit attempts and smoking 
cessation success within the UK (Lock et al., 2010; D. F. Mackay et al., 2011; 
Nagelhout et al., 2012), whilst smoke-free legislation in public places has been 
associated with feelings of stigmatisation among smokers (Betzner et al., 2012; 
Hargreaves et al., 2010; Ritchie et al., 2010a, 2010b). The current findings contribute 
towards the literature, as the qualitative results corroborate with previous findings 
regarding the association between stigma and smoke-free legislation but further to this, 
participants were found to directly attribute stigma and the de-normalisation of 
smoking, to their own motivation to quit; thus, the current findings provides further 
understanding and support regarding the relationship between smoke-free legislation 
and smoking cessation. 
 
Smokers have also been found to be more likely to quit if their significant others are 
non- or former smokers (Coppotelli & Orleans, 1985; Hanson et al., 1990; McBride et 
al., 1998). The present results provided further support and understanding regarding 
this relationship. Not only was living with another smoker a significant predictor of 
baseline smoking status as part of the quantitative research component, but smoking-
related social norms were found to be implicated in smoking cessation success as part 
of the qualitative research component. More specifically, the results of the qualitative 
interviews demonstrated how social smoking can be associated with a sense of 
belonging and therefore, smoking cessation can lead to feelings of social isolation, 
which could impede smoking cessation attempts. 
 
A number of key research contributions were identified with regards to the delivery of 
SSS. Previous research has been limited in relation to exploring barriers to use of 
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pharmacotherapy products. One previous study explored barriers to nicotine 
replacement therapy use among a small number of smokers (Silla et al., 2014); 
however, the present study contributed to understandings of pharmacotherapy choice, 
as a number of barriers to the use of nicotine patches, as well as varenicline were 
identified. Furthermore, previous research argues that there is limited support to 
suggest that the delivery of feedback pertaining to exhaled CO is effective in 
enhancing smoking cessation success (Bize et al., 2012). The current project, however, 
suggests that SSS users perceive regular exhaled CO feedback as beneficial in 
promoting their smoking cessation attempt, among former smokers, at least. 
 
9.3.2 Contribution to tobacco control practice 
Much of the current findings also contribute towards tobacco control practice, with 
particular emphasis on the delivery of SSS. Potential implications for tobacco control 
practice will now be explored. Quit rates have remained fairly consistent in previous 
years within SSS (NCSCT, 2014), and therefore, an innovative and low-cost 
intervention to promote smoking cessation success would certainly be welcomed. As 
described, the present findings suggest that the LLP intervention may be appropriate 
for delivery within SSS, as the delivery of the LLP intervention would be timely and 
easily communicated by non-clinicians, with basic training. More specifically, recent 
former smokers could benefit from receiving the LLP intervention, as it may be 
viewed as a means of reinforcing smoking cessation success. Other possible settings 
for the delivery of the LLP intervention, include GP surgeries, hospital settings, and 
electronic health resources available to the public. 
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As previously described, perceived relative risk of lung cancer was found to predict 
follow-up smoking status among baseline current smokers; however, most participants 
were found to underestimate perceived relative risk of lung cancer, whilst the majority 
of participants overestimated lung cancer survival and lung cancer worry was typically 
low. Differences in risk perception across smoking status might suggest that better 
education is required as former smokers might underestimate their personal perceived 
lung cancer risk, however, further research is required to fully understand the 
relationship between smoking status and risk perception. Inclusion of figures 
pertaining to relative risk could be an effective means of communicating lung cancer 
risk in future health campaigns; previous research suggests that relative risk is often 
viewed as higher compared with absolute risk (Akl et al., 2011) and the present 
findings suggest that perceived relative risk of lung cancer is implicated in follow-up 
smoking status. 
 
The findings pertaining to the association between age and smoking cessation also 
have important implications for tobacco control practice. For example, participants 
described how milestone birthdays were often used as target quit dates or knowledge 
of such dates promoted motivation to quit; therefore, age targeted campaigns may 
prove particularly effective in promoting smoking cessation success. This is 
particularly feasible in relation to promoting re-engagement with SSS, as re-invitation 
letters could be issued at specific times of the year relevant to service users who have 
disengaged with the service, thus potentially prompting re-engagement. 
 
Self-talk was consistently employed by participants in an effort to avoid temptation to 
smoke and to promote smoking cessation success. Previous research suggests that self-
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talk may be beneficial in regulating smoking behaviour (Kelly et al., 2010; Merchant 
et al., 2013; Naughton et al., 2013). Currently, NCSCT (2014) guidance pertaining to 
behaviour change techniques fails to acknowledge the role self-talk in self-regulation 
associated with smoking. The current findings, alongside the aforementioned studies, 
demonstrate the potential benefit of delivering cognitive and self-regulatory function 
training within SSS, as implementation could further promote smoking cessation 
success.  
 
 
The reported sense of social isolation among recent former smokers affiliated with 
social networks of smokers, also has implications for tobacco control practice. Recent 
former smokers in such situations may benefit from more intensive SSS support, 
which might include training in coping mechanisms specific to situations whereby 
service users may be particularly vulnerable to feelings of isolation. Furthermore, the 
current results also suggest that delivering exhaled CO feedback in SSS is beneficial 
in promoting smoking cessation success among recent former smokers, as it 
presumably reinforces the behaviour change; the current findings support the 
continued implementation of feedback in SSS and other primary or secondary care 
services, in which it may be applicable. 
 
9.3.3 Contribution to tobacco control policy 
The current project findings were most relevant to tobacco control knowledge and 
practice, although there were some key implications in relation to tobacco control 
policy additionally. For example, issues regarding the impact of smoke-free legislation 
on smoking cessation success and the delivery of smoking-related public health 
campaigns were noted. 
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The qualitative results demonstrated a relationship between smoke-free legislation and 
smoking cessation, which supports the implementation of tobacco control policies that 
intend to make smoking less desirable, acceptable and accessible (DH, 2011); 
however, the present findings also demonstrate how many smokers appeared 
marginalised in society as a consequence of the smoke-free legislation. Several 
smokers described how they were excluded from some social and leisure 
opportunities, whilst those from poorer backgrounds suffered greater deprivation as a 
consequence of increased cigarette prices. Future efforts should remain sensitive to 
the effect of tobacco control legislation on current smokers, whilst delivering effective 
tobacco control legislation. 
 
Previous research also suggests that fear appeals (e.g. images of diseased lungs) 
influence smoking cessation intention and success (Gallopel-Morvan et al., 2011; 
Hammond et al., 2004). Fear appeals are often implemented as part of tobacco control 
campaigns and graphic images depicting smoking-related disease are frequently 
featured as part of such campaigns. The current results corroborate previous findings 
regarding the effect of fear appeals on smoking cessation, as participants in the current 
project commonly referred and responded to such fear appeals, whilst some 
participants attributed fear appeals to smoking cessation. 
 
9.4. Future research directions 
Future research directions were discussed in greater detail throughout the discussion 
sections of the previous results chapters; however, this current section considers the 
key directions for future research in consideration of the PhD project overall. 
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One of the essential research directions would be to either extend recruitment for the 
current project or to devise a large-scale trial to test the efficacy of the LLP 
intervention further, due to the current project entailing insufficient statistical power 
to conclude the findings; a sample size of at least 673 current smokers would be 
required to achieve appropriate statistical power (see Section 3.5.1). Further research 
should also attempt to address the current project limitations, which were discussed in 
greater detail following each of the results chapters. In particular, consistent collection 
of exhaled CO measurements at follow-up may have been a beneficial attribute to the 
project design (West et al., 2005), whilst the inclusion of a measure of self-reported 
prolonged abstinence may have also increased the validity of the results (Hughes et 
al., 2010). Future research directions might also consider the application of the LLP 
intervention among other populations, such as current smokers from primary and 
secondary care settings, as well as non-help-seeking populations. The LLP 
intervention effect upon individuals who are not preparing to change behaviour would 
certainly be of interest. 
 
Some issues were identified in undertaking the qualitative and quantitative methods 
concurrently. Although efforts were made to purposively sample patients for the 
qualitative study, across treatment groups, this was not always possible. As some 
participants described the qualitative work as “therapeutic”, participation in the 
qualitative research may in itself have had an extraneous effect on the quantitative 
investigation. If a similar design is to be implemented, it would be beneficial to 
conduct the qualitative and quantitative methods sequentially. For example, the 
qualitative research could be conducted firstly to establish barriers and facilitators to 
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communicating lung cancer risk, which could inform the design of the quantitative 
study. This, however, was not possible in the current project, due to time and financial 
constraints. 
 
The results of the qualitative analysis demonstrated how the majority of participants 
felt that the lung cancer risk projections they received as part of the LLP intervention 
were perceived as being particularly low. Although participant reactions to the LLP 
intervention might illustrate maladaptive behaviour in response to fear appeals (Witte 
& Allen, 2000), it is likely that these reactions were due to the delivery of risk 
information pertaining to five-year risk, as the findings suggest that some participants 
failed to understand the concept of five-year risk. It would therefore be of interest to 
develop and evaluate the effect on smoking cessation success, of an intervention based 
on an alternate lung cancer risk prediction model that calculates lifetime risk. 
Furthermore, the development of a risk model, which considers and incorporates 
several smoking-related diseases, would also be of value. Potentially, integration of 
such factors would generate increased risk projections, making the intervention more 
salient and in turn, increasing smoking cessation rates. 
 
The current project also demonstrates how risk perceptions fail to fully explain 
behaviour change, as the predictive value of risk perceptions in the quantitative 
research component was inconsistent and the qualitative research component revealed 
how many medically unwell smokers described being fully aware of the implications 
of smoking, yet they continued to smoke; these experiences fit well with new addiction 
theories, such as PRIME theory (West & Brown, 2013). Simultaneously, researchers 
suggest that not one particular theory can explain addiction (Ross & Kincaid, 2010). 
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Future research should endeavour to consider studying the experiences of medically 
unwell smokers specifically, to improve understandings regarding addictive 
behaviours.  
 
The current project not only highlighted the impact of the LLP intervention on 
smoking behaviour but the qualitative results provided further evidence for the 
implementation of several other tobacco control strategies. Health and financial 
implications of smoking were widely discussed throughout the qualitative interviews. 
Although it is hugely important to develop and explore new and innovative 
interventions designed to promote smoking cessation, the impact established tobacco 
control approaches, such as increasing tobacco costs, continues to be exhibited. The 
current project highlights the importance of adopting a holistic approach to tobacco 
control research, practice, and policy in future. 
 
9.5 Final conclusion 
This was the first project, to the researcher’s knowledge, to explore the utility of a lung 
cancer risk prediction model in the context of smoking cessation. A mixed methods 
approach was adopted to primarily explore whether application of the LLP 
intervention was associated with follow-up smoking status and lung cancer risk 
perceptions. The LLP intervention was developed using the LLP risk model and 
involved calculation and communication of projected lung cancer risk, based on both 
smoking and non-smoking behaviour. Factors implicated in smoking cessation success 
and smoking-related risk perceptions were also explored as part of the PhD thesis. 
 
The key finding of the current project was that application of the LLP intervention was 
associated with follow-up smoking status among baseline former smoker but not 
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among baseline current smokers. Furthermore, the LLP intervention had no significant 
effect on any of the follow-up lung cancer risk perceptions. Aspects of the health 
behaviour model, the TTM (J. O. Prochaska & DiClemente, 1983) were found to 
provide some explanation for the exhibited difference in effect between current and 
recent former smokers and the absence of an effect on follow-up risk perceptions, as 
the model suggests that different processes of change (such as, reinforcement 
management) are associated with different stages of behaviour change (such as, the 
maintenance stage). It should be noted, however, that there were few former smokers 
at follow-up in relation to the analysis of baseline current smokers; further research 
involving a larger sample size could help to identify further significant results. 
 
As previously described, a recruitment extension or implementation of a large trial 
would now be required to confirm the current results, as the present project resulted in 
a limited sample size. Further research would also benefit from inclusion of a measure 
exploring prolonged abstinence and biochemical verification of self-reported smoking 
status. If further research can validate the results of the current project, the LLP 
intervention could be feasibly delivered within SSS, particularly as it would incur little 
cost or time to deliver. Ultimately, this could result in improvements in smoking 
cessation rates or sustained abstinence, which would subsequently reduce smoking-
related disease and deaths. 
 
A review of the literature suggested that perceived personal lung cancer risk might 
have been predicted by several baseline participant characteristics; in particular, age 
and smoking status were found to be strong predictors. The qualitative research 
component complemented the quantitative results, providing further support for an 
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association between age and risk perception, in addition to identifying several other 
factors implicated in smoking-related risk perception. These findings provide detail 
regarding the role that risk perception plays in smoking behaviour and demonstrate 
the complexity of risk perception. A better understanding of risk perception will 
ultimately inform the development of risk communication tools. 
 
An extensive range of factors implicated in smoking cessation success were also 
derived from both quantitative and qualitative research components, including age, 
marital status, living with another smoker, baseline quit duration, lung cancer risk 
perceptions, motivation, self-efficacy and self-doubt, self-regulation, smoker identity, 
perceived benefits of quitting, social norms, stigma, and various aspects of SSS. The 
wide variation in factors identified demonstrates how smoking is a highly complex 
addiction, for which there is little consensus on the extent to which any single 
contributing factor can effectively explain addictive behaviours (Ross & Kincaid, 
2010). Future research should continue to endeavour to understand addiction, as new 
theories and addiction models continue to emerge (Westermeyer, 2013); doing so, will 
better inform tobacco control knowledge, practice and policy, which will ultimately, 
enhance smoking cessation rates. 
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Appendix A. Processes of change implicated in the health behaviour model, the 
Transtheoretical Model of Change (TTM) 
 
The ten processes of change are defined as follows (Velicer, Prochaska, Fava, 
Norman, & Redding, 1998): 
 
1. Consciousness raising: Becoming increasingly aware of the causes, 
consequences and treatment of the problematic behaviour. Interventions that 
may encourage awareness can include feedback, education, confrontation, 
interpretation, bibliotherapy, and media campaigns. 
 
2. Dramatic relief: Increased emotional experiences, whereby reduced affect may 
follow if appropriate action is accomplished. Psychodrama, role playing, 
grieving, and personal testimonies, are all examples of techniques that can 
induce emotional experiences. 
 
3. Environmental re-evaluation: Combination of cognitive and affective 
assessments regarding the impact of the individual’s behaviour upon their 
social environment e.g. the impact of drinking alcohol on others. Re-
assessments can be induced through empathy training, documentaries, and 
family interventions. 
 
4. Social liberation: Increased social opportunities or alternatives for non-
problematic behaviours. Advocacy, empowerment procedures, and 
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appropriate policies can provide increased opportunities, particularly for those 
who have experienced deprivation or oppression. 
 
5. Self-re-evaluation: Combination of cognitive and affective assessments 
regarding the individual’s self-image, whether that be with the problematic 
behaviour or without. Value clarification, healthy role models, and imagery, 
are all strategies that may encourage self-re-evaluation. 
 
6. Stimulus control: Removal of cues that may prompt the problematic behaviour 
or adding prompts for healthy alternatives to the behaviour. Avoidance, 
environmental re-engineering, and self-help groups can be utilised as a means 
of stimulus control. 
 
7. Helping relationships: Experiencing caring, accepting, trusting and supportive 
relationships. Sources of social support can vary from family members to 
counsellor support. 
 
8. Counterconditioning: Learning and developing new, healthier behaviours in 
replacement of the problematic behaviour. Useful strategies to enforce 
counterconditioning may include learning relaxation techniques for stress, or 
developing assertion techniques to counter peer pressure. 
 
9. Reinforcement management: Implementation of punishment and rewards for 
enforcing certain behaviours, whether they are implemented by the individual 
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or by others. Procedures for reinforcement can include contingency contracts, 
positive self-statements, and group recognition. 
 
10. Self-liberation: Often regarded as willpower, self-liberation refers to one’s 
belief in their ability to change, and commitment to act on their belief. Self-
liberation has been found to be enhanced by multiple rather than single choices, 
such as New Year’s resolutions and public testimonies. 
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Appendix B. Roy Castle FagEnds (RCFE) e-mail communication regarding service 
cessation rates 
E-mail communication removed as contains personal contact details for RCFE staff.  
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Appendix C. List of Roy Castle FagEnds (RCFE) drop-in session locations 
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Appendix D. Participant information sheet
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Appendix E. Consent form 
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Appendix F. Baseline questionnaire 
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Appendix G. Control leaflet 
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Appendix H. Follow-up questionnaire 
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Appendix I. Follow-up letter 
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Appendix J. Interview schedule 
 
1. For some people, there are lots of reasons to quit smoking but there can also 
be plenty of barriers and challenges too – tell me about how this is for you and 
your experiences. 
2. Have you tried to quit in the past? If yes, when and what do you think triggered 
you to start smoking again? Do you feel that anything has changed this time? 
3. If no, what made you decide to quit smoking this time? 
4. How did you react when you were given the information on lung cancer risk? 
What kind of feelings or emotions did you experience? 
5. (Recap results with participant) Did you expect your risk to be this level if you 
carried on smoking? Why do you think you felt like that? 
6. (Recap results with participant) Did you expect your risk to be this level if you 
quit smoking? Why do you think you felt like that? 
7. Has receiving the lung risk information affected your motivation to quit 
smoking? Do you feel more or less motivated? In what ways? 
8. How did you feel about the way the information was presented to you? 
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Appendix K. Ethical Approval 
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Appendix L. PhD researcher’s NIHR Good Clinical Practice certificate 
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Appendix M. Variable transformation 
 
This appendix describes some of the questionnaire variables, which were transformed 
due to low cell frequencies. In cases whereby low cell frequencies exist, it is preferable 
to transform the data to avoid low cell frequencies and therefore, enable the 
development of robust regression models (A. Field, 2013).  The reformed variables 
are referred to throughout the thesis results; this appendix simply highlights the 
frequencies in relation to the original variables. 
 
Firstly, socio-demographic variables were addressed. Table 17 displays the list of 
socio-demographic variables selected for recoding due to low cell frequencies, 
including ethnicity, marital status, highest educational attainment, and socio-economic 
status. The method of ethnicity and highest educational attainment recoding has been 
previously adopted elsewhere (Sherratt et al., 2015). Ethnicity was transformed into 
two values: (1) White (White British, White Irish, and White Other); (2) Other (Black 
British, Black Caribbean, Black African, Black Other, Asian British, Asian Indian, 
Asian Other, Asian Pakistani, Ethnic Chinese, Ethnic Other, Mixed African, Mixed 
Asian, Mixed Caribbean, Mixed Other, and Other). 
 
The variable levels for highest educational attainment were recoded into the following 
two groups: (1) Basic or no qualifications (i.e. General Certificate of Secondary 
Education level [GCSE] or below) (None, 1-5 O Levels/GCSEs, or 5+ O 
Levels/GCSEs); (2) Higher qualifications and other (1 A level, 2+ A levels, First 
degree, Higher degree, NVQ 1, NVQ 2, NVQ 3, NVQ 4-5/HNC/HND, Professional 
qualification, and Other).  
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Table 17. Original values for socio-demographic variables among follow-up datasets 
Baseline variable Baseline current smokers 
(n = 297) 
Baseline recent former smokers  
(n = 216) 
Ethnicity †   
 White British 260 (88.4) 192 (89.3) 
 White Irish 6 (2.0) 4 (1.9) 
 White Other 5 (1.7) 1 (0.5) 
 Black British 0 (0.0) 0 (0.0) 
 Black Caribbean 0 (0.0) 0 (0.0) 
 Black African 0 (0.0) 2 (0.9) 
 Black Other 7 (2.4) 5 (2.3) 
 Asian British 0 (0.0) 0 (0.0) 
 Asian Indian 0 (0.0) 0 (0.0) 
 Asian Other 0 (0.0) 1 (0.5) 
 Asian Pakistani 2 (0.7) 0 (0.0) 
 Ethnic Chinese 0 (0.0) 0 (0.0) 
 Ethnic Other 0 (0.0) 1 (0.5) 
 Mixed African 2 (0.7) 0 (0.0) 
 Mixed Asian 0 (0.0) 2 (0.9) 
 Mixed Caribbean 3 (1.0) 4 (1.9) 
 Mixed Other 1 (0.3) 1 (0.5) 
 Other 8 (2.7) 0 (0.0) 
Marital status †   
 Single 157 (53.2) 92 (43.0) 
 Married 50 (16.9) 57 (26.6) 
 Living together 44 (14.9) 27 (12.6) 
 Divorced/separated 33 (11.2) 34 (15.9) 
 Other 5 (1.7) 3 (1.4) 
 Widowed 6 (2.0) 1 (0.5) 
Highest educational attainment†  
 None 55 (19.0) 43 (20.0) 
 1-5 O Levels/GCSEs 66 (22.8) 56 (26.0) 
 5+ O Levels/GCSEs 15 (5.2) 15 (7.0) 
 1 A level 5 (1.7) 2 (0.9) 
 2+ A levels 17 (5.9) 5 (2.3) 
 First degree 20 (6.9) 11 (5.1) 
 Higher degree 6 (2.1) 5 (2.3) 
 NVQ 1 6 (2.1) 3 (1.4) 
 NVQ 2  25 (8.6) 22 (10.2) 
 NVQ 3 25 (8.6) 14 (6.5) 
 NVQ 4-5/HNC/HND 13 (4.5) 14 (6.5) 
 Professional Qualification 15 (5.2) 10 (4.7) 
 Other 22 (7.6) 15 (7.0) 
Socio-economic status †   
 Most deprived 255 (86.1) 182 (84.3) 
 Above average 24 (8.1) 25 (11.6) 
 Average 15 (5.1) 8 (3.7) 
 Below average 2 (0.7) 1 (0.5) 
 Least deprived 0 (0.0) 0 (0.0) 
† Figures do not equate to 297 and 216, in the respective baseline current smokers 
and baseline recent former smokers datasets, due to some missing data 
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It was also necessary to recode marital status, due to several low cell frequencies. 
Three levels were defined, as follows: (1) Other (Divorced, Separated, Other, and 
Widow); (2) Single (Single), and; (3) Married or living together (Married, Living 
together). The distribution in regards to socio-economic status was additionally 
uneven, with a number of low cell frequencies. It was therefore necessary to recode 
socio-economic status into two categories: (1) Most deprived (Most deprived); (2) 
Least deprived (Above average, Average, Below average, Least deprived). 
 
All variables associated with lung cancer risk perception were additionally reformed 
due to low cell frequencies. Table 18 provides the frequencies among lung cancer risk 
perception variables with low cell frequencies, prior to transformation. 
Transformation of lung cancer risk perceptions were considered by exploring both 
baseline and follow-up lung cancer risk perceptions across both follow-up datasets. It 
was necessary to reform repeated measure variables at baseline and follow-up to 
ensure consistency. Again, the reformed variables are referred to throughout the thesis 
results. 
 
Firstly, perceived personal lung cancer risk was recoded. The results displayed that 
the cell frequencies for “Very low” and “Very high” were considerably low in 
comparison to some other levels. The variable levels were therefore reduced to the 
following three levels: (1) Low (Very low, Low); (2) Moderate (Moderate); (3) High 
(High, Very high). 
 
Secondly, perceived average smoker lung cancer risk levels were recoded, as few 
participants responded to a number of the lower levels, particularly at follow-up. The 
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variable levels were therefore recoded into three levels: (1) “Very low to moderate” 
(Very low, Low, Moderate); (2) Somewhat high (Somewhat high); (3) Very high 
(Very high). 
 
Thirdly, perceived relative risk of lung cancer was recoded, as few follow-up 
participants viewed relative risk as “About the same as a non-smoker”. The five levels 
were recoded into four, including: (1) About the same to a little higher than a non-
smoker (About the same risk as a non-smoker, A little higher risk that a non-smoker); 
(2) Twice as high risk than a non-smoker (Twice as high risk than a non-smoker); (3) 
Five times higher risk than a non-smoker (Five times higher risk than a non-smoker); 
(4) Ten times higher risk than a non-smoker (Ten times higher risk than a non-smoker). 
 
Fourthly, lung cancer worry was considered. A limited number of cell frequencies 
were apparent in regard to the level, “All the time” among follow-up participants. The 
variables levels were therefore recoded into three levels, as follows: (1) Rarely or 
never (Rarely or never); (2) Sometimes (Sometimes); (3) Often to all the time (Often, 
All the time). 
 
Lastly, perceived lung cancer survival was investigated. The final level for perceived 
lung cancer survival had a substantially low frequency of cells and therefore, the five 
variable levels were combined into four levels, as follows: (1) Less than three quarters 
(Less than three quarters); (2) About a quarter (About a quarter); (3) About half (About 
half); (4) About three quarters to nearly all (About three quarters, Nearly all).   
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Appendix N. Initial proportional odds (PO) regression model for prediction of 
baseline perceived personal lung cancer risk 
 
Baseline variable Odds 
(95% CI) 
Lower 
(95% CI) 
Upper 
(95% CI) 
P value 
Age 1.026 1.009 1.043 0.003* 
Ethnicity    0.227 
 Other 0.656 0.331 1.300  
 (base = White)     
Smoking status    p<0.001* 
 Former 0.344 0.238 0.498  
 (base = Current)     
Age started smoking 0.983 0.943 1.024 0.418 
FTND 1.053 0.974 1.139 0.193 
Perceived average smoker lung cancer risk   
 Somewhat high 3.094 1.846 5.187 p<0.001* 
 Very high 2.545 1.557 4.161 p<0.001* 
 (base = Very low to moderate)     
Perceived relative risk of lung cancer    
 Twice as high risk 2.162 1.258 3.715 0.005* 
 Five times higher risk 1.356 0.787 2.336 0.273 
 Ten times higher risk 1.091 0.609 1.957 0.769 
 (base = About the same to a little 
higher risk) 
    
Lung cancer worry     
 Sometimes 1.292 0.816 2.045 0.275 
 Often or all the time 1.116 0.734 1.696 0.607 
 (base = Rarely or never)     
FTND = Fagerström Test of Nicotine Dependence, * p < 0.05 
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Appendix O. Initial binary logistic regression model for prediction of baseline 
smoking status 
 
Baseline variable Odds 
(95% CI) 
Lower 
(95% CI) 
Upper 
(95% CI) 
P-value 
Age 1.031 1.009 1.054 0.006* 
Marital status     
 Single 1.586 0.992 2.538 0.054 
 Married or living together 1.306 0.708 2.410 0.394 
 (Base = Other)     
Highest educational attainment    0.438 
 Higher qualifications  0.848 0.559 1.286  
 (Base = Basic or no qualifications)     
Living with another smoker    0.018* 
 Yes 0.572 0.360 0.908  
 (Base = No)     
FTND 1.103 0.981 1.241 0.100 
Cigarettes per day 0.850 1.002 0.978 1.028 
Perceived personal lung cancer risk    
 Moderate 0.513 0.304 0.866 0.013* 
 High 0.208 0.115 0.374 p<0.001* 
 (Base = Low)     
Perceived average smoker lung cancer risk    
 Somewhat high 1.498 0.835 2.688 0.176 
 Very high 1.027 0.551 1.917 0.932 
 (Base = Very low to moderate)     
Perceived relative risk of lung cancer    
 Twice as high risk 1.669 0.844 3.299 0.141 
 Five times higher risk 1.525 0.799 2.912 0.201 
 Ten times higher risk 2.570 1.351 4.888 0.004* 
 (Base = About the same to a little 
higher risk) 
    
Lung cancer worry     
 Sometimes 0.758 0.468 1.227 0.260 
 Often or all the time 0.574 0.334 0.985 0.044* 
 (Base = Rarely or never)     
FTND = Fagerström Test of Nicotine Dependence, * p < 0.05 
  
400 
 
Appendix P. Initial binary logistic regression model for prediction of follow-up 
smoking status among baseline current smokers 
 
Baseline variable Odds 
(95% CI) 
Lower 
(95% CI) 
Upper 
(95% CI) 
P-value 
Ethnicity    0.028* 
 White 3.223 1.137 9.134  
 (Base = Other)     
Socio-economic status    0.105 
 Most deprived  0.429 0.154 1.193  
 (Base = Least deprived)     
Age started smoking 1.042 0.975 1.114 0.222 
Living with another smoker    0.114 
 Yes 0.595 0.312 1.134  
 (Base = No)    0.079 
FTND 0.886 0.775 1.014  
Perceived relative risk of lung cancer    
 Twice as high risk 1.301 0.375 4.510 0.679 
 Five times higher risk 2.200 0.786 6.157 0.133 
 Ten times higher risk 4.212 1.550 11.445 0.005* 
 (Base = About the same to a little 
higher risk) 
    
FTND = Fagerström Test of Nicotine Dependence, * p < 0.05 
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Appendix Q: List of publications and conference abstracts 
Sherratt, F., Marcus, M. W., Field, J. K., & Robinson, J. (2016). Application of a lung 
cancer risk prediction model for the promotion of smoking cessation. Manuscript 
under review in American Journal of Health Promotion. 
 
Purpose. The current project sought to examine whether delivery of lung cancer risk 
projections (calculated using the Liverpool Lung Project [LLP] risk model) predicted 
follow-up smoking status. Design. Two single-blinded randomised controlled trials 
(RCTs). Setting. Stop Smoking Services in Liverpool (UK). Subjects. Baseline current
 smokers (N = 297) and baseline recent former smokers (N = 216) were 
recruited. Intervention. Participants allocated to treatment groups were provided with 
personalised lung cancer risk projections, calculated using the LLP risk model. 
Measures. Baseline and follow-up questionnaires explored socio-demographics, 
smoking behavior and lung cancer risk perceptions. Analysis. Bivariate analyses 
identified significant differences between treatment groups and logistic regression 
models were developed to investigate the treatment effect on the outcome variables. 
Results.  Lung cancer risk projections were not found to predict follow-up smoking 
status in the trial of baseline current smokers; however, they did predict follow-up 
smoking status in the trial of baseline recent former smokers (OR 1.91, 95% CI 1.03 
3.55). Conclusion. The current study suggests that lung cancer risk projections may 
promote abstinence among individuals who have quit smoking, but not motivate 
smokers to quit. 
 
Sherratt, F., Chen, Y., Field, J. K., & Robinson, J. (2014, Jul). Exploring reactions to 
risk and uncertainty in the context of smoking and lung cancer. Paper presented at the 
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XVIII International Sociology Association World Congress of Sociology, Yokohama, 
Japan. 
 
Research examining the sociology of diagnosis has demonstrated how the provision 
of a clinical diagnosis from a health professional can promote identification of 
illness or disease, facilitate behaviour change, and enhance adoption or resistance of 
illness identities (Jutel and Nettleton, 2011). Further examination of such frameworks 
could contribute towards achieving a richer understanding of health communication 
compliancy, thus enabling better management or avoidance of ill health and disease. 
The current study examines such frameworks within the context of a Stop Smoking 
Service (FagEnds, Liverpool) and the study has been designed to replicate a 
recognised model of diagnosis. However, rather than a clinical diagnosis, smokers 
receive a personalised lung cancer risk assessment – essentially providing them with 
a diagnosis of uncertainty. The primary aim of this study will be to ascertain whether 
provision of personalised lung cancer risk information alongside health advice, will 
enhance smoking cessation. This mixed-method paper will disseminate the 
findings of a randomised controlled study consisting of ~300 smokers, in which the 
control arm receive generalised lung cancer risk information and the intervention arm 
receive a personalised lung cancer risk assessment, using the Liverpool Lung Project 
Risk Model  (Cassidy et al., 2008). It is anticipated that provision of personalised lung 
cancer risk information may encourage behaviour change i.e. smoking cessation and 
long-term maintenance of this change at six-month follow-up. In support of the 
aforementioned quantitative survey, qualitative interviews will also be conducted with 
a selection of participants (N = 30), which aims to provide further explanation as to 
the impact of receipt of a diagnosis of uncertainty and the subsequent behaviour and 
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attitudes of which it may entail. Overall, it is anticipated that the findings will 
contribute towards our understanding of the sociology of diagnosis and may help to 
inform the development of future health risk communications. 
 
Sherratt, F., Marcus, M., Robinson, J., & Field, J. K. (2014, Apr). Do health risk 
perceptions influence smoking cessation? Poster session presented at the University 
of Liverpool Postgraduate Poster Day 2014, Liverpool, UK. 
 
Research examining health risk perceptions and smoking cessation has rendered 
mixed results regarding the strength of this relationship. A better understanding of 
this relationship could inform effective health risk communication among smokers. 
This poster presents preliminary results from two aspects of the PhD: questionnaires 
(N = 521) and telephone interviews (N = 24), both with smokers. Although results 
highlighted the complexity of the relationship, they suggested that health risk 
perceptions were a smoking cessation contributor. The final component of the PhD - 
six-month follow-up questionnaires, will enhance our understanding of the impact of 
risk perceptions on smoking cessation, and help to inform future risk communications.  
 
Sherratt, F., Chen, Y., Marcus, M., Robinson, J., & Field, J. K. (2013, Nov). Smokers' 
lung cancer risk perceptions and smoking cessation success: A longitudinal study. 
Poster session presented at the 9th National Cancer Research Institute (NCRI) Cancer 
Conference, Liverpool, UK. 
 
Background. In the UK, lung cancer accounts for 6% of all deaths (Office for National 
Statistics, 2011) and smoking is responsible for 86% of lung cancer incidence (Parkin, 
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2011). Thus, smoking cessation has been highlighted as the most effective strategy to 
reduce lung cancer risk (Thun, 2010). One suggested explanation as to why individuals 
continue to smoke despite being informed of the potential harms, is due to individuals
 underestimating personal risk of smoking-related disease (e.g. lung cancer); 
known as unrealistic optimism (Weinstein, 1983, 1984). Cross-sectional surveys 
have demonstrated an association between unrealistic optimism and lower 
motivation to quit smoking (Dillard, McCaul, & Klein, 2006; Weinstein, Marcus, & 
Moser, 2005). The current study aims to examine the role and impact of unrealistic 
optimism for smokers attending stop-smoking services, by utilising a longitudinal 
design. Methodology. Smokers (N=600) will be recruited from Roy Castle FagEnds 
stop-smoking services across Liverpool, currently contemplating or actively quitting 
smoking. Baseline and six-month follow-up questionnaires will be completed, 
whereby the following will be measured: smoking status, lung cancer risk perceptions, 
and objective lung cancer risk (calculated using the validated Liverpool Lung Project 
lung cancer risk prediction model [Cassidy et al., 2006; Raji et al., 2012]). Univariate 
statistics and multivariate linear regression models will be used to analyse the results. 
Results. Preliminary results utilising the current sample of 39 participants, consisting 
of 46% males and 54% females, revealed the median participant age as 43 years (IQR 
= 31-51). All participants will be classified as high risk of lung cancer if they continue 
to smoke, however, 64%  perceived their risk of lung cancer as lower than the 
average smoker. The poster will present further results based on the complete sample 
(N=600). Conclusions. By conducting this study, a better understanding of the 
relationship between lung cancer risk perceptions and smoking cessation success is 
likely to be achieved. The findings from this study will contribute towards researchers’ 
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understanding of smoking cessation processes and could potentially inform future 
smoking cessation interventions. 
 
Sherratt, F., Robinson, J., & Field, J. K. (2013, Sep). The significance of lung cancer 
risk perceptions among individuals quitting smoking: A mixed-method study. Poster 
session presented at the British Sociological Association Medical Sociology Annual 
Conference, York, UK. 
 
It is often assumed that individuals will engage in health behaviour change, at which 
point they perceive their risk as reasonably high; this is frequently advocated by 
effective risk communication literature (Fischhoff, 1998) and many health behaviour 
models, such as the Health Belief Model (Rosenstock, 1966). Although some studies 
support the relationship between risk perceptions and health behaviours (Brewer et al., 
2007), others suggest a substantially weaker association (Gerrard, Gibbons, & 
Bushman, 1996). It has been suggested that this may be due to methodological 
shortfalls, such as utilising cross-sectional, correlational designs to examine the 
association, alongside inadequate knowledge of potentially moderating factors (Klein, 
Zajac, & Monin, 2009). The present study incorporates qualitative and quantitative 
methods to investigate how relevant and fluid lung cancer risk perceptions can be in 
the process of smoking cessation; it examines their influence on smoking cessation 
and the extent to which lung cancer risk communication can be effective in facilitating 
cessation. Current and former smokers (N=30) will be recruited from Roy Castle 
FagEnds smoking cessation services across Liverpool. Participants will initially 
complete a psychosocial questionnaire, measuring lung cancer risk perceptions. 
Subsequently, they will be provided with objective lung cancer risk calculations, based 
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on risk factors personal to them, by utilising the Liverpool Lung Project (LLP) Risk 
Model (Cassidy et al., 2008). Lastly, participants will be requested to complete a semi-
structured interview, exploring the nature of risk perceptions relevant to smoking 
cessation and reactions to the provision of lung cancer risk information. The study 
protocol and the results will be discussed in relation to their implications for smoking 
cessation services and campaigns.  
 
Sherratt, F., Chen, Y., Field, J. K., & Robinson, J. (2013, May). The impact of 
providing individualised lung cancer risk projections on smoking cessation 
success (LCRSC). Poster session presented at the Liverpool Cancer Research UK 
Centre Annual Meeting, Liverpool, UK. 
 
In the UK, lung cancer accounts for 6% of all deaths (Office for National Statistics, 
2011) and smoking is responsible for 86% of lung cancer cases (Parkin, 2011). In the 
context of smoking, unrealistic optimism is the underestimation of one’s own risk of 
a harmful outcome in comparison to the average smoker; an attribute associated with 
lower motivation to quit smoking (Dillard, McCaul, & Klein, 2006). LCRSC is a 
randomised controlled study which aims to examine whether providing smokers with 
individualised, lung cancer risk projections (using the Liverpool Lung Project Risk 
Model [Cassidy et al., 2008]) alongside standard care, reduces the frequent 
discrepancy between perceived and objective risk, thus enhancing smoking cessation. 
Participants (N=700) will be recruited from Roy Castle FagEnds smoking cessation 
services across Liverpool and smoking status will be recorded at baseline and 6-month 
follow-up. The poster will present the study protocol and the potential outcomes will 
be discussed in relation to their implications for smoking cessation treatment. 
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Sherratt, F., Chen, Y., Hyde. R., Field, J. K., & Robinson, J. (2012, Nov). Smoking 
and attitudes to lung cancer: A review of the literature. Poster session presented at the 
8th National Cancer Research Institute (NCRI) Cancer Conference, Liverpool, UK. 
 
Background. Smoking cessation has been highlighted as the single most effective 
strategy to reduce lung cancer risk among the 1.3 billion smokers worldwide (Thun et 
al., 2010). Despite 63% of smokers in the UK reporting a willingness to quit smoking 
(Robinson and Harris, 2011) and NICE producing evidence-based guidance on 
effective smoking cessation strategies, smoking cessation success rates stand at a mere 
1-5% of smokers per year (Song et al., 2002). It is clearly necessary to consider 
alternative strategies to motivate smokers to quit. Methods. Here we report the findings 
from a systematic review of the literature, designed to further explore the relationship 
between smoking and attitudes towards lung cancer. We consider gaining a greater 
understanding of the associations between variables and their contribution towards 
differences in attitudes towards lung cancer risk, and uptake of smoking cessation 
services and/or quitting. Results. Perceived individual risk has been found to correlate 
with motivation to quit smoking (Tessaro et al., 1997), which in turn is associated with 
smoking cessation (Boardman et al., 2005). Perceived risk of lung cancer is elevated 
among smokers (Rutten et al., 2011), yet smokers have been found to underestimate 
their personal risk of developing lung cancer when compared to other smokers 
(Weinstein et al., 2005). Furthermore, current smokers are more likely to attribute lung 
cancer to smoking-independent factors, such as inheritance (Kaphingst et al., 2009), 
which may adversely affect perceived risk and cessation motivation. Conclusions. The 
outcome of this review could potentially inform future smoking cessation 
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interventions within the Liverpool Lung Project in conjunction with the Roy Castle 
smoking cessation service (http://www.stopsmoking.org.uk/) and contribute to the 
reduction of future lung cancer incidence. 
 
 
